data_2ebu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ebu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.612 0.72 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 129.7 18.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -86.2 92.34 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -114.67 -139.68 7.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -91.64 -175.09 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.778 0.323 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.71 -20.4 13.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -127.09 32.83 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 28.1 p -75.55 -17.4 60.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.96 10.14 10.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -68.79 116.32 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.05 -21.55 24.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 24.2 mt -90.07 150.14 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.48 148.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.4 148.53 49.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.05 108.09 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 25.8 mt -91.28 123.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.7 t -120.65 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.25 -153.86 32.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -127.13 154.55 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.1 mt -132.79 136.51 46.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -60.36 -63.62 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.808 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 419' ' ' GLU . 23.0 p -35.92 -56.65 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -143.15 155.75 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.16 160.56 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -39.84 -37.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.58 -55.13 8.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -51.16 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.8 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -58.3 -57.58 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.1 p -48.9 -30.52 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.51 -61.72 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.7 mt -51.22 -34.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.5 -28.84 46.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -66.15 -14.95 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 90.7 m-85 -110.5 -9.42 14.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 117.93 -24.84 8.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.9 157.56 21.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -106.63 156.29 18.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.5 t -134.3 116.68 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.6 t -136.78 134.94 37.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.34 45.99 3.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -160.12 135.46 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.79 130.04 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.3 t -130.91 173.42 10.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -76.43 -19.58 57.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -88.98 -16.77 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 96.7 m -48.05 127.58 12.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.99 -39.8 9.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 73.1 m-85 -144.64 150.77 37.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 6.4 tp -117.98 107.89 14.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.61 106.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 6.6 mtt -92.11 165.99 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -152.26 -118.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 453' ' ' ASP . 11.4 ptm180 -119.49 173.22 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.8 t70 34.54 38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 452' ' ' ARG . 61.5 m -99.82 151.9 20.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -77.08 163.24 52.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.442 ' H ' ' NE2' ' A' ' 456' ' ' GLN . 2.3 pm0 -92.27 -12.31 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 1.8 t -69.48 -34.77 74.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -58.03 -43.79 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.426 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 86.1 p -66.36 -52.42 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.1 -64.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -54.21 -49.12 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -47.77 -58.33 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.25 -50.17 67.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -47.33 -55.83 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.2 mt -66.54 -26.11 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.55 53.05 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 47.5 m -110.4 136.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.503 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -79.77 117.81 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 15.5 mt -89.7 130.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.416 HD11 ' C ' ' A' ' 474' ' ' GLY . 21.2 pt -147.25 166.59 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 472' ' ' GLU . 0.4 OUTLIER -107.59 171.11 7.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 473' ' ' ASP . 2.6 pp20? -37.21 -43.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 472' ' ' GLU . 16.2 t70 -60.8 -51.99 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . 0.416 ' C ' HD11 ' A' ' 470' ' ' ILE . . . -55.65 -35.21 61.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.16 -47.32 83.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.27 -53.05 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -53.14 -39.85 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.28 -15.54 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.513 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 78.9 mt -90.18 -19.3 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.6 -20.97 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.5 p -91.86 -38.32 12.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 40.7 mmm -67.29 143.6 97.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.523 0.677 . . . . 0.0 110.908 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.81 -178.42 2.35 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.73 166.05 19.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.436 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.0 mttm . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.894 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.429 ' CG2' ' HD2' ' A' ' 400' ' ' PRO . 27.5 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.627 0.727 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 399' ' ' ILE . 54.1 Cg_endo -69.75 117.93 5.38 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.65 2.234 . . . . 0.0 112.373 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -70.28 108.79 4.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -129.96 -146.29 5.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -79.34 -175.24 4.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.65 -25.59 12.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -124.31 30.47 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 27.5 p -70.38 -16.31 62.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 61.0 mt -121.12 9.21 10.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -65.79 133.79 51.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 92.35 -33.52 4.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.54 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.464 HD12 ' CE ' ' A' ' 482' ' ' MET . 12.4 mt -79.06 139.94 38.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 81.9 mt -105.07 156.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 411' ' ' ILE . 91.5 m-85 -142.64 150.42 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.39 99.12 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 45.3 mt -81.81 130.99 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.455 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.6 t -128.88 145.98 51.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.35 42.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.89 152.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 111.107 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.419 ' CD2' ' HA3' ' A' ' 451' ' ' GLY . 7.1 mt -122.92 173.85 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.73 -69.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 60.8 p -40.58 -44.23 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.469 HD11 ' CB ' ' A' ' 426' ' ' ALA . 2.0 pp -142.08 176.98 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -122.88 164.33 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 -42.49 -31.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.83 -68.61 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -44.67 -53.06 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.469 ' CB ' HD11 ' A' ' 421' ' ' ILE . . . -52.53 -42.52 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -58.46 -50.35 74.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 21.1 p -54.59 -34.89 62.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.55 -65.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.411 HG21 ' C ' ' A' ' 435' ' ' GLY . 55.2 mt -47.31 -40.02 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -76.08 -31.87 58.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.57 -16.08 62.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 70.9 m-85 -113.34 3.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.89 -32.17 7.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.411 ' C ' HG21 ' A' ' 430' ' ' ILE . . . -47.77 163.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -116.23 156.43 26.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.9 t -130.7 128.01 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 149.86 41.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -89.72 9.17 78.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -127.91 137.24 52.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 46.6 t -87.9 108.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.2 m -110.49 -178.62 3.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.441 ' HA ' ' CD1' ' A' ' 465' ' ' LEU . 0.0 OUTLIER -77.59 -20.18 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -26.46 54.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 10.1 m -46.47 133.86 9.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 4.9 m-80 -102.47 -22.13 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 67.5 m-85 -156.01 155.11 32.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 469' ' ' ILE . 17.2 tp -125.41 111.63 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 34.3 t -93.57 107.05 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.455 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 26.8 mtm -110.39 175.78 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -158.55 -147.45 4.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.5 ptt180 -69.39 174.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.4 m-20 34.75 39.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.1 p -96.78 -177.6 3.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -143.83 174.55 24.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.445 ' H ' ' NE2' ' A' ' 456' ' ' GLN . 1.2 pm0 -97.24 24.7 6.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.354 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 15.1 t -86.08 -42.92 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.29 -39.62 28.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.0 p -71.46 -30.53 66.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -52.47 65.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.03 -28.39 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.38 74.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.73 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -45.81 -41.06 10.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 443' ' ' LYS . 11.6 mt -85.41 -24.03 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 103.5 51.05 1.0 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 59.1 m -100.56 138.9 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.152 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.402 ' CE ' ' HA ' ' A' ' 468' ' ' LYS . 0.3 OUTLIER -74.36 117.32 16.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 448' ' ' LEU . 34.0 mt -94.96 131.36 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.6 pt -142.84 174.23 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.62 178.97 4.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -41.06 -45.43 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.03 -55.08 24.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.28 -30.29 4.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.519 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.0 tp -67.92 -59.87 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.53 -42.85 45.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.949 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.89 -36.99 85.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.75 -22.9 66.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.466 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 58.6 mt -83.43 -28.3 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -88.86 -22.3 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.7 p -91.23 -47.87 7.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.464 ' CE ' HD12 ' A' ' 410' ' ' LEU . 11.9 mmm -59.61 139.39 89.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.504 0.669 . . . . 0.0 110.908 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.74 -165.18 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.46 157.09 17.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.637 0.732 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 117.7 5.24 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -76.78 95.37 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -108.54 -152.37 15.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.472 ' CB ' ' HA2' ' A' ' 484' ' ' GLY . . . -70.9 -177.13 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 2.8 pt-20 -101.05 -29.15 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.468 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 67.7 m-20 -122.14 20.11 10.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 19.9 p -59.26 -25.64 64.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 68.0 mt -108.36 14.9 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.67 143.3 34.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 86.33 -16.6 43.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.1 153.2 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 95.4 mt -113.49 155.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.416 ' N ' ' CG2' ' A' ' 411' ' ' ILE . 91.1 m-85 -144.29 135.31 25.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.84 100.37 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.88 121.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 130.8 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.15 -152.27 22.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.81 152.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 1.8 mt -132.25 159.4 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.24 -65.19 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 10.6 t -39.74 -31.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -161.2 160.88 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.12 170.32 8.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -47.95 -20.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -92.56 -65.86 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -42.07 -37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.66 -42.33 67.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -58.76 -58.58 7.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 28.1 t -47.07 -36.76 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -64.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 63.4 mt -49.89 -44.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.16 -32.65 73.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -66.06 -17.75 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.464 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 57.0 m-85 -108.21 1.57 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.02 -29.65 10.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.25 153.34 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 437' ' ' VAL . 9.3 tmtm? -105.78 146.92 29.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.465 ' N ' ' HD3' ' A' ' 436' ' ' LYS . 99.5 t -122.45 121.34 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 9.0 t -139.44 143.82 37.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -91.24 44.96 2.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -163.56 121.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.78 126.45 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.6 m -128.49 169.12 14.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -68.32 -21.65 64.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -85.44 -7.05 59.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.6 m -61.26 127.37 31.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -97.3 -29.12 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -151.83 150.96 30.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 14.2 tp -119.76 108.85 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.43 105.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.2 mtt -80.27 168.98 18.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.23 -110.37 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 453' ' ' ASP . 14.7 mmt180 -125.66 172.39 9.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 452' ' ' ARG . 29.4 t0 34.56 39.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 96.6 p -83.64 165.88 18.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -113.31 130.29 9.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.49 -20.71 21.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 87.4 p -69.73 -30.24 67.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -63.11 -56.19 18.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.9 t -63.93 -45.96 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -40.3 -53.69 2.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -64.98 -35.57 81.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -61.66 -63.15 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.079 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.32 -41.39 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.54 69.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.5 -26.22 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.8 48.95 1.56 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 468' ' ' LYS . 19.8 m -111.49 145.68 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 467' ' ' THR . 27.4 mttp -84.24 142.43 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.953 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 25.9 mt -109.61 127.88 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.23 172.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 472' ' ' GLU . 51.0 m-20 -117.86 170.73 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 471' ' ' ASP . 6.7 pt-20 -35.92 -41.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.71 -51.44 62.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.31 -27.64 32.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 52.0 tp -69.76 -51.75 31.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.3 mt -52.26 -48.73 65.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.08 -36.7 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.18 -17.25 57.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.439 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 30.7 mt -88.56 -15.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -106.95 -15.29 14.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 20.9 p -97.82 -41.73 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 12.2 mmm -64.43 140.73 98.05 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.71 -173.26 0.68 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.698 2.265 . . . . 0.0 112.382 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.472 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -107.34 151.27 16.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.468 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 1.8 mptp? . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.1 mm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.58 0.705 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 125.98 12.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 0.0 112.303 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -107.02 -150.3 16.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 433' ' ' TYR . . . -78.95 -175.03 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -100.19 -27.78 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -123.07 31.4 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.97 -19.33 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.8 -5.94 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.19 126.39 27.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.11 -23.71 32.64 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.469 HD12 ' CE ' ' A' ' 482' ' ' MET . 15.0 mt -94.25 153.96 17.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 412' ' ' PHE . 81.8 mt -116.46 143.51 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 88.3 m-85 -134.48 146.23 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 93.9 t -121.08 112.79 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 87.4 mt -95.56 121.48 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.154 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.4 t -122.95 147.36 46.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.32 -154.16 47.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.17 142.19 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.96 140.24 48.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -47.63 74.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 78.6 p -50.86 -50.11 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 426' ' ' ALA . 1.2 pt -151.48 168.47 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -97.81 162.06 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -38.9 -45.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -65.21 -62.43 1.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -46.37 -62.98 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.452 ' CB ' HD12 ' A' ' 421' ' ' ILE . . . -52.38 -53.51 44.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -44.04 -53.35 6.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.4 t -49.88 -31.22 11.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.07 -60.06 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 72.6 mt -53.68 -40.03 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.08 -25.35 55.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -67.24 -20.01 65.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.486 ' CE2' HG22 ' A' ' 479' ' ' ILE . 60.4 m-85 -111.92 7.96 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.47 -38.38 3.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.501 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.29 156.54 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -110.14 148.23 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.54 123.11 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 12.0 t -137.61 161.68 35.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -102.24 22.9 36.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -143.53 140.63 30.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 458' ' ' LYS . 21.1 t -93.58 110.87 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.8 p -115.95 -175.66 2.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -70.35 -22.43 62.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -80.44 -17.54 51.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 18.2 m -58.53 139.38 55.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.51 -31.21 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.543 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 76.1 m-85 -149.48 140.58 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 10.9 tp -110.72 106.43 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.0 t -77.46 102.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.93 166.71 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -156.54 -126.79 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 mmt-85 -110.64 175.11 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.7 t0 34.41 38.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.9 p -83.39 118.29 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 457' ' ' SER . . . -82.53 24.06 5.22 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 455' ' ' GLY . 13.5 pt20 36.16 30.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 455' ' ' GLY . 17.3 t -80.66 -29.46 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 441' ' ' VAL . 23.2 mtmt -93.15 -22.68 18.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 93.0 p -69.51 -16.03 63.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.47 -62.76 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -62.7 -46.19 89.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -48.01 -56.12 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.18 66.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -77.96 -18.53 55.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.17 15.04 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.11 29.26 62.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 67.7 m -82.16 127.79 33.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.112 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -74.39 129.94 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 92.2 mt -102.79 121.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 29.7 pt -127.9 173.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.9 p30 -118.34 166.84 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.85 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 471' ' ' ASP . 4.9 pm0 -35.31 -32.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 471' ' ' ASP . 12.4 t0 -71.93 -53.74 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -51.62 -36.55 40.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.59 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 77.6 mt -52.84 -49.21 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -59.38 -41.59 89.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.53 -16.68 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.486 HG22 ' CE2' ' A' ' 433' ' ' TYR . 39.5 mt -89.24 -16.71 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -107.6 -13.66 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -100.48 -31.36 11.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.469 ' CE ' HD12 ' A' ' 410' ' ' LEU . 33.1 mmm -76.27 140.51 69.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.854 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.28 166.45 19.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.2 mttp . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.657 0.741 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 121.0 7.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.309 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -75.59 95.95 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -118.71 -133.46 4.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -100.05 -175.17 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.413 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 2.7 pt-20 -102.55 -23.7 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 73.5 m-80 -125.64 30.55 5.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 18.3 p -71.52 -19.26 62.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.407 HD11 ' CG1' ' A' ' 479' ' ' ILE . 84.4 mt -118.66 9.43 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.62 139.28 40.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.07 31.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.406 HD13 ' CE ' ' A' ' 482' ' ' MET . 12.3 mt -93.71 164.23 13.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.434 HD12 ' CG ' ' A' ' 444' ' ' LYS . 73.0 mt -123.33 145.05 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -131.44 155.03 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.422 HG22 ' CG2' ' A' ' 445' ' ' THR . 95.5 t -133.6 105.14 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 54.8 mt -85.93 133.1 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -134.4 130.52 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.177 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.05 -151.31 21.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.454 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.02 154.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.86 147.83 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.89 -58.81 3.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 30.1 t -42.34 -44.81 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.43 158.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 424' ' ' ASP . 15.1 mt-10 -99.58 159.77 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -38.14 -31.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 422' ' ' GLU . 0.2 OUTLIER -76.55 -64.64 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -43.39 -60.91 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -46.63 -45.96 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -54.67 -43.16 72.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -61.11 -38.36 86.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.4 -63.09 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 62.9 mt -45.96 -37.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.35 -34.7 48.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -56.45 -16.24 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.517 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 98.6 m-85 -115.3 -3.47 12.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.44 -45.48 1.28 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -41.18 141.2 1.13 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -102.37 160.44 14.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.36 119.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 12.5 t -124.37 166.44 15.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.7 50.58 0.77 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -170.96 124.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.23 111.69 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' SER . . . . . 0.411 ' HB3' ' CD ' ' A' ' 444' ' ' LYS . 12.9 t -126.67 -175.01 3.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -67.29 -53.52 29.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.434 ' CG ' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -50.76 -19.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 413' ' ' VAL . 35.8 m -62.73 123.7 19.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.401 ' CG ' HD23 ' A' ' 410' ' ' LEU . 8.9 m120 -87.29 -53.32 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 468' ' ' LYS . 57.1 m-85 -126.51 160.21 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 468' ' ' LYS . 10.5 tp -129.94 104.76 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -77.75 105.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.0 mmt -87.9 171.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -169.24 -127.52 0.93 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.0 mmp_? -92.46 167.15 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.3 t70 34.08 36.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 452' ' ' ARG . 54.5 p -69.75 127.19 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.99 139.95 27.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -64.57 -11.7 37.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.937 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 96.3 p -78.91 -27.11 43.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -66.66 -42.91 85.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 460' ' ' ASP . 33.7 p -81.29 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 459' ' ' SER . 0.3 OUTLIER -36.9 -57.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -60.33 -44.5 95.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 465' ' ' LEU . . . -54.46 -64.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -37.99 -52.74 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.93 76.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 462' ' ' ALA . 11.3 mt -92.32 23.11 4.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 40.12 60.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.501 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 20.9 m -110.99 136.15 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 447' ' ' TYR . 21.2 mttp -76.11 141.76 41.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 13.9 mt -118.57 141.67 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.8 pt -152.08 171.09 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -115.83 177.99 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 0.6 OUTLIER -45.75 -35.16 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 21.3 t0 -71.46 -52.08 20.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.91 -45.43 70.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.522 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 50.1 tp -50.55 -41.52 54.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.98 -51.35 62.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.467 ' O ' ' CG ' ' A' ' 482' ' ' MET . 14.5 mt -65.52 -17.04 64.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.517 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 62.5 mt -87.65 -17.46 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -103.97 -28.72 11.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.1 p -85.84 -25.38 26.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.134 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.467 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 63.7 mmm -82.02 140.68 46.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.76 -165.86 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.88 19.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.5 mttt . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 45.6 mm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -65.33 104.25 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.94 -152.11 8.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.436 ' CB ' ' HA2' ' A' ' 484' ' ' GLY . . . -88.0 -174.97 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -100.53 -26.94 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.465 ' O ' ' CE ' ' A' ' 485' ' ' LYS . 50.7 m-80 -123.23 27.32 7.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 26.5 p -68.43 -10.12 53.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.01 8.97 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . 0.43 ' CD ' ' OD1' ' A' ' 405' ' ' ASN . 14.9 tt0 -68.22 124.24 22.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.33 -29.49 12.25 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 482' ' ' MET . 72.2 mt -81.06 143.3 32.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 93.2 mt -109.15 144.53 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 38.5 m-85 -129.22 155.35 45.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.12 102.35 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 30.7 mt -84.27 126.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.6 t -132.31 118.43 19.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.47 -161.02 16.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.09 132.0 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.26 179.88 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.57 -42.55 6.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.5 m -63.52 -55.22 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.41 130.5 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.03 156.23 37.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 423' ' ' ARG . 0.8 OUTLIER -40.24 -35.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -49.09 -47.67 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.57 88.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.44 -57.6 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -46.94 -28.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.873 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.21 -53.13 7.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.99 -34.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.88 -29.42 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -61.64 -16.11 45.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.809 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 79.3 m-85 -114.12 -1.78 13.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 110.74 -36.53 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.46 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -44.52 148.68 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -101.2 160.89 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.6 t -137.35 108.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 8.9 t -128.73 150.08 50.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -95.14 50.89 1.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.71 147.42 25.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 54.7 t -99.18 101.75 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 85.0 p -123.19 175.25 6.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.47 -16.4 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -27.2 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.0 m -58.2 120.28 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.503 ' OD1' ' CE1' ' A' ' 447' ' ' TYR . 2.9 t-20 -91.83 -41.01 10.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE1' ' OD1' ' A' ' 446' ' ' ASN . 95.3 m-85 -130.12 156.11 45.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 11.2 tp -131.21 105.68 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.14 104.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.427 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 3.4 mmt -82.7 163.6 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.42 -134.95 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 1.1 mmp_? -87.9 163.27 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 17.4 t70 34.42 36.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 452' ' ' ARG . 3.2 m -83.49 116.32 22.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -59.55 128.36 46.72 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -51.26 -35.88 39.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 90.3 p -46.17 -47.32 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -43.51 -52.99 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.427 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 1.2 t -68.65 -61.05 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 22.8 t70 -38.09 -62.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -58.83 -33.59 70.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -62.93 -50.07 72.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.65 -55.6 27.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -46.97 -50.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.14 -28.76 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.77 48.71 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.521 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.1 m -104.33 150.09 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -90.54 133.04 35.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.1 mp -104.76 120.16 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.88 170.77 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 474' ' ' GLY . 0.9 OUTLIER -120.83 168.49 11.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 471' ' ' ASP . 12.1 pt-20 -35.05 -44.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.44 -43.49 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -58.97 -29.78 65.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.35 -49.34 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.01 -46.75 75.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.72 -40.73 80.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.22 -17.68 20.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.466 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 74.5 mt -86.91 -18.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -102.92 -25.93 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.8 p -84.69 -46.84 11.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.441 ' CE ' HD11 ' A' ' 410' ' ' LEU . 10.7 mmm -59.85 141.06 89.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.528 0.68 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.84 -170.31 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -118.11 153.27 17.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 405' ' ' ASN . 6.0 mtmm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.8 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.634 0.73 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.442 ' CD ' HD21 ' A' ' 476' ' ' LEU . 53.5 Cg_endo -69.81 120.31 7.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.631 2.221 . . . . 0.0 112.362 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -77.01 98.75 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -117.48 -152.25 9.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -84.6 -174.96 5.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -99.76 -21.42 15.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -126.74 31.55 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 22.6 p -72.68 -19.77 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 55.5 mt -119.12 11.34 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -74.03 116.16 14.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 112.57 -28.15 9.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.438 ' CD1' ' SD ' ' A' ' 482' ' ' MET . 6.5 mt -87.76 149.45 24.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.28 152.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 83.1 m-85 -139.39 140.24 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.17 99.72 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.31 126.42 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.8 t -132.28 118.23 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.88 -170.19 17.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 417' ' ' VAL . 2.2 m -122.5 123.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 0.0 111.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.52 -179.39 4.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -102.74 -67.07 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.2 t -39.97 -47.22 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -150.57 122.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.93 174.5 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -49.25 -57.56 6.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.61 -42.76 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -65.02 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.27 -22.37 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -72.4 -51.22 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.5 m -58.15 -36.18 72.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.39 -63.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.2 mt -48.9 -38.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -75.47 -29.0 59.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -65.75 -14.76 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.459 ' CE2' HG23 ' A' ' 479' ' ' ILE . 72.5 m-85 -113.84 -0.44 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.0 -25.16 19.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.05 150.28 14.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -101.56 146.66 27.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.35 118.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 11.5 t -134.85 154.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.09 -35.35 27.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.28 142.14 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 t -81.79 137.65 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 59.3 m -123.04 -175.74 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -82.05 -16.54 49.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -89.43 -10.2 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 1.9 m -52.48 121.14 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -88.69 -34.12 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.519 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 71.4 m-85 -150.5 131.24 14.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 12.0 tp -97.62 110.51 23.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.0 t -84.17 102.16 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.436 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 2.8 mmt -80.85 166.21 21.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -166.42 -148.82 5.71 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.3 ttt180 -68.08 151.55 46.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.807 0.336 . . . . 0.0 110.883 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 452' ' ' ARG . 23.8 t70 36.39 44.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 12.1 t -78.24 103.0 7.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -48.24 136.86 15.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -56.93 -45.89 82.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.3 t -37.98 -43.84 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -49.07 -56.61 8.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.436 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 8.4 t -68.16 -34.04 75.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.74 -65.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.19 -37.29 84.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -54.22 -54.78 35.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.06 69.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.15 -56.23 18.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 46.2 mt -71.28 -0.18 9.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 68.47 53.18 22.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.5 m -105.96 129.84 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.153 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -67.07 132.71 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.62 129.07 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.4 pt -137.28 178.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.89 171.94 9.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.29 -40.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.83 -46.49 65.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.13 -33.21 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 29.6 tp -66.9 -58.39 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.442 HD21 ' CD ' ' A' ' 400' ' ' PRO . 10.2 mt -45.31 -52.06 10.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -53.99 -48.16 70.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.32 -25.1 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.459 HG23 ' CE2' ' A' ' 433' ' ' TYR . 62.3 mt -77.37 -27.01 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.5 -11.35 25.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 31.0 p -101.62 -36.03 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.438 ' SD ' ' CD1' ' A' ' 410' ' ' LEU . 2.7 mtp -73.77 140.16 77.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.722 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.3 Cg_endo -69.74 -163.82 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.394 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -134.57 175.36 20.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.439 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 43.5 mttm . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.968 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.617 0.722 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 126.23 13.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -82.02 99.65 9.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -119.71 -150.02 8.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -82.73 -175.01 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.41 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.3 pt-20 -99.15 -24.0 15.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 72.3 m-80 -123.49 35.5 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 20.2 p -75.37 -9.0 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.8 mt -131.79 5.68 4.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.96 120.62 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.54 -27.3 17.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.459 HD11 ' CE ' ' A' ' 482' ' ' MET . 20.8 mt -88.98 142.28 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 444' ' ' LYS . 74.9 mt -101.29 151.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.161 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -139.51 146.19 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 85.7 t -124.99 102.76 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 14.5 mt -90.01 121.52 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.39 137.44 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.96 -165.64 51.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -105.74 159.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.155 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.1 mt -140.97 142.29 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.5 -39.28 94.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.414 ' C ' HD12 ' A' ' 421' ' ' ILE . 5.7 t -60.78 -65.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.414 HD12 ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -146.78 141.78 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -67.27 173.56 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -45.04 67.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.45 -42.33 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -61.38 -66.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.25 -37.18 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -54.87 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.0 m -47.06 -37.25 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.42 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 46.2 mt -46.46 -36.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.86 -34.45 57.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -61.08 -18.46 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.479 ' CE2' HD13 ' A' ' 479' ' ' ILE . 88.7 m-85 -108.42 -2.11 19.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.25 -36.61 4.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.98 148.77 2.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -101.02 154.37 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.13 119.21 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 10.0 t -135.02 142.92 46.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . 0.524 ' C ' ' ND2' ' A' ' 440' ' ' ASN . . . -88.07 42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . 0.524 ' ND2' ' C ' ' A' ' 439' ' ' GLY . 1.5 m-80 -162.86 128.85 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.91 0.386 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 39.5 t -81.36 105.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 m -111.51 -174.48 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -71.82 -25.08 61.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.447 ' HB2' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -81.83 -17.52 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.0 m -60.37 128.11 35.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -94.43 -38.2 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.11 153.29 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.07 102.81 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.25 107.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.9 ptp -122.28 169.38 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.74 -104.46 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.3 OUTLIER -82.59 148.15 28.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.1 m-20 35.68 53.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 99.2 p -94.17 125.36 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -67.5 146.02 46.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -94.01 -30.67 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 0.0 110.891 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -55.27 -19.31 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -94.53 -44.72 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.928 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 84.8 p -59.62 -30.55 68.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.53 -54.55 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -54.78 -23.98 20.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -74.36 -60.56 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.16 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -68.95 -64.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 18.3 mt -54.66 -29.66 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.51 43.36 1.59 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.437 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 27.6 m -103.14 135.54 44.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.112 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -74.97 138.05 42.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.5 130.57 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 35.8 pt -142.7 172.21 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.3 p-10 -115.4 169.0 9.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -39.8 -25.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 471' ' ' ASP . 25.8 t70 -74.97 -49.49 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -61.51 -31.01 76.08 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 24.3 tp -64.02 -49.3 72.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.72 -51.94 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -57.49 -34.65 69.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.4 -15.06 32.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 433' ' ' TYR . 55.5 mt -89.22 -24.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.17 -29.01 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.1 p -82.69 -38.56 23.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.459 ' CE ' HD11 ' A' ' 410' ' ' LEU . 18.4 mmm -69.57 142.06 91.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 0.0 110.895 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -135.07 169.16 23.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 36.1 mttt . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 15.0 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.635 0.731 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 120.29 7.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.72 2.28 . . . . 0.0 112.401 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 108.46 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -130.56 -141.12 4.83 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.431 ' O ' ' CD2' ' A' ' 433' ' ' TYR . . . -95.0 -176.15 3.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.28 -24.73 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 36.1 m-20 -124.58 29.55 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 17.2 p -68.54 -23.57 64.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.2 mt -114.74 2.66 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -66.57 145.22 55.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 85.94 -26.37 6.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.84 159.45 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.449 HD12 ' CG ' ' A' ' 444' ' ' LYS . 96.7 mt -122.11 155.12 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 55.4 m-85 -142.55 145.72 33.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.99 100.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 49.3 mt -81.4 122.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' THR . . . . . 0.469 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.7 t -126.6 115.13 19.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 106.95 -153.92 16.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.66 158.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 111.156 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.84 159.51 41.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 420' ' ' SER . 4.0 tp10 -77.21 -69.44 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 419' ' ' GLU . 20.1 m -35.22 -61.82 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.32 161.68 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' A' ' 422' ' ' GLU . 6.9 mp0 -102.76 164.12 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 16.4 tpt85 -42.48 -30.87 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -65.76 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.93 -55.2 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.35 -53.22 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -44.91 -51.19 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 32.5 t -52.62 -34.06 49.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.47 -67.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 435' ' ' GLY . 65.4 mt -46.25 -35.79 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.56 -28.88 37.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -63.59 -19.78 65.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.518 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 66.7 m-85 -112.47 2.29 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 435' ' ' GLY . . . 112.21 -45.87 1.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.525 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -37.97 148.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -102.06 161.42 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.61 125.01 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 12.8 t -144.16 170.49 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -118.65 50.86 0.78 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -156.35 135.19 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 107.31 15.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 -175.12 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.459 ' HD3' ' CD2' ' A' ' 465' ' ' LEU . 0.0 OUTLIER -73.39 -48.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -50.65 -28.71 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.457 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 89.2 m -55.36 124.27 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.073 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -95.66 -44.74 7.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.566 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 61.4 m-85 -128.7 159.39 35.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 35.1 tp -130.09 102.88 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.03 107.96 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.469 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 24.0 mtm -112.65 179.85 3.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.34 -102.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.6 mmm-85 -92.41 161.24 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.2 t70 34.37 48.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.9 p -87.62 168.42 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -117.8 143.36 17.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 -28.84 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 89.7 p -59.54 -21.55 60.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 459' ' ' SER . 34.3 mttm -86.5 -67.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 458' ' ' LYS . 13.5 p -36.57 -64.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 461' ' ' LYS . 0.2 OUTLIER -42.09 -51.73 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . 0.497 ' N ' ' CG ' ' A' ' 460' ' ' ASP . 0.0 OUTLIER -63.11 -31.74 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 459' ' ' SER . . . -65.2 -48.17 74.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.34 83.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.92 -30.63 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.459 ' CD2' ' HD3' ' A' ' 443' ' ' LYS . 14.0 mt -87.96 -24.23 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.18 28.45 5.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.453 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 4.1 m -92.95 137.36 32.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.356 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -81.22 114.29 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 81.9 mt -86.02 131.83 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.414 HD13 ' C ' ' A' ' 474' ' ' GLY . 7.5 pt -148.98 178.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -117.94 -179.28 3.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.58 -29.95 12.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.08 -51.21 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 470' ' ' ILE . . . -54.95 -30.94 54.95 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.505 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.44 -42.78 95.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.31 -52.96 61.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -59.26 -30.24 68.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.07 -15.18 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.518 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 69.7 mt -88.68 -20.54 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -102.62 -24.55 13.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 36.7 p -87.66 -31.36 19.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 25.9 mmm -75.88 141.1 71.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.51 20.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.434 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 50.3 mttm . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.623 0.725 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 132.82 24.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.315 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -80.82 84.58 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -99.15 -157.58 29.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -74.0 -175.09 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 111.069 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -101.65 -21.29 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.2 29.92 5.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 15.8 p -69.5 -21.73 63.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.9 mt -111.77 -0.77 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.28 115.47 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.3 26.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.77 140.3 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 80.6 mt -106.83 149.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 82.4 m-85 -135.61 157.57 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.07 106.98 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 423' ' ' ARG . 39.1 mt -88.16 126.35 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.7 t -132.64 116.08 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 105.05 -154.47 17.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.09 155.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.07 152.89 49.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -74.36 -63.26 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 419' ' ' GLU . 48.1 m -37.67 -39.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.2 pt -161.19 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 423' ' ' ARG . 56.4 mt-10 -94.75 162.16 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.452 ' HD2' ' CG2' ' A' ' 414' ' ' ILE . 13.8 tpt180 -38.36 -35.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 427' ' ' LYS . 4.8 t70 -74.91 -66.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.872 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -43.78 -42.44 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.61 -30.96 67.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 424' ' ' ASP . 21.2 ttmt -67.19 -51.18 56.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.8 m -55.87 -25.29 41.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.59 -57.1 4.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.478 HG23 ' CD1' ' A' ' 412' ' ' PHE . 22.5 mt -54.7 -45.71 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -72.44 -26.89 62.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -67.07 -14.68 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.509 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 73.7 m-85 -115.02 8.64 15.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.27 -6.8 63.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -70.79 170.11 47.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -126.94 154.13 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.4 t -129.78 123.16 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.07 172.23 7.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.42 10.84 61.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.71 149.78 16.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.28 117.79 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.9 m -121.75 177.62 5.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -59.09 -15.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.15 -21.64 22.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 96.1 m -61.06 126.63 28.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -93.7 -38.58 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.553 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 60.0 m-85 -138.94 148.33 43.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 9.0 tp -115.05 104.26 11.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.51 104.62 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 12.7 mtt -86.29 176.13 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -174.08 -123.76 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 2.2 mmp_? -96.94 156.95 16.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.6 t70 34.56 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 29.2 m -60.35 161.03 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -89.53 175.58 42.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -95.62 -47.12 6.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 94.2 p -57.16 -27.77 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -55.08 -58.28 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 460' ' ' ASP . 3.9 t -73.07 -54.74 7.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.794 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 17.9 t70 -37.6 -70.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -55.06 -34.92 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.38 -65.39 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -50.14 -21.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -75.44 -65.31 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.18 -5.83 15.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 83.54 49.77 4.75 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 25.0 m -94.52 133.96 37.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -80.92 102.24 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 48.3 mt -73.91 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.6 pt -147.81 165.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -114.24 179.31 3.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.5 -25.41 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.93 -40.38 18.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -69.15 -34.65 76.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.3 tp -64.23 -41.19 97.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.19 -40.8 95.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -34.75 79.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.521 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.3 mt -64.49 -14.76 58.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.509 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 49.5 mt -92.37 -17.57 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -103.54 -22.79 13.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.7 p -91.96 -31.78 15.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 19.7 mmm -74.05 140.48 77.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.597 0.713 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.99 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -129.55 171.67 20.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.5 mttp . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.907 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.417 ' CG2' ' HD2' ' A' ' 400' ' ' PRO . 30.4 mm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.614 0.721 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 399' ' ' ILE . 53.3 Cg_endo -69.81 118.54 5.74 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.309 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -60.1 107.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -131.61 -144.3 5.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.479 ' CB ' ' CA ' ' A' ' 484' ' ' GLY . . . -96.44 -175.66 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.59 -21.25 17.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -126.04 18.24 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 15.6 p -58.59 -12.29 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 70.5 mt -127.46 5.28 6.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.24 148.81 49.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.88 -29.33 3.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.6 152.6 22.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.899 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 86.4 mt -114.68 154.32 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -139.01 152.48 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.29 101.9 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.1 mt -84.48 128.11 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.2 t -126.04 134.23 51.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.85 -159.45 41.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.463 HG22 ' CG ' ' A' ' 452' ' ' ARG . 4.2 m -122.95 160.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.5 mt -137.62 158.25 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 420' ' ' SER . 24.4 tt0 -80.76 -66.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 419' ' ' GLU . 27.3 m -38.49 -41.74 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.77 170.5 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -111.78 166.43 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -44.13 -40.17 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 424' ' ' ASP . 2.2 t0 -68.45 -63.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -48.18 -58.86 3.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.17 53.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -69.7 -50.13 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.8 t -54.94 -32.78 61.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -63.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.402 HD12 ' CG2' ' A' ' 437' ' ' VAL . 73.5 mt -46.99 -48.5 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.174 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.78 -38.58 91.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.93 -14.69 9.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.435 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 72.8 m-85 -113.77 5.05 16.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 103.61 -37.47 3.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 407' ' ' LEU . . . -46.42 152.91 1.08 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -102.8 154.5 19.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.402 ' CG2' HD12 ' A' ' 430' ' ' ILE . 55.4 t -131.98 124.72 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 11.9 t -139.62 171.09 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.171 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.1 -33.43 6.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.532 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -94.18 139.12 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 40.2 t -90.09 127.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 18.0 m -122.14 -174.68 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.66 -11.86 59.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -89.29 -20.29 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 56.3 m -52.85 131.64 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.65 -40.06 9.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -141.15 153.37 45.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.41 106.33 11.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 105.4 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 9.1 mtt -87.37 168.76 12.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -153.62 -111.98 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.463 ' CG ' HG22 ' A' ' 417' ' ' VAL . 0.0 OUTLIER -128.28 173.15 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 8.7 t0 34.45 38.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 83.1 p -80.38 -178.17 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -112.09 -168.88 18.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -104.6 -41.39 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.8 m -51.72 -45.7 63.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.31 -57.58 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 460' ' ' ASP . 54.8 p -66.35 -57.05 8.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 459' ' ' SER . 3.9 t70 -35.07 -61.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -59.07 -57.26 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -41.97 -58.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.65 78.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -51.27 -42.99 61.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.71 -24.58 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 94.3 56.84 1.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 88.9 m -112.36 136.43 51.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -70.78 135.82 48.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 71.0 mt -107.84 123.52 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.08 165.49 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -110.14 175.2 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -38.72 -44.51 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.76 -49.59 57.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.63 -22.62 25.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.79 -47.96 28.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.72 -44.7 90.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.407 ' ND2' HG23 ' A' ' 481' ' ' THR . 39.9 t30 -58.5 -34.69 71.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.423 ' O ' ' CG ' ' A' ' 482' ' ' MET . 11.1 mt -64.97 -15.06 61.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.15 -15.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -106.18 -31.05 8.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.407 HG23 ' ND2' ' A' ' 477' ' ' ASN . 40.1 p -83.24 -27.83 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 32.0 mmm -77.49 142.65 67.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 0.0 110.844 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -165.91 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.479 ' CA ' ' CB ' ' A' ' 403' ' ' ALA . . . -134.2 158.39 23.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.463 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 46.7 mttm . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 0.0 110.894 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.8 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.591 0.71 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 122.37 9.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -76.96 96.18 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -111.17 -141.53 8.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.462 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -87.43 -175.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -102.61 -22.39 13.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -126.14 31.19 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.6 -19.62 62.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.4 mt -117.44 7.16 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.38 133.73 51.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 89.38 -25.62 10.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.411 ' CD1' ' HE2' ' A' ' 482' ' ' MET . 84.9 mt -83.48 143.46 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.97 149.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -139.65 148.6 42.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.61 101.63 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 34.2 mt -83.12 128.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.0 t -130.57 143.57 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.55 -144.96 34.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.14 152.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.63 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -65.98 -61.03 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 31.8 m -38.23 -59.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.91 153.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.91 175.03 9.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -55.08 -46.89 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -63.27 -55.8 21.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -62.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.3 -48.44 25.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -48.28 -55.21 11.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.0 m -50.87 -37.36 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.17 -65.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 435' ' ' GLY . 49.9 mt -46.69 -39.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.22 -27.52 42.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -64.93 -19.4 65.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.514 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 76.0 m-85 -110.86 4.56 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.27 -25.0 23.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 430' ' ' ILE . . . -52.71 170.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.468 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 154.47 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.21 121.71 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.26 158.1 42.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.176 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -100.13 50.36 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -164.46 144.26 7.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.57 104.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 22.2 m -128.16 174.51 9.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -53.61 -56.65 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.81 -30.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 29.3 m -57.7 130.64 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -99.08 -35.13 10.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.47 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 67.3 m-85 -143.82 164.67 29.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 22.7 tp -131.01 110.6 11.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.91 104.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.427 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 4.4 mmt -96.73 159.89 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -146.36 -140.21 3.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -93.54 164.78 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.5 t70 38.29 46.83 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 20.3 p -83.18 -177.91 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -109.65 -179.68 20.96 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -108.28 -12.49 15.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.5 m -74.46 -49.3 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -56.54 -53.16 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.427 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 53.2 p -61.06 -42.71 99.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.89 -67.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 462' ' ' ALA . 32.4 tptt -59.8 -54.46 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -36.26 -46.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.085 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.57 49.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -50.86 -47.5 60.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 -26.89 63.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 87.91 50.49 3.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 468' ' ' LYS . 40.0 m -98.8 148.23 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 111.139 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.47 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 13.2 mmmt -79.85 112.65 17.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 63.7 mt -90.73 124.85 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.19 165.6 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.29 176.55 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -28.61 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.08 -49.09 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.84 61.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.74 -36.73 70.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.74 -33.37 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -70.17 -29.49 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.65 -22.91 64.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.514 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 67.4 mt -83.3 -16.88 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -103.45 -10.81 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 50.9 p -106.16 -39.41 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.411 ' HE2' ' CD1' ' A' ' 410' ' ' LEU . 34.3 mmm -66.87 141.65 96.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.572 0.701 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -164.17 0.12 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.727 2.285 . . . . 0.0 112.35 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -131.7 166.82 22.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.4 mttm . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.592 0.71 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 122.94 9.61 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -81.9 107.9 14.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.98 -138.73 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.46 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -93.74 -174.94 3.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.413 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.5 pt-20 -99.65 -20.9 16.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 70.7 m-80 -127.25 28.09 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 23.9 p -66.74 -21.95 66.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.94 17.3 10.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.67 146.61 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.52 2.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.454 HD12 ' CE ' ' A' ' 482' ' ' MET . 80.6 mt -77.16 152.18 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.452 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 67.3 mt -118.26 139.99 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.414 ' N ' HG21 ' A' ' 411' ' ' ILE . 48.3 m-85 -125.62 148.33 49.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.1 104.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 437' ' ' VAL . 75.3 mt -86.55 126.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -131.48 125.92 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.53 -149.88 20.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.03 146.41 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.2 mt -117.14 166.85 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -90.85 -57.29 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.5 m -48.69 -29.28 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -163.72 173.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -104.94 -176.29 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.78 -38.79 87.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.25 -50.81 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -53.98 -58.57 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.88 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.109 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -49.53 -50.09 43.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 47.4 t -56.0 -40.24 73.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.1 tp -65.07 -63.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.401 HD12 ' CG2' ' A' ' 437' ' ' VAL . 64.6 mt -45.79 -40.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -77.75 -33.16 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -57.74 -20.81 37.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.499 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 81.5 m-85 -109.2 -4.76 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.12 -35.43 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.62 154.52 0.84 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -109.01 159.98 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 414' ' ' ILE . 79.8 t -131.71 118.02 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.73 139.06 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.67 3.75 72.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -115.3 131.62 56.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.77 120.38 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.9 m -128.75 -175.25 3.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.407 ' CG ' HD22 ' A' ' 465' ' ' LEU . 55.0 mtpt -71.76 -42.99 66.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -58.26 -25.56 61.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 24.3 m -51.46 138.26 22.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.14 -48.51 4.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 468' ' ' LYS . 87.1 m-85 -130.51 153.45 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 5.0 tp -120.15 104.34 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.0 105.24 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 7.1 mtt -80.98 175.61 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -164.9 -109.24 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.5 mmt180 -125.78 165.6 18.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.6 t0 34.32 37.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 452' ' ' ARG . 20.0 m -77.59 136.17 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.16 124.09 9.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -56.99 -23.02 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.8 t -65.88 -15.17 62.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -82.83 -48.45 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 88.1 p -67.43 -25.49 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.48 -46.24 64.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -37.34 47.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.21 69.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.11 89.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -53.91 -46.35 71.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.407 HD22 ' CG ' ' A' ' 443' ' ' LYS . 16.1 mt -76.16 -24.84 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.63 49.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 54.6 m -100.0 135.77 40.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.519 ' CB ' ' CD1' ' A' ' 447' ' ' TYR . 10.1 mmtp -72.56 117.67 14.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.422 ' C ' HG21 ' A' ' 470' ' ' ILE . 21.6 mt -90.71 128.66 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.422 HG21 ' C ' ' A' ' 469' ' ' ILE . 42.6 pt -141.42 170.99 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.5 178.19 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.75 -35.91 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.87 -37.65 73.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -64.35 -31.58 81.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.06 -52.95 35.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.3 -51.98 66.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.98 -38.12 67.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.5 mt -60.55 -20.55 60.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.499 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 70.7 mt -84.84 -14.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -109.9 -7.83 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.4 p -107.75 -42.07 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.454 ' CE ' HD12 ' A' ' 410' ' ' LEU . 9.9 mtp -64.89 143.48 98.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.508 0.671 . . . . 0.0 110.874 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -165.75 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -139.74 164.19 26.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 33.5 mttm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.603 0.716 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 117.88 5.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.61 101.24 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.78 -156.56 10.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -73.73 -175.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.86 -28.09 12.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -122.65 28.98 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 14.7 p -69.05 -14.61 63.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.94 -2.58 11.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.96 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.7 20.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.6 mt -86.67 134.56 33.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 412' ' ' PHE . 45.6 mt -99.56 155.68 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 56.0 m-85 -145.01 148.99 34.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 51.6 t -128.97 104.91 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 28.1 mt -85.99 133.87 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.7 t -130.54 141.57 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -151.17 42.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.508 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 m -130.22 153.13 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.57 161.7 24.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.89 -61.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.1 p -48.45 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.14 122.16 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.49 178.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.99 -40.19 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.08 -61.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -43.94 -47.99 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.82 92.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -55.09 -52.16 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -54.75 -39.7 68.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.85 -57.94 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 26.0 mt -49.08 -49.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.11 -34.86 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -58.73 -16.87 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.516 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 64.4 m-85 -113.11 11.38 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.26 -28.83 12.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -50.16 168.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -121.21 151.86 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.82 127.86 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 3.1 t -143.02 170.19 16.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.92 -26.81 8.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -93.1 137.73 32.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.75 109.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 m -121.06 179.08 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -54.66 -46.16 73.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -26.93 16.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 28.9 m -55.0 117.99 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -90.31 -39.72 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.527 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 92.1 m-85 -137.88 155.62 48.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 3.1 tp -125.25 107.01 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.2 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 8.4 mmt -93.58 157.57 16.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -140.47 -117.24 1.38 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.2 ptp180 -123.15 170.64 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.865 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 2.2 t70 34.43 37.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 452' ' ' ARG . 29.0 m -95.54 150.85 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -74.92 161.06 53.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -85.24 -33.44 22.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -54.45 -46.59 73.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -46.71 -27.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.4 p -88.87 -47.07 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -42.42 -43.06 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -73.47 -39.5 64.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.16 -57.46 12.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 466' ' ' GLY . . . -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -42.91 -48.66 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.36 -16.75 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 463' ' ' ALA . . . 89.01 55.27 2.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 18.1 m -109.43 138.49 45.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.1 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.18 127.17 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.99 124.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . 0.407 HD12 ' CA ' ' A' ' 475' ' ' LEU . 23.2 pt -130.62 177.78 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.05 -179.25 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.11 -28.62 18.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.15 -45.24 15.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -63.99 -28.46 72.82 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.407 ' CA ' HD12 ' A' ' 470' ' ' ILE . 61.5 tp -67.87 -40.0 83.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.959 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.03 -30.15 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -70.68 -38.93 73.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.73 -17.34 34.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.516 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 87.5 mt -86.92 -24.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.76 -9.88 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.1 p -103.54 -41.66 5.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 13.0 mmm -67.12 139.88 95.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -165.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -125.63 170.39 17.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 mttp . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.563 0.697 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 117.38 5.05 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.227 . . . . 0.0 112.379 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -79.95 84.3 5.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -100.21 -138.18 10.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -91.88 -174.86 3.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.36 -21.08 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.432 ' O ' ' NZ ' ' A' ' 485' ' ' LYS . 76.3 m-20 -126.77 33.3 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.54 -10.47 59.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 79.0 mt -128.37 6.8 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.9 118.5 9.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.38 -30.69 9.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.95 140.16 36.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 412' ' ' PHE . 75.3 mt -106.28 142.97 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 61.2 m-85 -130.42 148.1 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 438' ' ' THR . 84.9 t -122.47 101.87 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.89 123.27 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.4 t -122.74 144.21 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -153.15 45.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 11.5 m -130.94 160.83 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 7.5 mt -137.68 151.69 48.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -75.95 -62.66 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 8.9 m -40.39 -42.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 4.7 pt -150.51 162.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 424' ' ' ASP . 14.8 mt-10 -102.67 155.53 18.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 422' ' ' GLU . 9.5 tpt85 -35.68 -32.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 422' ' ' GLU . 3.3 m-20 -73.8 -66.59 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -41.1 -65.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -41.09 -44.49 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -53.35 -52.88 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 t -51.13 -39.57 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -60.27 3.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 37.4 mt -55.33 -43.71 72.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.81 -31.18 67.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -63.46 -31.03 72.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -96.28 4.84 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.23 -27.58 19.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -48.38 161.08 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -110.82 154.79 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.69 114.92 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' THR . . . . . 0.408 ' CG2' HG22 ' A' ' 413' ' ' VAL . 13.8 t -130.72 170.27 14.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -112.38 51.76 0.68 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -172.55 150.03 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.6 109.24 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' SER . . . . . 0.475 ' HB2' ' CE ' ' A' ' 444' ' ' LYS . 1.7 m -127.63 -176.13 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.835 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -61.14 -40.29 93.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.475 ' CE ' ' HB2' ' A' ' 442' ' ' SER . 0.0 OUTLIER -64.41 -25.45 68.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.6 m -61.68 136.63 58.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -105.48 -49.48 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.56 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 72.5 m-85 -129.62 154.96 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 11.3 tp -122.78 102.81 8.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.5 t -77.5 104.65 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.6 mtp -77.01 178.6 6.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 175.9 44.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.415 ' HG3' ' N ' ' A' ' 453' ' ' ASP . 1.0 OUTLIER -53.32 146.81 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 452' ' ' ARG . 1.6 t70 43.57 54.28 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.7 m -106.71 127.99 53.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -52.33 150.14 9.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.81 -39.76 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -44.31 -39.63 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -50.7 -41.88 56.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.2 p -73.55 -29.13 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -54.91 -56.97 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -63.12 -47.51 82.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -42.97 -56.15 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.22 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.32 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.47 -30.91 68.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 101.92 42.57 2.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 468' ' ' LYS . 94.9 m -97.5 140.37 32.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.458 ' N ' HG23 ' A' ' 467' ' ' THR . 12.3 mmtt -81.63 109.64 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 72.5 mt -82.97 129.69 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.131 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.6 pt -140.33 173.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 472' ' ' GLU . 3.0 p30 -120.81 172.5 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 3.0 pm0 -35.15 -43.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 32.7 t0 -66.23 -52.79 44.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -50.8 -42.03 45.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 53.7 tp -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.8 -51.9 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.0 -36.52 65.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.1 -25.77 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.58 -27.27 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -91.31 -28.48 17.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -83.26 -47.89 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 15.4 mmm -57.77 141.86 79.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.892 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.73 169.67 22.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 405' ' ' ASN . 23.8 mttp . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.1 mm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.623 0.725 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 116.42 4.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.39 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -75.94 83.13 2.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -96.92 -142.44 13.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 406' ' ' CYS . . . -79.16 -174.96 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 5.1 pt-20 -103.22 -33.03 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 404' ' ' GLU . 51.2 m-80 -122.47 26.28 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 403' ' ' ALA . 17.2 p -63.03 -16.24 59.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.11 7.38 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.95 128.48 36.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.79 21.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.469 HD13 ' CE ' ' A' ' 482' ' ' MET . 7.5 mt -87.74 145.64 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 444' ' ' LYS . 68.4 mt -110.84 147.39 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -132.77 138.99 47.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.73 101.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.451 ' CD1' HG11 ' A' ' 437' ' ' VAL . 62.5 mt -81.06 119.63 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -121.36 116.02 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.48 -153.12 18.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.03 158.17 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.23 148.62 49.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.7 -58.12 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.5 m -44.71 -41.92 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 3.0 pt -152.17 161.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.118 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.58 168.35 9.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -45.68 -35.56 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 427' ' ' LYS . 14.1 t70 -77.48 -63.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -38.76 -48.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -66.05 -37.67 86.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 424' ' ' ASP . 50.7 tttt -58.88 -45.21 90.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -23.04 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 20.4 tp -81.47 -64.23 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.405 ' CG1' HD21 ' A' ' 475' ' ' LEU . 27.6 mt -48.12 -36.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -76.68 -29.81 56.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.65 -14.55 61.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 81.4 m-85 -114.01 6.91 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.19 -26.87 22.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.57 165.89 2.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -122.07 159.93 26.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 414' ' ' ILE . 94.5 t -133.62 117.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.3 t -132.24 164.41 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.93 49.3 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -169.59 134.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.887 0.375 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 81.2 t -79.9 121.01 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 29.8 t -127.69 179.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -71.39 -25.92 62.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.416 ' HB2' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -79.59 -15.25 57.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -61.82 119.25 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -93.83 -40.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 80.6 m-85 -133.18 153.98 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.47 108.38 11.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.38 102.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.3 ptp -103.59 170.99 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 -103.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 453' ' ' ASP . 15.9 mmt180 -91.09 159.53 16.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.9 t70 34.4 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.3 t -82.78 105.64 13.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -56.01 173.76 1.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -113.22 -3.49 13.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.0 t -75.29 -32.62 61.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -81.87 -57.89 3.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.0 p -46.0 -58.58 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -38.45 -43.73 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -69.07 -49.54 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -40.87 -58.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.44 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.29 -24.34 63.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.8 mt -98.76 17.79 18.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.77 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.472 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 60.6 m -103.48 126.49 50.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.107 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.425 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.2 OUTLIER -72.39 111.44 7.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 16.8 mt -81.97 122.5 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 28.0 pt -137.96 172.41 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.89 175.42 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -38.62 -46.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -67.77 -49.56 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.91 -30.22 9.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . 0.405 HD21 ' CG1' ' A' ' 430' ' ' ILE . 50.9 tp -71.64 -62.22 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 29.9 mt -43.09 -41.93 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.23 -36.69 82.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.89 -23.07 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.513 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 60.4 mt -81.09 -15.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.129 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -105.36 -8.8 17.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 -38.79 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.469 ' CE ' HD13 ' A' ' 410' ' ' LEU . 2.5 mtp -62.93 142.26 97.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.1 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.94 155.23 17.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.527 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.468 ' HG3' ' CB ' ' A' ' 405' ' ' ASN . 4.5 ptpp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.1 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.594 0.711 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.45 13.31 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 0.0 112.348 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -89.33 94.75 10.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.76 -135.73 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -93.28 -175.0 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -100.72 -19.56 15.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -128.24 30.82 5.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 27.5 p -71.69 -11.21 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.87 13.49 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.84 122.65 23.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.89 -35.24 5.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.8 157.78 29.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.769 0.319 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.1 154.17 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 38.6 m-85 -142.16 153.2 43.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 98.5 t -133.06 102.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 33.1 mt -83.68 122.74 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -125.74 132.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.16 -153.71 23.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.37 152.73 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.354 . . . . 0.0 111.139 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.424 ' CD2' ' HA3' ' A' ' 451' ' ' GLY . 1.2 mt -132.12 164.03 27.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -85.39 -66.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.5 p -41.92 -27.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -161.88 165.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.91 164.45 13.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -39.29 -36.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 424' ' ' ASP . 37.5 t0 -73.85 -66.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 424' ' ' ASP . 18.0 mm-40 -36.88 -53.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.81 77.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 424' ' ' ASP . 38.3 tttt -58.4 -46.14 86.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -40.83 97.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.1 tp -63.47 -62.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 54.8 mt -44.42 -43.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -75.35 -35.78 61.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -54.33 -21.83 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.425 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 96.6 m-85 -108.33 -3.78 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 115.59 -40.3 2.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.22 162.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.7 125.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 3.5 t -137.64 139.93 40.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -86.33 46.81 3.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -157.86 126.65 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -80.6 100.83 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.179 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 51.9 m -121.29 164.73 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -50.94 -52.96 37.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.54 -32.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.464 HG22 ' CG2' ' A' ' 467' ' ' THR . 88.9 m -48.94 130.69 18.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -99.15 -30.19 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.562 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 65.9 m-85 -148.68 145.66 27.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 15.6 tp -115.81 98.88 6.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.21 106.05 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.5 139.03 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -122.24 -114.02 2.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -92.5 167.78 11.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 27.0 t70 38.02 45.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 70.4 m -101.55 173.26 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -99.18 147.48 18.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 457' ' ' SER . 49.0 tp60 -82.92 -47.41 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.893 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 456' ' ' GLN . 11.3 t -36.24 -46.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -55.37 -65.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.3 t -50.51 -44.78 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -46.81 -58.1 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -66.91 -43.39 83.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -45.38 -50.74 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.076 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.98 88.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.083 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.27 70.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 22.3 mt -93.76 22.97 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 51.61 52.65 32.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' THR . . . . . 0.464 ' CG2' HG22 ' A' ' 445' ' ' THR . 20.5 m -109.68 126.27 53.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.136 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 106.42 4.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 62.6 mt -84.52 125.08 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.36 174.57 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -116.4 177.35 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -39.06 -46.28 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.91 -55.86 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.3 -38.27 19.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.539 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.56 -51.69 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.04 -50.45 72.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.923 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.17 -33.55 65.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.405 HD11 ' CD2' ' A' ' 447' ' ' TYR . 12.5 mt -66.78 -15.92 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.425 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 56.1 mt -89.06 -25.4 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -93.56 -28.16 16.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 27.2 p -84.09 -41.5 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 23.2 mmm -65.79 140.6 97.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.0 Cg_endo -69.83 -164.34 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.645 2.23 . . . . 0.0 112.315 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.58 174.2 20.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.4 mttm . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 17.0 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.614 0.721 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 122.96 9.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.709 2.272 . . . . 0.0 112.364 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -73.7 119.64 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -138.83 -156.72 7.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -79.29 -175.01 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.066 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.36 -20.54 15.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -126.91 29.52 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 32.0 p -68.98 -18.63 64.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.04 16.14 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -78.89 121.48 24.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.7 -24.51 21.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.467 HD11 ' CE ' ' A' ' 482' ' ' MET . 25.7 mt -89.85 150.09 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.428 HD13 ' CG ' ' A' ' 444' ' ' LYS . 68.5 mt -112.5 144.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 57.0 m-85 -132.07 152.2 51.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.83 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 96.3 t -131.33 110.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.26 121.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 4.0 t -124.69 115.06 20.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.07 -153.8 16.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.31 150.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.64 145.14 51.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -72.44 -44.03 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 11.0 m -55.04 -42.13 72.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.854 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.33 161.01 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.91 169.76 10.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -52.12 -30.34 25.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.44 -55.95 4.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -47.37 -54.64 10.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -53.46 -53.53 50.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -51.94 -40.58 61.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.7 tp -64.22 -53.61 46.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.41 HG22 ' C ' ' A' ' 435' ' ' GLY . 59.3 mt -54.37 -38.98 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -77.86 -30.41 50.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -58.04 -24.28 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.497 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 71.7 m-85 -110.34 4.79 21.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.83 -33.13 6.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.496 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -43.74 146.71 1.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -104.24 159.54 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.26 116.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 5.1 t -132.21 148.36 52.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.11 53.5 1.37 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 114.08 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.879 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.94 99.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.7 m -119.59 -175.16 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -63.34 -54.87 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -47.19 -28.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 49.4 m -58.37 126.0 25.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -95.53 -42.93 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 46.1 m-85 -132.12 149.48 52.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 9.2 tp -120.05 106.95 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.14 102.76 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 6.1 mtt -82.79 161.92 21.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -154.61 -169.64 19.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -68.03 147.05 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.901 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.9 t70 43.24 52.18 5.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.6 p -81.86 176.38 9.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.77 141.44 15.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -74.78 -33.3 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 55.8 m -58.71 -41.64 86.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -55.06 -61.15 2.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 460' ' ' ASP . 28.6 p -51.83 -44.75 63.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 459' ' ' SER . 8.1 t70 -35.59 -67.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 462' ' ' ALA . 7.2 mptt -57.87 -56.39 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -34.28 -48.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.99 84.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 461' ' ' LYS . . . -68.68 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 28.2 mt -54.79 -32.07 59.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 86.97 62.98 1.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 6.7 m -107.06 139.24 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.167 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -69.14 105.4 2.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 88.5 mt -85.62 131.11 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.54 177.38 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -126.05 177.34 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -38.87 -48.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -63.07 -49.52 74.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -56.67 -26.22 52.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 64.0 tp -73.39 -48.08 36.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.58 -44.08 97.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -61.63 -28.77 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.67 -15.8 62.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 31.0 mt -87.24 -17.31 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.75 -29.26 11.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 58.3 p -83.31 -45.5 13.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.467 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.3 mmm -60.34 142.0 90.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.83 -166.69 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.316 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.89 165.01 24.38 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 35.8 mttm . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.596 0.712 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.14 5.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.353 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -71.97 102.62 2.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -125.78 -161.17 10.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.435 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -73.08 -175.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.731 0.301 . . . . 0.0 111.111 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -101.33 -20.84 15.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -126.04 36.73 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 29.1 p -78.67 -6.46 55.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.96 5.55 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -69.35 116.76 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.31 -16.94 34.79 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.463 ' CD1' ' HE2' ' A' ' 482' ' ' MET . 48.8 mt -99.47 138.6 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 28.5 mt -101.96 151.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 43.4 m-85 -136.72 143.69 43.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.08 109.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 50.4 mt -90.5 120.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.5 t -118.74 113.03 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . 0.443 ' O ' ' NH1' ' A' ' 423' ' ' ARG . . . 99.21 175.17 31.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.482 ' O ' ' CG2' ' A' ' 417' ' ' VAL . 1.8 m -94.47 122.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 420' ' ' SER . 4.6 mt -90.26 100.45 13.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -40.88 -25.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 418' ' ' LEU . 4.3 p -71.97 -62.71 1.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 425' ' ' GLU . 0.4 OUTLIER -140.52 132.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -65.57 -175.55 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 416' ' ' GLY . 8.2 mmp_? -58.71 -58.29 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -29.48 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 421' ' ' ILE . 9.3 mt-10 -71.04 -64.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -54.02 -62.51 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -41.85 -27.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.33 -51.45 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . 0.425 HG22 ' C ' ' A' ' 435' ' ' GLY . 45.2 mt -61.03 -35.87 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.26 -29.66 38.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -60.56 -21.25 62.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -111.11 2.51 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.43 -27.52 15.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -48.63 157.15 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -114.57 157.56 22.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.5 t -131.73 123.45 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.59 155.72 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -101.29 37.03 3.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -160.16 125.14 3.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.402 HG22 ' CD ' ' A' ' 458' ' ' LYS . 96.0 t -67.28 118.42 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 75.4 m -123.24 157.94 31.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.47 ' CB ' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -61.48 -14.34 28.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -86.59 -22.74 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 26.3 m -51.86 133.57 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.462 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 5.4 m-80 -97.22 -25.2 15.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 69.8 m-85 -157.57 131.11 7.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.13 116.23 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.35 94.52 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 6.4 mmt -86.39 166.47 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -159.59 -107.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -126.92 168.49 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.8 m-20 37.72 46.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.6 m -99.98 175.99 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.32 -177.51 40.27 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.435 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -115.18 -19.61 10.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.4 p -77.63 -19.16 55.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.402 ' CD ' HG22 ' A' ' 441' ' ' VAL . 36.9 mmtm -72.49 -39.45 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 42.7 p -73.96 -52.18 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.38 -44.46 8.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -47.06 50.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.65 47.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.0 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -54.84 -58.7 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.068 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.47 HD21 ' CB ' ' A' ' 443' ' ' LYS . 12.3 mt -61.35 -23.7 65.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 93.64 53.81 1.76 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 3.5 m -107.98 134.59 50.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.14 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -74.91 116.67 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 88.3 mt -87.3 123.55 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 50.2 pt -140.1 168.98 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 471' ' ' ASP . 0.6 OUTLIER -115.26 173.92 6.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.4 pt-20 -34.12 -45.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -60.34 3.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.41 8.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 23.2 tp -44.4 -45.64 9.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.73 -46.79 83.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.12 -31.29 71.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 20.1 mt -82.96 -17.6 10.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.9 -16.91 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.842 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.1 p -97.04 -33.72 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.463 ' HE2' ' CD1' ' A' ' 410' ' ' LEU . 30.7 mmm -72.18 142.51 84.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.874 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -165.48 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.334 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -137.17 169.36 24.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 25.7 mttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.948 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 12.7 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.665 0.745 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.463 ' CD ' HD12 ' A' ' 476' ' ' LEU . 53.7 Cg_endo -69.72 128.75 16.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.738 2.292 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.474 ' HE3' ' N ' ' A' ' 402' ' ' GLY . 0.0 OUTLIER -65.22 103.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLY . . . . . 0.474 ' N ' ' HE3' ' A' ' 401' ' ' LYS . . . -124.3 -161.48 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.486 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -74.3 -175.0 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.723 0.297 . . . . 0.0 111.121 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.81 -23.79 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -125.08 30.84 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' CYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 19.8 p -69.49 -13.08 62.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.17 7.18 7.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -63.55 137.29 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 87.73 -29.91 5.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . 0.432 ' CD1' ' HE1' ' A' ' 482' ' ' MET . 76.7 mt -79.23 148.63 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 90.7 mt -119.91 145.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 67.1 m-85 -132.21 153.62 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 99.5 t -128.56 103.2 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.417 HG23 ' NH1' ' A' ' 423' ' ' ARG . 21.6 mt -85.18 124.4 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -122.73 139.81 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 85.63 -157.04 30.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 417' ' ' VAL . 4.7 m -135.32 123.9 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.389 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.18 149.42 23.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -55.06 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.4 m -45.13 -53.83 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 2.1 pt -142.15 128.44 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.98 165.04 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.417 ' NH1' HG23 ' A' ' 414' ' ' ILE . 0.1 OUTLIER -41.96 -43.62 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 425' ' ' GLU . 1.1 m-20 -64.25 -66.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 424' ' ' ASP . 37.9 mm-40 -36.75 -71.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -41.21 -56.03 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -39.84 -62.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -33.78 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 432' ' ' ARG . 15.5 tp -71.8 -66.23 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 30.8 mt -45.81 -33.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.66 -25.06 26.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 429' ' ' LEU . 14.9 ttm180 -65.08 -16.9 63.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' TYR . . . . . 0.51 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 93.9 m-85 -115.92 6.9 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.87 -37.71 3.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.3 149.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -105.1 165.91 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.63 132.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.18 129.95 20.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.52 76.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -104.77 139.69 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.9 t -76.01 127.37 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 p -123.24 170.3 10.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -32.93 73.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.922 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -70.5 -19.15 62.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.0 m -51.02 133.73 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 7.8 m120 -106.69 -22.81 12.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' TYR . . . . . 0.538 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 58.2 m-85 -156.06 154.95 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.3 106.49 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.2 97.5 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.463 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 9.4 mtt -78.61 170.5 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -158.54 -107.51 0.24 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 ptp180 -131.11 172.75 11.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.2 m-20 34.53 38.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.6 t -83.08 -175.04 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -127.27 141.98 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -13.15 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.32 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 14.8 t -73.46 -44.63 57.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -55.71 -48.25 75.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.463 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 46.2 p -68.88 -33.76 74.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.52 -42.63 92.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -77.23 -34.07 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -63.37 -54.91 29.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.34 68.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 37.3 mt -71.44 -25.72 62.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 102.48 51.39 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 468' ' ' LYS . 41.2 m -113.86 141.8 46.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.336 . . . . 0.0 111.159 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' LYS . . . . . 0.41 ' N ' HG22 ' A' ' 467' ' ' THR . 20.3 mtmm -85.56 139.95 31.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.22 122.01 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.8 179.49 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 474' ' ' GLY . 2.1 p-10 -124.79 166.76 15.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -38.96 -30.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.8 -42.96 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -59.65 -35.11 84.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.463 HD12 ' CD ' ' A' ' 400' ' ' PRO . 0.5 OUTLIER -50.89 -49.26 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -57.58 -44.41 85.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.26 -17.72 3.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.51 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 97.5 mt -87.21 -28.23 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -98.32 -13.34 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 43.3 p -97.11 -43.14 7.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' MET . . . . . 0.432 ' HE1' ' CD1' ' A' ' 410' ' ' LEU . 30.2 mmm -66.64 142.6 97.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.842 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.75 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.636 2.224 . . . . 0.0 112.386 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.07 157.75 20.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.5 mttt . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.916 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.6 t -166.74 110.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 1.7 t -98.77 168.75 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 76.57 167.66 26.32 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -76.27 129.65 36.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.837 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 36.8 t -62.17 -54.76 36.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -119.15 -134.13 4.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 393' ' ' ALA . 0.1 OUTLIER -92.09 -21.84 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 392' ' ' LYS . . . 36.87 47.0 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.25 134.13 39.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 156.83 -24.01 0.48 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.446 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.5 t -87.88 28.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.403 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.06 175.63 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.24 121.85 23.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.3 mm -81.97 120.74 78.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 129.7 18.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -86.2 92.34 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -114.67 -139.68 7.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -91.64 -175.09 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.778 0.323 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.71 -20.4 13.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -127.09 32.83 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 28.1 p -75.55 -17.4 60.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 59.5 mt -121.96 10.14 10.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -68.79 116.32 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.05 -21.55 24.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 24.2 mt -90.07 150.14 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.48 148.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.4 148.53 49.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.05 108.09 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 25.8 mt -91.28 123.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.7 t -120.65 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.25 -153.86 32.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -127.13 154.55 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.1 mt -132.79 136.51 46.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -60.36 -63.62 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.808 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 419' ' ' GLU . 23.0 p -35.92 -56.65 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -143.15 155.75 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.16 160.56 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -39.84 -37.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.58 -55.13 8.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -51.16 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.8 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -58.3 -57.58 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.1 p -48.9 -30.52 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.51 -61.72 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.7 mt -51.22 -34.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.5 -28.84 46.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -66.15 -14.95 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 90.7 m-85 -110.5 -9.42 14.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.968 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 117.93 -24.84 8.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.9 157.56 21.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -106.63 156.29 18.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.5 t -134.3 116.68 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.6 t -136.78 134.94 37.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.34 45.99 3.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -160.12 135.46 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 62.2 t -74.79 130.04 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.3 t -130.91 173.42 10.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -76.43 -19.58 57.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -88.98 -16.77 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 96.7 m -48.05 127.58 12.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.99 -39.8 9.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 73.1 m-85 -144.64 150.77 37.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 6.4 tp -117.98 107.89 14.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.61 106.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 6.6 mtt -92.11 165.99 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -152.26 -118.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 453' ' ' ASP . 11.4 ptm180 -119.49 173.22 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.8 t70 34.54 38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 452' ' ' ARG . 61.5 m -99.82 151.9 20.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -77.08 163.24 52.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.442 ' H ' ' NE2' ' A' ' 456' ' ' GLN . 2.3 pm0 -92.27 -12.31 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 1.8 t -69.48 -34.77 74.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -58.03 -43.79 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.426 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 86.1 p -66.36 -52.42 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.1 -64.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -54.21 -49.12 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -47.77 -58.33 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.25 -50.17 67.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -47.33 -55.83 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.2 mt -66.54 -26.11 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.55 53.05 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 47.5 m -110.4 136.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.503 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -79.77 117.81 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 15.5 mt -89.7 130.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.416 HD11 ' C ' ' A' ' 474' ' ' GLY . 21.2 pt -147.25 166.59 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 472' ' ' GLU . 0.4 OUTLIER -107.59 171.11 7.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 473' ' ' ASP . 2.6 pp20? -37.21 -43.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 472' ' ' GLU . 16.2 t70 -60.8 -51.99 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . 0.416 ' C ' HD11 ' A' ' 470' ' ' ILE . . . -55.65 -35.21 61.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.16 -47.32 83.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.949 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.27 -53.05 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -53.14 -39.85 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.28 -15.54 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.513 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 78.9 mt -90.18 -19.3 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.6 -20.97 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.5 p -91.86 -38.32 12.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 40.7 mmm -67.29 143.6 97.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.523 0.677 . . . . 0.0 110.908 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.81 -178.42 2.35 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.73 166.05 19.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.436 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -135.57 161.03 36.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 486' ' ' LYS . 0.1 OUTLIER -96.98 110.23 22.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 30.9 t -69.18 155.22 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -56.77 -38.74 72.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.14 135.56 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.16 148.65 22.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.71 119.82 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 493' ' ' VAL . . . -61.51 -178.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.084 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 492' ' ' ALA . 14.7 p 34.17 39.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.55 65.87 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 13.0 t -147.08 161.65 40.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.0 m -150.55 164.44 35.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 55.6 m -59.08 -54.68 44.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.882 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.38 -53.69 3.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 1.1 t -57.93 119.49 6.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.864 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 2.1 m -86.08 42.93 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 145.19 141.36 3.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -45.1 -57.32 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.321 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -160.57 133.17 6.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.35 102.41 5.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -124.43 61.08 0.6 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.43 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.3 t -121.41 28.85 7.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.456 ' HD2' ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -120.47 168.0 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -125.18 113.73 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.429 ' CG2' ' HD2' ' A' ' 400' ' ' PRO . 27.5 mm -76.93 135.66 67.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 399' ' ' ILE . 54.1 Cg_endo -69.75 117.93 5.38 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.65 2.234 . . . . 0.0 112.373 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -70.28 108.79 4.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -129.96 -146.29 5.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -79.34 -175.24 4.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.65 -25.59 12.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -124.31 30.47 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 27.5 p -70.38 -16.31 62.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 61.0 mt -121.12 9.21 10.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -65.79 133.79 51.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 92.35 -33.52 4.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.54 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.464 HD12 ' CE ' ' A' ' 482' ' ' MET . 12.4 mt -79.06 139.94 38.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.878 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 81.9 mt -105.07 156.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 411' ' ' ILE . 91.5 m-85 -142.64 150.42 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.39 99.12 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 45.3 mt -81.81 130.99 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.455 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.6 t -128.88 145.98 51.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.35 42.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.89 152.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 111.107 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.419 ' CD2' ' HA3' ' A' ' 451' ' ' GLY . 7.1 mt -122.92 173.85 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.73 -69.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 397' ' ' LYS . 60.8 p -40.58 -44.23 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.469 HD11 ' CB ' ' A' ' 426' ' ' ALA . 2.0 pp -142.08 176.98 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -122.88 164.33 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 -42.49 -31.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.83 -68.61 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -44.67 -53.06 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.469 ' CB ' HD11 ' A' ' 421' ' ' ILE . . . -52.53 -42.52 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -58.46 -50.35 74.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 21.1 p -54.59 -34.89 62.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.55 -65.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.411 HG21 ' C ' ' A' ' 435' ' ' GLY . 55.2 mt -47.31 -40.02 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -76.08 -31.87 58.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.57 -16.08 62.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 70.9 m-85 -113.34 3.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.89 -32.17 7.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.411 ' C ' HG21 ' A' ' 430' ' ' ILE . . . -47.77 163.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -116.23 156.43 26.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.9 t -130.7 128.01 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 149.86 41.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -89.72 9.17 78.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -127.91 137.24 52.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 46.6 t -87.9 108.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.2 m -110.49 -178.62 3.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.441 ' HA ' ' CD1' ' A' ' 465' ' ' LEU . 0.0 OUTLIER -77.59 -20.18 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -26.46 54.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 10.1 m -46.47 133.86 9.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 4.9 m-80 -102.47 -22.13 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 67.5 m-85 -156.01 155.11 32.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 469' ' ' ILE . 17.2 tp -125.41 111.63 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 34.3 t -93.57 107.05 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.455 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 26.8 mtm -110.39 175.78 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -158.55 -147.45 4.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.5 ptt180 -69.39 174.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.4 m-20 34.75 39.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.1 p -96.78 -177.6 3.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -143.83 174.55 24.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.445 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 1.2 pm0 -97.24 24.7 6.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.354 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 15.1 t -86.08 -42.92 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.29 -39.62 28.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.0 p -71.46 -30.53 66.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -52.47 65.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.03 -28.39 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.38 74.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.73 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -45.81 -41.06 10.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 443' ' ' LYS . 11.6 mt -85.41 -24.03 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 103.5 51.05 1.0 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 59.1 m -100.56 138.9 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.152 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.402 ' HA ' ' CE ' ' A' ' 468' ' ' LYS . 0.3 OUTLIER -74.36 117.32 16.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 448' ' ' LEU . 34.0 mt -94.96 131.36 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.6 pt -142.84 174.23 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.62 178.97 4.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -41.06 -45.43 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.03 -55.08 24.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.28 -30.29 4.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.519 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.0 tp -67.92 -59.87 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.53 -42.85 45.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.949 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.89 -36.99 85.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.1 mt -62.75 -22.9 66.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.466 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 58.6 mt -83.43 -28.3 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -88.86 -22.3 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.7 p -91.23 -47.87 7.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.464 ' CE ' HD12 ' A' ' 410' ' ' LEU . 11.9 mmm -59.61 139.39 89.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.504 0.669 . . . . 0.0 110.908 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.74 -165.18 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.46 157.09 17.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -134.62 165.18 25.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -117.9 108.08 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.953 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 43.5 t -102.05 169.47 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -91.45 43.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -114.3 151.89 32.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -106.39 170.63 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.0 mp -100.99 127.31 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.089 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -117.51 103.83 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.067 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.37 89.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -102.76 129.0 49.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 11.4 t -89.74 3.75 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.1 p -75.64 159.21 31.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.855 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 62.9 p -69.84 150.88 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -92.52 -103.99 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.4 t -62.73 109.97 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.3 m -137.33 127.71 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -81.95 113.74 3.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -86.1 -43.87 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 81.72 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.58 -8.37 41.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 140.75 -117.67 1.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.49 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.1 t -133.35 34.08 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -133.8 171.38 14.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.18 132.84 38.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.73 125.18 91.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 0.0 111.108 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 117.7 5.24 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -76.78 95.37 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -108.54 -152.37 15.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.472 ' CB ' ' HA2' ' A' ' 484' ' ' GLY . . . -70.9 -177.13 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 2.8 pt-20 -101.05 -29.15 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.468 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 67.7 m-20 -122.14 20.11 10.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 19.9 p -59.26 -25.64 64.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 68.0 mt -108.36 14.9 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.67 143.3 34.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 86.33 -16.6 43.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.1 153.2 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 95.4 mt -113.49 155.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.416 ' N ' ' CG2' ' A' ' 411' ' ' ILE . 91.1 m-85 -144.29 135.31 25.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.84 100.37 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.88 121.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 130.8 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.15 -152.27 22.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.81 152.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 1.8 mt -132.25 159.4 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.24 -65.19 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 10.6 t -39.74 -31.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -161.2 160.88 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.12 170.32 8.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -47.95 -20.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -92.56 -65.86 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -42.07 -37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.66 -42.33 67.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -58.76 -58.58 7.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 28.1 t -47.07 -36.76 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -64.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 63.4 mt -49.89 -44.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.16 -32.65 73.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -66.06 -17.75 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.464 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 57.0 m-85 -108.21 1.57 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.02 -29.65 10.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.25 153.34 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 437' ' ' VAL . 9.3 tmtm? -105.78 146.92 29.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.465 ' N ' ' HD3' ' A' ' 436' ' ' LYS . 99.5 t -122.45 121.34 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 9.0 t -139.44 143.82 37.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -91.24 44.96 2.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -163.56 121.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.78 126.45 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.6 m -128.49 169.12 14.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -68.32 -21.65 64.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -85.44 -7.05 59.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.6 m -61.26 127.37 31.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -97.3 -29.12 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -151.83 150.96 30.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 14.2 tp -119.76 108.85 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.43 105.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.2 mtt -80.27 168.98 18.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.23 -110.37 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 453' ' ' ASP . 14.7 mmt180 -125.66 172.39 9.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 452' ' ' ARG . 29.4 t0 34.56 39.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 96.6 p -83.64 165.88 18.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -113.31 130.29 9.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.49 -20.71 21.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 87.4 p -69.73 -30.24 67.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -63.11 -56.19 18.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.9 t -63.93 -45.96 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -40.3 -53.69 2.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -64.98 -35.57 81.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -61.66 -63.15 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.079 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.32 -41.39 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.54 69.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.5 -26.22 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.8 48.95 1.56 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 468' ' ' LYS . 19.8 m -111.49 145.68 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 467' ' ' THR . 27.4 mttp -84.24 142.43 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.953 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 25.9 mt -109.61 127.88 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.23 172.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 472' ' ' GLU . 51.0 m-20 -117.86 170.73 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 471' ' ' ASP . 6.7 pt-20 -35.92 -41.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.71 -51.44 62.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.31 -27.64 32.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 52.0 tp -69.76 -51.75 31.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.3 mt -52.26 -48.73 65.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.08 -36.7 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.18 -17.25 57.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.439 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 30.7 mt -88.56 -15.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -106.95 -15.29 14.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 20.9 p -97.82 -41.73 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 12.2 mmm -64.43 140.73 98.05 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 110.909 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.71 -173.26 0.68 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.698 2.265 . . . . 0.0 112.382 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.472 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -107.34 151.27 16.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.468 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 1.8 mptp? -127.98 154.79 45.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 485' ' ' LYS . 15.7 mtpt 33.15 47.59 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.832 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.6 p -86.71 104.36 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 488' ' ' LYS . 0.0 OUTLIER -52.93 -32.68 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -108.9 128.22 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.72 157.15 42.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 492' ' ' ALA . 49.6 mm -121.95 84.81 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 491' ' ' ILE . . . 34.43 48.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.7 108.12 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 50.01 42.21 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.1 m -56.62 131.62 49.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 1.5 t -154.39 150.47 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 38.6 m -107.7 104.64 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -167.32 -101.71 0.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.0 t -126.25 -49.73 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.0 t -71.48 108.79 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 87.62 79.73 1.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -108.25 115.05 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -50.75 115.76 1.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.5 pp -98.51 -13.19 20.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 155.44 60.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 2.2 m 48.29 28.2 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.943 0.401 . . . . 0.0 110.862 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -108.34 176.98 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.61 116.3 14.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.1 mm -86.91 124.62 68.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 125.98 12.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 0.0 112.303 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -107.02 -150.3 16.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 433' ' ' TYR . . . -78.95 -175.03 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -100.19 -27.78 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -123.07 31.4 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.97 -19.33 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.8 -5.94 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.19 126.39 27.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.11 -23.71 32.64 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.469 HD12 ' CE ' ' A' ' 482' ' ' MET . 15.0 mt -94.25 153.96 17.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 412' ' ' PHE . 81.8 mt -116.46 143.51 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 88.3 m-85 -134.48 146.23 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 93.9 t -121.08 112.79 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 87.4 mt -95.56 121.48 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.154 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.4 t -122.95 147.36 46.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.32 -154.16 47.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.17 142.19 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.96 140.24 48.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -47.63 74.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 78.6 p -50.86 -50.11 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 426' ' ' ALA . 1.2 pt -151.48 168.47 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -97.81 162.06 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -38.9 -45.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -65.21 -62.43 1.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -46.37 -62.98 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.452 ' CB ' HD12 ' A' ' 421' ' ' ILE . . . -52.38 -53.51 44.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -44.04 -53.35 6.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.4 t -49.88 -31.22 11.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.07 -60.06 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 72.6 mt -53.68 -40.03 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.08 -25.35 55.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -67.24 -20.01 65.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.486 ' CE2' HG22 ' A' ' 479' ' ' ILE . 60.4 m-85 -111.92 7.96 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.47 -38.38 3.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.501 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.29 156.54 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -110.14 148.23 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.54 123.11 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 12.0 t -137.61 161.68 35.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -102.24 22.9 36.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -143.53 140.63 30.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' A' ' 458' ' ' LYS . 21.1 t -93.58 110.87 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.8 p -115.95 -175.66 2.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -70.35 -22.43 62.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -80.44 -17.54 51.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 18.2 m -58.53 139.38 55.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.51 -31.21 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.543 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 76.1 m-85 -149.48 140.58 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 10.9 tp -110.72 106.43 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.0 t -77.46 102.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.93 166.71 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -156.54 -126.79 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 mmt-85 -110.64 175.11 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.7 t0 34.41 38.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.9 p -83.39 118.29 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 457' ' ' SER . . . -82.53 24.06 5.22 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 455' ' ' GLY . 13.5 pt20 36.16 30.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 455' ' ' GLY . 17.3 t -80.66 -29.46 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 441' ' ' VAL . 23.2 mtmt -93.15 -22.68 18.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 93.0 p -69.51 -16.03 63.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.47 -62.76 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -62.7 -46.19 89.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -48.01 -56.12 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.18 66.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -77.96 -18.53 55.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.17 15.04 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.11 29.26 62.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 67.7 m -82.16 127.79 33.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.112 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -74.39 129.94 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 92.2 mt -102.79 121.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 29.7 pt -127.9 173.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.9 p30 -118.34 166.84 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.85 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 471' ' ' ASP . 4.9 pm0 -35.31 -32.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 471' ' ' ASP . 12.4 t0 -71.93 -53.74 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -51.62 -36.55 40.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.59 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 77.6 mt -52.84 -49.21 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -59.38 -41.59 89.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.53 -16.68 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.486 HG22 ' CE2' ' A' ' 433' ' ' TYR . 39.5 mt -89.24 -16.71 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -107.6 -13.66 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -100.48 -31.36 11.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.469 ' CE ' HD12 ' A' ' 410' ' ' LEU . 33.1 mmm -76.27 140.51 69.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.854 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.28 166.45 19.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -133.94 157.95 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.43 164.34 25.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 28.8 t -173.88 142.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -53.29 -35.72 60.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -66.15 144.97 56.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -148.43 176.34 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 36.0 mt -96.41 87.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -45.54 153.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.41 127.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.3 82.9 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 15.2 m -50.39 147.7 4.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 52.4 p -124.59 -46.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.878 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 5.3 t -62.68 -60.87 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.46 -115.66 4.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.471 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.9 m -130.42 -49.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.898 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 16.6 m -72.76 142.6 48.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -169.29 -101.23 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -169.93 133.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.05 150.76 22.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.35 -20.66 56.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 113.09 -84.47 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 10.6 p -73.25 1.76 8.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -175.01 167.97 3.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.05 119.7 30.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 42.8 mm -82.26 122.74 79.49 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.657 0.741 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 121.0 7.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.309 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -75.59 95.95 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -118.71 -133.46 4.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -100.05 -175.17 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.413 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 2.7 pt-20 -102.55 -23.7 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 73.5 m-80 -125.64 30.55 5.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 18.3 p -71.52 -19.26 62.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.407 HD11 ' CG1' ' A' ' 479' ' ' ILE . 84.4 mt -118.66 9.43 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.62 139.28 40.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.07 31.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.406 HD13 ' CE ' ' A' ' 482' ' ' MET . 12.3 mt -93.71 164.23 13.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.434 HD12 ' CG ' ' A' ' 444' ' ' LYS . 73.0 mt -123.33 145.05 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -131.44 155.03 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.422 HG22 ' CG2' ' A' ' 445' ' ' THR . 95.5 t -133.6 105.14 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 54.8 mt -85.93 133.1 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -134.4 130.52 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.177 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.05 -151.31 21.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.454 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.02 154.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.86 147.83 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.89 -58.81 3.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 30.1 t -42.34 -44.81 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.43 158.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 424' ' ' ASP . 15.1 mt-10 -99.58 159.77 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -38.14 -31.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 422' ' ' GLU . 0.2 OUTLIER -76.55 -64.64 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -43.39 -60.91 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -46.63 -45.96 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -54.67 -43.16 72.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -61.11 -38.36 86.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.4 -63.09 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 62.9 mt -45.96 -37.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.35 -34.7 48.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -56.45 -16.24 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.517 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 98.6 m-85 -115.3 -3.47 12.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.44 -45.48 1.28 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -41.18 141.2 1.13 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -102.37 160.44 14.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.0 t -128.36 119.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 12.5 t -124.37 166.44 15.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.7 50.58 0.77 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -170.96 124.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.23 111.69 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' SER . . . . . 0.411 ' HB3' ' CD ' ' A' ' 444' ' ' LYS . 12.9 t -126.67 -175.01 3.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -67.29 -53.52 29.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.434 ' CG ' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -50.76 -19.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 413' ' ' VAL . 35.8 m -62.73 123.7 19.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.401 ' CG ' HD23 ' A' ' 410' ' ' LEU . 8.9 m120 -87.29 -53.32 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.512 ' CE2' ' HD2' ' A' ' 468' ' ' LYS . 57.1 m-85 -126.51 160.21 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 468' ' ' LYS . 10.5 tp -129.94 104.76 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -77.75 105.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.0 mmt -87.9 171.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -169.24 -127.52 0.93 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.0 mmp_? -92.46 167.15 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.3 t70 34.08 36.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 452' ' ' ARG . 54.5 p -69.75 127.19 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.99 139.95 27.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -64.57 -11.7 37.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.937 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 96.3 p -78.91 -27.11 43.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -66.66 -42.91 85.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 460' ' ' ASP . 33.7 p -81.29 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 459' ' ' SER . 0.3 OUTLIER -36.9 -57.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -60.33 -44.5 95.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 465' ' ' LEU . . . -54.46 -64.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -37.99 -52.74 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.93 76.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 462' ' ' ALA . 11.3 mt -92.32 23.11 4.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 40.12 60.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.501 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 20.9 m -110.99 136.15 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 447' ' ' TYR . 21.2 mttp -76.11 141.76 41.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 13.9 mt -118.57 141.67 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.8 pt -152.08 171.09 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -115.83 177.99 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 0.6 OUTLIER -45.75 -35.16 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 21.3 t0 -71.46 -52.08 20.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.91 -45.43 70.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.522 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 50.1 tp -50.55 -41.52 54.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.98 -51.35 62.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.467 ' O ' ' CG ' ' A' ' 482' ' ' MET . 14.5 mt -65.52 -17.04 64.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.517 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 62.5 mt -87.65 -17.46 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -103.97 -28.72 11.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.1 p -85.84 -25.38 26.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.134 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.467 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 63.7 mmm -82.02 140.68 46.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.76 -165.86 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.88 19.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -134.82 152.17 51.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -92.78 89.71 6.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 1.8 m -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt 65.87 42.63 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 490' ' ' GLU . 23.6 m-85 -112.84 159.9 18.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 489' ' ' TYR . 37.6 mt-10 -37.93 139.71 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.44 106.03 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -67.4 105.57 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.072 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.92 141.68 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.105 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.92 51.72 10.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 82.2 p -116.12 94.71 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.14 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 496' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 1.6 t 67.23 42.88 2.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 39.0 m -99.13 -59.89 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -118.44 174.69 15.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.5 m -80.37 176.25 9.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.838 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 14.3 t -88.75 86.84 7.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 36.86 46.29 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.75 107.74 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.72 50.97 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.9 tt -83.89 112.25 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -151.03 36.03 0.9 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.454 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.4 t -103.48 19.04 20.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.893 0.378 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.421 ' NZ ' ' HA ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -104.53 150.96 24.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -113.38 116.32 29.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 45.6 mm -89.32 122.37 68.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -65.33 104.25 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.94 -152.11 8.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.436 ' CB ' ' HA2' ' A' ' 484' ' ' GLY . . . -88.0 -174.97 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -100.53 -26.94 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.465 ' O ' ' CE ' ' A' ' 485' ' ' LYS . 50.7 m-80 -123.23 27.32 7.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 26.5 p -68.43 -10.12 53.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.01 8.97 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . 0.43 ' CD ' ' OD1' ' A' ' 405' ' ' ASN . 14.9 tt0 -68.22 124.24 22.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.33 -29.49 12.25 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 482' ' ' MET . 72.2 mt -81.06 143.3 32.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 93.2 mt -109.15 144.53 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.422 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 38.5 m-85 -129.22 155.35 45.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.12 102.35 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 30.7 mt -84.27 126.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.6 t -132.31 118.43 19.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.47 -161.02 16.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.09 132.0 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.26 179.88 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.57 -42.55 6.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.5 m -63.52 -55.22 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.41 130.5 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.03 156.23 37.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 423' ' ' ARG . 0.8 OUTLIER -40.24 -35.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -49.09 -47.67 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.57 88.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.44 -57.6 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -46.94 -28.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.873 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.21 -53.13 7.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.99 -34.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.88 -29.42 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -61.64 -16.11 45.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.809 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 79.3 m-85 -114.12 -1.78 13.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 110.74 -36.53 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.46 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -44.52 148.68 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -101.2 160.89 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.6 t -137.35 108.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 8.9 t -128.73 150.08 50.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -95.14 50.89 1.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.71 147.42 25.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 54.7 t -99.18 101.75 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 85.0 p -123.19 175.25 6.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.47 -16.4 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -27.2 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.0 m -58.2 120.28 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.503 ' OD1' ' CE1' ' A' ' 447' ' ' TYR . 2.9 t-20 -91.83 -41.01 10.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE1' ' OD1' ' A' ' 446' ' ' ASN . 95.3 m-85 -130.12 156.11 45.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 11.2 tp -131.21 105.68 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.14 104.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.427 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 3.4 mmt -82.7 163.6 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.42 -134.95 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 1.1 mmp_? -87.9 163.27 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 17.4 t70 34.42 36.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 452' ' ' ARG . 3.2 m -83.49 116.32 22.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -59.55 128.36 46.72 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -51.26 -35.88 39.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 90.3 p -46.17 -47.32 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -43.51 -52.99 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.427 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 1.2 t -68.65 -61.05 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 22.8 t70 -38.09 -62.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -58.83 -33.59 70.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -62.93 -50.07 72.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.65 -55.6 27.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -46.97 -50.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.14 -28.76 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.77 48.71 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.521 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.1 m -104.33 150.09 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -90.54 133.04 35.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.1 mp -104.76 120.16 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.88 170.77 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 474' ' ' GLY . 0.9 OUTLIER -120.83 168.49 11.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 471' ' ' ASP . 12.1 pt-20 -35.05 -44.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.44 -43.49 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -58.97 -29.78 65.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.35 -49.34 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.01 -46.75 75.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.72 -40.73 80.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.22 -17.68 20.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.466 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 74.5 mt -86.91 -18.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -102.92 -25.93 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.8 p -84.69 -46.84 11.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.441 ' CE ' HD11 ' A' ' 410' ' ' LEU . 10.7 mmm -59.85 141.06 89.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.528 0.68 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.84 -170.31 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -118.11 153.27 17.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 405' ' ' ASN . 6.0 mtmm -130.66 167.75 18.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -117.42 135.77 53.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 89.9 p -118.44 160.72 21.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -102.94 -40.51 6.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.71 136.91 51.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -113.99 145.54 41.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.04 98.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -117.72 105.58 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.0 p -42.74 139.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.33 167.88 17.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 75.0 p -48.37 158.52 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.6 p -159.35 127.87 5.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 110.881 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.8 t -168.7 165.01 12.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 177.22 68.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.8 m -65.0 135.78 56.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.3 m -78.58 -33.62 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -102.1 95.28 1.29 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.44 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -108.0 17.09 22.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.09 143.4 44.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.6 tp -83.57 -11.2 57.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 98.91 -21.08 47.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 2.1 m -131.16 27.96 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.838 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -147.53 160.93 42.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -134.36 139.33 45.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.17 131.74 80.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.634 0.73 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.442 ' CD ' HD21 ' A' ' 476' ' ' LEU . 53.5 Cg_endo -69.81 120.31 7.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.631 2.221 . . . . 0.0 112.362 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -77.01 98.75 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -117.48 -152.25 9.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -84.6 -174.96 5.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -99.76 -21.42 15.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -126.74 31.55 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 22.6 p -72.68 -19.77 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 55.5 mt -119.12 11.34 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -74.03 116.16 14.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 112.57 -28.15 9.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.438 ' CD1' ' SD ' ' A' ' 482' ' ' MET . 6.5 mt -87.76 149.45 24.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.28 152.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 83.1 m-85 -139.39 140.24 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.17 99.72 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.31 126.42 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.8 t -132.28 118.23 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.88 -170.19 17.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 417' ' ' VAL . 2.2 m -122.5 123.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 0.0 111.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.52 -179.39 4.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -102.74 -67.07 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.2 t -39.97 -47.22 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -150.57 122.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.93 174.5 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -49.25 -57.56 6.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.61 -42.76 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -65.02 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.27 -22.37 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -72.4 -51.22 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.5 m -58.15 -36.18 72.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.39 -63.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.2 mt -48.9 -38.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -75.47 -29.0 59.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -65.75 -14.76 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.459 ' CE2' HG23 ' A' ' 479' ' ' ILE . 72.5 m-85 -113.84 -0.44 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.0 -25.16 19.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.05 150.28 14.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -101.56 146.66 27.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.35 118.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 11.5 t -134.85 154.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.09 -35.35 27.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.28 142.14 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 33.7 t -81.79 137.65 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 59.3 m -123.04 -175.74 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -82.05 -16.54 49.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -89.43 -10.2 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 1.9 m -52.48 121.14 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -88.69 -34.12 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.519 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 71.4 m-85 -150.5 131.24 14.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 12.0 tp -97.62 110.51 23.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.0 t -84.17 102.16 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.436 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 2.8 mmt -80.85 166.21 21.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -166.42 -148.82 5.71 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.3 ttt180 -68.08 151.55 46.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.807 0.336 . . . . 0.0 110.883 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 452' ' ' ARG . 23.8 t70 36.39 44.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 12.1 t -78.24 103.0 7.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -48.24 136.86 15.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -56.93 -45.89 82.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.3 t -37.98 -43.84 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -49.07 -56.61 8.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.436 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 8.4 t -68.16 -34.04 75.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.74 -65.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.19 -37.29 84.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -54.22 -54.78 35.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.06 69.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.15 -56.23 18.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 46.2 mt -71.28 -0.18 9.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 68.47 53.18 22.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.5 m -105.96 129.84 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.153 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -67.07 132.71 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.62 129.07 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.4 pt -137.28 178.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.89 171.94 9.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -39.29 -40.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.83 -46.49 65.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.13 -33.21 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 29.6 tp -66.9 -58.39 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.442 HD21 ' CD ' ' A' ' 400' ' ' PRO . 10.2 mt -45.31 -52.06 10.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -53.99 -48.16 70.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.0 mt -51.32 -25.1 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.459 HG23 ' CE2' ' A' ' 433' ' ' TYR . 62.3 mt -77.37 -27.01 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.5 -11.35 25.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 31.0 p -101.62 -36.03 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.438 ' SD ' ' CD1' ' A' ' 410' ' ' LEU . 2.7 mtp -73.77 140.16 77.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.722 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.3 Cg_endo -69.74 -163.82 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.394 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -134.57 175.36 20.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.439 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.73 136.23 35.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -56.16 160.26 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 29.5 t -163.9 124.99 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -55.37 -42.84 74.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -94.01 157.91 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -151.34 151.46 31.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 16.7 mm -122.46 106.28 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -61.58 154.99 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 10.5 p -78.02 153.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.49 106.25 11.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 31.5 p -98.9 110.77 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.909 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.5 m -123.09 123.86 41.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.832 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 29.7 m -72.59 164.37 26.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -74.86 -95.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.476 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.3 t -48.44 144.74 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 56.0 p -89.89 151.32 21.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 59.85 113.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -103.11 124.14 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -147.59 164.97 31.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -127.16 24.25 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 88.35 -135.57 13.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.1 m -101.01 37.57 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 110.857 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -128.33 151.06 49.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 399' ' ' ILE . 5.4 tp10 -123.98 144.86 49.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.424 ' N ' ' HG3' ' A' ' 398' ' ' GLU . 40.7 mm -77.49 129.35 77.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.722 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 126.23 13.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -82.02 99.65 9.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -119.71 -150.02 8.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -82.73 -175.01 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.41 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.3 pt-20 -99.15 -24.0 15.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 72.3 m-80 -123.49 35.5 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 20.2 p -75.37 -9.0 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.8 mt -131.79 5.68 4.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.96 120.62 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.54 -27.3 17.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.459 HD11 ' CE ' ' A' ' 482' ' ' MET . 20.8 mt -88.98 142.28 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 444' ' ' LYS . 74.9 mt -101.29 151.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.161 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -139.51 146.19 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 85.7 t -124.99 102.76 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 14.5 mt -90.01 121.52 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.39 137.44 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.96 -165.64 51.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -105.74 159.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.155 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.1 mt -140.97 142.29 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.5 -39.28 94.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.414 ' C ' HD12 ' A' ' 421' ' ' ILE . 5.7 t -60.78 -65.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.414 HD12 ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -146.78 141.78 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -67.27 173.56 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -45.04 67.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.45 -42.33 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -61.38 -66.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.25 -37.18 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -54.87 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.0 m -47.06 -37.25 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.42 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 46.2 mt -46.46 -36.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.86 -34.45 57.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -61.08 -18.46 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.479 ' CE2' HD13 ' A' ' 479' ' ' ILE . 88.7 m-85 -108.42 -2.11 19.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.25 -36.61 4.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.98 148.77 2.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -101.02 154.37 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.13 119.21 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 10.0 t -135.02 142.92 46.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . 0.524 ' C ' ' ND2' ' A' ' 440' ' ' ASN . . . -88.07 42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . 0.524 ' ND2' ' C ' ' A' ' 439' ' ' GLY . 1.5 m-80 -162.86 128.85 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.91 0.386 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 39.5 t -81.36 105.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 m -111.51 -174.48 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -71.82 -25.08 61.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.447 ' HB2' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -81.83 -17.52 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.0 m -60.37 128.11 35.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -94.43 -38.2 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.11 153.29 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 52.2 tp -119.07 102.81 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.25 107.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.9 ptp -122.28 169.38 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.74 -104.46 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.3 OUTLIER -82.59 148.15 28.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.1 m-20 35.68 53.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 99.2 p -94.17 125.36 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -67.5 146.02 46.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -94.01 -30.67 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 0.0 110.891 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -55.27 -19.31 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -94.53 -44.72 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.928 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 84.8 p -59.62 -30.55 68.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.53 -54.55 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -54.78 -23.98 20.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -74.36 -60.56 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.16 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -68.95 -64.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 18.3 mt -54.66 -29.66 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.51 43.36 1.59 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.437 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 27.6 m -103.14 135.54 44.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.112 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -74.97 138.05 42.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 66.7 mt -109.5 130.57 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 35.8 pt -142.7 172.21 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.3 p-10 -115.4 169.0 9.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -39.8 -25.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 471' ' ' ASP . 25.8 t70 -74.97 -49.49 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -61.51 -31.01 76.08 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 24.3 tp -64.02 -49.3 72.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.72 -51.94 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -57.49 -34.65 69.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.4 -15.06 32.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 433' ' ' TYR . 55.5 mt -89.22 -24.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.17 -29.01 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.1 p -82.69 -38.56 23.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.459 ' CE ' HD11 ' A' ' 410' ' ' LEU . 18.4 mmm -69.57 142.06 91.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 0.0 110.895 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -135.07 169.16 23.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -133.42 155.42 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -98.01 85.3 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 57.4 p -72.78 149.58 43.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -45.16 -51.89 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -87.4 127.24 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -99.24 167.48 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.34 125.21 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -94.13 139.34 31.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.53 138.69 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -49.52 167.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 90.6 m -147.24 132.21 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 4.2 t -67.49 109.62 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 18.2 p -166.02 118.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 389' ' ' SER . . . -161.63 62.99 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 388' ' ' GLY . 1.9 t 35.41 43.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 41.0 m -115.98 117.84 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 392' ' ' LYS . . . 140.11 -179.62 18.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 391' ' ' GLY . 14.4 pttt 34.62 44.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -126.74 144.05 51.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.3 tt -73.25 117.74 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -125.67 65.04 0.56 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.541 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.7 t -134.29 22.35 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 0.0 110.851 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -153.62 177.35 11.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -123.16 124.66 43.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 15.0 mm -86.12 120.1 72.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.635 0.731 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 120.29 7.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.72 2.28 . . . . 0.0 112.401 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 108.46 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -130.56 -141.12 4.83 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.431 ' O ' ' CD2' ' A' ' 433' ' ' TYR . . . -95.0 -176.15 3.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.28 -24.73 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 36.1 m-20 -124.58 29.55 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 17.2 p -68.54 -23.57 64.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.2 mt -114.74 2.66 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -66.57 145.22 55.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 85.94 -26.37 6.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.84 159.45 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.449 HD12 ' CG ' ' A' ' 444' ' ' LYS . 96.7 mt -122.11 155.12 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 55.4 m-85 -142.55 145.72 33.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.99 100.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 49.3 mt -81.4 122.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.469 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.7 t -126.6 115.13 19.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 106.95 -153.92 16.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.66 158.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 111.156 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.84 159.51 41.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 420' ' ' SER . 4.0 tp10 -77.21 -69.44 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 419' ' ' GLU . 20.1 m -35.22 -61.82 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.32 161.68 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' A' ' 422' ' ' GLU . 6.9 mp0 -102.76 164.12 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 16.4 tpt85 -42.48 -30.87 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -65.76 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.93 -55.2 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.35 -53.22 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -44.91 -51.19 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 32.5 t -52.62 -34.06 49.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.47 -67.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 435' ' ' GLY . 65.4 mt -46.25 -35.79 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.56 -28.88 37.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -63.59 -19.78 65.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.518 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 66.7 m-85 -112.47 2.29 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 435' ' ' GLY . . . 112.21 -45.87 1.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.525 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -37.97 148.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -102.06 161.42 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.61 125.01 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 12.8 t -144.16 170.49 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -118.65 50.86 0.78 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -156.35 135.19 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 107.31 15.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 -175.12 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.459 ' HD3' ' CD2' ' A' ' 465' ' ' LEU . 0.0 OUTLIER -73.39 -48.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -50.65 -28.71 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.457 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 89.2 m -55.36 124.27 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.073 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -95.66 -44.74 7.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.566 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 61.4 m-85 -128.7 159.39 35.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 35.1 tp -130.09 102.88 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.03 107.96 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.469 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 24.0 mtm -112.65 179.85 3.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.34 -102.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.6 mmm-85 -92.41 161.24 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.2 t70 34.37 48.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.9 p -87.62 168.42 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -117.8 143.36 17.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 -28.84 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 89.7 p -59.54 -21.55 60.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 459' ' ' SER . 34.3 mttm -86.5 -67.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 458' ' ' LYS . 13.5 p -36.57 -64.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 461' ' ' LYS . 0.2 OUTLIER -42.09 -51.73 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . 0.497 ' N ' ' CG ' ' A' ' 460' ' ' ASP . 0.0 OUTLIER -63.11 -31.74 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 459' ' ' SER . . . -65.2 -48.17 74.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.34 83.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.92 -30.63 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.459 ' CD2' ' HD3' ' A' ' 443' ' ' LYS . 14.0 mt -87.96 -24.23 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.18 28.45 5.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.453 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 4.1 m -92.95 137.36 32.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.356 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -81.22 114.29 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 81.9 mt -86.02 131.83 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.414 HD13 ' C ' ' A' ' 474' ' ' GLY . 7.5 pt -148.98 178.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -117.94 -179.28 3.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.58 -29.95 12.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.08 -51.21 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 470' ' ' ILE . . . -54.95 -30.94 54.95 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.505 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.44 -42.78 95.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.31 -52.96 61.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -59.26 -30.24 68.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.07 -15.18 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.518 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 69.7 mt -88.68 -20.54 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -102.62 -24.55 13.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 36.7 p -87.66 -31.36 19.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 25.9 mmm -75.88 141.1 71.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.51 20.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.434 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 50.3 mttm -138.41 158.04 45.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -108.04 90.24 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.6 t -85.66 145.8 27.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -72.66 -35.13 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.976 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.83 174.43 5.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.06 144.04 29.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 62.2 mt -97.55 121.21 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.05 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.24 140.21 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -98.07 142.98 29.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 29.3 p -73.28 100.32 3.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.156 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.862 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.8 t -157.47 166.52 32.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 97.9 p -40.15 128.93 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 162.35 161.29 11.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.473 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 9.1 t -63.03 101.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 2.2 m -165.74 157.87 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -107.58 147.17 16.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -87.5 -55.41 3.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.42 164.91 3.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.63 154.83 46.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -155.25 153.61 24.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.8 m 59.57 25.34 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.857 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -172.29 157.14 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -124.84 114.89 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 23.5 mm -90.34 119.7 69.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.623 0.725 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 132.82 24.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.315 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -80.82 84.58 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -99.15 -157.58 29.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -74.0 -175.09 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 111.069 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -101.65 -21.29 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.2 29.92 5.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 15.8 p -69.5 -21.73 63.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 20.9 mt -111.77 -0.77 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.28 115.47 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.3 26.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.77 140.3 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 80.6 mt -106.83 149.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 82.4 m-85 -135.61 157.57 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.07 106.98 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.452 ' CG2' ' HD2' ' A' ' 423' ' ' ARG . 39.1 mt -88.16 126.35 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.7 t -132.64 116.08 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 105.05 -154.47 17.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.09 155.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.4 mt -138.07 152.89 49.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -74.36 -63.26 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 419' ' ' GLU . 48.1 m -37.67 -39.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.2 pt -161.19 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 423' ' ' ARG . 56.4 mt-10 -94.75 162.16 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.452 ' HD2' ' CG2' ' A' ' 414' ' ' ILE . 13.8 tpt180 -38.36 -35.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 427' ' ' LYS . 4.8 t70 -74.91 -66.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.872 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -43.78 -42.44 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.61 -30.96 67.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 424' ' ' ASP . 21.2 ttmt -67.19 -51.18 56.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.8 m -55.87 -25.29 41.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.59 -57.1 4.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.478 HG23 ' CD1' ' A' ' 412' ' ' PHE . 22.5 mt -54.7 -45.71 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -72.44 -26.89 62.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -67.07 -14.68 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.509 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 73.7 m-85 -115.02 8.64 15.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.27 -6.8 63.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -70.79 170.11 47.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -126.94 154.13 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.4 t -129.78 123.16 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.07 172.23 7.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.42 10.84 61.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.71 149.78 16.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.28 117.79 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.9 m -121.75 177.62 5.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -59.09 -15.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -90.15 -21.64 22.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 96.1 m -61.06 126.63 28.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -93.7 -38.58 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.553 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 60.0 m-85 -138.94 148.33 43.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 9.0 tp -115.05 104.26 11.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.51 104.62 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 12.7 mtt -86.29 176.13 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -174.08 -123.76 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 2.2 mmp_? -96.94 156.95 16.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.6 t70 34.56 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 29.2 m -60.35 161.03 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -89.53 175.58 42.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -95.62 -47.12 6.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 94.2 p -57.16 -27.77 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -55.08 -58.28 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 460' ' ' ASP . 3.9 t -73.07 -54.74 7.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.794 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 17.9 t70 -37.6 -70.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -55.06 -34.92 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.38 -65.39 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -50.14 -21.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -75.44 -65.31 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.18 -5.83 15.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 83.54 49.77 4.75 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 25.0 m -94.52 133.96 37.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -80.92 102.24 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 48.3 mt -73.91 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.6 pt -147.81 165.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -114.24 179.31 3.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.5 -25.41 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.93 -40.38 18.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -69.15 -34.65 76.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.3 tp -64.23 -41.19 97.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 78.5 mt -61.19 -40.8 95.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -34.75 79.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.521 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.3 mt -64.49 -14.76 58.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.509 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 49.5 mt -92.37 -17.57 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -103.54 -22.79 13.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.7 p -91.96 -31.78 15.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 19.7 mmm -74.05 140.48 77.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.597 0.713 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.99 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -129.55 171.67 20.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -139.46 142.44 37.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -84.99 102.93 13.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 12.2 t -118.31 165.83 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -70.54 -25.66 63.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -70.55 147.02 49.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -147.92 149.03 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 4.6 mp -98.07 120.35 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -88.24 112.1 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' ' 494' ' ' GLU . 5.9 p -132.92 141.83 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.419 ' N ' HG21 ' A' ' 493' ' ' VAL . 12.3 tp10 -122.27 89.74 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 11.1 t -83.74 150.38 25.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 30.6 m -94.22 -47.92 6.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 13.8 t -161.28 153.38 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -59.33 145.74 44.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.5 p -86.86 114.76 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.823 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 99.7 p -99.71 177.05 5.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 101.51 -163.16 17.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.462 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -75.49 145.36 41.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.9 90.05 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.074 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tp -106.5 146.03 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -148.66 59.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.8 m -122.71 23.8 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.856 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.425 ' NZ ' ' HA ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -118.7 149.99 40.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.927 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -102.13 126.11 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.417 ' CG2' ' HD2' ' A' ' 400' ' ' PRO . 30.4 mm -94.37 135.39 24.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 111.139 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 399' ' ' ILE . 53.3 Cg_endo -69.81 118.54 5.74 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.309 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -60.1 107.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -131.61 -144.3 5.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.479 ' CB ' ' CA ' ' A' ' 484' ' ' GLY . . . -96.44 -175.66 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.59 -21.25 17.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -126.04 18.24 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 15.6 p -58.59 -12.29 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 70.5 mt -127.46 5.28 6.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.24 148.81 49.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.88 -29.33 3.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.6 152.6 22.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.899 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 86.4 mt -114.68 154.32 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -139.01 152.48 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.29 101.9 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.1 mt -84.48 128.11 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.2 t -126.04 134.23 51.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.85 -159.45 41.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.463 HG22 ' CG ' ' A' ' 452' ' ' ARG . 4.2 m -122.95 160.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.5 mt -137.62 158.25 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 420' ' ' SER . 24.4 tt0 -80.76 -66.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 419' ' ' GLU . 27.3 m -38.49 -41.74 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.77 170.5 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -111.78 166.43 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -44.13 -40.17 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 424' ' ' ASP . 2.2 t0 -68.45 -63.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -48.18 -58.86 3.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.17 53.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -69.7 -50.13 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.8 t -54.94 -32.78 61.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -63.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.402 HD12 ' CG2' ' A' ' 437' ' ' VAL . 73.5 mt -46.99 -48.5 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.174 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.78 -38.58 91.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.93 -14.69 9.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.435 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 72.8 m-85 -113.77 5.05 16.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 103.61 -37.47 3.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 407' ' ' LEU . . . -46.42 152.91 1.08 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -102.8 154.5 19.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.402 ' CG2' HD12 ' A' ' 430' ' ' ILE . 55.4 t -131.98 124.72 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 11.9 t -139.62 171.09 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.171 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.1 -33.43 6.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.532 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -94.18 139.12 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 40.2 t -90.09 127.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 18.0 m -122.14 -174.68 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.66 -11.86 59.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.419 ' NZ ' ' HB3' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -89.29 -20.29 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 56.3 m -52.85 131.64 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.65 -40.06 9.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -141.15 153.37 45.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.41 106.33 11.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 105.4 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 9.1 mtt -87.37 168.76 12.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -153.62 -111.98 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.463 ' CG ' HG22 ' A' ' 417' ' ' VAL . 0.0 OUTLIER -128.28 173.15 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 8.7 t0 34.45 38.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 83.1 p -80.38 -178.17 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -112.09 -168.88 18.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -104.6 -41.39 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.8 m -51.72 -45.7 63.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.31 -57.58 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 460' ' ' ASP . 54.8 p -66.35 -57.05 8.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 459' ' ' SER . 3.9 t70 -35.07 -61.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -59.07 -57.26 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -41.97 -58.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.65 78.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -51.27 -42.99 61.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.3 mt -80.71 -24.58 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 94.3 56.84 1.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 88.9 m -112.36 136.43 51.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -70.78 135.82 48.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 71.0 mt -107.84 123.52 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.08 165.49 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -110.14 175.2 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -38.72 -44.51 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.76 -49.59 57.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.63 -22.62 25.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.79 -47.96 28.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.72 -44.7 90.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.407 ' ND2' HG23 ' A' ' 481' ' ' THR . 39.9 t30 -58.5 -34.69 71.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.423 ' O ' ' CG ' ' A' ' 482' ' ' MET . 11.1 mt -64.97 -15.06 61.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.15 -15.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -106.18 -31.05 8.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.407 HG23 ' ND2' ' A' ' 477' ' ' ASN . 40.1 p -83.24 -27.83 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 32.0 mmm -77.49 142.65 67.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 0.0 110.844 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -165.91 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.479 ' CA ' ' CB ' ' A' ' 403' ' ' ALA . . . -134.2 158.39 23.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.463 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -127.9 172.31 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.12 146.83 40.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 2.1 t -135.85 143.94 45.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -54.75 10.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -115.06 131.51 56.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -104.63 170.08 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.0 mt -104.76 118.47 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.66 65.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.089 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.74 128.94 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.95 91.41 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.0 t -160.79 127.67 4.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 78.3 p -81.17 -43.92 18.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 36.7 t -118.03 160.06 22.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.822 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -146.99 -61.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 92.8 p -68.03 113.68 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 58.2 p -109.29 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 69.02 167.26 4.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -135.98 155.38 50.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -104.08 108.47 19.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.457 HD23 ' CG2' ' A' ' 421' ' ' ILE . 4.3 pp -79.17 -8.22 58.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 158.1 -133.2 3.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 4.0 m -104.06 36.82 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -116.06 174.04 6.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.95 123.28 36.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.95 121.39 68.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 122.37 9.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -76.96 96.18 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -111.17 -141.53 8.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.462 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -87.43 -175.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.13 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -102.61 -22.39 13.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -126.14 31.19 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.6 -19.62 62.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.4 mt -117.44 7.16 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.38 133.73 51.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 89.38 -25.62 10.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.411 ' CD1' ' HE2' ' A' ' 482' ' ' MET . 84.9 mt -83.48 143.46 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.97 149.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -139.65 148.6 42.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 88.9 t -125.61 101.63 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 34.2 mt -83.12 128.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.0 t -130.57 143.57 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.55 -144.96 34.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.14 152.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.63 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -65.98 -61.03 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 31.8 m -38.23 -59.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.457 ' CG2' HD23 ' A' ' 394' ' ' LEU . 1.4 pt -140.91 153.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.91 175.03 9.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -55.08 -46.89 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -63.27 -55.8 21.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -62.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.3 -48.44 25.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -48.28 -55.21 11.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.0 m -50.87 -37.36 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.17 -65.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 435' ' ' GLY . 49.9 mt -46.69 -39.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.22 -27.52 42.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -64.93 -19.4 65.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.514 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 76.0 m-85 -110.86 4.56 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.27 -25.0 23.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 430' ' ' ILE . . . -52.71 170.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.468 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 154.47 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.21 121.71 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.26 158.1 42.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.176 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -100.13 50.36 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -164.46 144.26 7.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.57 104.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 22.2 m -128.16 174.51 9.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -53.61 -56.65 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.81 -30.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 29.3 m -57.7 130.64 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -99.08 -35.13 10.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.47 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 67.3 m-85 -143.82 164.67 29.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 22.7 tp -131.01 110.6 11.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.91 104.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.427 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 4.4 mmt -96.73 159.89 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -146.36 -140.21 3.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -93.54 164.78 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.5 t70 38.29 46.83 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 20.3 p -83.18 -177.91 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -109.65 -179.68 20.96 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -108.28 -12.49 15.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.5 m -74.46 -49.3 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -56.54 -53.16 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.427 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 53.2 p -61.06 -42.71 99.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.89 -67.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 462' ' ' ALA . 32.4 tptt -59.8 -54.46 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -36.26 -46.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.085 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.57 49.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -50.86 -47.5 60.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 -26.89 63.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 87.91 50.49 3.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 468' ' ' LYS . 40.0 m -98.8 148.23 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 111.139 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.47 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 13.2 mmmt -79.85 112.65 17.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 63.7 mt -90.73 124.85 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.19 165.6 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.29 176.55 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -28.61 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.08 -49.09 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.84 61.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.74 -36.73 70.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.74 -33.37 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -70.17 -29.49 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.65 -22.91 64.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.514 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 67.4 mt -83.3 -16.88 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -103.45 -10.81 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 50.9 p -106.16 -39.41 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.411 ' HE2' ' CD1' ' A' ' 410' ' ' LEU . 34.3 mmm -66.87 141.65 96.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.572 0.701 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -164.17 0.12 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.727 2.285 . . . . 0.0 112.35 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -131.7 166.82 22.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 486' ' ' LYS . 31.4 mttm -139.52 166.3 24.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 485' ' ' LYS . 12.9 mtmt 33.23 46.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 93.0 p -120.25 171.7 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 488' ' ' LYS . 0.0 OUTLIER -113.34 -32.42 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -59.08 161.05 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.7 170.07 9.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 66.4 mt -99.79 119.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -106.07 135.42 47.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 89.8 t -97.46 131.12 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.64 131.22 11.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 69.9 p -42.57 133.81 3.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.183 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 51.0 m -103.62 99.78 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.356 . . . . 0.0 110.854 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 62.3 m -56.79 127.99 34.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 148.52 -52.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 1.4 t -54.77 163.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 50.8 p -101.87 167.22 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . 0.455 ' CA ' ' HG3' ' A' ' 425' ' ' GLU . . . 65.58 115.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -111.59 39.45 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -76.42 147.39 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.1 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -108.61 -10.22 15.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 118.81 0.64 15.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 33.0 m -116.44 16.93 15.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 110.809 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -125.97 96.25 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.29 131.26 35.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 14.6 mm -90.04 125.47 60.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.592 0.71 . . . . 0.0 111.1 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 122.94 9.61 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -81.9 107.9 14.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.98 -138.73 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.46 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -93.74 -174.94 3.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.413 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.5 pt-20 -99.65 -20.9 16.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.413 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 70.7 m-80 -127.25 28.09 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 23.9 p -66.74 -21.95 66.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.94 17.3 10.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.67 146.61 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.52 2.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.454 HD12 ' CE ' ' A' ' 482' ' ' MET . 80.6 mt -77.16 152.18 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.452 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 67.3 mt -118.26 139.99 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.414 ' N ' HG21 ' A' ' 411' ' ' ILE . 48.3 m-85 -125.62 148.33 49.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.1 104.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.406 ' CD1' HG13 ' A' ' 437' ' ' VAL . 75.3 mt -86.55 126.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -131.48 125.92 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.53 -149.88 20.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.03 146.41 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.2 mt -117.14 166.85 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -90.85 -57.29 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.5 m -48.69 -29.28 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -163.72 173.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -104.94 -176.29 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.78 -38.79 87.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.25 -50.81 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.455 ' HG3' ' CA ' ' A' ' 391' ' ' GLY . 5.1 mp0 -53.98 -58.57 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.88 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.109 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -49.53 -50.09 43.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 47.4 t -56.0 -40.24 73.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.1 tp -65.07 -63.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.401 HD12 ' CG2' ' A' ' 437' ' ' VAL . 64.6 mt -45.79 -40.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -77.75 -33.16 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -57.74 -20.81 37.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.499 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 81.5 m-85 -109.2 -4.76 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.12 -35.43 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.62 154.52 0.84 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -109.01 159.98 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 414' ' ' ILE . 79.8 t -131.71 118.02 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.73 139.06 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.67 3.75 72.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -115.3 131.62 56.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.77 120.38 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.9 m -128.75 -175.25 3.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.407 ' CG ' HD22 ' A' ' 465' ' ' LEU . 55.0 mtpt -71.76 -42.99 66.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -58.26 -25.56 61.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 24.3 m -51.46 138.26 22.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.14 -48.51 4.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 468' ' ' LYS . 87.1 m-85 -130.51 153.45 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 5.0 tp -120.15 104.34 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.0 105.24 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 7.1 mtt -80.98 175.61 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -164.9 -109.24 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.5 mmt180 -125.78 165.6 18.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.6 t0 34.32 37.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 452' ' ' ARG . 20.0 m -77.59 136.17 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.16 124.09 9.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -56.99 -23.02 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.8 t -65.88 -15.17 62.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -82.83 -48.45 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 88.1 p -67.43 -25.49 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.48 -46.24 64.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -37.34 47.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.21 69.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.11 89.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -53.91 -46.35 71.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.407 HD22 ' CG ' ' A' ' 443' ' ' LYS . 16.1 mt -76.16 -24.84 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.63 49.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 54.6 m -100.0 135.77 40.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.519 ' CB ' ' CD1' ' A' ' 447' ' ' TYR . 10.1 mmtp -72.56 117.67 14.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.422 ' C ' HG21 ' A' ' 470' ' ' ILE . 21.6 mt -90.71 128.66 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.422 HG21 ' C ' ' A' ' 469' ' ' ILE . 42.6 pt -141.42 170.99 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.5 178.19 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.75 -35.91 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.87 -37.65 73.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -64.35 -31.58 81.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.06 -52.95 35.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.3 -51.98 66.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.98 -38.12 67.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.5 mt -60.55 -20.55 60.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.499 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 70.7 mt -84.84 -14.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -109.9 -7.83 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.4 p -107.75 -42.07 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.454 ' CE ' HD12 ' A' ' 410' ' ' LEU . 9.9 mtp -64.89 143.48 98.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.508 0.671 . . . . 0.0 110.874 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -165.75 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -139.74 164.19 26.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -123.96 153.5 41.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -99.92 99.65 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.899 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 45.4 t -82.82 136.73 34.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.839 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -61.81 -29.32 70.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 490' ' ' GLU . 2.0 p90 -113.26 144.64 42.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . 0.566 ' O ' ' CD2' ' A' ' 489' ' ' TYR . 12.3 pt-20 -78.91 164.78 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.7 mm -99.73 111.09 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -128.1 114.96 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.33 137.6 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.152 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -88.15 111.98 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 t -120.74 158.15 28.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.4 p -123.14 169.66 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 28.4 p -110.6 -3.75 15.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 141.95 100.65 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -124.42 137.87 54.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.893 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 82.8 p -76.39 155.92 33.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -90.23 -157.27 33.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -107.91 129.17 55.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -151.4 127.8 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 395' ' ' GLY . 10.9 tp -165.38 154.36 12.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.426 ' N ' ' HG ' ' A' ' 394' ' ' LEU . . . -59.4 -120.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.458 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 50.1 m -116.88 38.04 3.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -105.28 173.69 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -125.42 112.99 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.64 116.6 39.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 117.88 5.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.61 101.24 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.78 -156.56 10.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -73.73 -175.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.114 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.86 -28.09 12.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -122.65 28.98 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 14.7 p -69.05 -14.61 63.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.94 -2.58 11.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.96 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.7 20.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 57.6 mt -86.67 134.56 33.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 412' ' ' PHE . 45.6 mt -99.56 155.68 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 56.0 m-85 -145.01 148.99 34.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 51.6 t -128.97 104.91 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 28.1 mt -85.99 133.87 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.7 t -130.54 141.57 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -151.17 42.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.508 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 m -130.22 153.13 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 16.9 mt -123.57 161.7 24.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.89 -61.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.1 p -48.45 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.14 122.16 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.49 178.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.99 -40.19 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.08 -61.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -43.94 -47.99 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.82 92.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -55.09 -52.16 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -54.75 -39.7 68.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.85 -57.94 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 26.0 mt -49.08 -49.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.11 -34.86 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -58.73 -16.87 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.516 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 64.4 m-85 -113.11 11.38 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.26 -28.83 12.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -50.16 168.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -121.21 151.86 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.82 127.86 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 3.1 t -143.02 170.19 16.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.92 -26.81 8.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -93.1 137.73 32.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.75 109.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 m -121.06 179.08 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -54.66 -46.16 73.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -26.93 16.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 28.9 m -55.0 117.99 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -90.31 -39.72 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.527 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 92.1 m-85 -137.88 155.62 48.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 3.1 tp -125.25 107.01 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.2 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 8.4 mmt -93.58 157.57 16.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -140.47 -117.24 1.38 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.2 ptp180 -123.15 170.64 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.865 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 2.2 t70 34.43 37.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 452' ' ' ARG . 29.0 m -95.54 150.85 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -74.92 161.06 53.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -85.24 -33.44 22.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -54.45 -46.59 73.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -46.71 -27.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.4 p -88.87 -47.07 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -42.42 -43.06 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -73.47 -39.5 64.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.16 -57.46 12.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 466' ' ' GLY . . . -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -42.91 -48.66 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.36 -16.75 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 463' ' ' ALA . . . 89.01 55.27 2.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 18.1 m -109.43 138.49 45.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.1 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.18 127.17 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.99 124.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . 0.407 HD12 ' CA ' ' A' ' 475' ' ' LEU . 23.2 pt -130.62 177.78 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.05 -179.25 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.11 -28.62 18.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.15 -45.24 15.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -63.99 -28.46 72.82 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.407 ' CA ' HD12 ' A' ' 470' ' ' ILE . 61.5 tp -67.87 -40.0 83.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.959 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.03 -30.15 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -70.68 -38.93 73.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.4 mt -59.73 -17.34 34.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.516 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 87.5 mt -86.92 -24.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.76 -9.88 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.1 p -103.54 -41.66 5.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 13.0 mmm -67.12 139.88 95.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -165.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -125.63 170.39 17.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -138.02 160.27 39.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -99.45 118.62 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 32.1 t -121.12 172.07 8.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -42.47 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.56 148.09 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . 0.407 ' OE2' ' C ' ' A' ' 490' ' ' GLU . 0.0 OUTLIER -132.35 162.86 30.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.37 127.52 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.69 159.09 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.77 122.28 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -89.4 149.01 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 57.6 m -88.65 135.85 33.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 87.1 p -118.85 -44.25 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.0 110.899 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.9 t -54.55 128.7 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -116.4 141.44 16.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.526 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.7 t -41.14 100.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.5 m -135.14 127.01 29.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -118.83 71.58 0.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 110.28 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 394' ' ' LEU . . . -143.89 132.78 22.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 393' ' ' ALA . 9.8 tt -37.57 98.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -114.92 -26.28 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.485 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 12.7 p -76.9 1.61 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.994 0.426 . . . . 0.0 110.898 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -139.22 -178.89 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -135.99 124.02 22.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.36 127.11 93.12 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.563 0.697 . . . . 0.0 111.099 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 117.38 5.05 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.227 . . . . 0.0 112.379 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -79.95 84.3 5.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -100.21 -138.18 10.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -91.88 -174.86 3.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.36 -21.08 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.432 ' O ' ' NZ ' ' A' ' 485' ' ' LYS . 76.3 m-20 -126.77 33.3 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.54 -10.47 59.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 79.0 mt -128.37 6.8 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.9 118.5 9.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.38 -30.69 9.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.95 140.16 36.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 412' ' ' PHE . 75.3 mt -106.28 142.97 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 61.2 m-85 -130.42 148.1 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 438' ' ' THR . 84.9 t -122.47 101.87 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.89 123.27 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 8.4 t -122.74 144.21 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -153.15 45.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 11.5 m -130.94 160.83 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 7.5 mt -137.68 151.69 48.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -75.95 -62.66 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 8.9 m -40.39 -42.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 4.7 pt -150.51 162.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 424' ' ' ASP . 14.8 mt-10 -102.67 155.53 18.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 422' ' ' GLU . 9.5 tpt85 -35.68 -32.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 422' ' ' GLU . 3.3 m-20 -73.8 -66.59 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -41.1 -65.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -41.09 -44.49 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -53.35 -52.88 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 t -51.13 -39.57 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -60.27 3.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 37.4 mt -55.33 -43.71 72.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.81 -31.18 67.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -63.46 -31.03 72.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -96.28 4.84 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.23 -27.58 19.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -48.38 161.08 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -110.82 154.79 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.69 114.92 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' THR . . . . . 0.408 ' CG2' HG22 ' A' ' 413' ' ' VAL . 13.8 t -130.72 170.27 14.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -112.38 51.76 0.68 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -172.55 150.03 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.6 109.24 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' SER . . . . . 0.475 ' HB2' ' CE ' ' A' ' 444' ' ' LYS . 1.7 m -127.63 -176.13 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.835 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -61.14 -40.29 93.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.475 ' CE ' ' HB2' ' A' ' 442' ' ' SER . 0.0 OUTLIER -64.41 -25.45 68.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.6 m -61.68 136.63 58.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -105.48 -49.48 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.56 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 72.5 m-85 -129.62 154.96 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 11.3 tp -122.78 102.81 8.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.5 t -77.5 104.65 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.6 mtp -77.01 178.6 6.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 175.9 44.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.415 ' HG3' ' N ' ' A' ' 453' ' ' ASP . 1.0 OUTLIER -53.32 146.81 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.415 ' N ' ' HG3' ' A' ' 452' ' ' ARG . 1.6 t70 43.57 54.28 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.7 m -106.71 127.99 53.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -52.33 150.14 9.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.81 -39.76 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -44.31 -39.63 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -50.7 -41.88 56.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.2 p -73.55 -29.13 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -54.91 -56.97 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -63.12 -47.51 82.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -42.97 -56.15 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.22 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.32 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.47 -30.91 68.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 101.92 42.57 2.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 468' ' ' LYS . 94.9 m -97.5 140.37 32.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.458 ' N ' HG23 ' A' ' 467' ' ' THR . 12.3 mmtt -81.63 109.64 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 72.5 mt -82.97 129.69 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.131 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.6 pt -140.33 173.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 472' ' ' GLU . 3.0 p30 -120.81 172.5 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 3.0 pm0 -35.15 -43.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 32.7 t0 -66.23 -52.79 44.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -50.8 -42.03 45.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 53.7 tp -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.8 -51.9 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.0 -36.52 65.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.1 -25.77 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.58 -27.27 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -91.31 -28.48 17.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -83.26 -47.89 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 15.4 mmm -57.77 141.86 79.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.892 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.73 169.67 22.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 405' ' ' ASN . 23.8 mttp -134.61 113.15 11.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -57.33 127.56 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 50.9 p -129.32 145.52 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -67.87 -44.31 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -101.95 -176.29 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -115.24 178.12 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.58 115.38 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.65 13.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 13.8 p -46.61 136.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -133.38 126.91 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 26.7 m -89.91 111.67 22.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 57.9 m -91.67 165.81 13.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 63.5 p -154.27 141.97 19.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -128.76 -136.74 4.21 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.2 p -134.88 125.14 26.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 15.5 t -76.75 132.41 39.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 137.54 106.12 0.75 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -91.16 -55.12 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.8 132.38 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 395' ' ' GLY . 7.2 tt -58.23 113.39 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . 37.17 -135.6 0.77 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.4 t -96.71 34.04 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.877 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -120.15 -179.75 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -127.9 119.58 25.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.1 mm -81.32 121.24 80.02 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.623 0.725 . . . . 0.0 111.15 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 116.42 4.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.39 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -75.94 83.13 2.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -96.92 -142.44 13.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 406' ' ' CYS . . . -79.16 -174.96 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 5.1 pt-20 -103.22 -33.03 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 404' ' ' GLU . 51.2 m-80 -122.47 26.28 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 403' ' ' ALA . 17.2 p -63.03 -16.24 59.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.11 7.38 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.95 128.48 36.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.79 21.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.469 HD13 ' CE ' ' A' ' 482' ' ' MET . 7.5 mt -87.74 145.64 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 444' ' ' LYS . 68.4 mt -110.84 147.39 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -132.77 138.99 47.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.73 101.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.451 ' CD1' HG11 ' A' ' 437' ' ' VAL . 62.5 mt -81.06 119.63 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.1 t -121.36 116.02 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.48 -153.12 18.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.03 158.17 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.23 148.62 49.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.7 -58.12 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.5 m -44.71 -41.92 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 3.0 pt -152.17 161.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.118 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.58 168.35 9.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -45.68 -35.56 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 427' ' ' LYS . 14.1 t70 -77.48 -63.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -38.76 -48.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -66.05 -37.67 86.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 424' ' ' ASP . 50.7 tttt -58.88 -45.21 90.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -23.04 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 20.4 tp -81.47 -64.23 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.405 ' CG1' HD21 ' A' ' 475' ' ' LEU . 27.6 mt -48.12 -36.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -76.68 -29.81 56.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.65 -14.55 61.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 479' ' ' ILE . 81.4 m-85 -114.01 6.91 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.19 -26.87 22.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.57 165.89 2.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -122.07 159.93 26.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 414' ' ' ILE . 94.5 t -133.62 117.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.3 t -132.24 164.41 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.93 49.3 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -169.59 134.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.887 0.375 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 81.2 t -79.9 121.01 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 29.8 t -127.69 179.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -71.39 -25.92 62.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.416 ' HB2' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -79.59 -15.25 57.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -61.82 119.25 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -93.83 -40.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 80.6 m-85 -133.18 153.98 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.47 108.38 11.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.38 102.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.3 ptp -103.59 170.99 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 -103.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 453' ' ' ASP . 15.9 mmt180 -91.09 159.53 16.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.9 t70 34.4 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.3 t -82.78 105.64 13.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -56.01 173.76 1.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -113.22 -3.49 13.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.0 t -75.29 -32.62 61.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -81.87 -57.89 3.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.0 p -46.0 -58.58 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -38.45 -43.73 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -69.07 -49.54 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -40.87 -58.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.44 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.29 -24.34 63.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.8 mt -98.76 17.79 18.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.77 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.472 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 60.6 m -103.48 126.49 50.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.107 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.425 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.2 OUTLIER -72.39 111.44 7.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 16.8 mt -81.97 122.5 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 28.0 pt -137.96 172.41 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.89 175.42 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -38.62 -46.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -67.77 -49.56 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.91 -30.22 9.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . 0.405 HD21 ' CG1' ' A' ' 430' ' ' ILE . 50.9 tp -71.64 -62.22 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 29.9 mt -43.09 -41.93 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.23 -36.69 82.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.89 -23.07 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.513 HG21 ' CZ ' ' A' ' 433' ' ' TYR . 60.4 mt -81.09 -15.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.129 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -105.36 -8.8 17.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 -38.79 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.469 ' CE ' HD13 ' A' ' 410' ' ' LEU . 2.5 mtp -62.93 142.26 97.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.1 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.94 155.23 17.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.527 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.468 ' HG3' ' CB ' ' A' ' 405' ' ' ASN . 4.5 ptpp? -140.46 146.77 38.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -70.01 139.01 52.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 1.9 t -66.77 158.94 29.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -76.09 -37.12 58.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -81.23 162.51 23.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.15 166.83 16.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.0 mp -93.59 127.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -92.41 135.43 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 494' ' ' GLU . 8.8 p -70.1 140.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 493' ' ' VAL . 14.9 pt-20 -58.26 117.8 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 65.5 p -109.93 102.69 11.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.3 m -39.87 148.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 24.1 p -76.35 156.26 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 151.72 -120.19 1.06 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.519 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.2 m -119.36 159.77 23.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -60.21 -45.22 93.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -140.5 176.43 21.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -122.92 112.47 17.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . 67.28 54.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.094 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 395' ' ' GLY . 0.1 OUTLIER -85.46 -15.4 43.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . 33.96 43.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.5 p -122.11 2.57 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.837 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.404 ' HB2' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -158.38 146.28 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -122.65 123.54 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.82 121.49 84.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.711 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.45 13.31 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 0.0 112.348 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -89.33 94.75 10.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.76 -135.73 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -93.28 -175.0 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -100.72 -19.56 15.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -128.24 30.82 5.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 27.5 p -71.69 -11.21 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.87 13.49 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.84 122.65 23.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.89 -35.24 5.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.8 157.78 29.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.769 0.319 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 77.5 mt -115.1 154.17 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 38.6 m-85 -142.16 153.2 43.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 98.5 t -133.06 102.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 33.1 mt -83.68 122.74 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -125.74 132.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.16 -153.71 23.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.37 152.73 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.354 . . . . 0.0 111.139 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.424 ' CD2' ' HA3' ' A' ' 451' ' ' GLY . 1.2 mt -132.12 164.03 27.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -85.39 -66.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.5 p -41.92 -27.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -161.88 165.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.91 164.45 13.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -39.29 -36.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 424' ' ' ASP . 37.5 t0 -73.85 -66.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 424' ' ' ASP . 18.0 mm-40 -36.88 -53.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.81 77.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 424' ' ' ASP . 38.3 tttt -58.4 -46.14 86.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -40.83 97.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.1 tp -63.47 -62.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 54.8 mt -44.42 -43.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -75.35 -35.78 61.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -54.33 -21.83 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.425 ' CZ ' HG22 ' A' ' 479' ' ' ILE . 96.6 m-85 -108.33 -3.78 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 115.59 -40.3 2.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.22 162.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.7 125.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 3.5 t -137.64 139.93 40.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -86.33 46.81 3.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -157.86 126.65 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.3 t -80.6 100.83 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.179 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 51.9 m -121.29 164.73 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -50.94 -52.96 37.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.54 -32.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.464 HG22 ' CG2' ' A' ' 467' ' ' THR . 88.9 m -48.94 130.69 18.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -99.15 -30.19 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.562 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 65.9 m-85 -148.68 145.66 27.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 15.6 tp -115.81 98.88 6.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.21 106.05 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.5 139.03 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -122.24 -114.02 2.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -92.5 167.78 11.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 27.0 t70 38.02 45.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 70.4 m -101.55 173.26 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -99.18 147.48 18.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 457' ' ' SER . 49.0 tp60 -82.92 -47.41 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.893 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 456' ' ' GLN . 11.3 t -36.24 -46.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -55.37 -65.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.3 t -50.51 -44.78 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -46.81 -58.1 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -66.91 -43.39 83.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -45.38 -50.74 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.076 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.98 88.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.083 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.27 70.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 22.3 mt -93.76 22.97 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 51.61 52.65 32.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' THR . . . . . 0.464 ' CG2' HG22 ' A' ' 445' ' ' THR . 20.5 m -109.68 126.27 53.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.136 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 106.42 4.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 62.6 mt -84.52 125.08 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.36 174.57 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -116.4 177.35 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -39.06 -46.28 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.91 -55.86 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.3 -38.27 19.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.539 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.56 -51.69 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.04 -50.45 72.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.923 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.17 -33.55 65.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.405 HD11 ' CD2' ' A' ' 447' ' ' TYR . 12.5 mt -66.78 -15.92 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.425 HG22 ' CZ ' ' A' ' 433' ' ' TYR . 56.1 mt -89.06 -25.4 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -93.56 -28.16 16.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 27.2 p -84.09 -41.5 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 23.2 mmm -65.79 140.6 97.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.0 Cg_endo -69.83 -164.34 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.645 2.23 . . . . 0.0 112.315 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.58 174.2 20.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -139.5 129.5 25.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -74.95 117.25 16.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 8.6 t -43.17 134.76 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -47.55 35.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -101.75 155.75 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -59.49 142.35 52.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 492' ' ' ALA . 20.4 mm -98.53 142.17 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 491' ' ' ILE . . . -100.86 97.37 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.78 129.32 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 40.66 45.12 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.9 p -102.12 131.83 48.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 t -108.43 111.93 24.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.841 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 19.0 m -103.08 84.4 2.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -168.64 -167.07 28.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.2 p -135.64 141.04 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.6 m -81.48 88.79 6.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -158.08 63.96 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -144.11 139.54 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -118.68 158.09 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 pp -129.03 8.74 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 154.98 33.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.9 m 57.65 38.11 27.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -103.88 174.66 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.57 102.6 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 17.0 mm -79.17 120.21 79.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 122.96 9.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.709 2.272 . . . . 0.0 112.364 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -73.7 119.64 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -138.83 -156.72 7.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -79.29 -175.01 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.066 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.36 -20.54 15.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -126.91 29.52 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 32.0 p -68.98 -18.63 64.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.04 16.14 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -78.89 121.48 24.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.7 -24.51 21.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.467 HD11 ' CE ' ' A' ' 482' ' ' MET . 25.7 mt -89.85 150.09 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.428 HD13 ' CG ' ' A' ' 444' ' ' LYS . 68.5 mt -112.5 144.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.423 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 57.0 m-85 -132.07 152.2 51.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.83 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 96.3 t -131.33 110.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.26 121.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 4.0 t -124.69 115.06 20.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.07 -153.8 16.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.31 150.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.64 145.14 51.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -72.44 -44.03 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 11.0 m -55.04 -42.13 72.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.854 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.33 161.01 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.91 169.76 10.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -52.12 -30.34 25.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.44 -55.95 4.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -47.37 -54.64 10.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -53.46 -53.53 50.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -51.94 -40.58 61.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.7 tp -64.22 -53.61 46.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.41 HG22 ' C ' ' A' ' 435' ' ' GLY . 59.3 mt -54.37 -38.98 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -77.86 -30.41 50.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -58.04 -24.28 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.497 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 71.7 m-85 -110.34 4.79 21.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.83 -33.13 6.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.496 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -43.74 146.71 1.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -104.24 159.54 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.26 116.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 5.1 t -132.21 148.36 52.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.11 53.5 1.37 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 114.08 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.879 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.94 99.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.7 m -119.59 -175.16 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -63.34 -54.87 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -47.19 -28.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.431 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 49.4 m -58.37 126.0 25.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -95.53 -42.93 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 46.1 m-85 -132.12 149.48 52.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 9.2 tp -120.05 106.95 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.14 102.76 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 6.1 mtt -82.79 161.92 21.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -154.61 -169.64 19.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -68.03 147.05 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.901 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.9 t70 43.24 52.18 5.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.6 p -81.86 176.38 9.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.77 141.44 15.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -74.78 -33.3 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 55.8 m -58.71 -41.64 86.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -55.06 -61.15 2.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 460' ' ' ASP . 28.6 p -51.83 -44.75 63.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 459' ' ' SER . 8.1 t70 -35.59 -67.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 462' ' ' ALA . 7.2 mptt -57.87 -56.39 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -34.28 -48.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.99 84.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 461' ' ' LYS . . . -68.68 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 28.2 mt -54.79 -32.07 59.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 86.97 62.98 1.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 6.7 m -107.06 139.24 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.167 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -69.14 105.4 2.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 88.5 mt -85.62 131.11 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.54 177.38 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -126.05 177.34 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -38.87 -48.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -63.07 -49.52 74.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -56.67 -26.22 52.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 64.0 tp -73.39 -48.08 36.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.58 -44.08 97.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -61.63 -28.77 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.67 -15.8 62.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 31.0 mt -87.24 -17.31 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.75 -29.26 11.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 58.3 p -83.31 -45.5 13.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.467 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.3 mmm -60.34 142.0 90.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.83 -166.69 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.316 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.89 165.01 24.38 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.524 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -135.44 120.49 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -73.04 86.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 16.5 m -104.6 136.16 44.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -75.55 -42.72 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -60.61 108.63 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.11 168.82 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 18.2 mm -112.84 70.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . 49.45 50.06 18.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.6 p -46.25 122.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.451 ' O ' ' CD ' ' A' ' 494' ' ' GLU . 2.5 pp20? -103.66 135.48 45.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 21.6 p -119.84 98.22 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.895 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.5 p -72.13 142.72 49.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 94.6 p -129.99 104.75 7.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 175.66 -162.67 32.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.5 p -62.25 140.78 58.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.1 t -109.79 120.68 43.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 97.99 161.59 30.79 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.469 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -81.82 113.01 19.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.306 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -84.91 169.49 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 394' ' ' LEU . 7.5 tt -79.86 -12.59 59.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 103.7 -65.97 0.34 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.8 p -85.47 2.14 45.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -164.12 179.13 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -136.53 141.88 43.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 34.4 mm -86.96 122.3 71.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.14 5.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.353 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -71.97 102.62 2.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -125.78 -161.17 10.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.435 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -73.08 -175.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.731 0.301 . . . . 0.0 111.111 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -101.33 -20.84 15.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -126.04 36.73 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 29.1 p -78.67 -6.46 55.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.96 5.55 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -69.35 116.76 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.31 -16.94 34.79 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.463 ' CD1' ' HE2' ' A' ' 482' ' ' MET . 48.8 mt -99.47 138.6 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 28.5 mt -101.96 151.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 43.4 m-85 -136.72 143.69 43.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 60.8 t -121.08 109.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 50.4 mt -90.5 120.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.5 t -118.74 113.03 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.443 ' O ' ' NH1' ' A' ' 423' ' ' ARG . . . 99.21 175.17 31.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.482 ' O ' ' CG2' ' A' ' 417' ' ' VAL . 1.8 m -94.47 122.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 420' ' ' SER . 4.6 mt -90.26 100.45 13.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -40.88 -25.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 418' ' ' LEU . 4.3 p -71.97 -62.71 1.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 425' ' ' GLU . 0.4 OUTLIER -140.52 132.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -65.57 -175.55 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 416' ' ' GLY . 8.2 mmp_? -58.71 -58.29 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -29.48 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 421' ' ' ILE . 9.3 mt-10 -71.04 -64.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -54.02 -62.51 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -41.85 -27.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.33 -51.45 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . 0.425 HG22 ' C ' ' A' ' 435' ' ' GLY . 45.2 mt -61.03 -35.87 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.26 -29.66 38.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -60.56 -21.25 62.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -111.11 2.51 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.43 -27.52 15.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -48.63 157.15 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -114.57 157.56 22.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.5 t -131.73 123.45 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.59 155.72 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -101.29 37.03 3.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -160.16 125.14 3.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.402 HG22 ' CD ' ' A' ' 458' ' ' LYS . 96.0 t -67.28 118.42 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 75.4 m -123.24 157.94 31.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.47 ' CB ' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -61.48 -14.34 28.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -86.59 -22.74 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 26.3 m -51.86 133.57 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.462 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 5.4 m-80 -97.22 -25.2 15.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 69.8 m-85 -157.57 131.11 7.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 18.1 tp -98.13 116.23 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.35 94.52 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 6.4 mmt -86.39 166.47 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -159.59 -107.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -126.92 168.49 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.8 m-20 37.72 46.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.6 m -99.98 175.99 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.32 -177.51 40.27 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.435 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -115.18 -19.61 10.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.4 p -77.63 -19.16 55.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.402 ' CD ' HG22 ' A' ' 441' ' ' VAL . 36.9 mmtm -72.49 -39.45 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 42.7 p -73.96 -52.18 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.38 -44.46 8.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -47.06 50.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -53.02 -53.65 47.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.0 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -54.84 -58.7 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.068 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.47 HD21 ' CB ' ' A' ' 443' ' ' LYS . 12.3 mt -61.35 -23.7 65.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 93.64 53.81 1.76 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 3.5 m -107.98 134.59 50.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.14 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -74.91 116.67 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 88.3 mt -87.3 123.55 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 50.2 pt -140.1 168.98 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 471' ' ' ASP . 0.6 OUTLIER -115.26 173.92 6.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.4 pt-20 -34.12 -45.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -60.34 3.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.41 8.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 23.2 tp -44.4 -45.64 9.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.73 -46.79 83.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -62.12 -31.29 71.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 20.1 mt -82.96 -17.6 10.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.9 -16.91 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.842 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.1 p -97.04 -33.72 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.463 ' HE2' ' CD1' ' A' ' 410' ' ' LEU . 30.7 mmm -72.18 142.51 84.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.874 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -165.48 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.334 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -137.17 169.36 24.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -136.52 129.24 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.2 106.58 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 75.0 p -68.12 145.27 54.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -14.3 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -119.51 147.06 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -99.38 153.04 19.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 71.3 mt -102.86 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.171 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -78.4 118.58 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 p -52.7 131.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -157.31 138.35 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 19.2 p -71.02 159.92 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.6 m -124.82 121.77 35.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.795 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 53.0 m -98.42 130.47 45.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -118.09 83.85 0.36 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 16.8 t -79.14 115.44 18.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 68.1 m -115.06 116.86 29.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 173.03 -45.92 0.16 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm 44.64 47.19 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -151.39 140.91 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.547 ' O ' ' C ' ' A' ' 395' ' ' GLY . 1.1 pt? -125.09 -172.51 2.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . -25.62 -90.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -120.48 33.08 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 394' ' ' LEU . 2.1 mmmm -137.04 152.54 50.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -119.22 119.11 33.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.36 121.86 71.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.665 0.745 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.463 ' CD ' HD12 ' A' ' 476' ' ' LEU . 53.7 Cg_endo -69.72 128.75 16.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.738 2.292 . . . . 0.0 112.32 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.474 ' HE3' ' N ' ' A' ' 402' ' ' GLY . 0.0 OUTLIER -65.22 103.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . 0.474 ' N ' ' HE3' ' A' ' 401' ' ' LYS . . . -124.3 -161.48 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.486 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -74.3 -175.0 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.723 0.297 . . . . 0.0 111.121 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.81 -23.79 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -125.08 30.84 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' CYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 483' ' ' PRO . 19.8 p -69.49 -13.08 62.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.17 7.18 7.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -63.55 137.29 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 87.73 -29.91 5.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . 0.432 ' CD1' ' HE1' ' A' ' 482' ' ' MET . 76.7 mt -79.23 148.63 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 90.7 mt -119.91 145.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 67.1 m-85 -132.21 153.62 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 99.5 t -128.56 103.2 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.417 HG23 ' NH1' ' A' ' 423' ' ' ARG . 21.6 mt -85.18 124.4 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -122.73 139.81 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 85.63 -157.04 30.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.406 ' O ' ' CG2' ' A' ' 417' ' ' VAL . 4.7 m -135.32 123.9 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.389 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.18 149.42 23.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -55.06 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.4 m -45.13 -53.83 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 2.1 pt -142.15 128.44 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.98 165.04 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.417 ' NH1' HG23 ' A' ' 414' ' ' ILE . 0.1 OUTLIER -41.96 -43.62 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 425' ' ' GLU . 1.1 m-20 -64.25 -66.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 424' ' ' ASP . 37.9 mm-40 -36.75 -71.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -41.21 -56.03 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -39.84 -62.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -33.78 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 432' ' ' ARG . 15.5 tp -71.8 -66.23 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 30.8 mt -45.81 -33.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.66 -25.06 26.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 429' ' ' LEU . 14.9 ttm180 -65.08 -16.9 63.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' TYR . . . . . 0.51 ' CZ ' HG23 ' A' ' 479' ' ' ILE . 93.9 m-85 -115.92 6.9 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.87 -37.71 3.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.3 149.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -105.1 165.91 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.63 132.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.18 129.95 20.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.52 76.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -104.77 139.69 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 90.9 t -76.01 127.37 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 p -123.24 170.3 10.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -32.93 73.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.922 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -70.5 -19.15 62.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.0 m -51.02 133.73 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 7.8 m120 -106.69 -22.81 12.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' TYR . . . . . 0.538 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 58.2 m-85 -156.06 154.95 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.3 106.49 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.2 97.5 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.463 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 9.4 mtt -78.61 170.5 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -158.54 -107.51 0.24 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 ptp180 -131.11 172.75 11.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.2 m-20 34.53 38.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.6 t -83.08 -175.04 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -127.27 141.98 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -13.15 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.32 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 14.8 t -73.46 -44.63 57.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -55.71 -48.25 75.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.463 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 46.2 p -68.88 -33.76 74.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.52 -42.63 92.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -77.23 -34.07 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -63.37 -54.91 29.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.34 68.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 37.3 mt -71.44 -25.72 62.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 102.48 51.39 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 468' ' ' LYS . 41.2 m -113.86 141.8 46.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.336 . . . . 0.0 111.159 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' LYS . . . . . 0.41 ' N ' HG22 ' A' ' 467' ' ' THR . 20.3 mtmm -85.56 139.95 31.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.22 122.01 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.8 179.49 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 474' ' ' GLY . 2.1 p-10 -124.79 166.76 15.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -38.96 -30.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.8 -42.96 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -59.65 -35.11 84.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.463 HD12 ' CD ' ' A' ' 400' ' ' PRO . 0.5 OUTLIER -50.89 -49.26 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -57.58 -44.41 85.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.26 -17.72 3.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.51 HG23 ' CZ ' ' A' ' 433' ' ' TYR . 97.5 mt -87.21 -28.23 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -98.32 -13.34 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 43.3 p -97.11 -43.14 7.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' MET . . . . . 0.432 ' HE1' ' CD1' ' A' ' 410' ' ' LEU . 30.2 mmm -66.64 142.6 97.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.842 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.75 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.636 2.224 . . . . 0.0 112.386 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.07 157.75 20.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -135.45 115.38 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 486' ' ' LYS . 0.1 OUTLIER -72.4 136.58 46.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 42.2 t -134.6 153.7 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -121.34 -28.39 4.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.68 10.61 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.79 140.3 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 61.0 mt -116.48 74.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . 38.71 52.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.02 112.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.72 154.27 38.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 76.9 p -143.01 130.63 21.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.612 0.72 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 129.7 18.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -86.2 92.34 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -114.67 -139.68 7.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.64 -175.09 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.778 0.323 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.71 -20.4 13.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -127.09 32.83 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 28.1 p -75.55 -17.4 60.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 410' ' ' LEU . 59.5 mt -121.96 10.14 10.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -68.79 116.32 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.05 -21.55 24.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 24.2 mt -90.07 150.14 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.48 148.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.4 148.53 49.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 448' ' ' LEU . 99.5 t -127.05 108.09 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 25.8 mt -91.28 123.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.7 t -120.65 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.25 -153.86 32.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -127.13 154.55 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.1 mt -132.79 136.51 46.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -60.36 -63.62 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.808 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 419' ' ' GLU . 23.0 p -35.92 -56.65 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.5 OUTLIER -143.15 155.75 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.16 160.56 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -39.84 -37.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.58 -55.13 8.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.4 ' CD ' HG22 ' A' ' 421' ' ' ILE . 17.3 mt-10 -51.16 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.39 -40.8 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 437' ' ' VAL . 36.2 tttm -58.3 -57.58 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.1 p -48.9 -30.52 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.51 -61.72 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 475' ' ' LEU . 33.7 mt -51.22 -34.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.5 -28.84 46.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -66.15 -14.95 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.5 -9.42 14.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 117.93 -24.84 8.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.9 157.56 21.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -106.63 156.29 18.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 427' ' ' LYS . 77.5 t -134.3 116.68 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.6 t -136.78 134.94 37.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.34 45.99 3.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -160.12 135.46 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.569 HG23 ' HD2' ' A' ' 458' ' ' LYS . 62.2 t -74.79 130.04 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.3 t -130.91 173.42 10.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -76.43 -19.58 57.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -88.98 -16.77 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.401 HG22 ' CG2' ' A' ' 467' ' ' THR . 96.7 m -48.05 127.58 12.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.99 -39.8 9.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 73.1 m-85 -144.64 150.77 37.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 413' ' ' VAL . 6.4 tp -117.98 107.89 14.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.61 106.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.6 mtt -92.11 165.99 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -152.26 -118.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 453' ' ' ASP . 11.4 ptm180 -119.49 173.22 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.8 t70 34.54 38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 452' ' ' ARG . 61.5 m -99.82 151.9 20.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -77.08 163.24 52.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -12.31 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 1.8 t -69.48 -34.77 74.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 441' ' ' VAL . 3.9 tppt? -58.03 -43.79 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.435 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 86.1 p -66.36 -52.42 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.1 -64.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -54.21 -49.12 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -47.77 -58.33 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.25 -50.17 67.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -47.33 -55.83 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.2 mt -66.54 -26.11 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.55 53.05 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.401 ' CG2' HG22 ' A' ' 445' ' ' THR . 47.5 m -110.4 136.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 0.0 111.16 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.503 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -79.77 117.81 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 450' ' ' MET . 15.5 mt -89.7 130.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.2 pt -147.25 166.59 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 472' ' ' GLU . 0.4 OUTLIER -107.59 171.11 7.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 473' ' ' ASP . 2.6 pp20? -37.21 -43.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 473' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 472' ' ' GLU . 16.2 t70 -60.8 -51.99 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -55.65 -35.21 61.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 430' ' ' ILE . 57.1 tp -63.16 -47.32 83.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.27 -53.05 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -53.14 -39.85 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.28 -15.54 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 78.9 mt -90.18 -19.3 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.6 -20.97 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.5 p -91.86 -38.32 12.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.521 ' CE ' HD11 ' A' ' 410' ' ' LEU . 40.7 mmm -67.29 143.6 97.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.523 0.677 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.81 -178.42 2.35 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -126.73 166.05 19.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.436 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.0 mttm . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.894 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.474 HG23 ' HD2' ' A' ' 400' ' ' PRO . 27.5 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.627 0.727 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 399' ' ' ILE . 54.1 Cg_endo -69.75 117.93 5.38 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.65 2.234 . . . . 0.0 112.373 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -70.28 108.79 4.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -129.96 -146.29 5.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.34 -175.24 4.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.65 -25.59 12.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -124.31 30.47 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -70.38 -16.31 62.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 61.0 mt -121.12 9.21 10.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -65.79 133.79 51.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 92.35 -33.52 4.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.54 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.06 139.94 38.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.878 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 81.9 mt -105.07 156.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 91.5 m-85 -142.64 150.42 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 438' ' ' THR . 65.8 t -130.39 99.12 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 45.3 mt -81.81 130.99 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.446 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.6 t -128.88 145.98 51.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.35 42.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.89 152.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 111.107 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 451' ' ' GLY . 7.1 mt -122.92 173.85 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.73 -69.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 60.8 p -40.58 -44.23 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 1.11 HD13 ' HB2' ' A' ' 426' ' ' ALA . 2.0 pp -142.08 176.98 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -122.88 164.33 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 -42.49 -31.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.83 -68.61 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -44.67 -53.06 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 1.11 ' HB2' HD13 ' A' ' 421' ' ' ILE . . . -52.53 -42.52 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 437' ' ' VAL . 39.8 tttm -58.46 -50.35 74.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 21.1 p -54.59 -34.89 62.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.55 -65.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 435' ' ' GLY . 55.2 mt -47.31 -40.02 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -76.08 -31.87 58.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.57 -16.08 62.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 479' ' ' ILE . 70.9 m-85 -113.34 3.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.89 -32.17 7.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -47.77 163.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -116.23 156.43 26.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 427' ' ' LYS . 84.9 t -130.7 128.01 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.836 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -141.26 149.86 41.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -89.72 9.17 78.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -127.91 137.24 52.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 462' ' ' ALA . 46.6 t -87.9 108.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.2 m -110.49 -178.62 3.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.928 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -77.59 -20.18 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -26.46 54.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 10.1 m -46.47 133.86 9.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 4.9 m-80 -102.47 -22.13 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 67.5 m-85 -156.01 155.11 32.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.889 HD23 HG12 ' A' ' 469' ' ' ILE . 17.2 tp -125.41 111.63 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 34.3 t -93.57 107.05 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.446 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 26.8 mtm -110.39 175.78 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 418' ' ' LEU . . . -158.55 -147.45 4.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.5 ptt180 -69.39 174.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.4 m-20 34.75 39.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.1 p -96.78 -177.6 3.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -143.83 174.55 24.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.24 24.7 6.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.354 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 15.1 t -86.08 -42.92 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.29 -39.62 28.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.0 p -71.46 -30.53 66.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -52.47 65.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.419 ' NZ ' HD11 ' A' ' 465' ' ' LEU . 0.9 OUTLIER -74.03 -28.39 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.444 ' HB2' HG11 ' A' ' 441' ' ' VAL . . . -69.67 -42.38 74.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.73 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -45.81 -41.06 10.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.928 HD13 ' HA ' ' A' ' 443' ' ' LYS . 11.6 mt -85.41 -24.03 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 103.5 51.05 1.0 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 59.1 m -100.56 138.9 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.152 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 468' ' ' LYS . 0.3 OUTLIER -74.36 117.32 16.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.889 HG12 HD23 ' A' ' 448' ' ' LEU . 34.0 mt -94.96 131.36 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.6 pt -142.84 174.23 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.62 178.97 4.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.438 ' OE1' HD22 ' A' ' 418' ' ' LEU . 5.7 pt-20 -41.06 -45.43 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.03 -55.08 24.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 470' ' ' ILE . . . -46.28 -30.29 4.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.0 tp -67.92 -59.87 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.53 -42.85 45.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.949 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.89 -36.99 85.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.1 mt -62.75 -22.9 66.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.408 HD13 ' CE2' ' A' ' 433' ' ' TYR . 58.6 mt -83.43 -28.3 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -88.86 -22.3 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.7 p -91.23 -47.87 7.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 11.9 mmm -59.61 139.39 89.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.504 0.669 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.74 -165.18 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.46 157.09 17.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.637 0.732 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 117.7 5.24 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -76.78 95.37 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -108.54 -152.37 15.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -70.9 -177.13 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 2.8 pt-20 -101.05 -29.15 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.498 ' ND2' ' OE1' ' A' ' 408' ' ' GLU . 23.4 m120 -122.14 20.11 10.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.923 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.9 p -59.26 -25.64 64.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.466 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 68.0 mt -108.36 14.9 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLU . . . . . 0.498 ' OE1' ' ND2' ' A' ' 405' ' ' ASN . 8.7 tp10 -79.67 143.3 34.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 86.33 -16.6 43.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.59 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.5 mt -100.1 153.2 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 412' ' ' PHE . 95.4 mt -113.49 155.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 411' ' ' ILE . 91.1 m-85 -144.29 135.31 25.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 438' ' ' THR . 41.9 t -115.84 100.37 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.88 121.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 130.8 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.15 -152.27 22.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.81 152.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -132.25 159.4 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.24 -65.19 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 421' ' ' ILE . 10.6 t -39.74 -31.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 420' ' ' SER . 1.3 pt -161.2 160.88 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.12 170.32 8.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -47.95 -20.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -92.56 -65.86 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -42.07 -37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.66 -42.33 67.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 25.3 ttmt -58.76 -58.58 7.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 28.1 t -47.07 -36.76 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -64.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 475' ' ' LEU . 63.4 mt -49.89 -44.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.16 -32.65 73.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -66.06 -17.75 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 57.0 m-85 -108.21 1.57 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.02 -29.65 10.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.25 153.34 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 437' ' ' VAL . 9.3 tmtm? -105.78 146.92 29.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 99.5 t -122.45 121.34 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.626 ' O ' HG13 ' A' ' 413' ' ' VAL . 9.0 t -139.44 143.82 37.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -91.24 44.96 2.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -163.56 121.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.78 126.45 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.6 m -128.49 169.12 14.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -68.32 -21.65 64.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -85.44 -7.05 59.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.6 m -61.26 127.37 31.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -97.3 -29.12 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -151.83 150.96 30.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 469' ' ' ILE . 14.2 tp -119.76 108.85 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.43 105.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.502 ' HG3' HG23 ' A' ' 469' ' ' ILE . 4.2 mtt -80.27 168.98 18.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.23 -110.37 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 453' ' ' ASP . 14.7 mmt180 -125.66 172.39 9.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 452' ' ' ARG . 29.4 t0 34.56 39.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 96.6 p -83.64 165.88 18.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -113.31 130.29 9.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.49 -20.71 21.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 87.4 p -69.73 -30.24 67.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -63.11 -56.19 18.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.9 t -63.93 -45.96 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -40.3 -53.69 2.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -64.98 -35.57 81.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -61.66 -63.15 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.079 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.32 -41.39 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.54 69.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.5 -26.22 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.8 48.95 1.56 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 19.8 m -111.49 145.68 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -84.24 142.43 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 448' ' ' LEU . 25.9 mt -109.61 127.88 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.23 172.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 472' ' ' GLU . 51.0 m-20 -117.86 170.73 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.721 ' HB3' HD13 ' A' ' 418' ' ' LEU . 6.7 pt-20 -35.92 -41.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.71 -51.44 62.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.31 -27.64 32.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 430' ' ' ILE . 52.0 tp -69.76 -51.75 31.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 479' ' ' ILE . 90.3 mt -52.26 -48.73 65.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.08 -36.7 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.18 -17.25 57.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 476' ' ' LEU . 30.7 mt -88.56 -15.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -106.95 -15.29 14.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 20.9 p -97.82 -41.73 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 410' ' ' LEU . 12.2 mmm -64.43 140.73 98.05 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.71 -173.26 0.68 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.698 2.265 . . . . 0.0 112.382 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -107.34 151.27 16.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 1.8 mptp? . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.1 mm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.58 0.705 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 125.98 12.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 0.0 112.303 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -107.02 -150.3 16.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -78.95 -175.03 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -100.19 -27.78 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -123.07 31.4 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.0 p -68.97 -19.33 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.8 -5.94 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.19 126.39 27.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.11 -23.71 32.64 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 15.0 mt -94.25 153.96 17.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 81.8 mt -116.46 143.51 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 88.3 m-85 -134.48 146.23 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 438' ' ' THR . 93.9 t -121.08 112.79 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 87.4 mt -95.56 121.48 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.154 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.4 t -122.95 147.36 46.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.32 -154.16 47.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.17 142.19 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.565 HD22 ' OE1' ' A' ' 472' ' ' GLU . 8.9 mt -113.96 140.24 48.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -47.63 74.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 78.6 p -50.86 -50.11 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.2 pt -151.48 168.47 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -97.81 162.06 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -38.9 -45.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -65.21 -62.43 1.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -46.37 -62.98 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -52.38 -53.51 44.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -44.04 -53.35 6.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.4 t -49.88 -31.22 11.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.07 -60.06 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 475' ' ' LEU . 72.6 mt -53.68 -40.03 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.08 -25.35 55.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -67.24 -20.01 65.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 403' ' ' ALA . 60.4 m-85 -111.92 7.96 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.47 -38.38 3.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.501 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.29 156.54 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -110.14 148.23 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.54 123.11 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.0 t -137.61 161.68 35.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -102.24 22.9 36.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -143.53 140.63 30.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 458' ' ' LYS . 21.1 t -93.58 110.87 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.8 p -115.95 -175.66 2.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -70.35 -22.43 62.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -80.44 -17.54 51.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 18.2 m -58.53 139.38 55.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.51 -31.21 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.555 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 76.1 m-85 -149.48 140.58 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 469' ' ' ILE . 10.9 tp -110.72 106.43 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.0 t -77.46 102.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.403 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 3.2 mmt -75.93 166.71 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -156.54 -126.79 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 mmt-85 -110.64 175.11 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.7 t0 34.41 38.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.9 p -83.39 118.29 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 457' ' ' SER . . . -82.53 24.06 5.22 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 455' ' ' GLY . 13.5 pt20 36.16 30.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 455' ' ' GLY . 17.3 t -80.66 -29.46 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 441' ' ' VAL . 23.2 mtmt -93.15 -22.68 18.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.403 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 93.0 p -69.51 -16.03 63.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.47 -62.76 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -62.7 -46.19 89.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -48.01 -56.12 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.18 66.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -77.96 -18.53 55.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.17 15.04 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.11 29.26 62.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.569 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 67.7 m -82.16 127.79 33.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.112 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -74.39 129.94 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.573 HG12 HD23 ' A' ' 448' ' ' LEU . 92.2 mt -102.79 121.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 29.7 pt -127.9 173.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.9 p30 -118.34 166.84 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.85 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.565 ' OE1' HD22 ' A' ' 418' ' ' LEU . 4.9 pm0 -35.31 -32.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 471' ' ' ASP . 12.4 t0 -71.93 -53.74 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -51.62 -36.55 40.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 430' ' ' ILE . 46.0 tp -61.59 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 77.6 mt -52.84 -49.21 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -59.38 -41.59 89.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.6 mt -58.53 -16.68 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 479' ' ' ILE . 39.5 mt -89.24 -16.71 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -107.6 -13.66 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -100.48 -31.36 11.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 33.1 mmm -76.27 140.51 69.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.854 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.28 166.45 19.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.2 mttp . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.657 0.741 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 121.0 7.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.309 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -75.59 95.95 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -118.71 -133.46 4.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -100.05 -175.17 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.55 -23.7 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -125.64 30.55 5.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 18.3 p -71.52 -19.26 62.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.55 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 84.4 mt -118.66 9.43 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.62 139.28 40.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.07 31.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.42 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.3 mt -93.71 164.23 13.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.404 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 73.0 mt -123.33 145.05 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 12.4 m-85 -131.44 155.03 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.537 ' O ' HD12 ' A' ' 448' ' ' LEU . 95.5 t -133.6 105.14 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 430' ' ' ILE . 54.8 mt -85.93 133.1 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -134.4 130.52 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.177 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.05 -151.31 21.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.454 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.02 154.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.86 147.83 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.89 -58.81 3.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 30.1 t -42.34 -44.81 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.43 158.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 424' ' ' ASP . 15.1 mt-10 -99.58 159.77 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -38.14 -31.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 422' ' ' GLU . 0.2 OUTLIER -76.55 -64.64 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -43.39 -60.91 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -46.63 -45.96 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 437' ' ' VAL . 28.7 tttt -54.67 -43.16 72.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -61.11 -38.36 86.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.4 -63.09 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 414' ' ' ILE . 62.9 mt -45.96 -37.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.35 -34.7 48.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -56.45 -16.24 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -115.3 -3.47 12.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.44 -45.48 1.28 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -41.18 141.2 1.13 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -102.37 160.44 14.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 427' ' ' LYS . 59.0 t -128.36 119.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.493 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.5 t -124.37 166.44 15.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.7 50.58 0.77 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -170.96 124.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.23 111.69 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' SER . . . . . 0.412 ' HB3' ' CD ' ' A' ' 444' ' ' LYS . 12.9 t -126.67 -175.01 3.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -67.29 -53.52 29.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.412 ' CD ' ' HB3' ' A' ' 442' ' ' SER . 0.0 OUTLIER -50.76 -19.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.8 m -62.73 123.7 19.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.29 -53.32 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 468' ' ' LYS . 57.1 m-85 -126.51 160.21 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 413' ' ' VAL . 10.5 tp -129.94 104.76 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -77.75 105.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.0 mmt -87.9 171.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -169.24 -127.52 0.93 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.0 mmp_? -92.46 167.15 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.3 t70 34.08 36.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 452' ' ' ARG . 54.5 p -69.75 127.19 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.99 139.95 27.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.57 -11.7 37.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.937 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 96.3 p -78.91 -27.11 43.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -66.66 -42.91 85.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 460' ' ' ASP . 33.7 p -81.29 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 459' ' ' SER . 0.3 OUTLIER -36.9 -57.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -60.33 -44.5 95.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -54.46 -64.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -37.99 -52.74 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.93 76.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 462' ' ' ALA . 11.3 mt -92.32 23.11 4.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 40.12 60.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.501 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.596 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.9 m -110.99 136.15 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 447' ' ' TYR . 21.2 mttp -76.11 141.76 41.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 13.9 mt -118.57 141.67 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.597 HD13 HD12 ' A' ' 478' ' ' LEU . 25.8 pt -152.08 171.09 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -115.83 177.99 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 0.6 OUTLIER -45.75 -35.16 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 473' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 21.3 t0 -71.46 -52.08 20.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.91 -45.43 70.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.522 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 470' ' ' ILE . 50.1 tp -50.55 -41.52 54.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.98 -51.35 62.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 470' ' ' ILE . 14.5 mt -65.52 -17.04 64.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.65 -17.46 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -103.97 -28.72 11.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.1 p -85.84 -25.38 26.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.134 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.467 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 63.7 mmm -82.02 140.68 46.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.76 -165.86 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.88 19.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.5 mttt . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 45.6 mm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -65.33 104.25 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.94 -152.11 8.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -88.0 -174.97 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -100.53 -26.94 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.465 ' O ' ' CE ' ' A' ' 485' ' ' LYS . 50.7 m-80 -123.23 27.32 7.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 26.5 p -68.43 -10.12 53.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.01 8.97 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' GLU . . . . . 0.43 ' CD ' ' OD1' ' A' ' 405' ' ' ASN . 14.9 tt0 -68.22 124.24 22.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.33 -29.49 12.25 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.692 HD22 ' ND2' ' A' ' 446' ' ' ASN . 72.2 mt -81.06 143.3 32.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 444' ' ' LYS . 93.2 mt -109.15 144.53 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 38.5 m-85 -129.22 155.35 45.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 438' ' ' THR . 55.5 t -134.12 102.35 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 30.7 mt -84.27 126.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.6 t -132.31 118.43 19.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.47 -161.02 16.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.09 132.0 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 472' ' ' GLU . 10.0 mt -101.26 179.88 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.57 -42.55 6.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.5 m -63.52 -55.22 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.41 130.5 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.03 156.23 37.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 423' ' ' ARG . 0.8 OUTLIER -40.24 -35.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -49.09 -47.67 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.57 88.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.44 -57.6 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -46.94 -28.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.873 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.21 -53.13 7.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.99 -34.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.88 -29.42 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -61.64 -16.11 45.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.809 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.12 -1.78 13.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 110.74 -36.53 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.46 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -44.52 148.68 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -101.2 160.89 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.6 t -137.35 108.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 413' ' ' VAL . 8.9 t -128.73 150.08 50.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -95.14 50.89 1.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.71 147.42 25.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 54.7 t -99.18 101.75 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 85.0 p -123.19 175.25 6.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HD2' HD22 ' A' ' 465' ' ' LEU . 1.9 mptm? -68.47 -16.4 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.552 ' HB3' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -80.57 -27.2 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.0 m -58.2 120.28 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.692 ' ND2' HD22 ' A' ' 410' ' ' LEU . 7.2 t30 -91.83 -41.01 10.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.653 ' CE1' ' ND2' ' A' ' 446' ' ' ASN . 95.3 m-85 -130.12 156.11 45.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 469' ' ' ILE . 11.2 tp -131.21 105.68 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.14 104.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.651 ' HG2' HG23 ' A' ' 469' ' ' ILE . 3.4 mmt -82.7 163.6 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.42 -134.95 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 1.1 mmp_? -87.9 163.27 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 17.4 t70 34.42 36.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 452' ' ' ARG . 3.2 m -83.49 116.32 22.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -59.55 128.36 46.72 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -51.26 -35.88 39.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 90.3 p -46.17 -47.32 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -43.51 -52.99 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 1.2 t -68.65 -61.05 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 22.8 t70 -38.09 -62.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -58.83 -33.59 70.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -62.93 -50.07 72.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.65 -55.6 27.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -46.97 -50.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.42 HD22 ' HD2' ' A' ' 443' ' ' LYS . 13.0 mt -70.14 -28.76 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.77 48.71 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.521 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.58 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 29.1 m -104.33 150.09 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.102 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -90.54 133.04 35.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 450' ' ' MET . 3.1 mp -104.76 120.16 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.88 170.77 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 474' ' ' GLY . 0.9 OUTLIER -120.83 168.49 11.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 418' ' ' LEU . 12.1 pt-20 -35.05 -44.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.44 -43.49 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -58.97 -29.78 65.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.35 -49.34 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.01 -46.75 75.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.72 -40.73 80.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -58.22 -17.68 20.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 74.5 mt -86.91 -18.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -102.92 -25.93 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.8 p -84.69 -46.84 11.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.511 ' CE ' HD11 ' A' ' 410' ' ' LEU . 10.7 mmm -59.85 141.06 89.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.528 0.68 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.84 -170.31 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -118.11 153.27 17.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 405' ' ' ASN . 6.0 mtmm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.8 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.634 0.73 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.401 ' HD3' HD22 ' A' ' 476' ' ' LEU . 53.5 Cg_endo -69.81 120.31 7.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.631 2.221 . . . . 0.0 112.362 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -77.01 98.75 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -117.48 -152.25 9.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -84.6 -174.96 5.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -99.76 -21.42 15.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -126.74 31.55 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 22.6 p -72.68 -19.77 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 410' ' ' LEU . 55.5 mt -119.12 11.34 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -74.03 116.16 14.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 112.57 -28.15 9.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.545 HD11 ' CE ' ' A' ' 482' ' ' MET . 6.5 mt -87.76 149.45 24.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 444' ' ' LYS . 87.7 mt -110.28 152.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 83.1 m-85 -139.39 140.24 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 441' ' ' VAL . 89.0 t -119.17 99.72 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.31 126.42 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.8 t -132.28 118.23 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.88 -170.19 17.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 417' ' ' VAL . 2.2 m -122.5 123.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 0.0 111.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 472' ' ' GLU . 3.4 mt -97.52 -179.39 4.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -102.74 -67.07 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.2 t -39.97 -47.22 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -150.57 122.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.93 174.5 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -49.25 -57.56 6.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.61 -42.76 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -65.02 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.27 -22.37 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.2 tttt -72.4 -51.22 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.5 m -58.15 -36.18 72.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.39 -63.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.2 mt -48.9 -38.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -75.47 -29.0 59.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -65.75 -14.76 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.84 -0.44 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.0 -25.16 19.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.05 150.28 14.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -101.56 146.66 27.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 427' ' ' LYS . 54.9 t -125.35 118.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 413' ' ' VAL . 11.5 t -134.85 154.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.09 -35.35 27.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.28 142.14 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.667 ' HA ' HG21 ' A' ' 413' ' ' VAL . 33.7 t -81.79 137.65 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 59.3 m -123.04 -175.74 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.793 ' HA ' HD13 ' A' ' 465' ' ' LEU . 43.4 tttm -82.05 -16.54 49.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 411' ' ' ILE . 27.9 mmmt -89.43 -10.2 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 413' ' ' VAL . 1.9 m -52.48 121.14 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -88.69 -34.12 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.53 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 71.4 m-85 -150.5 131.24 14.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 450' ' ' MET . 12.0 tp -97.62 110.51 23.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.0 t -84.17 102.16 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.442 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 2.8 mmt -80.85 166.21 21.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -166.42 -148.82 5.71 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.3 ttt180 -68.08 151.55 46.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.807 0.336 . . . . 0.0 110.883 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 452' ' ' ARG . 23.8 t70 36.39 44.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 12.1 t -78.24 103.0 7.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -48.24 136.86 15.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -56.93 -45.89 82.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.3 t -37.98 -43.84 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -49.07 -56.61 8.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.442 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 8.4 t -68.16 -34.04 75.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.74 -65.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.403 ' HE3' HD11 ' A' ' 465' ' ' LEU . 36.2 tttt -62.19 -37.29 84.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -54.22 -54.78 35.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.06 69.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.15 -56.23 18.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.793 HD13 ' HA ' ' A' ' 443' ' ' LYS . 46.2 mt -71.28 -0.18 9.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 68.47 53.18 22.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.5 m -105.96 129.84 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.153 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -67.07 132.71 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.62 129.07 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.4 pt -137.28 178.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.89 171.94 9.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.72 ' HB3' HD13 ' A' ' 418' ' ' LEU . 5.9 pt-20 -39.29 -40.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.83 -46.49 65.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.13 -33.21 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 29.6 tp -66.9 -58.39 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 479' ' ' ILE . 10.2 mt -45.31 -52.06 10.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 481' ' ' THR . 4.1 m120 -53.99 -48.16 70.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 478' ' ' LEU . 9.0 mt -51.32 -25.1 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 476' ' ' LEU . 62.3 mt -77.37 -27.01 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.5 -11.35 25.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 477' ' ' ASN . 31.0 p -101.62 -36.03 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.545 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.7 mtp -73.77 140.16 77.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.722 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.3 Cg_endo -69.74 -163.82 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.394 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -134.57 175.36 20.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.439 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 43.5 mttm . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.968 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.617 0.722 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.475 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.2 Cg_endo -69.79 126.23 13.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -82.02 99.65 9.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -119.71 -150.02 8.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.413 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -82.73 -175.01 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.15 -24.0 15.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -123.49 35.5 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 20.2 p -75.37 -9.0 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.579 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 88.8 mt -131.79 5.68 4.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.96 120.62 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.54 -27.3 17.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.45 HD11 ' CE ' ' A' ' 482' ' ' MET . 20.8 mt -88.98 142.28 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 444' ' ' LYS . 74.9 mt -101.29 151.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.161 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 91.8 m-85 -139.51 146.19 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.795 HG22 HG23 ' A' ' 438' ' ' THR . 85.7 t -124.99 102.76 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 430' ' ' ILE . 14.5 mt -90.01 121.52 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.39 137.44 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.96 -165.64 51.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -105.74 159.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.155 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.582 HD22 ' HB3' ' A' ' 472' ' ' GLU . 5.1 mt -140.97 142.29 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.5 -39.28 94.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.509 ' CB ' HD13 ' A' ' 421' ' ' ILE . 5.7 t -60.78 -65.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -146.78 141.78 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -67.27 173.56 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -45.04 67.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.45 -42.33 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -61.38 -66.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.25 -37.18 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 42.2 tttm -54.87 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.0 m -47.06 -37.25 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.42 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 414' ' ' ILE . 46.2 mt -46.46 -36.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.86 -34.45 57.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -61.08 -18.46 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -108.42 -2.11 19.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.25 -36.61 4.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.98 148.77 2.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -101.02 154.37 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 89.8 t -127.13 119.21 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.795 HG23 HG22 ' A' ' 413' ' ' VAL . 10.0 t -135.02 142.92 46.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLY . . . . . 0.454 ' O ' ' CG ' ' A' ' 440' ' ' ASN . . . -88.07 42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 439' ' ' GLY . 3.8 m120 -162.86 128.85 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.91 0.386 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.678 ' CG2' HD13 ' A' ' 448' ' ' LEU . 39.5 t -81.36 105.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 m -111.51 -174.48 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -71.82 -25.08 61.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.52 ' O ' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -81.83 -17.52 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.0 m -60.37 128.11 35.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -94.43 -38.2 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.11 153.29 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.678 HD13 ' CG2' ' A' ' 441' ' ' VAL . 52.2 tp -119.07 102.81 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.25 107.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.9 ptp -122.28 169.38 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.74 -104.46 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.3 OUTLIER -82.59 148.15 28.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.1 m-20 35.68 53.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 99.2 p -94.17 125.36 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -67.5 146.02 46.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -94.01 -30.67 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 0.0 110.891 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -55.27 -19.31 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.588 ' HD3' HG23 ' A' ' 441' ' ' VAL . 6.0 ttmt -94.53 -44.72 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.928 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 84.8 p -59.62 -30.55 68.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.53 -54.55 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -54.78 -23.98 20.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -74.36 -60.56 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.16 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -68.95 -64.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 18.3 mt -54.66 -29.66 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.51 43.36 1.59 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.437 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 27.6 m -103.14 135.54 44.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.112 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -74.97 138.05 42.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.451 HG12 HD23 ' A' ' 448' ' ' LEU . 66.7 mt -109.5 130.57 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 35.8 pt -142.7 172.21 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.3 p-10 -115.4 169.0 9.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.582 ' HB3' HD22 ' A' ' 418' ' ' LEU . 1.7 pm0 -39.8 -25.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 471' ' ' ASP . 25.8 t70 -74.97 -49.49 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -61.51 -31.01 76.08 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 430' ' ' ILE . 24.3 tp -64.02 -49.3 72.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 400' ' ' PRO . 26.1 mt -59.72 -51.94 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -57.49 -34.65 69.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.4 -15.06 32.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 55.5 mt -89.22 -24.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.17 -29.01 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.1 p -82.69 -38.56 23.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 410' ' ' LEU . 18.4 mmm -69.57 142.06 91.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 0.0 110.895 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -135.07 169.16 23.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 36.1 mttt . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 15.0 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.635 0.731 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 120.29 7.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.72 2.28 . . . . 0.0 112.401 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 108.46 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -130.56 -141.12 4.83 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -95.0 -176.15 3.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.28 -24.73 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 36.1 m-20 -124.58 29.55 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -68.54 -23.57 64.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.2 mt -114.74 2.66 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -66.57 145.22 55.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 85.94 -26.37 6.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.84 159.45 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 412' ' ' PHE . 96.7 mt -122.11 155.12 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 55.4 m-85 -142.55 145.72 33.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 438' ' ' THR . 38.3 t -122.99 100.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.432 HD11 HD12 ' A' ' 430' ' ' ILE . 49.3 mt -81.4 122.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.461 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.7 t -126.6 115.13 19.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 106.95 -153.92 16.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.66 158.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 111.156 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -135.84 159.51 41.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 420' ' ' SER . 4.0 tp10 -77.21 -69.44 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 419' ' ' GLU . 20.1 m -35.22 -61.82 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.4 OUTLIER -131.32 161.68 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 422' ' ' GLU . 6.9 mp0 -102.76 164.12 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 16.4 tpt85 -42.48 -30.87 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -65.76 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.93 -55.2 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.35 -53.22 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.5 ' HA ' HG21 ' A' ' 437' ' ' VAL . 30.7 tttm -44.91 -51.19 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 32.5 t -52.62 -34.06 49.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.47 -67.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.465 HG22 ' C ' ' A' ' 435' ' ' GLY . 65.4 mt -46.25 -35.79 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.56 -28.88 37.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -63.59 -19.78 65.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 403' ' ' ALA . 66.7 m-85 -112.47 2.29 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 435' ' ' GLY . . . 112.21 -45.87 1.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.525 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -37.97 148.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -102.06 161.42 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 427' ' ' LYS . 55.7 t -133.61 125.01 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.506 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.8 t -144.16 170.49 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -118.65 50.86 0.78 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -156.35 135.19 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 107.31 15.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 -175.12 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.857 ' HD3' HD22 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -73.39 -48.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -50.65 -28.71 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.45 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 89.2 m -55.36 124.27 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.073 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -95.66 -44.74 7.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 61.4 m-85 -128.7 159.39 35.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.537 HD23 HG12 ' A' ' 469' ' ' ILE . 35.1 tp -130.09 102.88 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.03 107.96 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.461 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 24.0 mtm -112.65 179.85 3.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.34 -102.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.6 mmm-85 -92.41 161.24 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.2 t70 34.37 48.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.9 p -87.62 168.42 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -117.8 143.36 17.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 -28.84 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 89.7 p -59.54 -21.55 60.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 459' ' ' SER . 34.3 mttm -86.5 -67.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 458' ' ' LYS . 13.5 p -36.57 -64.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 461' ' ' LYS . 0.2 OUTLIER -42.09 -51.73 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.497 ' N ' ' CG ' ' A' ' 460' ' ' ASP . 0.0 OUTLIER -63.11 -31.74 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 459' ' ' SER . . . -65.2 -48.17 74.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.34 83.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.92 -30.63 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.857 HD22 ' HD3' ' A' ' 443' ' ' LYS . 14.0 mt -87.96 -24.23 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.18 28.45 5.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.453 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 4.1 m -92.95 137.36 32.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.356 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -81.22 114.29 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 448' ' ' LEU . 81.9 mt -86.02 131.83 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 475' ' ' LEU . 7.5 pt -148.98 178.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -117.94 -179.28 3.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.701 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.5 pm0 -50.58 -29.95 12.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.08 -51.21 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.95 -30.94 54.95 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 470' ' ' ILE . 32.1 tp -64.44 -42.78 95.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.31 -52.96 61.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -59.26 -30.24 68.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.0 mt -67.07 -15.18 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 69.7 mt -88.68 -20.54 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -102.62 -24.55 13.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 36.7 p -87.66 -31.36 19.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 25.9 mmm -75.88 141.1 71.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.51 20.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.434 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 50.3 mttm . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.404 HD13 ' CD2' ' A' ' 476' ' ' LEU . 23.5 mm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.623 0.725 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 132.82 24.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.315 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -80.82 84.58 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -99.15 -157.58 29.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.0 -175.09 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 111.069 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -101.65 -21.29 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.2 29.92 5.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.8 p -69.5 -21.73 63.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 410' ' ' LEU . 20.9 mt -111.77 -0.77 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.28 115.47 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.3 26.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.595 HD11 ' CE ' ' A' ' 482' ' ' MET . 19.8 mt -91.77 140.3 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 444' ' ' LYS . 80.6 mt -106.83 149.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 82.4 m-85 -135.61 157.57 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.07 106.98 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 423' ' ' ARG . 39.1 mt -88.16 126.35 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.7 t -132.64 116.08 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 105.05 -154.47 17.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.09 155.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.722 HD22 ' OE1' ' A' ' 472' ' ' GLU . 2.4 mt -138.07 152.89 49.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -74.36 -63.26 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 421' ' ' ILE . 48.1 m -37.67 -39.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.2 pt -161.19 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 423' ' ' ARG . 56.4 mt-10 -94.75 162.16 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 414' ' ' ILE . 13.8 tpt180 -38.36 -35.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 427' ' ' LYS . 4.8 t70 -74.91 -66.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.872 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 421' ' ' ILE . 14.1 mt-10 -43.78 -42.44 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.696 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -70.61 -30.96 67.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 424' ' ' ASP . 21.2 ttmt -67.19 -51.18 56.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.8 m -55.87 -25.29 41.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.59 -57.1 4.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.7 -45.71 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -72.44 -26.89 62.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -67.07 -14.68 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.02 8.64 15.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.27 -6.8 63.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -70.79 170.11 47.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -126.94 154.13 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.4 t -129.78 123.16 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.07 172.23 7.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.42 10.84 61.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.71 149.78 16.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 445' ' ' THR . 4.9 t -87.28 117.79 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.9 m -121.75 177.62 5.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 465' ' ' LEU . 27.3 ttmt -59.09 -15.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 411' ' ' ILE . 1.6 mppt? -90.15 -21.64 22.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.701 HG21 HG13 ' A' ' 441' ' ' VAL . 96.1 m -61.06 126.63 28.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -93.7 -38.58 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 478' ' ' LEU . 60.0 m-85 -138.94 148.33 43.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 469' ' ' ILE . 9.0 tp -115.05 104.26 11.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.51 104.62 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 12.7 mtt -86.29 176.13 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -174.08 -123.76 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 2.2 mmp_? -96.94 156.95 16.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.6 t70 34.56 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 29.2 m -60.35 161.03 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -89.53 175.58 42.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -95.62 -47.12 6.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 94.2 p -57.16 -27.77 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -55.08 -58.28 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 3.9 t -73.07 -54.74 7.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.794 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 17.9 t70 -37.6 -70.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' ALA . 13.7 mmtm -55.06 -34.92 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -58.38 -65.39 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -50.14 -21.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 461' ' ' LYS . . . -75.44 -65.31 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 443' ' ' LYS . 7.3 mt -67.18 -5.83 15.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 83.54 49.77 4.75 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.609 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 25.0 m -94.52 133.96 37.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.147 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -80.92 102.24 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.483 HG12 HD23 ' A' ' 448' ' ' LEU . 48.3 mt -73.91 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 478' ' ' LEU . 46.6 pt -147.81 165.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -114.24 179.31 3.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.722 ' OE1' HD22 ' A' ' 418' ' ' LEU . 0.4 OUTLIER -48.5 -25.41 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.93 -40.38 18.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -69.15 -34.65 76.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.419 ' CA ' HD12 ' A' ' 470' ' ' ILE . 59.3 tp -64.23 -41.19 97.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.404 ' CD2' HD13 ' A' ' 399' ' ' ILE . 78.5 mt -61.19 -40.8 95.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -34.75 79.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.3 mt -64.49 -14.76 58.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.37 -17.57 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -103.54 -22.79 13.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.7 p -91.96 -31.78 15.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.595 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.7 mmm -74.05 140.48 77.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.597 0.713 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.99 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -129.55 171.67 20.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.5 mttp . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.907 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.456 HG23 ' HD2' ' A' ' 400' ' ' PRO . 30.4 mm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.614 0.721 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 399' ' ' ILE . 53.3 Cg_endo -69.81 118.54 5.74 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.309 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -60.1 107.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -131.61 -144.3 5.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -96.44 -175.66 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.59 -21.25 17.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -126.04 18.24 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.6 p -58.59 -12.29 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 70.5 mt -127.46 5.28 6.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.24 148.81 49.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.88 -29.33 3.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.461 HD11 ' CE ' ' A' ' 482' ' ' MET . 16.4 mt -87.6 152.6 22.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 412' ' ' PHE . 86.4 mt -114.68 154.32 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.436 ' N ' HG22 ' A' ' 411' ' ' ILE . 68.1 m-85 -139.01 152.48 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 438' ' ' THR . 95.3 t -132.29 101.9 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.1 mt -84.48 128.11 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.2 t -126.04 134.23 51.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.85 -159.45 41.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 452' ' ' ARG . 4.2 m -122.95 160.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.5 mt -137.62 158.25 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 420' ' ' SER . 24.4 tt0 -80.76 -66.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 419' ' ' GLU . 27.3 m -38.49 -41.74 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.77 170.5 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -111.78 166.43 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -44.13 -40.17 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 2.2 t0 -68.45 -63.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -48.18 -58.86 3.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.17 53.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -69.7 -50.13 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.8 t -54.94 -32.78 61.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -63.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 475' ' ' LEU . 73.5 mt -46.99 -48.5 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.174 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.78 -38.58 91.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.93 -14.69 9.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.439 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 72.8 m-85 -113.77 5.05 16.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 103.61 -37.47 3.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 407' ' ' LEU . . . -46.42 152.91 1.08 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -102.8 154.5 19.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.98 124.72 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 413' ' ' VAL . 11.9 t -139.62 171.09 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.1 -33.43 6.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.532 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -94.18 139.12 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.482 HG23 ' HE3' ' A' ' 458' ' ' LYS . 40.2 t -90.09 127.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 18.0 m -122.14 -174.68 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.422 ' HA ' HD13 ' A' ' 465' ' ' LEU . 49.2 mtpt -76.66 -11.86 59.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -89.29 -20.29 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 56.3 m -52.85 131.64 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.65 -40.06 9.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -141.15 153.37 45.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 413' ' ' VAL . 7.4 tp -121.41 106.33 11.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 105.4 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.425 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.1 mtt -87.37 168.76 12.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -153.62 -111.98 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -128.28 173.15 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 8.7 t0 34.45 38.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 83.1 p -80.38 -178.17 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -112.09 -168.88 18.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -104.6 -41.39 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.8 m -51.72 -45.7 63.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.482 ' HE3' HG23 ' A' ' 441' ' ' VAL . 0.2 OUTLIER -45.31 -57.58 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 460' ' ' ASP . 54.8 p -66.35 -57.05 8.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 459' ' ' SER . 3.9 t70 -35.07 -61.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -59.07 -57.26 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -41.97 -58.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.65 78.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -51.27 -42.99 61.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 443' ' ' LYS . 17.3 mt -80.71 -24.58 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 94.3 56.84 1.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 88.9 m -112.36 136.43 51.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -70.78 135.82 48.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.425 HG23 ' HG3' ' A' ' 450' ' ' MET . 71.0 mt -107.84 123.52 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.08 165.49 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -110.14 175.2 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -38.72 -44.51 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.76 -49.59 57.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.63 -22.62 25.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.508 HD11 HG12 ' A' ' 430' ' ' ILE . 58.1 tp -74.79 -47.96 28.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.72 -44.7 90.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 481' ' ' THR . 39.9 t30 -58.5 -34.69 71.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -64.97 -15.06 61.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 479' ' ' ILE . 52.4 mt -90.15 -15.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -106.18 -31.05 8.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 477' ' ' ASN . 40.1 p -83.24 -27.83 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.461 ' CE ' HD11 ' A' ' 410' ' ' LEU . 32.0 mmm -77.49 142.65 67.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 0.0 110.844 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -165.91 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.479 ' CA ' ' CB ' ' A' ' 403' ' ' ALA . . . -134.2 158.39 23.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.463 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 46.7 mttm . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 0.0 110.894 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.8 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.591 0.71 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 122.37 9.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -76.96 96.18 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -111.17 -141.53 8.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.462 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -87.43 -175.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -102.61 -22.39 13.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -126.14 31.19 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.6 p -70.6 -19.62 62.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.4 mt -117.44 7.16 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.38 133.73 51.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 89.38 -25.62 10.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' ' 482' ' ' MET . 84.9 mt -83.48 143.46 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.97 149.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -139.65 148.6 42.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 438' ' ' THR . 88.9 t -125.61 101.63 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 430' ' ' ILE . 34.2 mt -83.12 128.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.436 HG21 ' SD ' ' A' ' 450' ' ' MET . 9.0 t -130.57 143.57 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.55 -144.96 34.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.14 152.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.63 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -65.98 -61.03 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 31.8 m -38.23 -59.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.4 pt -140.91 153.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.91 175.03 9.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -55.08 -46.89 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -63.27 -55.8 21.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -62.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -47.3 -48.44 25.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.6 tttt -48.28 -55.21 11.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.0 m -50.87 -37.36 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.17 -65.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 414' ' ' ILE . 49.9 mt -46.69 -39.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.22 -27.52 42.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -64.93 -19.4 65.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.522 ' CE2' HD13 ' A' ' 479' ' ' ILE . 76.0 m-85 -110.86 4.56 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.27 -25.0 23.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 430' ' ' ILE . . . -52.71 170.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.468 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 154.47 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 427' ' ' LYS . 39.9 t -129.21 121.71 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.515 HG23 HG22 ' A' ' 413' ' ' VAL . 0.1 OUTLIER -132.26 158.1 42.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.176 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -100.13 50.36 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -164.46 144.26 7.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.57 104.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 22.2 m -128.16 174.51 9.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -53.61 -56.65 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -40.81 -30.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 29.3 m -57.7 130.64 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -99.08 -35.13 10.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 468' ' ' LYS . 67.3 m-85 -143.82 164.67 29.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.517 HD23 HG12 ' A' ' 469' ' ' ILE . 22.7 tp -131.01 110.6 11.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.91 104.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.443 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 4.4 mmt -96.73 159.89 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -146.36 -140.21 3.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -93.54 164.78 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.5 t70 38.29 46.83 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 20.3 p -83.18 -177.91 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -109.65 -179.68 20.96 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -108.28 -12.49 15.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.5 m -74.46 -49.3 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -56.54 -53.16 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.443 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 53.2 p -61.06 -42.71 99.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.89 -67.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 462' ' ' ALA . 32.4 tptt -59.8 -54.46 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -36.26 -46.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.085 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.57 49.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -50.86 -47.5 60.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 -26.89 63.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 87.91 50.49 3.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 40.0 m -98.8 148.23 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 13.2 mmmt -79.85 112.65 17.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.517 HG12 HD23 ' A' ' 448' ' ' LEU . 63.7 mt -90.73 124.85 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.19 165.6 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.29 176.55 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -28.61 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.08 -49.09 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.84 61.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.74 -36.73 70.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.74 -33.37 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -70.17 -29.49 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.65 -22.91 64.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.522 HD13 ' CE2' ' A' ' 433' ' ' TYR . 67.4 mt -83.3 -16.88 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -103.45 -10.81 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 50.9 p -106.16 -39.41 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' ' 410' ' ' LEU . 34.3 mmm -66.87 141.65 96.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.572 0.701 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -164.17 0.12 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.727 2.285 . . . . 0.0 112.35 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -131.7 166.82 22.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.4 mttm . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.592 0.71 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 122.94 9.61 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -81.9 107.9 14.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.98 -138.73 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.74 -174.94 3.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.65 -20.9 16.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -127.25 28.09 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 23.9 p -66.74 -21.95 66.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.67 HD23 ' SD ' ' A' ' 482' ' ' MET . 78.0 mt -121.94 17.3 10.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.67 146.61 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.52 2.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 80.6 mt -77.16 152.18 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.473 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 67.3 mt -118.26 139.99 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -125.62 148.33 49.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.694 HG22 HG23 ' A' ' 438' ' ' THR . 48.9 t -124.1 104.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 430' ' ' ILE . 75.3 mt -86.55 126.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -131.48 125.92 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.53 -149.88 20.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.03 146.41 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 472' ' ' GLU . 8.2 mt -117.14 166.85 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -90.85 -57.29 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 421' ' ' ILE . 26.5 m -48.69 -29.28 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 420' ' ' SER . 0.8 OUTLIER -163.72 173.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.113 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -104.94 -176.29 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.78 -38.79 87.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.25 -50.81 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -53.98 -58.57 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.88 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.109 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 437' ' ' VAL . 43.6 tttm -49.53 -50.09 43.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 47.4 t -56.0 -40.24 73.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.1 tp -65.07 -63.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 414' ' ' ILE . 64.6 mt -45.79 -40.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -77.75 -33.16 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -57.74 -20.81 37.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.454 ' HD2' ' HG ' ' A' ' 406' ' ' CYS . 81.5 m-85 -109.2 -4.76 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.12 -35.43 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -46.62 154.52 0.84 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -109.01 159.98 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 427' ' ' LYS . 79.8 t -131.71 118.02 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 413' ' ' VAL . 0.5 OUTLIER -138.73 139.06 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.67 3.75 72.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -115.3 131.62 56.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.77 120.38 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.9 m -128.75 -175.25 3.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.704 ' HG2' HD22 ' A' ' 465' ' ' LEU . 55.0 mtpt -71.76 -42.99 66.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.473 ' HG3' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -58.26 -25.56 61.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 24.3 m -51.46 138.26 22.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.14 -48.51 4.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 468' ' ' LYS . 87.1 m-85 -130.51 153.45 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 5.0 tp -120.15 104.34 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.0 105.24 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.451 ' O ' HD21 ' A' ' 418' ' ' LEU . 7.1 mtt -80.98 175.61 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -164.9 -109.24 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.5 mmt180 -125.78 165.6 18.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.6 t0 34.32 37.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 452' ' ' ARG . 20.0 m -77.59 136.17 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.16 124.09 9.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -56.99 -23.02 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.8 t -65.88 -15.17 62.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -82.83 -48.45 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.41 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 88.1 p -67.43 -25.49 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.48 -46.24 64.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.578 ' HE2' HD21 ' A' ' 465' ' ' LEU . 0.2 OUTLIER -78.03 -37.34 47.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.21 69.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.11 89.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -53.91 -46.35 71.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 443' ' ' LYS . 16.1 mt -76.16 -24.84 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.63 49.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 54.6 m -100.0 135.77 40.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.519 ' CB ' ' CD1' ' A' ' 447' ' ' TYR . 10.1 mmtp -72.56 117.67 14.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.71 128.66 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 42.6 pt -141.42 170.99 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.5 178.19 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.633 ' HB3' HD22 ' A' ' 418' ' ' LEU . 0.3 OUTLIER -45.75 -35.91 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.87 -37.65 73.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -64.35 -31.58 81.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.429 HD11 HG12 ' A' ' 430' ' ' ILE . 43.5 tp -67.06 -52.95 35.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.3 -51.98 66.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.98 -38.12 67.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.5 mt -60.55 -20.55 60.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.444 HG23 ' CE2' ' A' ' 433' ' ' TYR . 70.7 mt -84.84 -14.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -109.9 -7.83 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.4 p -107.75 -42.07 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.67 ' SD ' HD23 ' A' ' 407' ' ' LEU . 9.9 mtp -64.89 143.48 98.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.508 0.671 . . . . 0.0 110.874 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -165.75 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -139.74 164.19 26.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 33.5 mttm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.603 0.716 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 117.88 5.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.61 101.24 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.78 -156.56 10.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -73.73 -175.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.86 -28.09 12.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -122.65 28.98 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 14.7 p -69.05 -14.61 63.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 433' ' ' TYR . 65.6 mt -117.94 -2.58 11.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.96 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.7 20.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.585 HD11 ' CE ' ' A' ' 482' ' ' MET . 57.6 mt -86.67 134.56 33.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 412' ' ' PHE . 45.6 mt -99.56 155.68 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 56.0 m-85 -145.01 148.99 34.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.778 HG22 HG23 ' A' ' 438' ' ' THR . 51.6 t -128.97 104.91 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 28.1 mt -85.99 133.87 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.7 t -130.54 141.57 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -151.17 42.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.508 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 m -130.22 153.13 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 472' ' ' GLU . 16.9 mt -123.57 161.7 24.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.89 -61.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.1 p -48.45 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' HB3' ' A' ' 425' ' ' GLU . 0.9 OUTLIER -122.14 122.16 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.49 178.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.99 -40.19 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.08 -61.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.54 ' HB3' HG22 ' A' ' 421' ' ' ILE . 3.8 mm-40 -43.94 -47.99 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.82 92.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.466 ' HA ' HG21 ' A' ' 437' ' ' VAL . 52.0 tttt -55.09 -52.16 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -54.75 -39.7 68.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.85 -57.94 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 26.0 mt -49.08 -49.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.11 -34.86 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -58.73 -16.87 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.615 ' CE2' HD13 ' A' ' 479' ' ' ILE . 64.4 m-85 -113.11 11.38 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.26 -28.83 12.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -50.16 168.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -121.21 151.86 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' A' ' 427' ' ' LYS . 98.1 t -127.82 127.86 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.778 HG23 HG22 ' A' ' 413' ' ' VAL . 3.1 t -143.02 170.19 16.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.92 -26.81 8.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -93.1 137.73 32.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.75 109.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 m -121.06 179.08 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -54.66 -46.16 73.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -53.0 -26.93 16.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.435 HG22 HG21 ' A' ' 467' ' ' THR . 28.9 m -55.0 117.99 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -90.31 -39.72 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.547 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 92.1 m-85 -137.88 155.62 48.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 469' ' ' ILE . 3.1 tp -125.25 107.01 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.2 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 8.4 mmt -93.58 157.57 16.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -140.47 -117.24 1.38 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.2 ptp180 -123.15 170.64 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.865 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 2.2 t70 34.43 37.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 452' ' ' ARG . 29.0 m -95.54 150.85 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -74.92 161.06 53.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -85.24 -33.44 22.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -54.45 -46.59 73.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -46.71 -27.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.4 p -88.87 -47.07 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -42.42 -43.06 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -73.47 -39.5 64.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.16 -57.46 12.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 466' ' ' GLY . . . -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -42.91 -48.66 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.36 -16.75 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 463' ' ' ALA . . . 89.01 55.27 2.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 445' ' ' THR . 18.1 m -109.43 138.49 45.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.1 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.18 127.17 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 448' ' ' LEU . 79.0 mt -99.99 124.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.429 HD12 ' CA ' ' A' ' 475' ' ' LEU . 23.2 pt -130.62 177.78 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.05 -179.25 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.696 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.6 pm0 -52.11 -28.62 18.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.15 -45.24 15.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -63.99 -28.46 72.82 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.429 ' CA ' HD12 ' A' ' 470' ' ' ILE . 61.5 tp -67.87 -40.0 83.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.959 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.03 -30.15 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -70.68 -38.93 73.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 470' ' ' ILE . 14.4 mt -59.73 -17.34 34.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.615 HD13 ' CE2' ' A' ' 433' ' ' TYR . 87.5 mt -86.92 -24.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.76 -9.88 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.1 p -103.54 -41.66 5.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.585 ' CE ' HD11 ' A' ' 410' ' ' LEU . 13.0 mmm -67.12 139.88 95.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -165.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -125.63 170.39 17.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 mttp . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.563 0.697 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 117.38 5.05 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.227 . . . . 0.0 112.379 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -79.95 84.3 5.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -100.21 -138.18 10.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.88 -174.86 3.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.36 -21.08 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -126.77 33.3 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.0 p -76.54 -10.47 59.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 410' ' ' LEU . 79.0 mt -128.37 6.8 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.9 118.5 9.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.38 -30.69 9.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 407' ' ' LEU . 21.0 mt -79.95 140.16 36.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 444' ' ' LYS . 75.3 mt -106.28 142.97 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 61.2 m-85 -130.42 148.1 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 438' ' ' THR . 84.9 t -122.47 101.87 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 430' ' ' ILE . 61.7 mt -83.89 123.27 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.402 HG23 ' OG ' ' A' ' 454' ' ' SER . 8.4 t -122.74 144.21 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -153.15 45.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 11.5 m -130.94 160.83 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 7.5 mt -137.68 151.69 48.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -75.95 -62.66 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 8.9 m -40.39 -42.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 426' ' ' ALA . 4.7 pt -150.51 162.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 424' ' ' ASP . 14.8 mt-10 -102.67 155.53 18.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 422' ' ' GLU . 9.5 tpt85 -35.68 -32.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 422' ' ' GLU . 3.3 m-20 -73.8 -66.59 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -41.1 -65.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.09 -44.49 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.425 ' HG3' HG11 ' A' ' 437' ' ' VAL . 11.6 tttp -53.35 -52.88 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 t -51.13 -39.57 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -60.27 3.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 414' ' ' ILE . 37.4 mt -55.33 -43.71 72.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.81 -31.18 67.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -63.46 -31.03 72.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 479' ' ' ILE . 78.0 m-85 -96.28 4.84 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.23 -27.58 19.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -48.38 161.08 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -110.82 154.79 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.425 HG11 ' HG3' ' A' ' 427' ' ' LYS . 59.0 t -129.69 114.92 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 413' ' ' VAL . 13.8 t -130.72 170.27 14.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -112.38 51.76 0.68 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ASN . . . . . 0.585 ' O ' HG21 ' A' ' 413' ' ' VAL . 7.6 t-20 -172.55 150.03 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 458' ' ' LYS . 57.8 t -102.6 109.24 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 444' ' ' LYS . 1.7 m -127.63 -176.13 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.835 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -61.14 -40.29 93.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.553 ' HG2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -64.41 -25.45 68.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.6 m -61.68 136.63 58.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.504 ' O ' HG23 ' A' ' 467' ' ' THR . 15.6 m120 -105.48 -49.48 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 478' ' ' LEU . 72.5 m-85 -129.62 154.96 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.631 HD23 HG12 ' A' ' 469' ' ' ILE . 11.3 tp -122.78 102.81 8.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.5 t -77.5 104.65 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.6 mtp -77.01 178.6 6.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 175.9 44.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 453' ' ' ASP . 1.0 OUTLIER -53.32 146.81 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 452' ' ' ARG . 1.6 t70 43.57 54.28 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 415' ' ' THR . 2.7 m -106.71 127.99 53.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -52.33 150.14 9.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.81 -39.76 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -44.31 -39.63 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' A' ' 441' ' ' VAL . 2.3 tppt? -50.7 -41.88 56.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.2 p -73.55 -29.13 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -54.91 -56.97 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -63.12 -47.51 82.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -42.97 -56.15 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.22 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.32 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.47 -30.91 68.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 101.92 42.57 2.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 446' ' ' ASN . 94.9 m -97.5 140.37 32.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -81.63 109.64 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.631 HG12 HD23 ' A' ' 448' ' ' LEU . 72.5 mt -82.97 129.69 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.131 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 475' ' ' LEU . 46.6 pt -140.33 173.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 472' ' ' GLU . 3.0 p30 -120.81 172.5 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.0 pm0 -35.15 -43.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 32.7 t0 -66.23 -52.79 44.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -50.8 -42.03 45.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.7 tp -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.8 -51.9 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.0 -36.52 65.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.636 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.4 mt -65.1 -25.77 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.2 mt -79.58 -27.27 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -91.31 -28.48 17.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -83.26 -47.89 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.415 ' CE ' HD11 ' A' ' 410' ' ' LEU . 15.4 mmm -57.77 141.86 79.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.73 169.67 22.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.8 mttp . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.1 mm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.623 0.725 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 116.42 4.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.39 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -75.94 83.13 2.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -96.92 -142.44 13.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.958 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.16 -174.96 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 5.1 pt-20 -103.22 -33.03 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.492 ' CB ' ' HG3' ' A' ' 485' ' ' LYS . 51.2 m-80 -122.47 26.28 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.958 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -63.03 -16.24 59.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.11 7.38 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.95 128.48 36.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.79 21.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.556 HD11 ' CE ' ' A' ' 482' ' ' MET . 7.5 mt -87.74 145.64 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 444' ' ' LYS . 68.4 mt -110.84 147.39 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -132.77 138.99 47.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 438' ' ' THR . 77.6 t -117.73 101.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 62.5 mt -81.06 119.63 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 415' ' ' THR . 9.1 t -121.36 116.02 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.48 -153.12 18.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.03 158.17 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 472' ' ' GLU . 0.9 OUTLIER -135.23 148.62 49.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.7 -58.12 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.5 m -44.71 -41.92 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 426' ' ' ALA . 3.0 pt -152.17 161.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.58 168.35 9.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -45.68 -35.56 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 427' ' ' LYS . 14.1 t70 -77.48 -63.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -38.76 -48.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -66.05 -37.67 86.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.612 ' HA ' HG21 ' A' ' 437' ' ' VAL . 50.7 tttt -58.88 -45.21 90.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -23.04 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 20.4 tp -81.47 -64.23 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 475' ' ' LEU . 27.6 mt -48.12 -36.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -76.68 -29.81 56.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.65 -14.55 61.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 479' ' ' ILE . 81.4 m-85 -114.01 6.91 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.19 -26.87 22.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.57 165.89 2.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -122.07 159.93 26.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 427' ' ' LYS . 94.5 t -133.62 117.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.552 HG23 HG22 ' A' ' 413' ' ' VAL . 13.3 t -132.24 164.41 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.93 49.3 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -169.59 134.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.887 0.375 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.483 HG23 ' HD2' ' A' ' 458' ' ' LYS . 81.2 t -79.9 121.01 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 29.8 t -127.69 179.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -71.39 -25.92 62.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.744 ' HB2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -79.59 -15.25 57.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -61.82 119.25 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.442 ' C ' HG23 ' A' ' 467' ' ' THR . 7.7 m-80 -93.83 -40.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 468' ' ' LYS . 80.6 m-85 -133.18 153.98 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 413' ' ' VAL . 11.6 tp -125.47 108.38 11.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.38 102.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.3 ptp -103.59 170.99 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 -103.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 453' ' ' ASP . 15.9 mmt180 -91.09 159.53 16.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.9 t70 34.4 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.3 t -82.78 105.64 13.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -56.01 173.76 1.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -113.22 -3.49 13.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.0 t -75.29 -32.62 61.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.483 ' HD2' HG23 ' A' ' 441' ' ' VAL . 31.2 mtmt -81.87 -57.89 3.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.0 p -46.0 -58.58 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -38.45 -43.73 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -69.07 -49.54 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.577 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -40.87 -58.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.44 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.29 -24.34 63.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.8 mt -98.76 17.79 18.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.77 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.472 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.577 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 60.6 m -103.48 126.49 50.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 447' ' ' TYR . 0.2 OUTLIER -72.39 111.44 7.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 16.8 mt -81.97 122.5 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 478' ' ' LEU . 28.0 pt -137.96 172.41 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.89 175.42 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 418' ' ' LEU . 16.4 pt-20 -38.62 -46.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -67.77 -49.56 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.91 -30.22 9.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 430' ' ' ILE . 50.9 tp -71.64 -62.22 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 29.9 mt -43.09 -41.93 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.23 -36.69 82.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 470' ' ' ILE . 11.0 mt -63.89 -23.07 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.508 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.4 mt -81.09 -15.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.129 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -105.36 -8.8 17.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 -38.79 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.5 mtp -62.93 142.26 97.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.1 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.94 155.23 17.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.527 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.492 ' HG3' ' CB ' ' A' ' 405' ' ' ASN . 4.5 ptpp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.1 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.594 0.711 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.589 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.6 Cg_endo -69.77 126.45 13.31 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 0.0 112.348 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -89.33 94.75 10.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.76 -135.73 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.28 -175.0 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -100.72 -19.56 15.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -128.24 30.82 5.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -71.69 -11.21 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.87 13.49 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.84 122.65 23.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.89 -35.24 5.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.8 157.78 29.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.769 0.319 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 412' ' ' PHE . 77.5 mt -115.1 154.17 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 38.6 m-85 -142.16 153.2 43.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.769 HG22 HG23 ' A' ' 438' ' ' THR . 98.5 t -133.06 102.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 426' ' ' ALA . 33.1 mt -83.68 122.74 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -125.74 132.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.16 -153.71 23.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.37 152.73 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.354 . . . . 0.0 111.139 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.2 mt -132.12 164.03 27.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -85.39 -66.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.5 p -41.92 -27.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 420' ' ' SER . 0.9 OUTLIER -161.88 165.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.91 164.45 13.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -39.29 -36.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 37.5 t0 -73.85 -66.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 424' ' ' ASP . 18.0 mm-40 -36.88 -53.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.584 ' HB3' HD13 ' A' ' 414' ' ' ILE . . . -56.53 -41.81 77.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 437' ' ' VAL . 38.3 tttt -58.4 -46.14 86.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -40.83 97.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.1 tp -63.47 -62.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 414' ' ' ILE . 54.8 mt -44.42 -43.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -75.35 -35.78 61.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -54.33 -21.83 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.33 -3.78 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 115.59 -40.3 2.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.22 162.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 427' ' ' LYS . 87.9 t -125.7 125.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.769 HG23 HG22 ' A' ' 413' ' ' VAL . 3.5 t -137.64 139.93 40.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -86.33 46.81 3.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -157.86 126.65 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 458' ' ' LYS . 48.3 t -80.6 100.83 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.179 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 51.9 m -121.29 164.73 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -50.94 -52.96 37.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -43.54 -32.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.9 m -48.94 130.69 18.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -99.15 -30.19 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 478' ' ' LEU . 65.9 m-85 -148.68 145.66 27.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.532 HD23 HG12 ' A' ' 469' ' ' ILE . 15.6 tp -115.81 98.88 6.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.21 106.05 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.5 139.03 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -122.24 -114.02 2.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -92.5 167.78 11.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 27.0 t70 38.02 45.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 70.4 m -101.55 173.26 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -99.18 147.48 18.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 457' ' ' SER . 49.0 tp60 -82.92 -47.41 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.893 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 456' ' ' GLN . 11.3 t -36.24 -46.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.496 ' HB3' HG21 ' A' ' 441' ' ' VAL . 24.0 mttm -55.37 -65.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.3 t -50.51 -44.78 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -46.81 -58.1 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -66.91 -43.39 83.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -45.38 -50.74 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.076 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.98 88.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.083 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.27 70.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 22.3 mt -93.76 22.97 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 51.61 52.65 32.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.525 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.5 m -109.68 126.27 53.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.136 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 106.42 4.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.532 HG12 HD23 ' A' ' 448' ' ' LEU . 62.6 mt -84.52 125.08 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 475' ' ' LEU . 14.7 pt -138.36 174.57 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -116.4 177.35 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.645 ' HB3' HD13 ' A' ' 418' ' ' LEU . 4.9 pt-20 -39.06 -46.28 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.91 -55.86 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.3 -38.27 19.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.539 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 470' ' ' ILE . 40.9 tp -58.56 -51.69 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.589 HD22 ' CD ' ' A' ' 400' ' ' PRO . 39.5 mt -57.04 -50.45 72.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.17 -33.55 65.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' ' 447' ' ' TYR . 12.5 mt -66.78 -15.92 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.06 -25.4 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -93.56 -28.16 16.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 27.2 p -84.09 -41.5 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 23.2 mmm -65.79 140.6 97.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.0 Cg_endo -69.83 -164.34 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.645 2.23 . . . . 0.0 112.315 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.58 174.2 20.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.4 mttm . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 17.0 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.614 0.721 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 122.96 9.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.709 2.272 . . . . 0.0 112.364 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -73.7 119.64 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -138.83 -156.72 7.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.29 -175.01 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.36 -20.54 15.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -126.91 29.52 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 32.0 p -68.98 -18.63 64.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.04 16.14 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -78.89 121.48 24.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.7 -24.51 21.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.478 HD11 ' CE ' ' A' ' 482' ' ' MET . 25.7 mt -89.85 150.09 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.5 144.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 57.0 m-85 -132.07 152.2 51.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.83 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 438' ' ' THR . 96.3 t -131.33 110.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.26 121.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 415' ' ' THR . 4.0 t -124.69 115.06 20.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.07 -153.8 16.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.428 ' CG2' ' HE ' ' A' ' 452' ' ' ARG . 2.4 m -131.31 150.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.64 145.14 51.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -72.44 -44.03 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 421' ' ' ILE . 11.0 m -55.04 -42.13 72.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.854 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.5 pt -156.33 161.01 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.91 169.76 10.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -52.12 -30.34 25.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.44 -55.95 4.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -47.37 -54.64 10.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.476 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' LYS . . . . . 0.43 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.8 tttm -53.46 -53.53 50.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -51.94 -40.58 61.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.7 tp -64.22 -53.61 46.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.503 HG12 HD11 ' A' ' 475' ' ' LEU . 59.3 mt -54.37 -38.98 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -77.86 -30.41 50.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -58.04 -24.28 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -110.34 4.79 21.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.83 -33.13 6.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.496 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -43.74 146.71 1.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -104.24 159.54 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 427' ' ' LYS . 91.8 t -133.26 116.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.61 ' O ' HG13 ' A' ' 413' ' ' VAL . 5.1 t -132.21 148.36 52.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.11 53.5 1.37 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 114.08 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.879 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.94 99.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.7 m -119.59 -175.16 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -63.34 -54.87 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -47.19 -28.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 49.4 m -58.37 126.0 25.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -95.53 -42.93 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 46.1 m-85 -132.12 149.48 52.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 469' ' ' ILE . 9.2 tp -120.05 106.95 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.14 102.76 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.636 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.1 mtt -82.79 161.92 21.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -154.61 -169.64 19.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.428 ' HE ' ' CG2' ' A' ' 417' ' ' VAL . 3.8 ttp180 -68.03 147.05 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.901 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.9 t70 43.24 52.18 5.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.6 p -81.86 176.38 9.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.77 141.44 15.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -74.78 -33.3 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 55.8 m -58.71 -41.64 86.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -55.06 -61.15 2.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 460' ' ' ASP . 28.6 p -51.83 -44.75 63.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 459' ' ' SER . 8.1 t70 -35.59 -67.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.462 ' HB3' HD12 ' A' ' 465' ' ' LEU . 7.2 mptt -57.87 -56.39 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -34.28 -48.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.99 84.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 461' ' ' LYS . . . -68.68 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 461' ' ' LYS . 28.2 mt -54.79 -32.07 59.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 86.97 62.98 1.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 6.7 m -107.06 139.24 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.167 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 19.5 mmtt -69.14 105.4 2.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.671 HG12 HD23 ' A' ' 448' ' ' LEU . 88.5 mt -85.62 131.11 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.54 177.38 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -126.05 177.34 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -38.87 -48.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -63.07 -49.52 74.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -56.67 -26.22 52.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 430' ' ' ILE . 64.0 tp -73.39 -48.08 36.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 479' ' ' ILE . 73.9 mt -62.58 -44.08 97.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 481' ' ' THR . 8.1 t-20 -61.63 -28.77 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.4 mt -70.67 -15.8 62.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 476' ' ' LEU . 31.0 mt -87.24 -17.31 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.75 -29.26 11.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 477' ' ' ASN . 58.3 p -83.31 -45.5 13.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.478 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.3 mmm -60.34 142.0 90.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.83 -166.69 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.316 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -133.89 165.01 24.38 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 35.8 mttm . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.596 0.712 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.14 5.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.353 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -71.97 102.62 2.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -125.78 -161.17 10.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.435 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.451 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -73.08 -175.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.731 0.301 . . . . 0.0 111.111 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -101.33 -20.84 15.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -126.04 36.73 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 29.1 p -78.67 -6.46 55.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 96.7 mt -132.96 5.55 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -69.35 116.76 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.31 -16.94 34.79 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.584 HD11 ' CE ' ' A' ' 482' ' ' MET . 48.8 mt -99.47 138.6 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 28.5 mt -101.96 151.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.429 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 43.4 m-85 -136.72 143.69 43.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 438' ' ' THR . 60.8 t -121.08 109.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.605 HG21 ' NE ' ' A' ' 423' ' ' ARG . 50.4 mt -90.5 120.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 415' ' ' THR . 6.5 t -118.74 113.03 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLY . . . . . 0.443 ' O ' ' NH1' ' A' ' 423' ' ' ARG . . . 99.21 175.17 31.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 417' ' ' VAL . 1.8 m -94.47 122.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.461 HD12 HH21 ' A' ' 423' ' ' ARG . 4.6 mt -90.26 100.45 13.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -40.88 -25.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 418' ' ' LEU . 4.3 p -71.97 -62.71 1.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 425' ' ' GLU . 0.4 OUTLIER -140.52 132.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -65.57 -175.55 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.605 ' NE ' HG21 ' A' ' 414' ' ' ILE . 8.2 mmp_? -58.71 -58.29 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -29.48 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 421' ' ' ILE . 9.3 mt-10 -71.04 -64.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -54.02 -62.51 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -41.85 -27.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.33 -51.45 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 475' ' ' LEU . 45.2 mt -61.03 -35.87 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.26 -29.66 38.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -60.56 -21.25 62.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -111.11 2.51 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.43 -27.52 15.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.436 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -48.63 157.15 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -114.57 157.56 22.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.5 t -131.73 123.45 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.851 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -134.59 155.72 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -101.29 37.03 3.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -160.16 125.14 3.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 458' ' ' LYS . 96.0 t -67.28 118.42 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 75.4 m -123.24 157.94 31.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.872 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -61.48 -14.34 28.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -86.59 -22.74 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 26.3 m -51.86 133.57 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.513 ' OD1' HD22 ' A' ' 410' ' ' LEU . 5.4 m-80 -97.22 -25.2 15.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 69.8 m-85 -157.57 131.11 7.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 469' ' ' ILE . 18.1 tp -98.13 116.23 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.35 94.52 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.506 ' CE ' HD21 ' A' ' 448' ' ' LEU . 6.4 mmt -86.39 166.47 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -159.59 -107.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -126.92 168.49 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.8 m-20 37.72 46.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.6 m -99.98 175.99 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.32 -177.51 40.27 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.435 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -115.18 -19.61 10.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.4 p -77.63 -19.16 55.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 441' ' ' VAL . 36.9 mmtm -72.49 -39.45 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 42.7 p -73.96 -52.18 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.38 -44.46 8.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -47.06 50.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -53.02 -53.65 47.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.079 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.0 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -54.84 -58.7 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.068 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 443' ' ' LYS . 12.3 mt -61.35 -23.7 65.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 93.64 53.81 1.76 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 3.5 m -107.98 134.59 50.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.14 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -74.91 116.67 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 448' ' ' LEU . 88.3 mt -87.3 123.55 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 475' ' ' LEU . 50.2 pt -140.1 168.98 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 471' ' ' ASP . 0.6 OUTLIER -115.26 173.92 6.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.4 pt-20 -34.12 -45.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -60.34 3.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.41 8.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 430' ' ' ILE . 23.2 tp -44.4 -45.64 9.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.73 -46.79 83.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -62.12 -31.29 71.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 478' ' ' LEU . 10.9 mt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 20.1 mt -82.96 -17.6 10.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.9 -16.91 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.842 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.1 p -97.04 -33.72 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.584 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.7 mmm -72.18 142.51 84.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.874 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -165.48 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.334 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -137.17 169.36 24.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 25.7 mttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.948 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 476' ' ' LEU . 12.7 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.665 0.745 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 128.75 16.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.738 2.292 . . . . 0.0 112.32 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 402' ' ' GLY . 0.0 OUTLIER -65.22 103.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLY . . . . . 0.494 ' N ' ' HE3' ' A' ' 401' ' ' LYS . . . -124.3 -161.48 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.486 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.3 -175.0 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.723 0.297 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.81 -23.79 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -125.08 30.84 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.8 p -69.49 -13.08 62.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.17 7.18 7.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -63.55 137.29 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 87.73 -29.91 5.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 76.7 mt -79.23 148.63 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 90.7 mt -119.91 145.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 67.1 m-85 -132.21 153.62 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.993 HG22 HG23 ' A' ' 438' ' ' THR . 99.5 t -128.56 103.2 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.521 HG22 ' NH1' ' A' ' 423' ' ' ARG . 21.6 mt -85.18 124.4 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -122.73 139.81 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 85.63 -157.04 30.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 417' ' ' VAL . 4.7 m -135.32 123.9 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.389 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.18 149.42 23.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -55.06 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.4 m -45.13 -53.83 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 426' ' ' ALA . 2.1 pt -142.15 128.44 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.98 165.04 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.521 ' NH1' HG22 ' A' ' 414' ' ' ILE . 0.1 OUTLIER -41.96 -43.62 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 425' ' ' GLU . 1.1 m-20 -64.25 -66.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 424' ' ' ASP . 37.9 mm-40 -36.75 -71.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.21 -56.03 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -39.84 -62.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -33.78 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 432' ' ' ARG . 15.5 tp -71.8 -66.23 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 414' ' ' ILE . 30.8 mt -45.81 -33.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.66 -25.06 26.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 429' ' ' LEU . 14.9 ttm180 -65.08 -16.9 63.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.92 6.9 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.87 -37.71 3.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.3 149.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -105.1 165.91 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.63 132.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' THR . . . . . 0.993 HG23 HG22 ' A' ' 413' ' ' VAL . 0.3 OUTLIER -143.18 129.95 20.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.52 76.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -104.77 139.69 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 413' ' ' VAL . 90.9 t -76.01 127.37 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 p -123.24 170.3 10.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.597 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -62.02 -32.93 73.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.922 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -70.5 -19.15 62.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.0 m -51.02 133.73 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 7.8 m120 -106.69 -22.81 12.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 58.2 m-85 -156.06 154.95 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 448' ' ' LEU . 1.8 tp -121.3 106.49 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.2 97.5 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.527 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.4 mtt -78.61 170.5 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -158.54 -107.51 0.24 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 ptp180 -131.11 172.75 11.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.2 m-20 34.53 38.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.6 t -83.08 -175.04 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -127.27 141.98 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -13.15 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.32 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 14.8 t -73.46 -44.63 57.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -55.71 -48.25 75.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.483 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 46.2 p -68.88 -33.76 74.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.52 -42.63 92.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LYS . . . . . 0.513 ' HE2' HD11 ' A' ' 465' ' ' LEU . 1.8 tmtp? -77.23 -34.07 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -63.37 -54.91 29.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.34 68.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.597 HD13 ' HA ' ' A' ' 443' ' ' LYS . 37.3 mt -71.44 -25.72 62.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 102.48 51.39 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 41.2 m -113.86 141.8 46.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.336 . . . . 0.0 111.159 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -85.56 139.95 31.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.527 HG23 ' HG3' ' A' ' 450' ' ' MET . 2.8 mp -102.22 122.01 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.8 179.49 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 474' ' ' GLY . 2.1 p-10 -124.79 166.76 15.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -38.96 -30.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.8 -42.96 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -59.65 -35.11 84.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 399' ' ' ILE . 0.5 OUTLIER -50.89 -49.26 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 481' ' ' THR . 50.0 t30 -57.58 -44.41 85.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.26 -17.72 3.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 97.5 mt -87.21 -28.23 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -98.32 -13.34 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 477' ' ' ASN . 43.3 p -97.11 -43.14 7.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.176 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.2 mmm -66.64 142.6 97.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.842 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 483' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.75 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.636 2.224 . . . . 0.0 112.386 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.07 157.75 20.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.5 mttt . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.916 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.6 t -166.74 110.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 1.7 t -98.77 168.75 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 76.57 167.66 26.32 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -76.27 129.65 36.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.837 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 36.8 t -62.17 -54.76 36.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -119.15 -134.13 4.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 393' ' ' ALA . 0.1 OUTLIER -92.09 -21.84 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 392' ' ' LYS . . . 36.87 47.0 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 395' ' ' GLY . 0.3 OUTLIER -53.25 134.13 39.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.612 ' N ' HD13 ' A' ' 394' ' ' LEU . . . 156.83 -24.01 0.48 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.446 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.5 t -87.88 28.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.403 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.677 ' HZ1' HD11 ' A' ' 476' ' ' LEU . 0.2 OUTLIER -167.06 175.63 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.24 121.85 23.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.3 mm -81.97 120.74 78.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 129.7 18.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -86.2 92.34 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -114.67 -139.68 7.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.64 -175.09 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.778 0.323 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.71 -20.4 13.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -127.09 32.83 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 28.1 p -75.55 -17.4 60.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 410' ' ' LEU . 59.5 mt -121.96 10.14 10.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -68.79 116.32 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.05 -21.55 24.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 24.2 mt -90.07 150.14 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.48 148.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.4 148.53 49.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 448' ' ' LEU . 99.5 t -127.05 108.09 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 25.8 mt -91.28 123.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.7 t -120.65 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.25 -153.86 32.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -127.13 154.55 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.1 mt -132.79 136.51 46.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -60.36 -63.62 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.808 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 419' ' ' GLU . 23.0 p -35.92 -56.65 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.5 OUTLIER -143.15 155.75 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.16 160.56 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -39.84 -37.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.58 -55.13 8.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.4 ' CD ' HG22 ' A' ' 421' ' ' ILE . 17.3 mt-10 -51.16 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.39 -40.8 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 437' ' ' VAL . 36.2 tttm -58.3 -57.58 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.1 p -48.9 -30.52 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.51 -61.72 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 475' ' ' LEU . 33.7 mt -51.22 -34.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.5 -28.84 46.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -66.15 -14.95 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.5 -9.42 14.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 117.93 -24.84 8.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.9 157.56 21.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -106.63 156.29 18.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 427' ' ' LYS . 77.5 t -134.3 116.68 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.6 t -136.78 134.94 37.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.34 45.99 3.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -160.12 135.46 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.569 HG23 ' HD2' ' A' ' 458' ' ' LYS . 62.2 t -74.79 130.04 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.3 t -130.91 173.42 10.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -76.43 -19.58 57.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -88.98 -16.77 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.401 HG22 ' CG2' ' A' ' 467' ' ' THR . 96.7 m -48.05 127.58 12.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.99 -39.8 9.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 73.1 m-85 -144.64 150.77 37.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 413' ' ' VAL . 6.4 tp -117.98 107.89 14.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.61 106.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.6 mtt -92.11 165.99 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -152.26 -118.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 453' ' ' ASP . 11.4 ptm180 -119.49 173.22 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.8 t70 34.54 38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 452' ' ' ARG . 61.5 m -99.82 151.9 20.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -77.08 163.24 52.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -12.31 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 1.8 t -69.48 -34.77 74.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 441' ' ' VAL . 3.9 tppt? -58.03 -43.79 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.435 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 86.1 p -66.36 -52.42 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.1 -64.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -54.21 -49.12 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -47.77 -58.33 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.25 -50.17 67.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -47.33 -55.83 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.2 mt -66.54 -26.11 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.55 53.05 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.401 ' CG2' HG22 ' A' ' 445' ' ' THR . 47.5 m -110.4 136.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 0.0 111.16 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.503 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -79.77 117.81 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 450' ' ' MET . 15.5 mt -89.7 130.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.2 pt -147.25 166.59 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 472' ' ' GLU . 0.4 OUTLIER -107.59 171.11 7.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 473' ' ' ASP . 2.6 pp20? -37.21 -43.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 472' ' ' GLU . 16.2 t70 -60.8 -51.99 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -55.65 -35.21 61.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 430' ' ' ILE . 57.1 tp -63.16 -47.32 83.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.677 HD11 ' HZ1' ' A' ' 397' ' ' LYS . 73.5 mt -57.27 -53.05 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -53.14 -39.85 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.28 -15.54 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 78.9 mt -90.18 -19.3 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.6 -20.97 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.5 p -91.86 -38.32 12.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.521 ' CE ' HD11 ' A' ' 410' ' ' LEU . 40.7 mmm -67.29 143.6 97.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.523 0.677 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.81 -178.42 2.35 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -126.73 166.05 19.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.436 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -135.57 161.03 36.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 486' ' ' LYS . 0.1 OUTLIER -96.98 110.23 22.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 30.9 t -69.18 155.22 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -56.77 -38.74 72.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.14 135.56 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.16 148.65 22.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.71 119.82 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 493' ' ' VAL . . . -61.51 -178.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.084 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 493' ' ' VAL . 14.7 p 34.17 39.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.55 65.87 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 13.0 t -147.08 161.65 40.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.0 m -150.55 164.44 35.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 55.6 m -59.08 -54.68 44.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.882 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.38 -53.69 3.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 1.1 t -57.93 119.49 6.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.864 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 2.1 m -86.08 42.93 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 145.19 141.36 3.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -45.1 -57.32 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.321 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -160.57 133.17 6.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.35 102.41 5.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -124.43 61.08 0.6 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.43 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.3 t -121.41 28.85 7.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.47 ' HD2' ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -120.47 168.0 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -125.18 113.73 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.474 HG23 ' HD2' ' A' ' 400' ' ' PRO . 27.5 mm -76.93 135.66 67.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 399' ' ' ILE . 54.1 Cg_endo -69.75 117.93 5.38 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.65 2.234 . . . . 0.0 112.373 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -70.28 108.79 4.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -129.96 -146.29 5.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.34 -175.24 4.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.65 -25.59 12.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -124.31 30.47 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -70.38 -16.31 62.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 61.0 mt -121.12 9.21 10.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -65.79 133.79 51.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 92.35 -33.52 4.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.54 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.06 139.94 38.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.878 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 81.9 mt -105.07 156.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 91.5 m-85 -142.64 150.42 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 438' ' ' THR . 65.8 t -130.39 99.12 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 45.3 mt -81.81 130.99 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.446 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.6 t -128.88 145.98 51.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.35 42.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.89 152.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 111.107 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 451' ' ' GLY . 7.1 mt -122.92 173.85 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.73 -69.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 397' ' ' LYS . 60.8 p -40.58 -44.23 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 1.11 HD13 ' HB2' ' A' ' 426' ' ' ALA . 2.0 pp -142.08 176.98 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -122.88 164.33 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 -42.49 -31.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.83 -68.61 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -44.67 -53.06 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 1.11 ' HB2' HD13 ' A' ' 421' ' ' ILE . . . -52.53 -42.52 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 437' ' ' VAL . 39.8 tttm -58.46 -50.35 74.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 21.1 p -54.59 -34.89 62.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.55 -65.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 435' ' ' GLY . 55.2 mt -47.31 -40.02 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -76.08 -31.87 58.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.57 -16.08 62.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 479' ' ' ILE . 70.9 m-85 -113.34 3.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.89 -32.17 7.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -47.77 163.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -116.23 156.43 26.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 427' ' ' LYS . 84.9 t -130.7 128.01 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.836 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -141.26 149.86 41.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -89.72 9.17 78.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -127.91 137.24 52.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 462' ' ' ALA . 46.6 t -87.9 108.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.2 m -110.49 -178.62 3.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.928 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -77.59 -20.18 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -26.46 54.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 10.1 m -46.47 133.86 9.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 4.9 m-80 -102.47 -22.13 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 67.5 m-85 -156.01 155.11 32.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.889 HD23 HG12 ' A' ' 469' ' ' ILE . 17.2 tp -125.41 111.63 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 34.3 t -93.57 107.05 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.446 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 26.8 mtm -110.39 175.78 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 418' ' ' LEU . . . -158.55 -147.45 4.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.5 ptt180 -69.39 174.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.4 m-20 34.75 39.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.1 p -96.78 -177.6 3.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -143.83 174.55 24.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.24 24.7 6.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.354 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 15.1 t -86.08 -42.92 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.29 -39.62 28.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.0 p -71.46 -30.53 66.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -52.47 65.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.419 ' NZ ' HD11 ' A' ' 465' ' ' LEU . 0.9 OUTLIER -74.03 -28.39 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.444 ' HB2' HG11 ' A' ' 441' ' ' VAL . . . -69.67 -42.38 74.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.73 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -45.81 -41.06 10.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.928 HD13 ' HA ' ' A' ' 443' ' ' LYS . 11.6 mt -85.41 -24.03 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 103.5 51.05 1.0 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 59.1 m -100.56 138.9 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.152 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 468' ' ' LYS . 0.3 OUTLIER -74.36 117.32 16.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.889 HG12 HD23 ' A' ' 448' ' ' LEU . 34.0 mt -94.96 131.36 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.6 pt -142.84 174.23 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.62 178.97 4.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.438 ' OE1' HD22 ' A' ' 418' ' ' LEU . 5.7 pt-20 -41.06 -45.43 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.03 -55.08 24.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 470' ' ' ILE . . . -46.28 -30.29 4.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.0 tp -67.92 -59.87 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.53 -42.85 45.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.949 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.89 -36.99 85.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.1 mt -62.75 -22.9 66.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.408 HD13 ' CE2' ' A' ' 433' ' ' TYR . 58.6 mt -83.43 -28.3 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -88.86 -22.3 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.7 p -91.23 -47.87 7.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 11.9 mmm -59.61 139.39 89.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.504 0.669 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.74 -165.18 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.46 157.09 17.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -134.62 165.18 25.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -117.9 108.08 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.953 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 43.5 t -102.05 169.47 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -91.45 43.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -114.3 151.89 32.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -106.39 170.63 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 491' ' ' ILE . 5.0 mp -100.99 127.31 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.089 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -117.51 103.83 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.067 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.37 89.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -102.76 129.0 49.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 11.4 t -89.74 3.75 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.1 p -75.64 159.21 31.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.855 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 62.9 p -69.84 150.88 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -92.52 -103.99 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.4 t -62.73 109.97 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.3 m -137.33 127.71 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -81.95 113.74 3.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -86.1 -43.87 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 81.72 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 394' ' ' LEU . 2.3 tt -68.58 -8.37 41.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 140.75 -117.67 1.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.49 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.1 t -133.35 34.08 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -133.8 171.38 14.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.18 132.84 38.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.73 125.18 91.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 0.0 111.108 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 117.7 5.24 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -76.78 95.37 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -108.54 -152.37 15.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -70.9 -177.13 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 2.8 pt-20 -101.05 -29.15 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.498 ' ND2' ' OE1' ' A' ' 408' ' ' GLU . 23.4 m120 -122.14 20.11 10.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.923 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.9 p -59.26 -25.64 64.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.466 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 68.0 mt -108.36 14.9 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLU . . . . . 0.498 ' OE1' ' ND2' ' A' ' 405' ' ' ASN . 8.7 tp10 -79.67 143.3 34.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 86.33 -16.6 43.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.59 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.5 mt -100.1 153.2 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 412' ' ' PHE . 95.4 mt -113.49 155.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 411' ' ' ILE . 91.1 m-85 -144.29 135.31 25.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 438' ' ' THR . 41.9 t -115.84 100.37 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.88 121.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 130.8 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.15 -152.27 22.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.81 152.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -132.25 159.4 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.24 -65.19 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 421' ' ' ILE . 10.6 t -39.74 -31.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 420' ' ' SER . 1.3 pt -161.2 160.88 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.12 170.32 8.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -47.95 -20.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -92.56 -65.86 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -42.07 -37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.66 -42.33 67.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 25.3 ttmt -58.76 -58.58 7.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 28.1 t -47.07 -36.76 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -64.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 475' ' ' LEU . 63.4 mt -49.89 -44.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.16 -32.65 73.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -66.06 -17.75 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 57.0 m-85 -108.21 1.57 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.02 -29.65 10.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.25 153.34 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 437' ' ' VAL . 9.3 tmtm? -105.78 146.92 29.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 99.5 t -122.45 121.34 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.626 ' O ' HG13 ' A' ' 413' ' ' VAL . 9.0 t -139.44 143.82 37.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -91.24 44.96 2.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -163.56 121.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.78 126.45 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.6 m -128.49 169.12 14.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -68.32 -21.65 64.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -85.44 -7.05 59.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.6 m -61.26 127.37 31.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -97.3 -29.12 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -151.83 150.96 30.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 469' ' ' ILE . 14.2 tp -119.76 108.85 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.43 105.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.502 ' HG3' HG23 ' A' ' 469' ' ' ILE . 4.2 mtt -80.27 168.98 18.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.23 -110.37 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 453' ' ' ASP . 14.7 mmt180 -125.66 172.39 9.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 452' ' ' ARG . 29.4 t0 34.56 39.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 96.6 p -83.64 165.88 18.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -113.31 130.29 9.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.49 -20.71 21.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 87.4 p -69.73 -30.24 67.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -63.11 -56.19 18.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.9 t -63.93 -45.96 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -40.3 -53.69 2.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -64.98 -35.57 81.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -61.66 -63.15 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.079 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.32 -41.39 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.54 69.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.5 -26.22 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.8 48.95 1.56 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 19.8 m -111.49 145.68 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -84.24 142.43 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 448' ' ' LEU . 25.9 mt -109.61 127.88 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.23 172.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 472' ' ' GLU . 51.0 m-20 -117.86 170.73 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.721 ' HB3' HD13 ' A' ' 418' ' ' LEU . 6.7 pt-20 -35.92 -41.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.71 -51.44 62.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.31 -27.64 32.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 430' ' ' ILE . 52.0 tp -69.76 -51.75 31.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 479' ' ' ILE . 90.3 mt -52.26 -48.73 65.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.08 -36.7 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.18 -17.25 57.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 476' ' ' LEU . 30.7 mt -88.56 -15.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -106.95 -15.29 14.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 20.9 p -97.82 -41.73 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 410' ' ' LEU . 12.2 mmm -64.43 140.73 98.05 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.71 -173.26 0.68 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.698 2.265 . . . . 0.0 112.382 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -107.34 151.27 16.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 1.8 mptp? -127.98 154.79 45.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 485' ' ' LYS . 15.7 mtpt 33.15 47.59 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.832 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.6 p -86.71 104.36 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 488' ' ' LYS . 0.0 OUTLIER -52.93 -32.68 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -108.9 128.22 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.72 157.15 42.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 492' ' ' ALA . 49.6 mm -121.95 84.81 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 491' ' ' ILE . . . 34.43 48.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.7 108.12 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 50.01 42.21 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.1 m -56.62 131.62 49.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 1.5 t -154.39 150.47 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 38.6 m -107.7 104.64 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -167.32 -101.71 0.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.0 t -126.25 -49.73 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.0 t -71.48 108.79 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 87.62 79.73 1.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 392' ' ' LYS . 9.1 tmtt? -108.25 115.05 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -50.75 115.76 1.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.738 HD13 HG23 ' A' ' 421' ' ' ILE . 1.5 pp -98.51 -13.19 20.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 155.44 60.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 2.2 m 48.29 28.2 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.943 0.401 . . . . 0.0 110.862 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -108.34 176.98 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.61 116.3 14.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.1 mm -86.91 124.62 68.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 125.98 12.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 0.0 112.303 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -107.02 -150.3 16.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -78.95 -175.03 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -100.19 -27.78 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -123.07 31.4 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.0 p -68.97 -19.33 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.8 -5.94 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.19 126.39 27.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.11 -23.71 32.64 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 15.0 mt -94.25 153.96 17.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 81.8 mt -116.46 143.51 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 88.3 m-85 -134.48 146.23 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 438' ' ' THR . 93.9 t -121.08 112.79 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 87.4 mt -95.56 121.48 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.154 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.4 t -122.95 147.36 46.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.32 -154.16 47.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.17 142.19 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.565 HD22 ' OE1' ' A' ' 472' ' ' GLU . 8.9 mt -113.96 140.24 48.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -47.63 74.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 78.6 p -50.86 -50.11 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.2 pt -151.48 168.47 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -97.81 162.06 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -38.9 -45.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -65.21 -62.43 1.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -46.37 -62.98 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -52.38 -53.51 44.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -44.04 -53.35 6.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.4 t -49.88 -31.22 11.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.07 -60.06 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 475' ' ' LEU . 72.6 mt -53.68 -40.03 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.08 -25.35 55.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -67.24 -20.01 65.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 403' ' ' ALA . 60.4 m-85 -111.92 7.96 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.47 -38.38 3.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.501 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.29 156.54 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -110.14 148.23 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.54 123.11 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.0 t -137.61 161.68 35.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -102.24 22.9 36.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -143.53 140.63 30.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 458' ' ' LYS . 21.1 t -93.58 110.87 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.8 p -115.95 -175.66 2.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -70.35 -22.43 62.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -80.44 -17.54 51.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 18.2 m -58.53 139.38 55.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.51 -31.21 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.555 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 76.1 m-85 -149.48 140.58 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 469' ' ' ILE . 10.9 tp -110.72 106.43 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.0 t -77.46 102.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.403 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 3.2 mmt -75.93 166.71 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -156.54 -126.79 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 mmt-85 -110.64 175.11 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.7 t0 34.41 38.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.9 p -83.39 118.29 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 457' ' ' SER . . . -82.53 24.06 5.22 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 455' ' ' GLY . 13.5 pt20 36.16 30.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 455' ' ' GLY . 17.3 t -80.66 -29.46 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 441' ' ' VAL . 23.2 mtmt -93.15 -22.68 18.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.403 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 93.0 p -69.51 -16.03 63.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.47 -62.76 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -62.7 -46.19 89.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -48.01 -56.12 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.18 66.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -77.96 -18.53 55.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.17 15.04 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.11 29.26 62.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.569 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 67.7 m -82.16 127.79 33.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.112 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -74.39 129.94 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.573 HG12 HD23 ' A' ' 448' ' ' LEU . 92.2 mt -102.79 121.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 29.7 pt -127.9 173.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.9 p30 -118.34 166.84 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.85 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.565 ' OE1' HD22 ' A' ' 418' ' ' LEU . 4.9 pm0 -35.31 -32.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 471' ' ' ASP . 12.4 t0 -71.93 -53.74 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -51.62 -36.55 40.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 430' ' ' ILE . 46.0 tp -61.59 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 77.6 mt -52.84 -49.21 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -59.38 -41.59 89.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.6 mt -58.53 -16.68 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 479' ' ' ILE . 39.5 mt -89.24 -16.71 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -107.6 -13.66 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -100.48 -31.36 11.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 33.1 mmm -76.27 140.51 69.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.854 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.28 166.45 19.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -133.94 157.95 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.43 164.34 25.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 28.8 t -173.88 142.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -53.29 -35.72 60.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -66.15 144.97 56.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -148.43 176.34 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 36.0 mt -96.41 87.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -45.54 153.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.41 127.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.3 82.9 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 15.2 m -50.39 147.7 4.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 52.4 p -124.59 -46.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.878 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 5.3 t -62.68 -60.87 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.46 -115.66 4.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.471 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.9 m -130.42 -49.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.898 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 16.6 m -72.76 142.6 48.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -169.29 -101.23 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -169.93 133.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.05 150.76 22.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 394' ' ' LEU . 2.9 tt -59.35 -20.66 56.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 113.09 -84.47 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 10.6 p -73.25 1.76 8.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -175.01 167.97 3.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.05 119.7 30.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 42.8 mm -82.26 122.74 79.49 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.657 0.741 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 121.0 7.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.309 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -75.59 95.95 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -118.71 -133.46 4.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -100.05 -175.17 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.55 -23.7 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -125.64 30.55 5.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 18.3 p -71.52 -19.26 62.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.55 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 84.4 mt -118.66 9.43 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.62 139.28 40.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.07 31.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.42 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.3 mt -93.71 164.23 13.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.404 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 73.0 mt -123.33 145.05 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 12.4 m-85 -131.44 155.03 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.537 ' O ' HD12 ' A' ' 448' ' ' LEU . 95.5 t -133.6 105.14 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 430' ' ' ILE . 54.8 mt -85.93 133.1 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -134.4 130.52 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.177 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.05 -151.31 21.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.454 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.02 154.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.86 147.83 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.89 -58.81 3.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 30.1 t -42.34 -44.81 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.43 158.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 424' ' ' ASP . 15.1 mt-10 -99.58 159.77 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -38.14 -31.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 422' ' ' GLU . 0.2 OUTLIER -76.55 -64.64 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -43.39 -60.91 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -46.63 -45.96 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 437' ' ' VAL . 28.7 tttt -54.67 -43.16 72.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -61.11 -38.36 86.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.4 -63.09 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 414' ' ' ILE . 62.9 mt -45.96 -37.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.35 -34.7 48.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -56.45 -16.24 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -115.3 -3.47 12.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.44 -45.48 1.28 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -41.18 141.2 1.13 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -102.37 160.44 14.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 427' ' ' LYS . 59.0 t -128.36 119.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.493 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.5 t -124.37 166.44 15.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.7 50.58 0.77 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -170.96 124.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.23 111.69 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' SER . . . . . 0.412 ' HB3' ' CD ' ' A' ' 444' ' ' LYS . 12.9 t -126.67 -175.01 3.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -67.29 -53.52 29.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.412 ' CD ' ' HB3' ' A' ' 442' ' ' SER . 0.0 OUTLIER -50.76 -19.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.8 m -62.73 123.7 19.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.29 -53.32 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 468' ' ' LYS . 57.1 m-85 -126.51 160.21 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 413' ' ' VAL . 10.5 tp -129.94 104.76 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -77.75 105.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.0 mmt -87.9 171.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -169.24 -127.52 0.93 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.0 mmp_? -92.46 167.15 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.3 t70 34.08 36.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 452' ' ' ARG . 54.5 p -69.75 127.19 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.99 139.95 27.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.57 -11.7 37.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.937 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 96.3 p -78.91 -27.11 43.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -66.66 -42.91 85.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 460' ' ' ASP . 33.7 p -81.29 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 459' ' ' SER . 0.3 OUTLIER -36.9 -57.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -60.33 -44.5 95.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -54.46 -64.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -37.99 -52.74 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.93 76.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 462' ' ' ALA . 11.3 mt -92.32 23.11 4.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 40.12 60.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.501 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.596 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.9 m -110.99 136.15 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 447' ' ' TYR . 21.2 mttp -76.11 141.76 41.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 13.9 mt -118.57 141.67 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.597 HD13 HD12 ' A' ' 478' ' ' LEU . 25.8 pt -152.08 171.09 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -115.83 177.99 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 0.6 OUTLIER -45.75 -35.16 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 473' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 21.3 t0 -71.46 -52.08 20.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.91 -45.43 70.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.522 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 470' ' ' ILE . 50.1 tp -50.55 -41.52 54.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.98 -51.35 62.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 470' ' ' ILE . 14.5 mt -65.52 -17.04 64.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.65 -17.46 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -103.97 -28.72 11.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.1 p -85.84 -25.38 26.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.134 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.467 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 63.7 mmm -82.02 140.68 46.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.76 -165.86 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.88 19.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -134.82 152.17 51.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -92.78 89.71 6.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 1.8 m -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt 65.87 42.63 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 490' ' ' GLU . 23.6 m-85 -112.84 159.9 18.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 489' ' ' TYR . 37.6 mt-10 -37.93 139.71 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.44 106.03 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -67.4 105.57 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.072 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 495' ' ' THR . 60.0 t -104.92 141.68 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.92 51.72 10.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 493' ' ' VAL . 82.2 p -116.12 94.71 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.14 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 496' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 1.6 t 67.23 42.88 2.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 39.0 m -99.13 -59.89 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -118.44 174.69 15.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.5 m -80.37 176.25 9.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.838 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 14.3 t -88.75 86.84 7.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 36.86 46.29 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.75 107.74 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.72 50.97 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.9 tt -83.89 112.25 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -151.03 36.03 0.9 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.454 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.4 t -103.48 19.04 20.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.893 0.378 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -104.53 150.96 24.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -113.38 116.32 29.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 45.6 mm -89.32 122.37 68.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -65.33 104.25 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.94 -152.11 8.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -88.0 -174.97 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -100.53 -26.94 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.465 ' O ' ' CE ' ' A' ' 485' ' ' LYS . 50.7 m-80 -123.23 27.32 7.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 26.5 p -68.43 -10.12 53.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.01 8.97 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLU . . . . . 0.43 ' CD ' ' OD1' ' A' ' 405' ' ' ASN . 14.9 tt0 -68.22 124.24 22.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.33 -29.49 12.25 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.692 HD22 ' ND2' ' A' ' 446' ' ' ASN . 72.2 mt -81.06 143.3 32.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 444' ' ' LYS . 93.2 mt -109.15 144.53 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 38.5 m-85 -129.22 155.35 45.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 438' ' ' THR . 55.5 t -134.12 102.35 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 30.7 mt -84.27 126.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.6 t -132.31 118.43 19.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.47 -161.02 16.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.09 132.0 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 472' ' ' GLU . 10.0 mt -101.26 179.88 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.57 -42.55 6.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.5 m -63.52 -55.22 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.41 130.5 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.03 156.23 37.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 423' ' ' ARG . 0.8 OUTLIER -40.24 -35.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -49.09 -47.67 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.57 88.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.44 -57.6 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -46.94 -28.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.873 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.21 -53.13 7.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.99 -34.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.88 -29.42 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -61.64 -16.11 45.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.809 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.12 -1.78 13.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 110.74 -36.53 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.46 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -44.52 148.68 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -101.2 160.89 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.6 t -137.35 108.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 413' ' ' VAL . 8.9 t -128.73 150.08 50.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -95.14 50.89 1.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.71 147.42 25.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 54.7 t -99.18 101.75 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 85.0 p -123.19 175.25 6.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HD2' HD22 ' A' ' 465' ' ' LEU . 1.9 mptm? -68.47 -16.4 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.552 ' HB3' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -80.57 -27.2 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.0 m -58.2 120.28 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.692 ' ND2' HD22 ' A' ' 410' ' ' LEU . 7.2 t30 -91.83 -41.01 10.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.653 ' CE1' ' ND2' ' A' ' 446' ' ' ASN . 95.3 m-85 -130.12 156.11 45.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 469' ' ' ILE . 11.2 tp -131.21 105.68 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.14 104.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.651 ' HG2' HG23 ' A' ' 469' ' ' ILE . 3.4 mmt -82.7 163.6 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.42 -134.95 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 1.1 mmp_? -87.9 163.27 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 17.4 t70 34.42 36.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 452' ' ' ARG . 3.2 m -83.49 116.32 22.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -59.55 128.36 46.72 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -51.26 -35.88 39.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 90.3 p -46.17 -47.32 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -43.51 -52.99 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 1.2 t -68.65 -61.05 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 22.8 t70 -38.09 -62.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -58.83 -33.59 70.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -62.93 -50.07 72.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.65 -55.6 27.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -46.97 -50.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.42 HD22 ' HD2' ' A' ' 443' ' ' LYS . 13.0 mt -70.14 -28.76 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.77 48.71 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.521 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.58 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 29.1 m -104.33 150.09 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.102 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -90.54 133.04 35.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 450' ' ' MET . 3.1 mp -104.76 120.16 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.88 170.77 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 474' ' ' GLY . 0.9 OUTLIER -120.83 168.49 11.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 418' ' ' LEU . 12.1 pt-20 -35.05 -44.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.44 -43.49 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -58.97 -29.78 65.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.35 -49.34 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.01 -46.75 75.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.72 -40.73 80.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -58.22 -17.68 20.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 74.5 mt -86.91 -18.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -102.92 -25.93 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.8 p -84.69 -46.84 11.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.511 ' CE ' HD11 ' A' ' 410' ' ' LEU . 10.7 mmm -59.85 141.06 89.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.528 0.68 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.84 -170.31 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -118.11 153.27 17.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 405' ' ' ASN . 6.0 mtmm -130.66 167.75 18.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -117.42 135.77 53.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 89.9 p -118.44 160.72 21.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -102.94 -40.51 6.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.71 136.91 51.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -113.99 145.54 41.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.04 98.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -117.72 105.58 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.0 p -42.74 139.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.33 167.88 17.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 75.0 p -48.37 158.52 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.6 p -159.35 127.87 5.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 110.881 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.8 t -168.7 165.01 12.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 177.22 68.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.8 m -65.0 135.78 56.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.3 m -78.58 -33.62 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -102.1 95.28 1.29 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.44 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -108.0 17.09 22.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.09 143.4 44.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.6 tp -83.57 -11.2 57.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 98.91 -21.08 47.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 2.1 m -131.16 27.96 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.838 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -147.53 160.93 42.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -134.36 139.33 45.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.17 131.74 80.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.634 0.73 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.401 ' HD3' HD22 ' A' ' 476' ' ' LEU . 53.5 Cg_endo -69.81 120.31 7.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.631 2.221 . . . . 0.0 112.362 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -77.01 98.75 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -117.48 -152.25 9.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -84.6 -174.96 5.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -99.76 -21.42 15.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -126.74 31.55 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 22.6 p -72.68 -19.77 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 410' ' ' LEU . 55.5 mt -119.12 11.34 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -74.03 116.16 14.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 112.57 -28.15 9.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.545 HD11 ' CE ' ' A' ' 482' ' ' MET . 6.5 mt -87.76 149.45 24.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 444' ' ' LYS . 87.7 mt -110.28 152.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 83.1 m-85 -139.39 140.24 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 441' ' ' VAL . 89.0 t -119.17 99.72 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.31 126.42 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.8 t -132.28 118.23 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.88 -170.19 17.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 417' ' ' VAL . 2.2 m -122.5 123.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 0.0 111.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 472' ' ' GLU . 3.4 mt -97.52 -179.39 4.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -102.74 -67.07 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.2 t -39.97 -47.22 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -150.57 122.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.93 174.5 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -49.25 -57.56 6.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.61 -42.76 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -65.02 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.27 -22.37 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.2 tttt -72.4 -51.22 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.5 m -58.15 -36.18 72.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.39 -63.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.2 mt -48.9 -38.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -75.47 -29.0 59.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -65.75 -14.76 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.84 -0.44 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.0 -25.16 19.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.05 150.28 14.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -101.56 146.66 27.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 427' ' ' LYS . 54.9 t -125.35 118.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 413' ' ' VAL . 11.5 t -134.85 154.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.09 -35.35 27.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.28 142.14 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.667 ' HA ' HG21 ' A' ' 413' ' ' VAL . 33.7 t -81.79 137.65 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 59.3 m -123.04 -175.74 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.793 ' HA ' HD13 ' A' ' 465' ' ' LEU . 43.4 tttm -82.05 -16.54 49.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 411' ' ' ILE . 27.9 mmmt -89.43 -10.2 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 413' ' ' VAL . 1.9 m -52.48 121.14 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -88.69 -34.12 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.53 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 71.4 m-85 -150.5 131.24 14.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 450' ' ' MET . 12.0 tp -97.62 110.51 23.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.0 t -84.17 102.16 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.442 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 2.8 mmt -80.85 166.21 21.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -166.42 -148.82 5.71 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.3 ttt180 -68.08 151.55 46.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.807 0.336 . . . . 0.0 110.883 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 452' ' ' ARG . 23.8 t70 36.39 44.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 12.1 t -78.24 103.0 7.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -48.24 136.86 15.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -56.93 -45.89 82.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.3 t -37.98 -43.84 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -49.07 -56.61 8.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.442 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 8.4 t -68.16 -34.04 75.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.74 -65.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.403 ' HE3' HD11 ' A' ' 465' ' ' LEU . 36.2 tttt -62.19 -37.29 84.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -54.22 -54.78 35.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.06 69.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.15 -56.23 18.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.793 HD13 ' HA ' ' A' ' 443' ' ' LYS . 46.2 mt -71.28 -0.18 9.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 68.47 53.18 22.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.5 m -105.96 129.84 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.153 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -67.07 132.71 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.62 129.07 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.4 pt -137.28 178.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.89 171.94 9.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.72 ' HB3' HD13 ' A' ' 418' ' ' LEU . 5.9 pt-20 -39.29 -40.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.83 -46.49 65.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.13 -33.21 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 29.6 tp -66.9 -58.39 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 479' ' ' ILE . 10.2 mt -45.31 -52.06 10.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 481' ' ' THR . 4.1 m120 -53.99 -48.16 70.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 478' ' ' LEU . 9.0 mt -51.32 -25.1 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 476' ' ' LEU . 62.3 mt -77.37 -27.01 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.5 -11.35 25.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 477' ' ' ASN . 31.0 p -101.62 -36.03 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.545 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.7 mtp -73.77 140.16 77.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.722 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.3 Cg_endo -69.74 -163.82 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.394 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -134.57 175.36 20.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.439 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.73 136.23 35.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -56.16 160.26 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 29.5 t -163.9 124.99 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -55.37 -42.84 74.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -94.01 157.91 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -151.34 151.46 31.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 16.7 mm -122.46 106.28 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -61.58 154.99 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 494' ' ' GLU . 10.5 p -78.02 153.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 493' ' ' VAL . 6.5 mm-40 -79.49 106.25 11.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 31.5 p -98.9 110.77 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.909 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.5 m -123.09 123.86 41.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.832 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 29.7 m -72.59 164.37 26.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -74.86 -95.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.476 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.3 t -48.44 144.74 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 56.0 p -89.89 151.32 21.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 59.85 113.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -103.11 124.14 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -147.59 164.97 31.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 394' ' ' LEU . 1.9 pt? -127.16 24.25 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 88.35 -135.57 13.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.1 m -101.01 37.57 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 110.857 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -128.33 151.06 49.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 399' ' ' ILE . 5.4 tp10 -123.98 144.86 49.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.415 ' N ' ' HG3' ' A' ' 398' ' ' GLU . 40.7 mm -77.49 129.35 77.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.722 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.475 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.2 Cg_endo -69.79 126.23 13.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -82.02 99.65 9.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -119.71 -150.02 8.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.413 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -82.73 -175.01 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.15 -24.0 15.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -123.49 35.5 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 20.2 p -75.37 -9.0 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.579 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 88.8 mt -131.79 5.68 4.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.96 120.62 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.54 -27.3 17.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.45 HD11 ' CE ' ' A' ' 482' ' ' MET . 20.8 mt -88.98 142.28 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 444' ' ' LYS . 74.9 mt -101.29 151.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.161 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 91.8 m-85 -139.51 146.19 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.795 HG22 HG23 ' A' ' 438' ' ' THR . 85.7 t -124.99 102.76 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 430' ' ' ILE . 14.5 mt -90.01 121.52 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.39 137.44 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.96 -165.64 51.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -105.74 159.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.155 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.582 HD22 ' HB3' ' A' ' 472' ' ' GLU . 5.1 mt -140.97 142.29 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.5 -39.28 94.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.509 ' CB ' HD13 ' A' ' 421' ' ' ILE . 5.7 t -60.78 -65.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -146.78 141.78 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -67.27 173.56 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -45.04 67.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.45 -42.33 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -61.38 -66.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.25 -37.18 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 42.2 tttm -54.87 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.0 m -47.06 -37.25 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.42 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 414' ' ' ILE . 46.2 mt -46.46 -36.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.86 -34.45 57.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -61.08 -18.46 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -108.42 -2.11 19.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.25 -36.61 4.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.98 148.77 2.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -101.02 154.37 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 89.8 t -127.13 119.21 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.795 HG23 HG22 ' A' ' 413' ' ' VAL . 10.0 t -135.02 142.92 46.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLY . . . . . 0.454 ' O ' ' CG ' ' A' ' 440' ' ' ASN . . . -88.07 42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 439' ' ' GLY . 3.8 m120 -162.86 128.85 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.91 0.386 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.678 ' CG2' HD13 ' A' ' 448' ' ' LEU . 39.5 t -81.36 105.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 m -111.51 -174.48 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -71.82 -25.08 61.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.52 ' O ' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -81.83 -17.52 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.0 m -60.37 128.11 35.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -94.43 -38.2 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.11 153.29 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.678 HD13 ' CG2' ' A' ' 441' ' ' VAL . 52.2 tp -119.07 102.81 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.25 107.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.9 ptp -122.28 169.38 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.74 -104.46 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.3 OUTLIER -82.59 148.15 28.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.1 m-20 35.68 53.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 99.2 p -94.17 125.36 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -67.5 146.02 46.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -94.01 -30.67 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 0.0 110.891 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -55.27 -19.31 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.588 ' HD3' HG23 ' A' ' 441' ' ' VAL . 6.0 ttmt -94.53 -44.72 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.928 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 84.8 p -59.62 -30.55 68.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.53 -54.55 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -54.78 -23.98 20.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -74.36 -60.56 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.16 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -68.95 -64.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 18.3 mt -54.66 -29.66 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.51 43.36 1.59 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.437 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 27.6 m -103.14 135.54 44.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.112 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -74.97 138.05 42.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.451 HG12 HD23 ' A' ' 448' ' ' LEU . 66.7 mt -109.5 130.57 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 35.8 pt -142.7 172.21 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.3 p-10 -115.4 169.0 9.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.582 ' HB3' HD22 ' A' ' 418' ' ' LEU . 1.7 pm0 -39.8 -25.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 471' ' ' ASP . 25.8 t70 -74.97 -49.49 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -61.51 -31.01 76.08 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 430' ' ' ILE . 24.3 tp -64.02 -49.3 72.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 400' ' ' PRO . 26.1 mt -59.72 -51.94 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -57.49 -34.65 69.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.4 -15.06 32.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 55.5 mt -89.22 -24.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.17 -29.01 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.1 p -82.69 -38.56 23.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 410' ' ' LEU . 18.4 mmm -69.57 142.06 91.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 0.0 110.895 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -135.07 169.16 23.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -133.42 155.42 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -98.01 85.3 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 57.4 p -72.78 149.58 43.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -45.16 -51.89 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -87.4 127.24 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -99.24 167.48 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.34 125.21 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -94.13 139.34 31.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.53 138.69 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -49.52 167.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 90.6 m -147.24 132.21 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 4.2 t -67.49 109.62 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 18.2 p -166.02 118.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 389' ' ' SER . . . -161.63 62.99 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 388' ' ' GLY . 1.9 t 35.41 43.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 41.0 m -115.98 117.84 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 392' ' ' LYS . . . 140.11 -179.62 18.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 391' ' ' GLY . 14.4 pttt 34.62 44.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -126.74 144.05 51.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.3 tt -73.25 117.74 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -125.67 65.04 0.56 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.541 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.7 t -134.29 22.35 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 0.0 110.851 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -153.62 177.35 11.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -123.16 124.66 43.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 15.0 mm -86.12 120.1 72.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.635 0.731 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 120.29 7.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.72 2.28 . . . . 0.0 112.401 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 108.46 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -130.56 -141.12 4.83 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -95.0 -176.15 3.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.28 -24.73 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 36.1 m-20 -124.58 29.55 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -68.54 -23.57 64.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.2 mt -114.74 2.66 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -66.57 145.22 55.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 85.94 -26.37 6.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.84 159.45 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 412' ' ' PHE . 96.7 mt -122.11 155.12 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 55.4 m-85 -142.55 145.72 33.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 438' ' ' THR . 38.3 t -122.99 100.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.432 HD11 HD12 ' A' ' 430' ' ' ILE . 49.3 mt -81.4 122.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.461 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.7 t -126.6 115.13 19.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 106.95 -153.92 16.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.66 158.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 111.156 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -135.84 159.51 41.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 420' ' ' SER . 4.0 tp10 -77.21 -69.44 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 419' ' ' GLU . 20.1 m -35.22 -61.82 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.4 OUTLIER -131.32 161.68 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 422' ' ' GLU . 6.9 mp0 -102.76 164.12 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 16.4 tpt85 -42.48 -30.87 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -65.76 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.93 -55.2 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.35 -53.22 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.5 ' HA ' HG21 ' A' ' 437' ' ' VAL . 30.7 tttm -44.91 -51.19 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 32.5 t -52.62 -34.06 49.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.47 -67.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.465 HG22 ' C ' ' A' ' 435' ' ' GLY . 65.4 mt -46.25 -35.79 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.56 -28.88 37.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -63.59 -19.78 65.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 403' ' ' ALA . 66.7 m-85 -112.47 2.29 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 435' ' ' GLY . . . 112.21 -45.87 1.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.525 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -37.97 148.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -102.06 161.42 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 427' ' ' LYS . 55.7 t -133.61 125.01 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.506 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.8 t -144.16 170.49 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -118.65 50.86 0.78 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -156.35 135.19 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 107.31 15.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 -175.12 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.857 ' HD3' HD22 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -73.39 -48.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -50.65 -28.71 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.45 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 89.2 m -55.36 124.27 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.073 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -95.66 -44.74 7.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 61.4 m-85 -128.7 159.39 35.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.537 HD23 HG12 ' A' ' 469' ' ' ILE . 35.1 tp -130.09 102.88 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.03 107.96 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.461 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 24.0 mtm -112.65 179.85 3.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.34 -102.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.6 mmm-85 -92.41 161.24 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.2 t70 34.37 48.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.9 p -87.62 168.42 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -117.8 143.36 17.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 -28.84 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 89.7 p -59.54 -21.55 60.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 459' ' ' SER . 34.3 mttm -86.5 -67.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 458' ' ' LYS . 13.5 p -36.57 -64.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 461' ' ' LYS . 0.2 OUTLIER -42.09 -51.73 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.497 ' N ' ' CG ' ' A' ' 460' ' ' ASP . 0.0 OUTLIER -63.11 -31.74 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 459' ' ' SER . . . -65.2 -48.17 74.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.34 83.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.92 -30.63 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.857 HD22 ' HD3' ' A' ' 443' ' ' LYS . 14.0 mt -87.96 -24.23 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.18 28.45 5.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.453 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 4.1 m -92.95 137.36 32.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.356 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -81.22 114.29 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 448' ' ' LEU . 81.9 mt -86.02 131.83 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 475' ' ' LEU . 7.5 pt -148.98 178.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -117.94 -179.28 3.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.701 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.5 pm0 -50.58 -29.95 12.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.08 -51.21 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.95 -30.94 54.95 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 470' ' ' ILE . 32.1 tp -64.44 -42.78 95.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.31 -52.96 61.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -59.26 -30.24 68.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.0 mt -67.07 -15.18 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 69.7 mt -88.68 -20.54 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -102.62 -24.55 13.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 36.7 p -87.66 -31.36 19.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 25.9 mmm -75.88 141.1 71.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.51 20.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.434 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 50.3 mttm -138.41 158.04 45.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -108.04 90.24 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.6 t -85.66 145.8 27.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -72.66 -35.13 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.976 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.83 174.43 5.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.06 144.04 29.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 62.2 mt -97.55 121.21 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.05 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.24 140.21 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -98.07 142.98 29.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 29.3 p -73.28 100.32 3.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.156 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.862 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.8 t -157.47 166.52 32.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 97.9 p -40.15 128.93 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 162.35 161.29 11.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.473 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 9.1 t -63.03 101.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 2.2 m -165.74 157.87 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -107.58 147.17 16.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -87.5 -55.41 3.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.42 164.91 3.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 394' ' ' LEU . 1.3 pt? -129.63 154.83 46.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -155.25 153.61 24.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.8 m 59.57 25.34 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.857 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -172.29 157.14 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -124.84 114.89 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.404 HD13 ' CD2' ' A' ' 476' ' ' LEU . 23.5 mm -90.34 119.7 69.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.623 0.725 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 132.82 24.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.315 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -80.82 84.58 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -99.15 -157.58 29.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.0 -175.09 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 111.069 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -101.65 -21.29 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.2 29.92 5.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.8 p -69.5 -21.73 63.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 410' ' ' LEU . 20.9 mt -111.77 -0.77 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.28 115.47 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.3 26.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.595 HD11 ' CE ' ' A' ' 482' ' ' MET . 19.8 mt -91.77 140.3 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 444' ' ' LYS . 80.6 mt -106.83 149.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 82.4 m-85 -135.61 157.57 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.07 106.98 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 423' ' ' ARG . 39.1 mt -88.16 126.35 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.7 t -132.64 116.08 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 105.05 -154.47 17.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.09 155.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.722 HD22 ' OE1' ' A' ' 472' ' ' GLU . 2.4 mt -138.07 152.89 49.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -74.36 -63.26 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 421' ' ' ILE . 48.1 m -37.67 -39.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.2 pt -161.19 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 423' ' ' ARG . 56.4 mt-10 -94.75 162.16 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 414' ' ' ILE . 13.8 tpt180 -38.36 -35.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 427' ' ' LYS . 4.8 t70 -74.91 -66.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.872 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 421' ' ' ILE . 14.1 mt-10 -43.78 -42.44 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.696 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -70.61 -30.96 67.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 424' ' ' ASP . 21.2 ttmt -67.19 -51.18 56.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.8 m -55.87 -25.29 41.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.59 -57.1 4.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.7 -45.71 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -72.44 -26.89 62.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -67.07 -14.68 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.02 8.64 15.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.27 -6.8 63.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -70.79 170.11 47.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -126.94 154.13 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.4 t -129.78 123.16 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.07 172.23 7.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.42 10.84 61.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.71 149.78 16.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 445' ' ' THR . 4.9 t -87.28 117.79 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.9 m -121.75 177.62 5.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 465' ' ' LEU . 27.3 ttmt -59.09 -15.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 411' ' ' ILE . 1.6 mppt? -90.15 -21.64 22.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.701 HG21 HG13 ' A' ' 441' ' ' VAL . 96.1 m -61.06 126.63 28.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -93.7 -38.58 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 478' ' ' LEU . 60.0 m-85 -138.94 148.33 43.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 469' ' ' ILE . 9.0 tp -115.05 104.26 11.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.51 104.62 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 12.7 mtt -86.29 176.13 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -174.08 -123.76 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 2.2 mmp_? -96.94 156.95 16.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.6 t70 34.56 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 29.2 m -60.35 161.03 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -89.53 175.58 42.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -95.62 -47.12 6.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 94.2 p -57.16 -27.77 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -55.08 -58.28 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 3.9 t -73.07 -54.74 7.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.794 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 17.9 t70 -37.6 -70.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' ALA . 13.7 mmtm -55.06 -34.92 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -58.38 -65.39 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -50.14 -21.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 461' ' ' LYS . . . -75.44 -65.31 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 443' ' ' LYS . 7.3 mt -67.18 -5.83 15.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 83.54 49.77 4.75 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.609 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 25.0 m -94.52 133.96 37.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.147 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -80.92 102.24 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.483 HG12 HD23 ' A' ' 448' ' ' LEU . 48.3 mt -73.91 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 478' ' ' LEU . 46.6 pt -147.81 165.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -114.24 179.31 3.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.722 ' OE1' HD22 ' A' ' 418' ' ' LEU . 0.4 OUTLIER -48.5 -25.41 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.93 -40.38 18.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -69.15 -34.65 76.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.419 ' CA ' HD12 ' A' ' 470' ' ' ILE . 59.3 tp -64.23 -41.19 97.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.404 ' CD2' HD13 ' A' ' 399' ' ' ILE . 78.5 mt -61.19 -40.8 95.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -34.75 79.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.3 mt -64.49 -14.76 58.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.37 -17.57 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -103.54 -22.79 13.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.7 p -91.96 -31.78 15.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.595 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.7 mmm -74.05 140.48 77.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.597 0.713 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.99 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -129.55 171.67 20.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -139.46 142.44 37.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -84.99 102.93 13.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 12.2 t -118.31 165.83 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -70.54 -25.66 63.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -70.55 147.02 49.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -147.92 149.03 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 491' ' ' ILE . 4.6 mp -98.07 120.35 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -88.24 112.1 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.9 p -132.92 141.83 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -122.27 89.74 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 11.1 t -83.74 150.38 25.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 30.6 m -94.22 -47.92 6.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 13.8 t -161.28 153.38 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -59.33 145.74 44.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.5 p -86.86 114.76 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.823 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 99.7 p -99.71 177.05 5.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 101.51 -163.16 17.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.462 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -75.49 145.36 41.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.9 90.05 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.074 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tp -106.5 146.03 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -148.66 59.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.8 m -122.71 23.8 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.856 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.431 ' HA ' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -118.7 149.99 40.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.927 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -102.13 126.11 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.456 HG23 ' HD2' ' A' ' 400' ' ' PRO . 30.4 mm -94.37 135.39 24.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 111.139 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 399' ' ' ILE . 53.3 Cg_endo -69.81 118.54 5.74 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.309 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -60.1 107.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -131.61 -144.3 5.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -96.44 -175.66 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.59 -21.25 17.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -126.04 18.24 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.6 p -58.59 -12.29 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 70.5 mt -127.46 5.28 6.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.24 148.81 49.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.88 -29.33 3.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.461 HD11 ' CE ' ' A' ' 482' ' ' MET . 16.4 mt -87.6 152.6 22.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 412' ' ' PHE . 86.4 mt -114.68 154.32 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.436 ' N ' HG22 ' A' ' 411' ' ' ILE . 68.1 m-85 -139.01 152.48 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 438' ' ' THR . 95.3 t -132.29 101.9 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.1 mt -84.48 128.11 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.2 t -126.04 134.23 51.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.85 -159.45 41.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 452' ' ' ARG . 4.2 m -122.95 160.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.5 mt -137.62 158.25 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 420' ' ' SER . 24.4 tt0 -80.76 -66.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 419' ' ' GLU . 27.3 m -38.49 -41.74 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.77 170.5 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -111.78 166.43 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -44.13 -40.17 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 2.2 t0 -68.45 -63.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -48.18 -58.86 3.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.17 53.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -69.7 -50.13 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.8 t -54.94 -32.78 61.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -63.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 475' ' ' LEU . 73.5 mt -46.99 -48.5 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.174 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.78 -38.58 91.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.93 -14.69 9.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.439 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 72.8 m-85 -113.77 5.05 16.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 103.61 -37.47 3.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 407' ' ' LEU . . . -46.42 152.91 1.08 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -102.8 154.5 19.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.98 124.72 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 413' ' ' VAL . 11.9 t -139.62 171.09 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.1 -33.43 6.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.532 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -94.18 139.12 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.482 HG23 ' HE3' ' A' ' 458' ' ' LYS . 40.2 t -90.09 127.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 18.0 m -122.14 -174.68 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.422 ' HA ' HD13 ' A' ' 465' ' ' LEU . 49.2 mtpt -76.66 -11.86 59.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -89.29 -20.29 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 56.3 m -52.85 131.64 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.65 -40.06 9.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -141.15 153.37 45.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 413' ' ' VAL . 7.4 tp -121.41 106.33 11.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 105.4 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.425 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.1 mtt -87.37 168.76 12.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -153.62 -111.98 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -128.28 173.15 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 8.7 t0 34.45 38.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 83.1 p -80.38 -178.17 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -112.09 -168.88 18.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -104.6 -41.39 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.8 m -51.72 -45.7 63.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.482 ' HE3' HG23 ' A' ' 441' ' ' VAL . 0.2 OUTLIER -45.31 -57.58 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 460' ' ' ASP . 54.8 p -66.35 -57.05 8.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 459' ' ' SER . 3.9 t70 -35.07 -61.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -59.07 -57.26 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -41.97 -58.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.65 78.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -51.27 -42.99 61.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 443' ' ' LYS . 17.3 mt -80.71 -24.58 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 94.3 56.84 1.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 88.9 m -112.36 136.43 51.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -70.78 135.82 48.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.425 HG23 ' HG3' ' A' ' 450' ' ' MET . 71.0 mt -107.84 123.52 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.08 165.49 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -110.14 175.2 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -38.72 -44.51 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.76 -49.59 57.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.63 -22.62 25.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.508 HD11 HG12 ' A' ' 430' ' ' ILE . 58.1 tp -74.79 -47.96 28.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.72 -44.7 90.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 481' ' ' THR . 39.9 t30 -58.5 -34.69 71.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -64.97 -15.06 61.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 479' ' ' ILE . 52.4 mt -90.15 -15.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -106.18 -31.05 8.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 477' ' ' ASN . 40.1 p -83.24 -27.83 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.461 ' CE ' HD11 ' A' ' 410' ' ' LEU . 32.0 mmm -77.49 142.65 67.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 0.0 110.844 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -165.91 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.479 ' CA ' ' CB ' ' A' ' 403' ' ' ALA . . . -134.2 158.39 23.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.463 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -127.9 172.31 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.12 146.83 40.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 2.1 t -135.85 143.94 45.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -54.75 10.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -115.06 131.51 56.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -104.63 170.08 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.0 mt -104.76 118.47 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.66 65.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.089 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.74 128.94 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.95 91.41 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.0 t -160.79 127.67 4.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 78.3 p -81.17 -43.92 18.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 36.7 t -118.03 160.06 22.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.822 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -146.99 -61.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 92.8 p -68.03 113.68 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 58.2 p -109.29 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 69.02 167.26 4.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -135.98 155.38 50.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -104.08 108.47 19.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 394' ' ' LEU . 4.3 pp -79.17 -8.22 58.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 158.1 -133.2 3.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 4.0 m -104.06 36.82 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -116.06 174.04 6.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.95 123.28 36.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.95 121.39 68.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 122.37 9.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -76.96 96.18 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -111.17 -141.53 8.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.462 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -87.43 -175.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -102.61 -22.39 13.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -126.14 31.19 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.6 p -70.6 -19.62 62.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.4 mt -117.44 7.16 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.38 133.73 51.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 89.38 -25.62 10.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' ' 482' ' ' MET . 84.9 mt -83.48 143.46 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.97 149.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -139.65 148.6 42.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 438' ' ' THR . 88.9 t -125.61 101.63 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 430' ' ' ILE . 34.2 mt -83.12 128.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.436 HG21 ' SD ' ' A' ' 450' ' ' MET . 9.0 t -130.57 143.57 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.55 -144.96 34.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.14 152.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.63 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -65.98 -61.03 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 31.8 m -38.23 -59.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.4 pt -140.91 153.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.91 175.03 9.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -55.08 -46.89 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -63.27 -55.8 21.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -62.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -47.3 -48.44 25.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.6 tttt -48.28 -55.21 11.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.0 m -50.87 -37.36 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.17 -65.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 414' ' ' ILE . 49.9 mt -46.69 -39.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.22 -27.52 42.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -64.93 -19.4 65.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.522 ' CE2' HD13 ' A' ' 479' ' ' ILE . 76.0 m-85 -110.86 4.56 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.27 -25.0 23.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 430' ' ' ILE . . . -52.71 170.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.468 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 154.47 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 427' ' ' LYS . 39.9 t -129.21 121.71 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.515 HG23 HG22 ' A' ' 413' ' ' VAL . 0.1 OUTLIER -132.26 158.1 42.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.176 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -100.13 50.36 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -164.46 144.26 7.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.57 104.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 22.2 m -128.16 174.51 9.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -53.61 -56.65 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -40.81 -30.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 29.3 m -57.7 130.64 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -99.08 -35.13 10.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 468' ' ' LYS . 67.3 m-85 -143.82 164.67 29.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.517 HD23 HG12 ' A' ' 469' ' ' ILE . 22.7 tp -131.01 110.6 11.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.91 104.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.443 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 4.4 mmt -96.73 159.89 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -146.36 -140.21 3.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -93.54 164.78 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.5 t70 38.29 46.83 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 20.3 p -83.18 -177.91 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -109.65 -179.68 20.96 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -108.28 -12.49 15.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.5 m -74.46 -49.3 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -56.54 -53.16 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.443 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 53.2 p -61.06 -42.71 99.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.89 -67.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 462' ' ' ALA . 32.4 tptt -59.8 -54.46 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -36.26 -46.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.085 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.57 49.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -50.86 -47.5 60.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 -26.89 63.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 87.91 50.49 3.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 40.0 m -98.8 148.23 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 13.2 mmmt -79.85 112.65 17.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.517 HG12 HD23 ' A' ' 448' ' ' LEU . 63.7 mt -90.73 124.85 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.19 165.6 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.29 176.55 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -28.61 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.08 -49.09 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.84 61.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.74 -36.73 70.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.74 -33.37 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -70.17 -29.49 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.65 -22.91 64.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.522 HD13 ' CE2' ' A' ' 433' ' ' TYR . 67.4 mt -83.3 -16.88 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -103.45 -10.81 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 50.9 p -106.16 -39.41 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' ' 410' ' ' LEU . 34.3 mmm -66.87 141.65 96.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.572 0.701 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -164.17 0.12 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.727 2.285 . . . . 0.0 112.35 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -131.7 166.82 22.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 486' ' ' LYS . 31.4 mttm -139.52 166.3 24.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 485' ' ' LYS . 12.9 mtmt 33.23 46.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 93.0 p -120.25 171.7 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 488' ' ' LYS . 0.0 OUTLIER -113.34 -32.42 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CD1' ' HD2' ' A' ' 488' ' ' LYS . 41.5 m-85 -59.08 161.05 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.7 170.07 9.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 66.4 mt -99.79 119.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -106.07 135.42 47.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 89.8 t -97.46 131.12 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.64 131.22 11.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 69.9 p -42.57 133.81 3.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.183 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 51.0 m -103.62 99.78 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.356 . . . . 0.0 110.854 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 62.3 m -56.79 127.99 34.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 148.52 -52.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 1.4 t -54.77 163.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 50.8 p -101.87 167.22 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' GLY . . . . . 0.475 ' CA ' ' HG3' ' A' ' 425' ' ' GLU . . . 65.58 115.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -111.59 39.45 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -76.42 147.39 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.1 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 394' ' ' LEU . 2.7 pt? -108.61 -10.22 15.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 118.81 0.64 15.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 33.0 m -116.44 16.93 15.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 110.809 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -125.97 96.25 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.29 131.26 35.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 14.6 mm -90.04 125.47 60.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.592 0.71 . . . . 0.0 111.1 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 122.94 9.61 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -81.9 107.9 14.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.98 -138.73 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.74 -174.94 3.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.65 -20.9 16.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -127.25 28.09 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 23.9 p -66.74 -21.95 66.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.67 HD23 ' SD ' ' A' ' 482' ' ' MET . 78.0 mt -121.94 17.3 10.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.67 146.61 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.52 2.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 80.6 mt -77.16 152.18 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.473 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 67.3 mt -118.26 139.99 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -125.62 148.33 49.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.694 HG22 HG23 ' A' ' 438' ' ' THR . 48.9 t -124.1 104.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 430' ' ' ILE . 75.3 mt -86.55 126.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -131.48 125.92 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.53 -149.88 20.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.03 146.41 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 472' ' ' GLU . 8.2 mt -117.14 166.85 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -90.85 -57.29 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 421' ' ' ILE . 26.5 m -48.69 -29.28 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 420' ' ' SER . 0.8 OUTLIER -163.72 173.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.113 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -104.94 -176.29 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.78 -38.79 87.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.25 -50.81 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.475 ' HG3' ' CA ' ' A' ' 391' ' ' GLY . 5.1 mp0 -53.98 -58.57 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.88 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.109 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 437' ' ' VAL . 43.6 tttm -49.53 -50.09 43.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 47.4 t -56.0 -40.24 73.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.1 tp -65.07 -63.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 414' ' ' ILE . 64.6 mt -45.79 -40.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -77.75 -33.16 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -57.74 -20.81 37.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.454 ' HD2' ' HG ' ' A' ' 406' ' ' CYS . 81.5 m-85 -109.2 -4.76 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.12 -35.43 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -46.62 154.52 0.84 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -109.01 159.98 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 427' ' ' LYS . 79.8 t -131.71 118.02 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 413' ' ' VAL . 0.5 OUTLIER -138.73 139.06 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.67 3.75 72.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -115.3 131.62 56.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.77 120.38 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.9 m -128.75 -175.25 3.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.704 ' HG2' HD22 ' A' ' 465' ' ' LEU . 55.0 mtpt -71.76 -42.99 66.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.473 ' HG3' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -58.26 -25.56 61.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 24.3 m -51.46 138.26 22.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.14 -48.51 4.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 468' ' ' LYS . 87.1 m-85 -130.51 153.45 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 5.0 tp -120.15 104.34 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.0 105.24 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.451 ' O ' HD21 ' A' ' 418' ' ' LEU . 7.1 mtt -80.98 175.61 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -164.9 -109.24 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.5 mmt180 -125.78 165.6 18.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.6 t0 34.32 37.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 452' ' ' ARG . 20.0 m -77.59 136.17 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.16 124.09 9.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -56.99 -23.02 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.8 t -65.88 -15.17 62.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -82.83 -48.45 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.41 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 88.1 p -67.43 -25.49 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.48 -46.24 64.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.578 ' HE2' HD21 ' A' ' 465' ' ' LEU . 0.2 OUTLIER -78.03 -37.34 47.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.21 69.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.11 89.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -53.91 -46.35 71.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 443' ' ' LYS . 16.1 mt -76.16 -24.84 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.63 49.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 54.6 m -100.0 135.77 40.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.519 ' CB ' ' CD1' ' A' ' 447' ' ' TYR . 10.1 mmtp -72.56 117.67 14.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.71 128.66 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 42.6 pt -141.42 170.99 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.5 178.19 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.633 ' HB3' HD22 ' A' ' 418' ' ' LEU . 0.3 OUTLIER -45.75 -35.91 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.87 -37.65 73.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -64.35 -31.58 81.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.429 HD11 HG12 ' A' ' 430' ' ' ILE . 43.5 tp -67.06 -52.95 35.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.3 -51.98 66.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.98 -38.12 67.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.5 mt -60.55 -20.55 60.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.444 HG23 ' CE2' ' A' ' 433' ' ' TYR . 70.7 mt -84.84 -14.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -109.9 -7.83 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.4 p -107.75 -42.07 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.67 ' SD ' HD23 ' A' ' 407' ' ' LEU . 9.9 mtp -64.89 143.48 98.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.508 0.671 . . . . 0.0 110.874 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -165.75 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -139.74 164.19 26.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -123.96 153.5 41.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -99.92 99.65 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.899 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 45.4 t -82.82 136.73 34.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.839 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -61.81 -29.32 70.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 490' ' ' GLU . 2.0 p90 -113.26 144.64 42.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' GLU . . . . . 0.566 ' O ' ' CD2' ' A' ' 489' ' ' TYR . 12.3 pt-20 -78.91 164.78 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.7 mm -99.73 111.09 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -128.1 114.96 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.33 137.6 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.152 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -88.15 111.98 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 t -120.74 158.15 28.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.4 p -123.14 169.66 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 28.4 p -110.6 -3.75 15.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 141.95 100.65 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -124.42 137.87 54.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.893 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 82.8 p -76.39 155.92 33.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -90.23 -157.27 33.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -107.91 129.17 55.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -151.4 127.8 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 397' ' ' LYS . 10.9 tp -165.38 154.36 12.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.434 ' N ' ' HG ' ' A' ' 394' ' ' LEU . . . -59.4 -120.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.458 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 50.1 m -116.88 38.04 3.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.554 ' HB2' HD21 ' A' ' 394' ' ' LEU . 12.6 mmtp -105.28 173.69 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -125.42 112.99 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.64 116.6 39.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 117.88 5.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.61 101.24 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.78 -156.56 10.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -73.73 -175.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.86 -28.09 12.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -122.65 28.98 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 14.7 p -69.05 -14.61 63.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 433' ' ' TYR . 65.6 mt -117.94 -2.58 11.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.96 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.7 20.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.585 HD11 ' CE ' ' A' ' 482' ' ' MET . 57.6 mt -86.67 134.56 33.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 412' ' ' PHE . 45.6 mt -99.56 155.68 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 56.0 m-85 -145.01 148.99 34.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.778 HG22 HG23 ' A' ' 438' ' ' THR . 51.6 t -128.97 104.91 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 28.1 mt -85.99 133.87 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.7 t -130.54 141.57 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -151.17 42.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.508 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 m -130.22 153.13 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 472' ' ' GLU . 16.9 mt -123.57 161.7 24.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.89 -61.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.1 p -48.45 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' HB3' ' A' ' 425' ' ' GLU . 0.9 OUTLIER -122.14 122.16 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.49 178.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.99 -40.19 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.08 -61.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.54 ' HB3' HG22 ' A' ' 421' ' ' ILE . 3.8 mm-40 -43.94 -47.99 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.82 92.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.466 ' HA ' HG21 ' A' ' 437' ' ' VAL . 52.0 tttt -55.09 -52.16 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -54.75 -39.7 68.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.85 -57.94 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 26.0 mt -49.08 -49.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.11 -34.86 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -58.73 -16.87 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.615 ' CE2' HD13 ' A' ' 479' ' ' ILE . 64.4 m-85 -113.11 11.38 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.26 -28.83 12.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -50.16 168.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -121.21 151.86 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' A' ' 427' ' ' LYS . 98.1 t -127.82 127.86 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.778 HG23 HG22 ' A' ' 413' ' ' VAL . 3.1 t -143.02 170.19 16.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.92 -26.81 8.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -93.1 137.73 32.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.75 109.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 m -121.06 179.08 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -54.66 -46.16 73.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -53.0 -26.93 16.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.435 HG22 HG21 ' A' ' 467' ' ' THR . 28.9 m -55.0 117.99 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -90.31 -39.72 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.547 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 92.1 m-85 -137.88 155.62 48.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 469' ' ' ILE . 3.1 tp -125.25 107.01 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.2 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 8.4 mmt -93.58 157.57 16.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -140.47 -117.24 1.38 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.2 ptp180 -123.15 170.64 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.865 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 2.2 t70 34.43 37.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 452' ' ' ARG . 29.0 m -95.54 150.85 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -74.92 161.06 53.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -85.24 -33.44 22.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -54.45 -46.59 73.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -46.71 -27.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.4 p -88.87 -47.07 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -42.42 -43.06 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -73.47 -39.5 64.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.16 -57.46 12.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 466' ' ' GLY . . . -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -42.91 -48.66 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.36 -16.75 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 463' ' ' ALA . . . 89.01 55.27 2.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 445' ' ' THR . 18.1 m -109.43 138.49 45.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.1 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.18 127.17 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 448' ' ' LEU . 79.0 mt -99.99 124.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.429 HD12 ' CA ' ' A' ' 475' ' ' LEU . 23.2 pt -130.62 177.78 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.05 -179.25 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.696 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.6 pm0 -52.11 -28.62 18.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.15 -45.24 15.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -63.99 -28.46 72.82 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.429 ' CA ' HD12 ' A' ' 470' ' ' ILE . 61.5 tp -67.87 -40.0 83.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.959 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.03 -30.15 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -70.68 -38.93 73.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 470' ' ' ILE . 14.4 mt -59.73 -17.34 34.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.615 HD13 ' CE2' ' A' ' 433' ' ' TYR . 87.5 mt -86.92 -24.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.76 -9.88 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.1 p -103.54 -41.66 5.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.585 ' CE ' HD11 ' A' ' 410' ' ' LEU . 13.0 mmm -67.12 139.88 95.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -165.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -125.63 170.39 17.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -138.02 160.27 39.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -99.45 118.62 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 32.1 t -121.12 172.07 8.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -42.47 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.56 148.09 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' GLU . . . . . 0.407 ' OE2' ' C ' ' A' ' 490' ' ' GLU . 0.0 OUTLIER -132.35 162.86 30.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.37 127.52 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.69 159.09 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.77 122.28 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -89.4 149.01 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 57.6 m -88.65 135.85 33.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 87.1 p -118.85 -44.25 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.0 110.899 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.9 t -54.55 128.7 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -116.4 141.44 16.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.526 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.7 t -41.14 100.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.5 m -135.14 127.01 29.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -118.83 71.58 0.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 110.28 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 394' ' ' LEU . . . -143.89 132.78 22.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 394' ' ' LEU . 9.8 tt -37.57 98.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -114.92 -26.28 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.485 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 12.7 p -76.9 1.61 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.994 0.426 . . . . 0.0 110.898 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.507 ' HB2' HD21 ' A' ' 394' ' ' LEU . 27.9 mttm -139.22 -178.89 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -135.99 124.02 22.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.36 127.11 93.12 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.563 0.697 . . . . 0.0 111.099 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 117.38 5.05 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.227 . . . . 0.0 112.379 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -79.95 84.3 5.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -100.21 -138.18 10.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.88 -174.86 3.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.36 -21.08 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -126.77 33.3 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.0 p -76.54 -10.47 59.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 410' ' ' LEU . 79.0 mt -128.37 6.8 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.9 118.5 9.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.38 -30.69 9.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 407' ' ' LEU . 21.0 mt -79.95 140.16 36.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 444' ' ' LYS . 75.3 mt -106.28 142.97 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 61.2 m-85 -130.42 148.1 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 438' ' ' THR . 84.9 t -122.47 101.87 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 430' ' ' ILE . 61.7 mt -83.89 123.27 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.402 HG23 ' OG ' ' A' ' 454' ' ' SER . 8.4 t -122.74 144.21 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -153.15 45.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 11.5 m -130.94 160.83 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 7.5 mt -137.68 151.69 48.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -75.95 -62.66 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.49 ' HB3' HD12 ' A' ' 394' ' ' LEU . 8.9 m -40.39 -42.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 426' ' ' ALA . 4.7 pt -150.51 162.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 424' ' ' ASP . 14.8 mt-10 -102.67 155.53 18.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 422' ' ' GLU . 9.5 tpt85 -35.68 -32.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 422' ' ' GLU . 3.3 m-20 -73.8 -66.59 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -41.1 -65.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.09 -44.49 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.425 ' HG3' HG11 ' A' ' 437' ' ' VAL . 11.6 tttp -53.35 -52.88 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 t -51.13 -39.57 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -60.27 3.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 414' ' ' ILE . 37.4 mt -55.33 -43.71 72.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.81 -31.18 67.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -63.46 -31.03 72.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 479' ' ' ILE . 78.0 m-85 -96.28 4.84 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.23 -27.58 19.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -48.38 161.08 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -110.82 154.79 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.425 HG11 ' HG3' ' A' ' 427' ' ' LYS . 59.0 t -129.69 114.92 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 413' ' ' VAL . 13.8 t -130.72 170.27 14.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -112.38 51.76 0.68 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ASN . . . . . 0.585 ' O ' HG21 ' A' ' 413' ' ' VAL . 7.6 t-20 -172.55 150.03 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 458' ' ' LYS . 57.8 t -102.6 109.24 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 444' ' ' LYS . 1.7 m -127.63 -176.13 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.835 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -61.14 -40.29 93.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.553 ' HG2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -64.41 -25.45 68.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.6 m -61.68 136.63 58.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.504 ' O ' HG23 ' A' ' 467' ' ' THR . 15.6 m120 -105.48 -49.48 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 478' ' ' LEU . 72.5 m-85 -129.62 154.96 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.631 HD23 HG12 ' A' ' 469' ' ' ILE . 11.3 tp -122.78 102.81 8.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.5 t -77.5 104.65 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.6 mtp -77.01 178.6 6.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 175.9 44.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 453' ' ' ASP . 1.0 OUTLIER -53.32 146.81 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 452' ' ' ARG . 1.6 t70 43.57 54.28 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 415' ' ' THR . 2.7 m -106.71 127.99 53.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -52.33 150.14 9.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.81 -39.76 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -44.31 -39.63 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' A' ' 441' ' ' VAL . 2.3 tppt? -50.7 -41.88 56.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.2 p -73.55 -29.13 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -54.91 -56.97 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -63.12 -47.51 82.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -42.97 -56.15 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.22 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.32 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.47 -30.91 68.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 101.92 42.57 2.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 446' ' ' ASN . 94.9 m -97.5 140.37 32.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -81.63 109.64 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.631 HG12 HD23 ' A' ' 448' ' ' LEU . 72.5 mt -82.97 129.69 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.131 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 475' ' ' LEU . 46.6 pt -140.33 173.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 472' ' ' GLU . 3.0 p30 -120.81 172.5 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.0 pm0 -35.15 -43.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 32.7 t0 -66.23 -52.79 44.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -50.8 -42.03 45.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.7 tp -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.8 -51.9 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.0 -36.52 65.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.636 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.4 mt -65.1 -25.77 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.2 mt -79.58 -27.27 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -91.31 -28.48 17.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -83.26 -47.89 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.415 ' CE ' HD11 ' A' ' 410' ' ' LEU . 15.4 mmm -57.77 141.86 79.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.73 169.67 22.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -134.61 113.15 11.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -57.33 127.56 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 50.9 p -129.32 145.52 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -67.87 -44.31 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -101.95 -176.29 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -115.24 178.12 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.58 115.38 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.65 13.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 13.8 p -46.61 136.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -133.38 126.91 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 26.7 m -89.91 111.67 22.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 57.9 m -91.67 165.81 13.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 63.5 p -154.27 141.97 19.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -128.76 -136.74 4.21 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.2 p -134.88 125.14 26.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 15.5 t -76.75 132.41 39.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 137.54 106.12 0.75 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -91.16 -55.12 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.8 132.38 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 395' ' ' GLY . 7.2 tt -58.23 113.39 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . 37.17 -135.6 0.77 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.4 t -96.71 34.04 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.877 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -120.15 -179.75 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -127.9 119.58 25.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.1 mm -81.32 121.24 80.02 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.623 0.725 . . . . 0.0 111.15 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 116.42 4.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.39 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -75.94 83.13 2.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -96.92 -142.44 13.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.958 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.16 -174.96 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 5.1 pt-20 -103.22 -33.03 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.492 ' CB ' ' HG3' ' A' ' 485' ' ' LYS . 51.2 m-80 -122.47 26.28 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.958 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -63.03 -16.24 59.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.11 7.38 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.95 128.48 36.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.79 21.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.556 HD11 ' CE ' ' A' ' 482' ' ' MET . 7.5 mt -87.74 145.64 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 444' ' ' LYS . 68.4 mt -110.84 147.39 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -132.77 138.99 47.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 438' ' ' THR . 77.6 t -117.73 101.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 62.5 mt -81.06 119.63 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 415' ' ' THR . 9.1 t -121.36 116.02 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.48 -153.12 18.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.03 158.17 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 472' ' ' GLU . 0.9 OUTLIER -135.23 148.62 49.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.7 -58.12 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.5 m -44.71 -41.92 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 426' ' ' ALA . 3.0 pt -152.17 161.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.58 168.35 9.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -45.68 -35.56 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 427' ' ' LYS . 14.1 t70 -77.48 -63.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -38.76 -48.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -66.05 -37.67 86.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.612 ' HA ' HG21 ' A' ' 437' ' ' VAL . 50.7 tttt -58.88 -45.21 90.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -23.04 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 20.4 tp -81.47 -64.23 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 475' ' ' LEU . 27.6 mt -48.12 -36.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -76.68 -29.81 56.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.65 -14.55 61.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 479' ' ' ILE . 81.4 m-85 -114.01 6.91 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.19 -26.87 22.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.57 165.89 2.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -122.07 159.93 26.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 427' ' ' LYS . 94.5 t -133.62 117.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.552 HG23 HG22 ' A' ' 413' ' ' VAL . 13.3 t -132.24 164.41 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.93 49.3 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -169.59 134.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.887 0.375 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.483 HG23 ' HD2' ' A' ' 458' ' ' LYS . 81.2 t -79.9 121.01 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 29.8 t -127.69 179.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -71.39 -25.92 62.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.744 ' HB2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -79.59 -15.25 57.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -61.82 119.25 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.442 ' C ' HG23 ' A' ' 467' ' ' THR . 7.7 m-80 -93.83 -40.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 468' ' ' LYS . 80.6 m-85 -133.18 153.98 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 413' ' ' VAL . 11.6 tp -125.47 108.38 11.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.38 102.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.3 ptp -103.59 170.99 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 -103.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 453' ' ' ASP . 15.9 mmt180 -91.09 159.53 16.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.9 t70 34.4 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.3 t -82.78 105.64 13.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -56.01 173.76 1.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -113.22 -3.49 13.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.0 t -75.29 -32.62 61.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.483 ' HD2' HG23 ' A' ' 441' ' ' VAL . 31.2 mtmt -81.87 -57.89 3.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.0 p -46.0 -58.58 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -38.45 -43.73 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -69.07 -49.54 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.577 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -40.87 -58.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.44 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.29 -24.34 63.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.8 mt -98.76 17.79 18.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.77 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.472 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.577 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 60.6 m -103.48 126.49 50.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 447' ' ' TYR . 0.2 OUTLIER -72.39 111.44 7.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 16.8 mt -81.97 122.5 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 478' ' ' LEU . 28.0 pt -137.96 172.41 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.89 175.42 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 418' ' ' LEU . 16.4 pt-20 -38.62 -46.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -67.77 -49.56 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.91 -30.22 9.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 430' ' ' ILE . 50.9 tp -71.64 -62.22 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 29.9 mt -43.09 -41.93 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.23 -36.69 82.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 470' ' ' ILE . 11.0 mt -63.89 -23.07 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.508 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.4 mt -81.09 -15.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.129 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -105.36 -8.8 17.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 -38.79 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.5 mtp -62.93 142.26 97.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.1 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.94 155.23 17.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.527 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.492 ' HG3' ' CB ' ' A' ' 405' ' ' ASN . 4.5 ptpp? -140.46 146.77 38.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -70.01 139.01 52.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 1.9 t -66.77 158.94 29.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -76.09 -37.12 58.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -81.23 162.51 23.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.15 166.83 16.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.0 mp -93.59 127.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -92.41 135.43 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.1 140.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 117.8 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 65.5 p -109.93 102.69 11.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.3 m -39.87 148.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 24.1 p -76.35 156.26 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 151.72 -120.19 1.06 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.519 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.2 m -119.36 159.77 23.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -60.21 -45.22 93.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -140.5 176.43 21.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 393' ' ' ALA . 11.1 ptpt -122.92 112.47 17.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 392' ' ' LYS . . . 67.28 54.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.094 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 395' ' ' GLY . 0.1 OUTLIER -85.46 -15.4 43.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . 33.96 43.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.5 p -122.11 2.57 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.837 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -158.38 146.28 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -122.65 123.54 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.82 121.49 84.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.711 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.589 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.6 Cg_endo -69.77 126.45 13.31 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 0.0 112.348 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -89.33 94.75 10.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.76 -135.73 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.28 -175.0 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -100.72 -19.56 15.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -128.24 30.82 5.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -71.69 -11.21 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.87 13.49 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.84 122.65 23.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.89 -35.24 5.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.8 157.78 29.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.769 0.319 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 412' ' ' PHE . 77.5 mt -115.1 154.17 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 38.6 m-85 -142.16 153.2 43.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.769 HG22 HG23 ' A' ' 438' ' ' THR . 98.5 t -133.06 102.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 426' ' ' ALA . 33.1 mt -83.68 122.74 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -125.74 132.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.16 -153.71 23.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.37 152.73 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.354 . . . . 0.0 111.139 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.2 mt -132.12 164.03 27.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -85.39 -66.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.5 p -41.92 -27.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 420' ' ' SER . 0.9 OUTLIER -161.88 165.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.91 164.45 13.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -39.29 -36.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 37.5 t0 -73.85 -66.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 424' ' ' ASP . 18.0 mm-40 -36.88 -53.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.584 ' HB3' HD13 ' A' ' 414' ' ' ILE . . . -56.53 -41.81 77.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 437' ' ' VAL . 38.3 tttt -58.4 -46.14 86.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -40.83 97.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.1 tp -63.47 -62.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 414' ' ' ILE . 54.8 mt -44.42 -43.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -75.35 -35.78 61.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -54.33 -21.83 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.33 -3.78 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 115.59 -40.3 2.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.22 162.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 427' ' ' LYS . 87.9 t -125.7 125.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.769 HG23 HG22 ' A' ' 413' ' ' VAL . 3.5 t -137.64 139.93 40.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -86.33 46.81 3.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -157.86 126.65 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 458' ' ' LYS . 48.3 t -80.6 100.83 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.179 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 51.9 m -121.29 164.73 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -50.94 -52.96 37.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -43.54 -32.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.9 m -48.94 130.69 18.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -99.15 -30.19 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 478' ' ' LEU . 65.9 m-85 -148.68 145.66 27.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.532 HD23 HG12 ' A' ' 469' ' ' ILE . 15.6 tp -115.81 98.88 6.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.21 106.05 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.5 139.03 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -122.24 -114.02 2.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -92.5 167.78 11.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 27.0 t70 38.02 45.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 70.4 m -101.55 173.26 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -99.18 147.48 18.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 457' ' ' SER . 49.0 tp60 -82.92 -47.41 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.893 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 456' ' ' GLN . 11.3 t -36.24 -46.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.496 ' HB3' HG21 ' A' ' 441' ' ' VAL . 24.0 mttm -55.37 -65.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.3 t -50.51 -44.78 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -46.81 -58.1 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -66.91 -43.39 83.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -45.38 -50.74 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.076 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.98 88.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.083 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.27 70.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 22.3 mt -93.76 22.97 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 51.61 52.65 32.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.525 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.5 m -109.68 126.27 53.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.136 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 106.42 4.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.532 HG12 HD23 ' A' ' 448' ' ' LEU . 62.6 mt -84.52 125.08 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 475' ' ' LEU . 14.7 pt -138.36 174.57 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -116.4 177.35 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.645 ' HB3' HD13 ' A' ' 418' ' ' LEU . 4.9 pt-20 -39.06 -46.28 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.91 -55.86 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.3 -38.27 19.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.539 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 470' ' ' ILE . 40.9 tp -58.56 -51.69 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.589 HD22 ' CD ' ' A' ' 400' ' ' PRO . 39.5 mt -57.04 -50.45 72.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.17 -33.55 65.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' ' 447' ' ' TYR . 12.5 mt -66.78 -15.92 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.06 -25.4 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -93.56 -28.16 16.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 27.2 p -84.09 -41.5 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 23.2 mmm -65.79 140.6 97.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.0 Cg_endo -69.83 -164.34 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.645 2.23 . . . . 0.0 112.315 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.58 174.2 20.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -139.5 129.5 25.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -74.95 117.25 16.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' SER . . . . . 0.627 ' CB ' HD11 ' A' ' 491' ' ' ILE . 8.6 t -43.17 134.76 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -47.55 35.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -101.75 155.75 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -59.49 142.35 52.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.627 HD11 ' CB ' ' A' ' 487' ' ' SER . 20.4 mm -98.53 142.17 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -100.86 97.37 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 491' ' ' ILE . 57.8 t -137.78 129.32 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 40.66 45.12 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.9 p -102.12 131.83 48.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 t -108.43 111.93 24.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.841 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 19.0 m -103.08 84.4 2.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -168.64 -167.07 28.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.2 p -135.64 141.04 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.6 m -81.48 88.79 6.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -158.08 63.96 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -144.11 139.54 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -118.68 158.09 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 pp -129.03 8.74 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 154.98 33.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.9 m 57.65 38.11 27.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -103.88 174.66 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.57 102.6 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 17.0 mm -79.17 120.21 79.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 122.96 9.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.709 2.272 . . . . 0.0 112.364 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -73.7 119.64 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -138.83 -156.72 7.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.29 -175.01 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.36 -20.54 15.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -126.91 29.52 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 32.0 p -68.98 -18.63 64.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.04 16.14 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -78.89 121.48 24.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.7 -24.51 21.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.478 HD11 ' CE ' ' A' ' 482' ' ' MET . 25.7 mt -89.85 150.09 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.5 144.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 57.0 m-85 -132.07 152.2 51.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.83 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 438' ' ' THR . 96.3 t -131.33 110.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.26 121.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 415' ' ' THR . 4.0 t -124.69 115.06 20.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.07 -153.8 16.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.428 ' CG2' ' HE ' ' A' ' 452' ' ' ARG . 2.4 m -131.31 150.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.64 145.14 51.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -72.44 -44.03 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 421' ' ' ILE . 11.0 m -55.04 -42.13 72.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.854 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.5 pt -156.33 161.01 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.91 169.76 10.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -52.12 -30.34 25.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.44 -55.95 4.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -47.37 -54.64 10.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.476 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' LYS . . . . . 0.43 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.8 tttm -53.46 -53.53 50.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -51.94 -40.58 61.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.7 tp -64.22 -53.61 46.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.503 HG12 HD11 ' A' ' 475' ' ' LEU . 59.3 mt -54.37 -38.98 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -77.86 -30.41 50.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -58.04 -24.28 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -110.34 4.79 21.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.83 -33.13 6.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.496 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -43.74 146.71 1.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -104.24 159.54 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 427' ' ' LYS . 91.8 t -133.26 116.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.61 ' O ' HG13 ' A' ' 413' ' ' VAL . 5.1 t -132.21 148.36 52.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.11 53.5 1.37 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 114.08 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.879 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.94 99.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.7 m -119.59 -175.16 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -63.34 -54.87 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -47.19 -28.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 49.4 m -58.37 126.0 25.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -95.53 -42.93 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 46.1 m-85 -132.12 149.48 52.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 469' ' ' ILE . 9.2 tp -120.05 106.95 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.14 102.76 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.636 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.1 mtt -82.79 161.92 21.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -154.61 -169.64 19.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.428 ' HE ' ' CG2' ' A' ' 417' ' ' VAL . 3.8 ttp180 -68.03 147.05 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.901 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.9 t70 43.24 52.18 5.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.6 p -81.86 176.38 9.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.77 141.44 15.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -74.78 -33.3 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 55.8 m -58.71 -41.64 86.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -55.06 -61.15 2.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 460' ' ' ASP . 28.6 p -51.83 -44.75 63.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 459' ' ' SER . 8.1 t70 -35.59 -67.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.462 ' HB3' HD12 ' A' ' 465' ' ' LEU . 7.2 mptt -57.87 -56.39 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -34.28 -48.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.99 84.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 461' ' ' LYS . . . -68.68 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 461' ' ' LYS . 28.2 mt -54.79 -32.07 59.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 86.97 62.98 1.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 6.7 m -107.06 139.24 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.167 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 19.5 mmtt -69.14 105.4 2.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.671 HG12 HD23 ' A' ' 448' ' ' LEU . 88.5 mt -85.62 131.11 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.54 177.38 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -126.05 177.34 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -38.87 -48.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -63.07 -49.52 74.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -56.67 -26.22 52.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 430' ' ' ILE . 64.0 tp -73.39 -48.08 36.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 479' ' ' ILE . 73.9 mt -62.58 -44.08 97.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 481' ' ' THR . 8.1 t-20 -61.63 -28.77 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.4 mt -70.67 -15.8 62.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 476' ' ' LEU . 31.0 mt -87.24 -17.31 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.75 -29.26 11.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 477' ' ' ASN . 58.3 p -83.31 -45.5 13.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.478 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.3 mmm -60.34 142.0 90.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.83 -166.69 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.316 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -133.89 165.01 24.38 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -135.44 120.49 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -73.04 86.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 16.5 m -104.6 136.16 44.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -75.55 -42.72 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -60.61 108.63 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.11 168.82 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 18.2 mm -112.84 70.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . 49.45 50.06 18.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 493' ' ' VAL . 7.6 p -46.25 122.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 494' ' ' GLU . . . . . 0.451 ' O ' ' CD ' ' A' ' 494' ' ' GLU . 2.5 pp20? -103.66 135.48 45.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 21.6 p -119.84 98.22 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.895 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.5 p -72.13 142.72 49.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 94.6 p -129.99 104.75 7.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 175.66 -162.67 32.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.5 p -62.25 140.78 58.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.1 t -109.79 120.68 43.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 97.99 161.59 30.79 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.469 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -81.82 113.01 19.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.306 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -84.91 169.49 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.967 HD23 ' O ' ' A' ' 394' ' ' LEU . 7.5 tt -79.86 -12.59 59.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 103.7 -65.97 0.34 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.8 p -85.47 2.14 45.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.404 ' HB2' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -164.12 179.13 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -136.53 141.88 43.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 34.4 mm -86.96 122.3 71.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.14 5.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.353 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -71.97 102.62 2.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -125.78 -161.17 10.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.435 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.451 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -73.08 -175.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.731 0.301 . . . . 0.0 111.111 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -101.33 -20.84 15.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -126.04 36.73 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 29.1 p -78.67 -6.46 55.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 96.7 mt -132.96 5.55 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -69.35 116.76 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.31 -16.94 34.79 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.584 HD11 ' CE ' ' A' ' 482' ' ' MET . 48.8 mt -99.47 138.6 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 28.5 mt -101.96 151.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.429 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 43.4 m-85 -136.72 143.69 43.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 438' ' ' THR . 60.8 t -121.08 109.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.605 HG21 ' NE ' ' A' ' 423' ' ' ARG . 50.4 mt -90.5 120.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 415' ' ' THR . 6.5 t -118.74 113.03 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.443 ' O ' ' NH1' ' A' ' 423' ' ' ARG . . . 99.21 175.17 31.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 417' ' ' VAL . 1.8 m -94.47 122.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.461 HD12 HH21 ' A' ' 423' ' ' ARG . 4.6 mt -90.26 100.45 13.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -40.88 -25.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 418' ' ' LEU . 4.3 p -71.97 -62.71 1.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 425' ' ' GLU . 0.4 OUTLIER -140.52 132.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -65.57 -175.55 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.605 ' NE ' HG21 ' A' ' 414' ' ' ILE . 8.2 mmp_? -58.71 -58.29 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -29.48 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 421' ' ' ILE . 9.3 mt-10 -71.04 -64.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -54.02 -62.51 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -41.85 -27.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.33 -51.45 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 475' ' ' LEU . 45.2 mt -61.03 -35.87 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.26 -29.66 38.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -60.56 -21.25 62.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -111.11 2.51 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.43 -27.52 15.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.436 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -48.63 157.15 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -114.57 157.56 22.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.5 t -131.73 123.45 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.851 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -134.59 155.72 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -101.29 37.03 3.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -160.16 125.14 3.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 458' ' ' LYS . 96.0 t -67.28 118.42 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 75.4 m -123.24 157.94 31.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.872 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -61.48 -14.34 28.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -86.59 -22.74 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 26.3 m -51.86 133.57 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.513 ' OD1' HD22 ' A' ' 410' ' ' LEU . 5.4 m-80 -97.22 -25.2 15.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 69.8 m-85 -157.57 131.11 7.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 469' ' ' ILE . 18.1 tp -98.13 116.23 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.35 94.52 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.506 ' CE ' HD21 ' A' ' 448' ' ' LEU . 6.4 mmt -86.39 166.47 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -159.59 -107.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -126.92 168.49 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.8 m-20 37.72 46.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.6 m -99.98 175.99 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.32 -177.51 40.27 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.435 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -115.18 -19.61 10.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.4 p -77.63 -19.16 55.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 441' ' ' VAL . 36.9 mmtm -72.49 -39.45 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 42.7 p -73.96 -52.18 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.38 -44.46 8.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -47.06 50.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -53.02 -53.65 47.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.079 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.0 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -54.84 -58.7 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.068 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 443' ' ' LYS . 12.3 mt -61.35 -23.7 65.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 93.64 53.81 1.76 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 3.5 m -107.98 134.59 50.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.14 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -74.91 116.67 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 448' ' ' LEU . 88.3 mt -87.3 123.55 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 475' ' ' LEU . 50.2 pt -140.1 168.98 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 471' ' ' ASP . 0.6 OUTLIER -115.26 173.92 6.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.4 pt-20 -34.12 -45.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -60.34 3.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.41 8.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 430' ' ' ILE . 23.2 tp -44.4 -45.64 9.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.73 -46.79 83.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -62.12 -31.29 71.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 478' ' ' LEU . 10.9 mt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 20.1 mt -82.96 -17.6 10.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.9 -16.91 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.842 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.1 p -97.04 -33.72 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.584 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.7 mmm -72.18 142.51 84.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.874 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -165.48 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.334 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -137.17 169.36 24.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -136.52 129.24 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.2 106.58 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 75.0 p -68.12 145.27 54.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -14.3 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -119.51 147.06 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -99.38 153.04 19.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 71.3 mt -102.86 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.171 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -78.4 118.58 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 p -52.7 131.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -157.31 138.35 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 19.2 p -71.02 159.92 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.6 m -124.82 121.77 35.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.795 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 53.0 m -98.42 130.47 45.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -118.09 83.85 0.36 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 16.8 t -79.14 115.44 18.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 68.1 m -115.06 116.86 29.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 173.03 -45.92 0.16 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm 44.64 47.19 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -151.39 140.91 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 397' ' ' LYS . 1.1 pt? -125.09 -172.51 2.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . -25.62 -90.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -120.48 33.08 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' LYS . . . . . 0.618 ' HB2' HD11 ' A' ' 394' ' ' LEU . 2.1 mmmm -137.04 152.54 50.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -119.22 119.11 33.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 476' ' ' LEU . 12.7 mm -87.36 121.86 71.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.665 0.745 . . . . 0.0 111.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 128.75 16.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.738 2.292 . . . . 0.0 112.32 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 402' ' ' GLY . 0.0 OUTLIER -65.22 103.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLY . . . . . 0.494 ' N ' ' HE3' ' A' ' 401' ' ' LYS . . . -124.3 -161.48 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.486 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.3 -175.0 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.723 0.297 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.81 -23.79 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -125.08 30.84 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.8 p -69.49 -13.08 62.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.17 7.18 7.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -63.55 137.29 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 87.73 -29.91 5.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 76.7 mt -79.23 148.63 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 90.7 mt -119.91 145.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 67.1 m-85 -132.21 153.62 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.993 HG22 HG23 ' A' ' 438' ' ' THR . 99.5 t -128.56 103.2 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.521 HG22 ' NH1' ' A' ' 423' ' ' ARG . 21.6 mt -85.18 124.4 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -122.73 139.81 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 85.63 -157.04 30.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 417' ' ' VAL . 4.7 m -135.32 123.9 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.389 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.18 149.42 23.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -55.06 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.4 m -45.13 -53.83 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 426' ' ' ALA . 2.1 pt -142.15 128.44 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.98 165.04 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.521 ' NH1' HG22 ' A' ' 414' ' ' ILE . 0.1 OUTLIER -41.96 -43.62 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 425' ' ' GLU . 1.1 m-20 -64.25 -66.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 424' ' ' ASP . 37.9 mm-40 -36.75 -71.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.21 -56.03 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -39.84 -62.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -33.78 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 432' ' ' ARG . 15.5 tp -71.8 -66.23 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 414' ' ' ILE . 30.8 mt -45.81 -33.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.66 -25.06 26.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 429' ' ' LEU . 14.9 ttm180 -65.08 -16.9 63.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.92 6.9 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.87 -37.71 3.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.3 149.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -105.1 165.91 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.63 132.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.993 HG23 HG22 ' A' ' 413' ' ' VAL . 0.3 OUTLIER -143.18 129.95 20.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.52 76.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -104.77 139.69 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 413' ' ' VAL . 90.9 t -76.01 127.37 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 p -123.24 170.3 10.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.597 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -62.02 -32.93 73.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.922 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -70.5 -19.15 62.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.0 m -51.02 133.73 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 7.8 m120 -106.69 -22.81 12.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 58.2 m-85 -156.06 154.95 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 448' ' ' LEU . 1.8 tp -121.3 106.49 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.2 97.5 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.527 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.4 mtt -78.61 170.5 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -158.54 -107.51 0.24 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 ptp180 -131.11 172.75 11.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.2 m-20 34.53 38.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.6 t -83.08 -175.04 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -127.27 141.98 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -13.15 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.32 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 14.8 t -73.46 -44.63 57.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -55.71 -48.25 75.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.483 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 46.2 p -68.88 -33.76 74.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.52 -42.63 92.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LYS . . . . . 0.513 ' HE2' HD11 ' A' ' 465' ' ' LEU . 1.8 tmtp? -77.23 -34.07 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -63.37 -54.91 29.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.34 68.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.597 HD13 ' HA ' ' A' ' 443' ' ' LYS . 37.3 mt -71.44 -25.72 62.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 102.48 51.39 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 41.2 m -113.86 141.8 46.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.336 . . . . 0.0 111.159 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -85.56 139.95 31.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.527 HG23 ' HG3' ' A' ' 450' ' ' MET . 2.8 mp -102.22 122.01 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.8 179.49 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 474' ' ' GLY . 2.1 p-10 -124.79 166.76 15.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -38.96 -30.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.8 -42.96 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -59.65 -35.11 84.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 399' ' ' ILE . 0.5 OUTLIER -50.89 -49.26 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 481' ' ' THR . 50.0 t30 -57.58 -44.41 85.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.26 -17.72 3.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 97.5 mt -87.21 -28.23 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -98.32 -13.34 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 477' ' ' ASN . 43.3 p -97.11 -43.14 7.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.176 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.2 mmm -66.64 142.6 97.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.842 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 483' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.75 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.636 2.224 . . . . 0.0 112.386 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.07 157.75 20.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -135.45 115.38 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 486' ' ' LYS . 0.1 OUTLIER -72.4 136.58 46.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 42.2 t -134.6 153.7 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -121.34 -28.39 4.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.68 10.61 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.79 140.3 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.507 ' O ' HG22 ' A' ' 491' ' ' ILE . 61.0 mt -116.48 74.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . 38.71 52.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 493' ' ' VAL . 7.9 p -58.02 112.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.72 154.27 38.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 76.9 p -143.01 130.63 21.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.612 0.72 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 129.7 18.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -86.2 92.34 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -114.67 -139.68 7.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.64 -175.09 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.778 0.323 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.71 -20.4 13.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -127.09 32.83 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 28.1 p -75.55 -17.4 60.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 410' ' ' LEU . 59.5 mt -121.96 10.14 10.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -68.79 116.32 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.05 -21.55 24.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 24.2 mt -90.07 150.14 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.48 148.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.4 148.53 49.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 448' ' ' LEU . 99.5 t -127.05 108.09 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 25.8 mt -91.28 123.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.7 t -120.65 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.25 -153.86 32.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -127.13 154.55 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.1 mt -132.79 136.51 46.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -60.36 -63.62 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.808 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 419' ' ' GLU . 23.0 p -35.92 -56.65 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.5 OUTLIER -143.15 155.75 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.16 160.56 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -39.84 -37.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.58 -55.13 8.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.4 ' CD ' HG22 ' A' ' 421' ' ' ILE . 17.3 mt-10 -51.16 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.39 -40.8 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 437' ' ' VAL . 36.2 tttm -58.3 -57.58 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.1 p -48.9 -30.52 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.51 -61.72 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 475' ' ' LEU . 33.7 mt -51.22 -34.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.5 -28.84 46.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -66.15 -14.95 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.5 -9.42 14.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 117.93 -24.84 8.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.9 157.56 21.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -106.63 156.29 18.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 427' ' ' LYS . 77.5 t -134.3 116.68 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.6 t -136.78 134.94 37.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.34 45.99 3.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -160.12 135.46 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.569 HG23 ' HD2' ' A' ' 458' ' ' LYS . 62.2 t -74.79 130.04 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.3 t -130.91 173.42 10.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -76.43 -19.58 57.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -88.98 -16.77 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.401 HG22 ' CG2' ' A' ' 467' ' ' THR . 96.7 m -48.05 127.58 12.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.99 -39.8 9.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 73.1 m-85 -144.64 150.77 37.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 413' ' ' VAL . 6.4 tp -117.98 107.89 14.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.61 106.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.6 mtt -92.11 165.99 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -152.26 -118.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 453' ' ' ASP . 11.4 ptm180 -119.49 173.22 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.8 t70 34.54 38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 452' ' ' ARG . 61.5 m -99.82 151.9 20.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -77.08 163.24 52.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 2.3 pm0 -92.27 -12.31 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 1.8 t -69.48 -34.77 74.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 441' ' ' VAL . 3.9 tppt? -58.03 -43.79 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.435 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 86.1 p -66.36 -52.42 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.1 -64.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -54.21 -49.12 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -47.77 -58.33 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.25 -50.17 67.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -47.33 -55.83 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.2 mt -66.54 -26.11 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.55 53.05 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.401 ' CG2' HG22 ' A' ' 445' ' ' THR . 47.5 m -110.4 136.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 0.0 111.16 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.503 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -79.77 117.81 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 450' ' ' MET . 15.5 mt -89.7 130.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.2 pt -147.25 166.59 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 472' ' ' GLU . 0.4 OUTLIER -107.59 171.11 7.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 473' ' ' ASP . 2.6 pp20? -37.21 -43.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 472' ' ' GLU . 16.2 t70 -60.8 -51.99 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -55.65 -35.21 61.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 430' ' ' ILE . 57.1 tp -63.16 -47.32 83.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.27 -53.05 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -53.14 -39.85 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.28 -15.54 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 78.9 mt -90.18 -19.3 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.6 -20.97 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.5 p -91.86 -38.32 12.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.521 ' CE ' HD11 ' A' ' 410' ' ' LEU . 40.7 mmm -67.29 143.6 97.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.523 0.677 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.81 -178.42 2.35 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -126.73 166.05 19.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.436 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.0 mttm . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.894 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.474 HG23 ' HD2' ' A' ' 400' ' ' PRO . 27.5 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.627 0.727 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 399' ' ' ILE . 54.1 Cg_endo -69.75 117.93 5.38 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.65 2.234 . . . . 0.0 112.373 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -70.28 108.79 4.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -129.96 -146.29 5.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.34 -175.24 4.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.65 -25.59 12.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -124.31 30.47 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -70.38 -16.31 62.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 61.0 mt -121.12 9.21 10.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -65.79 133.79 51.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 92.35 -33.52 4.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.54 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.06 139.94 38.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.878 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 81.9 mt -105.07 156.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 91.5 m-85 -142.64 150.42 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 438' ' ' THR . 65.8 t -130.39 99.12 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 45.3 mt -81.81 130.99 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.446 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.6 t -128.88 145.98 51.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.35 42.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.89 152.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 111.107 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 451' ' ' GLY . 7.1 mt -122.92 173.85 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.73 -69.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 60.8 p -40.58 -44.23 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 1.11 HD13 ' HB2' ' A' ' 426' ' ' ALA . 2.0 pp -142.08 176.98 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -122.88 164.33 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 -42.49 -31.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.83 -68.61 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -44.67 -53.06 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 1.11 ' HB2' HD13 ' A' ' 421' ' ' ILE . . . -52.53 -42.52 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 437' ' ' VAL . 39.8 tttm -58.46 -50.35 74.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 21.1 p -54.59 -34.89 62.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.55 -65.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 435' ' ' GLY . 55.2 mt -47.31 -40.02 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -76.08 -31.87 58.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.57 -16.08 62.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 479' ' ' ILE . 70.9 m-85 -113.34 3.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.89 -32.17 7.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -47.77 163.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -116.23 156.43 26.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 427' ' ' LYS . 84.9 t -130.7 128.01 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.836 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -141.26 149.86 41.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -89.72 9.17 78.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -127.91 137.24 52.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 462' ' ' ALA . 46.6 t -87.9 108.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.2 m -110.49 -178.62 3.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.928 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -77.59 -20.18 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -26.46 54.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 10.1 m -46.47 133.86 9.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 4.9 m-80 -102.47 -22.13 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 67.5 m-85 -156.01 155.11 32.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.889 HD23 HG12 ' A' ' 469' ' ' ILE . 17.2 tp -125.41 111.63 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 34.3 t -93.57 107.05 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.446 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 26.8 mtm -110.39 175.78 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 418' ' ' LEU . . . -158.55 -147.45 4.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.5 ptt180 -69.39 174.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.4 m-20 34.75 39.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.1 p -96.78 -177.6 3.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -143.83 174.55 24.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.503 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 1.2 pm0 -97.24 24.7 6.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.354 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 15.1 t -86.08 -42.92 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.29 -39.62 28.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.0 p -71.46 -30.53 66.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -52.47 65.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.419 ' NZ ' HD11 ' A' ' 465' ' ' LEU . 0.9 OUTLIER -74.03 -28.39 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.444 ' HB2' HG11 ' A' ' 441' ' ' VAL . . . -69.67 -42.38 74.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.73 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -45.81 -41.06 10.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.928 HD13 ' HA ' ' A' ' 443' ' ' LYS . 11.6 mt -85.41 -24.03 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 103.5 51.05 1.0 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 59.1 m -100.56 138.9 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.152 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 468' ' ' LYS . 0.3 OUTLIER -74.36 117.32 16.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.889 HG12 HD23 ' A' ' 448' ' ' LEU . 34.0 mt -94.96 131.36 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.6 pt -142.84 174.23 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.62 178.97 4.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.438 ' OE1' HD22 ' A' ' 418' ' ' LEU . 5.7 pt-20 -41.06 -45.43 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.03 -55.08 24.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 470' ' ' ILE . . . -46.28 -30.29 4.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.0 tp -67.92 -59.87 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.53 -42.85 45.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.949 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.89 -36.99 85.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.1 mt -62.75 -22.9 66.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.408 HD13 ' CE2' ' A' ' 433' ' ' TYR . 58.6 mt -83.43 -28.3 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -88.86 -22.3 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.7 p -91.23 -47.87 7.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 11.9 mmm -59.61 139.39 89.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.504 0.669 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.74 -165.18 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.46 157.09 17.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.637 0.732 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 117.7 5.24 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -76.78 95.37 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -108.54 -152.37 15.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -70.9 -177.13 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 2.8 pt-20 -101.05 -29.15 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.489 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 67.7 m-20 -122.14 20.11 10.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.923 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.9 p -59.26 -25.64 64.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.466 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 68.0 mt -108.36 14.9 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.67 143.3 34.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 86.33 -16.6 43.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.59 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.5 mt -100.1 153.2 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 412' ' ' PHE . 95.4 mt -113.49 155.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 411' ' ' ILE . 91.1 m-85 -144.29 135.31 25.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 438' ' ' THR . 41.9 t -115.84 100.37 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.88 121.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 130.8 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.15 -152.27 22.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.81 152.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -132.25 159.4 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.24 -65.19 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 421' ' ' ILE . 10.6 t -39.74 -31.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 420' ' ' SER . 1.3 pt -161.2 160.88 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.12 170.32 8.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -47.95 -20.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -92.56 -65.86 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -42.07 -37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.66 -42.33 67.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 25.3 ttmt -58.76 -58.58 7.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 28.1 t -47.07 -36.76 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -64.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 475' ' ' LEU . 63.4 mt -49.89 -44.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.16 -32.65 73.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -66.06 -17.75 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 57.0 m-85 -108.21 1.57 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.02 -29.65 10.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.25 153.34 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 437' ' ' VAL . 9.3 tmtm? -105.78 146.92 29.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 99.5 t -122.45 121.34 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.626 ' O ' HG13 ' A' ' 413' ' ' VAL . 9.0 t -139.44 143.82 37.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -91.24 44.96 2.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -163.56 121.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.78 126.45 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.6 m -128.49 169.12 14.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -68.32 -21.65 64.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -85.44 -7.05 59.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.6 m -61.26 127.37 31.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -97.3 -29.12 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -151.83 150.96 30.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 469' ' ' ILE . 14.2 tp -119.76 108.85 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.43 105.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.502 ' HG3' HG23 ' A' ' 469' ' ' ILE . 4.2 mtt -80.27 168.98 18.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.23 -110.37 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 453' ' ' ASP . 14.7 mmt180 -125.66 172.39 9.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 452' ' ' ARG . 29.4 t0 34.56 39.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 96.6 p -83.64 165.88 18.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -113.31 130.29 9.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.49 -20.71 21.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 87.4 p -69.73 -30.24 67.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -63.11 -56.19 18.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.9 t -63.93 -45.96 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -40.3 -53.69 2.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -64.98 -35.57 81.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -61.66 -63.15 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.079 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.32 -41.39 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.54 69.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.5 -26.22 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.8 48.95 1.56 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 19.8 m -111.49 145.68 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -84.24 142.43 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 448' ' ' LEU . 25.9 mt -109.61 127.88 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.23 172.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 472' ' ' GLU . 51.0 m-20 -117.86 170.73 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.721 ' HB3' HD13 ' A' ' 418' ' ' LEU . 6.7 pt-20 -35.92 -41.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.71 -51.44 62.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.31 -27.64 32.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 430' ' ' ILE . 52.0 tp -69.76 -51.75 31.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 479' ' ' ILE . 90.3 mt -52.26 -48.73 65.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.08 -36.7 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.18 -17.25 57.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 476' ' ' LEU . 30.7 mt -88.56 -15.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -106.95 -15.29 14.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 20.9 p -97.82 -41.73 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 410' ' ' LEU . 12.2 mmm -64.43 140.73 98.05 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.71 -173.26 0.68 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.698 2.265 . . . . 0.0 112.382 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -107.34 151.27 16.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 1.8 mptp? . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.1 mm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.58 0.705 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 125.98 12.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 0.0 112.303 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -107.02 -150.3 16.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -78.95 -175.03 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -100.19 -27.78 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -123.07 31.4 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.0 p -68.97 -19.33 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.8 -5.94 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.19 126.39 27.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.11 -23.71 32.64 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 15.0 mt -94.25 153.96 17.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 81.8 mt -116.46 143.51 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 88.3 m-85 -134.48 146.23 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 438' ' ' THR . 93.9 t -121.08 112.79 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 87.4 mt -95.56 121.48 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.154 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.4 t -122.95 147.36 46.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.32 -154.16 47.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.17 142.19 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.565 HD22 ' OE1' ' A' ' 472' ' ' GLU . 8.9 mt -113.96 140.24 48.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -47.63 74.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 78.6 p -50.86 -50.11 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.2 pt -151.48 168.47 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -97.81 162.06 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -38.9 -45.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -65.21 -62.43 1.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -46.37 -62.98 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -52.38 -53.51 44.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -44.04 -53.35 6.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.4 t -49.88 -31.22 11.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.07 -60.06 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 475' ' ' LEU . 72.6 mt -53.68 -40.03 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.08 -25.35 55.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -67.24 -20.01 65.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 403' ' ' ALA . 60.4 m-85 -111.92 7.96 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.47 -38.38 3.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.501 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.29 156.54 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -110.14 148.23 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.54 123.11 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.0 t -137.61 161.68 35.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -102.24 22.9 36.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -143.53 140.63 30.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 458' ' ' LYS . 21.1 t -93.58 110.87 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.8 p -115.95 -175.66 2.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -70.35 -22.43 62.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -80.44 -17.54 51.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 18.2 m -58.53 139.38 55.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.51 -31.21 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.555 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 76.1 m-85 -149.48 140.58 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 469' ' ' ILE . 10.9 tp -110.72 106.43 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.0 t -77.46 102.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.403 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 3.2 mmt -75.93 166.71 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -156.54 -126.79 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 mmt-85 -110.64 175.11 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.7 t0 34.41 38.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.9 p -83.39 118.29 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 457' ' ' SER . . . -82.53 24.06 5.22 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 455' ' ' GLY . 13.5 pt20 36.16 30.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 455' ' ' GLY . 17.3 t -80.66 -29.46 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 441' ' ' VAL . 23.2 mtmt -93.15 -22.68 18.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.403 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 93.0 p -69.51 -16.03 63.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.47 -62.76 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -62.7 -46.19 89.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -48.01 -56.12 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.18 66.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -77.96 -18.53 55.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.17 15.04 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.11 29.26 62.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.569 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 67.7 m -82.16 127.79 33.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.112 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -74.39 129.94 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.573 HG12 HD23 ' A' ' 448' ' ' LEU . 92.2 mt -102.79 121.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 29.7 pt -127.9 173.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.9 p30 -118.34 166.84 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.85 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.565 ' OE1' HD22 ' A' ' 418' ' ' LEU . 4.9 pm0 -35.31 -32.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 471' ' ' ASP . 12.4 t0 -71.93 -53.74 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -51.62 -36.55 40.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 430' ' ' ILE . 46.0 tp -61.59 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 77.6 mt -52.84 -49.21 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -59.38 -41.59 89.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.6 mt -58.53 -16.68 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 479' ' ' ILE . 39.5 mt -89.24 -16.71 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -107.6 -13.66 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -100.48 -31.36 11.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 33.1 mmm -76.27 140.51 69.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.854 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.28 166.45 19.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.2 mttp . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.657 0.741 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 121.0 7.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.309 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -75.59 95.95 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -118.71 -133.46 4.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -100.05 -175.17 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 2.7 pt-20 -102.55 -23.7 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 73.5 m-80 -125.64 30.55 5.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 18.3 p -71.52 -19.26 62.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.55 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 84.4 mt -118.66 9.43 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.62 139.28 40.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.07 31.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.42 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.3 mt -93.71 164.23 13.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.404 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 73.0 mt -123.33 145.05 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 12.4 m-85 -131.44 155.03 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.537 ' O ' HD12 ' A' ' 448' ' ' LEU . 95.5 t -133.6 105.14 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 430' ' ' ILE . 54.8 mt -85.93 133.1 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -134.4 130.52 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.177 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.05 -151.31 21.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.454 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.02 154.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.86 147.83 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.89 -58.81 3.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 30.1 t -42.34 -44.81 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.43 158.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 424' ' ' ASP . 15.1 mt-10 -99.58 159.77 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -38.14 -31.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 422' ' ' GLU . 0.2 OUTLIER -76.55 -64.64 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -43.39 -60.91 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -46.63 -45.96 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 437' ' ' VAL . 28.7 tttt -54.67 -43.16 72.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -61.11 -38.36 86.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.4 -63.09 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 414' ' ' ILE . 62.9 mt -45.96 -37.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.35 -34.7 48.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -56.45 -16.24 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -115.3 -3.47 12.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.44 -45.48 1.28 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -41.18 141.2 1.13 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -102.37 160.44 14.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 427' ' ' LYS . 59.0 t -128.36 119.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.493 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.5 t -124.37 166.44 15.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.7 50.58 0.77 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -170.96 124.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.23 111.69 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . 0.412 ' HB3' ' CD ' ' A' ' 444' ' ' LYS . 12.9 t -126.67 -175.01 3.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -67.29 -53.52 29.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.412 ' CD ' ' HB3' ' A' ' 442' ' ' SER . 0.0 OUTLIER -50.76 -19.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.8 m -62.73 123.7 19.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.29 -53.32 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 468' ' ' LYS . 57.1 m-85 -126.51 160.21 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 413' ' ' VAL . 10.5 tp -129.94 104.76 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -77.75 105.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.0 mmt -87.9 171.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -169.24 -127.52 0.93 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.0 mmp_? -92.46 167.15 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.3 t70 34.08 36.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 452' ' ' ARG . 54.5 p -69.75 127.19 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.99 139.95 27.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.436 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 1.6 pm0 -64.57 -11.7 37.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.937 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 96.3 p -78.91 -27.11 43.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -66.66 -42.91 85.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 460' ' ' ASP . 33.7 p -81.29 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 459' ' ' SER . 0.3 OUTLIER -36.9 -57.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -60.33 -44.5 95.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -54.46 -64.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -37.99 -52.74 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.93 76.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 462' ' ' ALA . 11.3 mt -92.32 23.11 4.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 40.12 60.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.501 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.596 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.9 m -110.99 136.15 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 447' ' ' TYR . 21.2 mttp -76.11 141.76 41.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 13.9 mt -118.57 141.67 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.597 HD13 HD12 ' A' ' 478' ' ' LEU . 25.8 pt -152.08 171.09 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -115.83 177.99 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 0.6 OUTLIER -45.75 -35.16 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 21.3 t0 -71.46 -52.08 20.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.91 -45.43 70.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.522 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 470' ' ' ILE . 50.1 tp -50.55 -41.52 54.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.98 -51.35 62.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 470' ' ' ILE . 14.5 mt -65.52 -17.04 64.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.65 -17.46 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -103.97 -28.72 11.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.1 p -85.84 -25.38 26.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.134 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.467 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 63.7 mmm -82.02 140.68 46.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.76 -165.86 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.88 19.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.5 mttt . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 45.6 mm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -65.33 104.25 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.94 -152.11 8.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -88.0 -174.97 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -100.53 -26.94 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.465 ' O ' ' CE ' ' A' ' 485' ' ' LYS . 50.7 m-80 -123.23 27.32 7.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 26.5 p -68.43 -10.12 53.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.01 8.97 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . 0.43 ' CD ' ' OD1' ' A' ' 405' ' ' ASN . 14.9 tt0 -68.22 124.24 22.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.33 -29.49 12.25 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.545 HD22 ' OD1' ' A' ' 446' ' ' ASN . 72.2 mt -81.06 143.3 32.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 444' ' ' LYS . 93.2 mt -109.15 144.53 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 38.5 m-85 -129.22 155.35 45.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 438' ' ' THR . 55.5 t -134.12 102.35 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 30.7 mt -84.27 126.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.6 t -132.31 118.43 19.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.47 -161.02 16.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.09 132.0 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 472' ' ' GLU . 10.0 mt -101.26 179.88 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.57 -42.55 6.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.5 m -63.52 -55.22 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.41 130.5 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.03 156.23 37.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 423' ' ' ARG . 0.8 OUTLIER -40.24 -35.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -49.09 -47.67 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.57 88.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.44 -57.6 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -46.94 -28.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.873 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.21 -53.13 7.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.99 -34.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.88 -29.42 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -61.64 -16.11 45.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.809 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.12 -1.78 13.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 110.74 -36.53 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.46 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -44.52 148.68 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -101.2 160.89 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.6 t -137.35 108.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 413' ' ' VAL . 8.9 t -128.73 150.08 50.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -95.14 50.89 1.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.71 147.42 25.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 54.7 t -99.18 101.75 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 85.0 p -123.19 175.25 6.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HD2' HD22 ' A' ' 465' ' ' LEU . 1.9 mptm? -68.47 -16.4 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.552 ' HB3' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -80.57 -27.2 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.0 m -58.2 120.28 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.545 ' OD1' HD22 ' A' ' 410' ' ' LEU . 2.9 t-20 -91.83 -41.01 10.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE1' ' OD1' ' A' ' 446' ' ' ASN . 95.3 m-85 -130.12 156.11 45.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 469' ' ' ILE . 11.2 tp -131.21 105.68 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.14 104.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.651 ' HG2' HG23 ' A' ' 469' ' ' ILE . 3.4 mmt -82.7 163.6 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.42 -134.95 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 1.1 mmp_? -87.9 163.27 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 17.4 t70 34.42 36.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 452' ' ' ARG . 3.2 m -83.49 116.32 22.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -59.55 128.36 46.72 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -51.26 -35.88 39.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 90.3 p -46.17 -47.32 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -43.51 -52.99 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 1.2 t -68.65 -61.05 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 22.8 t70 -38.09 -62.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -58.83 -33.59 70.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -62.93 -50.07 72.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.65 -55.6 27.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -46.97 -50.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.42 HD22 ' HD2' ' A' ' 443' ' ' LYS . 13.0 mt -70.14 -28.76 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.77 48.71 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.521 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.58 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 29.1 m -104.33 150.09 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.102 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -90.54 133.04 35.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 450' ' ' MET . 3.1 mp -104.76 120.16 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.88 170.77 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 474' ' ' GLY . 0.9 OUTLIER -120.83 168.49 11.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 418' ' ' LEU . 12.1 pt-20 -35.05 -44.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.44 -43.49 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -58.97 -29.78 65.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.35 -49.34 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.01 -46.75 75.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.72 -40.73 80.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -58.22 -17.68 20.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 74.5 mt -86.91 -18.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -102.92 -25.93 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.8 p -84.69 -46.84 11.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.511 ' CE ' HD11 ' A' ' 410' ' ' LEU . 10.7 mmm -59.85 141.06 89.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.528 0.68 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.84 -170.31 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -118.11 153.27 17.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 405' ' ' ASN . 6.0 mtmm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.8 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.634 0.73 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.401 ' HD3' HD22 ' A' ' 476' ' ' LEU . 53.5 Cg_endo -69.81 120.31 7.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.631 2.221 . . . . 0.0 112.362 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -77.01 98.75 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -117.48 -152.25 9.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -84.6 -174.96 5.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -99.76 -21.42 15.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -126.74 31.55 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 22.6 p -72.68 -19.77 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 410' ' ' LEU . 55.5 mt -119.12 11.34 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -74.03 116.16 14.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 112.57 -28.15 9.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.545 HD11 ' CE ' ' A' ' 482' ' ' MET . 6.5 mt -87.76 149.45 24.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 444' ' ' LYS . 87.7 mt -110.28 152.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 83.1 m-85 -139.39 140.24 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 441' ' ' VAL . 89.0 t -119.17 99.72 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.31 126.42 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.8 t -132.28 118.23 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.88 -170.19 17.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 417' ' ' VAL . 2.2 m -122.5 123.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 0.0 111.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 472' ' ' GLU . 3.4 mt -97.52 -179.39 4.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -102.74 -67.07 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.2 t -39.97 -47.22 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -150.57 122.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.93 174.5 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -49.25 -57.56 6.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.61 -42.76 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -65.02 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.27 -22.37 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.2 tttt -72.4 -51.22 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.5 m -58.15 -36.18 72.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.39 -63.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.2 mt -48.9 -38.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -75.47 -29.0 59.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -65.75 -14.76 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.84 -0.44 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.0 -25.16 19.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.05 150.28 14.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -101.56 146.66 27.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 427' ' ' LYS . 54.9 t -125.35 118.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 413' ' ' VAL . 11.5 t -134.85 154.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.09 -35.35 27.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.28 142.14 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.667 ' HA ' HG21 ' A' ' 413' ' ' VAL . 33.7 t -81.79 137.65 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 59.3 m -123.04 -175.74 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.793 ' HA ' HD13 ' A' ' 465' ' ' LEU . 43.4 tttm -82.05 -16.54 49.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 411' ' ' ILE . 27.9 mmmt -89.43 -10.2 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 413' ' ' VAL . 1.9 m -52.48 121.14 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -88.69 -34.12 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.53 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 71.4 m-85 -150.5 131.24 14.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 450' ' ' MET . 12.0 tp -97.62 110.51 23.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.0 t -84.17 102.16 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.442 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 2.8 mmt -80.85 166.21 21.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -166.42 -148.82 5.71 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.3 ttt180 -68.08 151.55 46.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.807 0.336 . . . . 0.0 110.883 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 452' ' ' ARG . 23.8 t70 36.39 44.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 12.1 t -78.24 103.0 7.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -48.24 136.86 15.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -56.93 -45.89 82.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.3 t -37.98 -43.84 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -49.07 -56.61 8.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.442 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 8.4 t -68.16 -34.04 75.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.74 -65.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.403 ' HE3' HD11 ' A' ' 465' ' ' LEU . 36.2 tttt -62.19 -37.29 84.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -54.22 -54.78 35.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.06 69.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.15 -56.23 18.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.793 HD13 ' HA ' ' A' ' 443' ' ' LYS . 46.2 mt -71.28 -0.18 9.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 68.47 53.18 22.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.5 m -105.96 129.84 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.153 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -67.07 132.71 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.62 129.07 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.4 pt -137.28 178.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.89 171.94 9.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.72 ' HB3' HD13 ' A' ' 418' ' ' LEU . 5.9 pt-20 -39.29 -40.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.83 -46.49 65.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.13 -33.21 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 29.6 tp -66.9 -58.39 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 479' ' ' ILE . 10.2 mt -45.31 -52.06 10.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 481' ' ' THR . 4.1 m120 -53.99 -48.16 70.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 478' ' ' LEU . 9.0 mt -51.32 -25.1 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 476' ' ' LEU . 62.3 mt -77.37 -27.01 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.5 -11.35 25.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 477' ' ' ASN . 31.0 p -101.62 -36.03 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.545 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.7 mtp -73.77 140.16 77.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.722 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.3 Cg_endo -69.74 -163.82 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.394 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -134.57 175.36 20.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.439 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 43.5 mttm . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.968 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.617 0.722 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.475 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.2 Cg_endo -69.79 126.23 13.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -82.02 99.65 9.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -119.71 -150.02 8.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.413 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -82.73 -175.01 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.414 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.3 pt-20 -99.15 -24.0 15.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.414 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 72.3 m-80 -123.49 35.5 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 20.2 p -75.37 -9.0 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.579 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 88.8 mt -131.79 5.68 4.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.96 120.62 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.54 -27.3 17.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.45 HD11 ' CE ' ' A' ' 482' ' ' MET . 20.8 mt -88.98 142.28 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 444' ' ' LYS . 74.9 mt -101.29 151.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.161 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 91.8 m-85 -139.51 146.19 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.795 HG22 HG23 ' A' ' 438' ' ' THR . 85.7 t -124.99 102.76 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 430' ' ' ILE . 14.5 mt -90.01 121.52 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.39 137.44 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.96 -165.64 51.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -105.74 159.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.155 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.582 HD22 ' HB3' ' A' ' 472' ' ' GLU . 5.1 mt -140.97 142.29 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.5 -39.28 94.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.509 ' CB ' HD13 ' A' ' 421' ' ' ILE . 5.7 t -60.78 -65.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -146.78 141.78 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -67.27 173.56 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -45.04 67.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.45 -42.33 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -61.38 -66.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.25 -37.18 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 42.2 tttm -54.87 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.0 m -47.06 -37.25 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.42 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 414' ' ' ILE . 46.2 mt -46.46 -36.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.86 -34.45 57.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -61.08 -18.46 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -108.42 -2.11 19.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.25 -36.61 4.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.98 148.77 2.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -101.02 154.37 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 89.8 t -127.13 119.21 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.795 HG23 HG22 ' A' ' 413' ' ' VAL . 10.0 t -135.02 142.92 46.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . 0.524 ' C ' ' ND2' ' A' ' 440' ' ' ASN . . . -88.07 42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . 0.524 ' ND2' ' C ' ' A' ' 439' ' ' GLY . 1.5 m-80 -162.86 128.85 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.91 0.386 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.678 ' CG2' HD13 ' A' ' 448' ' ' LEU . 39.5 t -81.36 105.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 m -111.51 -174.48 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -71.82 -25.08 61.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.52 ' O ' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -81.83 -17.52 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.0 m -60.37 128.11 35.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -94.43 -38.2 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.11 153.29 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.678 HD13 ' CG2' ' A' ' 441' ' ' VAL . 52.2 tp -119.07 102.81 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.25 107.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.9 ptp -122.28 169.38 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.74 -104.46 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.3 OUTLIER -82.59 148.15 28.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.1 m-20 35.68 53.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 99.2 p -94.17 125.36 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -67.5 146.02 46.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -94.01 -30.67 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 0.0 110.891 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -55.27 -19.31 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.588 ' HD3' HG23 ' A' ' 441' ' ' VAL . 6.0 ttmt -94.53 -44.72 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.928 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 84.8 p -59.62 -30.55 68.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.53 -54.55 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -54.78 -23.98 20.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -74.36 -60.56 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.16 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -68.95 -64.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 18.3 mt -54.66 -29.66 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.51 43.36 1.59 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.437 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 27.6 m -103.14 135.54 44.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.112 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -74.97 138.05 42.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.451 HG12 HD23 ' A' ' 448' ' ' LEU . 66.7 mt -109.5 130.57 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 35.8 pt -142.7 172.21 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.3 p-10 -115.4 169.0 9.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.582 ' HB3' HD22 ' A' ' 418' ' ' LEU . 1.7 pm0 -39.8 -25.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 471' ' ' ASP . 25.8 t70 -74.97 -49.49 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -61.51 -31.01 76.08 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 430' ' ' ILE . 24.3 tp -64.02 -49.3 72.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 400' ' ' PRO . 26.1 mt -59.72 -51.94 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -57.49 -34.65 69.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.4 -15.06 32.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 55.5 mt -89.22 -24.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.17 -29.01 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.1 p -82.69 -38.56 23.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 410' ' ' LEU . 18.4 mmm -69.57 142.06 91.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 0.0 110.895 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -135.07 169.16 23.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 36.1 mttt . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 15.0 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.635 0.731 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 120.29 7.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.72 2.28 . . . . 0.0 112.401 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 108.46 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -130.56 -141.12 4.83 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -95.0 -176.15 3.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.28 -24.73 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 36.1 m-20 -124.58 29.55 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -68.54 -23.57 64.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.2 mt -114.74 2.66 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -66.57 145.22 55.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 85.94 -26.37 6.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.84 159.45 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 412' ' ' PHE . 96.7 mt -122.11 155.12 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 55.4 m-85 -142.55 145.72 33.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 438' ' ' THR . 38.3 t -122.99 100.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.432 HD11 HD12 ' A' ' 430' ' ' ILE . 49.3 mt -81.4 122.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.461 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.7 t -126.6 115.13 19.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 106.95 -153.92 16.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.66 158.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 111.156 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -135.84 159.51 41.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 420' ' ' SER . 4.0 tp10 -77.21 -69.44 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 419' ' ' GLU . 20.1 m -35.22 -61.82 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.4 OUTLIER -131.32 161.68 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 422' ' ' GLU . 6.9 mp0 -102.76 164.12 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 16.4 tpt85 -42.48 -30.87 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -65.76 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.93 -55.2 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.35 -53.22 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.5 ' HA ' HG21 ' A' ' 437' ' ' VAL . 30.7 tttm -44.91 -51.19 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 32.5 t -52.62 -34.06 49.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.47 -67.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.465 HG22 ' C ' ' A' ' 435' ' ' GLY . 65.4 mt -46.25 -35.79 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.56 -28.88 37.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -63.59 -19.78 65.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 403' ' ' ALA . 66.7 m-85 -112.47 2.29 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 435' ' ' GLY . . . 112.21 -45.87 1.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.525 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -37.97 148.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -102.06 161.42 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 427' ' ' LYS . 55.7 t -133.61 125.01 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.506 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.8 t -144.16 170.49 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -118.65 50.86 0.78 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -156.35 135.19 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 107.31 15.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 -175.12 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.857 ' HD3' HD22 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -73.39 -48.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -50.65 -28.71 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.45 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 89.2 m -55.36 124.27 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.073 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -95.66 -44.74 7.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 61.4 m-85 -128.7 159.39 35.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.537 HD23 HG12 ' A' ' 469' ' ' ILE . 35.1 tp -130.09 102.88 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.03 107.96 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.461 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 24.0 mtm -112.65 179.85 3.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.34 -102.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.6 mmm-85 -92.41 161.24 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.2 t70 34.37 48.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.9 p -87.62 168.42 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -117.8 143.36 17.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 -28.84 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 89.7 p -59.54 -21.55 60.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 459' ' ' SER . 34.3 mttm -86.5 -67.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 458' ' ' LYS . 13.5 p -36.57 -64.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 461' ' ' LYS . 0.2 OUTLIER -42.09 -51.73 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.497 ' N ' ' CG ' ' A' ' 460' ' ' ASP . 0.0 OUTLIER -63.11 -31.74 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 459' ' ' SER . . . -65.2 -48.17 74.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.34 83.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.92 -30.63 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.857 HD22 ' HD3' ' A' ' 443' ' ' LYS . 14.0 mt -87.96 -24.23 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.18 28.45 5.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.453 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 4.1 m -92.95 137.36 32.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.356 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -81.22 114.29 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 448' ' ' LEU . 81.9 mt -86.02 131.83 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 475' ' ' LEU . 7.5 pt -148.98 178.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -117.94 -179.28 3.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.701 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.5 pm0 -50.58 -29.95 12.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.08 -51.21 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.95 -30.94 54.95 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 470' ' ' ILE . 32.1 tp -64.44 -42.78 95.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.31 -52.96 61.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -59.26 -30.24 68.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.0 mt -67.07 -15.18 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 69.7 mt -88.68 -20.54 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -102.62 -24.55 13.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 36.7 p -87.66 -31.36 19.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 25.9 mmm -75.88 141.1 71.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.51 20.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.434 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 50.3 mttm . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.404 HD13 ' CD2' ' A' ' 476' ' ' LEU . 23.5 mm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.623 0.725 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 132.82 24.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.315 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -80.82 84.58 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -99.15 -157.58 29.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.0 -175.09 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 111.069 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -101.65 -21.29 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.2 29.92 5.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.8 p -69.5 -21.73 63.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 410' ' ' LEU . 20.9 mt -111.77 -0.77 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.28 115.47 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.3 26.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.595 HD11 ' CE ' ' A' ' 482' ' ' MET . 19.8 mt -91.77 140.3 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 444' ' ' LYS . 80.6 mt -106.83 149.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 82.4 m-85 -135.61 157.57 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.07 106.98 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 423' ' ' ARG . 39.1 mt -88.16 126.35 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.7 t -132.64 116.08 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 105.05 -154.47 17.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.09 155.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.722 HD22 ' OE1' ' A' ' 472' ' ' GLU . 2.4 mt -138.07 152.89 49.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -74.36 -63.26 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 421' ' ' ILE . 48.1 m -37.67 -39.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.2 pt -161.19 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 423' ' ' ARG . 56.4 mt-10 -94.75 162.16 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 414' ' ' ILE . 13.8 tpt180 -38.36 -35.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 427' ' ' LYS . 4.8 t70 -74.91 -66.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.872 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 421' ' ' ILE . 14.1 mt-10 -43.78 -42.44 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.696 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -70.61 -30.96 67.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 424' ' ' ASP . 21.2 ttmt -67.19 -51.18 56.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.8 m -55.87 -25.29 41.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.59 -57.1 4.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.7 -45.71 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -72.44 -26.89 62.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -67.07 -14.68 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.02 8.64 15.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.27 -6.8 63.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -70.79 170.11 47.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -126.94 154.13 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.4 t -129.78 123.16 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.07 172.23 7.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.42 10.84 61.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.71 149.78 16.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 445' ' ' THR . 4.9 t -87.28 117.79 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.9 m -121.75 177.62 5.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 465' ' ' LEU . 27.3 ttmt -59.09 -15.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 411' ' ' ILE . 1.6 mppt? -90.15 -21.64 22.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.701 HG21 HG13 ' A' ' 441' ' ' VAL . 96.1 m -61.06 126.63 28.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -93.7 -38.58 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 478' ' ' LEU . 60.0 m-85 -138.94 148.33 43.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 469' ' ' ILE . 9.0 tp -115.05 104.26 11.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.51 104.62 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 12.7 mtt -86.29 176.13 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -174.08 -123.76 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 2.2 mmp_? -96.94 156.95 16.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.6 t70 34.56 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 29.2 m -60.35 161.03 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -89.53 175.58 42.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -95.62 -47.12 6.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 94.2 p -57.16 -27.77 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -55.08 -58.28 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 3.9 t -73.07 -54.74 7.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.794 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 17.9 t70 -37.6 -70.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' ALA . 13.7 mmtm -55.06 -34.92 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -58.38 -65.39 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -50.14 -21.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 461' ' ' LYS . . . -75.44 -65.31 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 443' ' ' LYS . 7.3 mt -67.18 -5.83 15.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 83.54 49.77 4.75 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.609 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 25.0 m -94.52 133.96 37.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.147 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -80.92 102.24 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.483 HG12 HD23 ' A' ' 448' ' ' LEU . 48.3 mt -73.91 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 478' ' ' LEU . 46.6 pt -147.81 165.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -114.24 179.31 3.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.722 ' OE1' HD22 ' A' ' 418' ' ' LEU . 0.4 OUTLIER -48.5 -25.41 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.93 -40.38 18.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -69.15 -34.65 76.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.419 ' CA ' HD12 ' A' ' 470' ' ' ILE . 59.3 tp -64.23 -41.19 97.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.404 ' CD2' HD13 ' A' ' 399' ' ' ILE . 78.5 mt -61.19 -40.8 95.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -34.75 79.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.3 mt -64.49 -14.76 58.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.37 -17.57 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -103.54 -22.79 13.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.7 p -91.96 -31.78 15.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.595 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.7 mmm -74.05 140.48 77.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.597 0.713 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.99 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -129.55 171.67 20.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.5 mttp . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.907 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.456 HG23 ' HD2' ' A' ' 400' ' ' PRO . 30.4 mm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.614 0.721 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 399' ' ' ILE . 53.3 Cg_endo -69.81 118.54 5.74 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.309 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -60.1 107.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -131.61 -144.3 5.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -96.44 -175.66 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.59 -21.25 17.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -126.04 18.24 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.6 p -58.59 -12.29 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 70.5 mt -127.46 5.28 6.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.24 148.81 49.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.88 -29.33 3.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.461 HD11 ' CE ' ' A' ' 482' ' ' MET . 16.4 mt -87.6 152.6 22.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 412' ' ' PHE . 86.4 mt -114.68 154.32 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.436 ' N ' HG22 ' A' ' 411' ' ' ILE . 68.1 m-85 -139.01 152.48 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 438' ' ' THR . 95.3 t -132.29 101.9 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.1 mt -84.48 128.11 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.2 t -126.04 134.23 51.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.85 -159.45 41.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 452' ' ' ARG . 4.2 m -122.95 160.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.5 mt -137.62 158.25 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 420' ' ' SER . 24.4 tt0 -80.76 -66.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 419' ' ' GLU . 27.3 m -38.49 -41.74 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.77 170.5 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -111.78 166.43 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -44.13 -40.17 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 2.2 t0 -68.45 -63.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -48.18 -58.86 3.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.17 53.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -69.7 -50.13 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.8 t -54.94 -32.78 61.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -63.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 475' ' ' LEU . 73.5 mt -46.99 -48.5 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.174 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.78 -38.58 91.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.93 -14.69 9.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.439 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 72.8 m-85 -113.77 5.05 16.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 103.61 -37.47 3.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 407' ' ' LEU . . . -46.42 152.91 1.08 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -102.8 154.5 19.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.98 124.72 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 413' ' ' VAL . 11.9 t -139.62 171.09 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.1 -33.43 6.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.532 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -94.18 139.12 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.482 HG23 ' HE3' ' A' ' 458' ' ' LYS . 40.2 t -90.09 127.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 18.0 m -122.14 -174.68 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.422 ' HA ' HD13 ' A' ' 465' ' ' LEU . 49.2 mtpt -76.66 -11.86 59.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -89.29 -20.29 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 56.3 m -52.85 131.64 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.65 -40.06 9.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -141.15 153.37 45.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 413' ' ' VAL . 7.4 tp -121.41 106.33 11.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 105.4 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.425 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.1 mtt -87.37 168.76 12.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -153.62 -111.98 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -128.28 173.15 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 8.7 t0 34.45 38.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 83.1 p -80.38 -178.17 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -112.09 -168.88 18.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -104.6 -41.39 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.8 m -51.72 -45.7 63.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.482 ' HE3' HG23 ' A' ' 441' ' ' VAL . 0.2 OUTLIER -45.31 -57.58 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 460' ' ' ASP . 54.8 p -66.35 -57.05 8.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 459' ' ' SER . 3.9 t70 -35.07 -61.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -59.07 -57.26 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -41.97 -58.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.65 78.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -51.27 -42.99 61.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 443' ' ' LYS . 17.3 mt -80.71 -24.58 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 94.3 56.84 1.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 88.9 m -112.36 136.43 51.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -70.78 135.82 48.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.425 HG23 ' HG3' ' A' ' 450' ' ' MET . 71.0 mt -107.84 123.52 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.08 165.49 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -110.14 175.2 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -38.72 -44.51 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.76 -49.59 57.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.63 -22.62 25.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.508 HD11 HG12 ' A' ' 430' ' ' ILE . 58.1 tp -74.79 -47.96 28.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.72 -44.7 90.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 481' ' ' THR . 39.9 t30 -58.5 -34.69 71.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -64.97 -15.06 61.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 479' ' ' ILE . 52.4 mt -90.15 -15.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -106.18 -31.05 8.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 477' ' ' ASN . 40.1 p -83.24 -27.83 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.461 ' CE ' HD11 ' A' ' 410' ' ' LEU . 32.0 mmm -77.49 142.65 67.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 0.0 110.844 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -165.91 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.479 ' CA ' ' CB ' ' A' ' 403' ' ' ALA . . . -134.2 158.39 23.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.463 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 46.7 mttm . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 0.0 110.894 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.8 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.591 0.71 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 122.37 9.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -76.96 96.18 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -111.17 -141.53 8.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.462 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -87.43 -175.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -102.61 -22.39 13.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -126.14 31.19 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.6 p -70.6 -19.62 62.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.4 mt -117.44 7.16 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.38 133.73 51.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 89.38 -25.62 10.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' ' 482' ' ' MET . 84.9 mt -83.48 143.46 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.97 149.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -139.65 148.6 42.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 438' ' ' THR . 88.9 t -125.61 101.63 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 430' ' ' ILE . 34.2 mt -83.12 128.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.436 HG21 ' SD ' ' A' ' 450' ' ' MET . 9.0 t -130.57 143.57 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.55 -144.96 34.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.14 152.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.63 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -65.98 -61.03 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 31.8 m -38.23 -59.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.4 pt -140.91 153.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.91 175.03 9.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -55.08 -46.89 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -63.27 -55.8 21.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -62.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -47.3 -48.44 25.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.6 tttt -48.28 -55.21 11.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.0 m -50.87 -37.36 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.17 -65.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 414' ' ' ILE . 49.9 mt -46.69 -39.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.22 -27.52 42.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -64.93 -19.4 65.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.522 ' CE2' HD13 ' A' ' 479' ' ' ILE . 76.0 m-85 -110.86 4.56 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.27 -25.0 23.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 430' ' ' ILE . . . -52.71 170.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.468 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 154.47 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 427' ' ' LYS . 39.9 t -129.21 121.71 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.515 HG23 HG22 ' A' ' 413' ' ' VAL . 0.1 OUTLIER -132.26 158.1 42.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.176 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -100.13 50.36 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -164.46 144.26 7.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.57 104.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 22.2 m -128.16 174.51 9.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -53.61 -56.65 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -40.81 -30.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 29.3 m -57.7 130.64 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -99.08 -35.13 10.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 468' ' ' LYS . 67.3 m-85 -143.82 164.67 29.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.517 HD23 HG12 ' A' ' 469' ' ' ILE . 22.7 tp -131.01 110.6 11.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.91 104.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.443 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 4.4 mmt -96.73 159.89 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -146.36 -140.21 3.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -93.54 164.78 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.5 t70 38.29 46.83 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 20.3 p -83.18 -177.91 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -109.65 -179.68 20.96 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -108.28 -12.49 15.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.5 m -74.46 -49.3 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -56.54 -53.16 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.443 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 53.2 p -61.06 -42.71 99.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.89 -67.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 462' ' ' ALA . 32.4 tptt -59.8 -54.46 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -36.26 -46.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.085 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.57 49.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -50.86 -47.5 60.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 -26.89 63.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 87.91 50.49 3.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 40.0 m -98.8 148.23 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 13.2 mmmt -79.85 112.65 17.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.517 HG12 HD23 ' A' ' 448' ' ' LEU . 63.7 mt -90.73 124.85 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.19 165.6 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.29 176.55 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -28.61 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.08 -49.09 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.84 61.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.74 -36.73 70.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.74 -33.37 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -70.17 -29.49 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.65 -22.91 64.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.522 HD13 ' CE2' ' A' ' 433' ' ' TYR . 67.4 mt -83.3 -16.88 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -103.45 -10.81 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 50.9 p -106.16 -39.41 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' ' 410' ' ' LEU . 34.3 mmm -66.87 141.65 96.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.572 0.701 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -164.17 0.12 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.727 2.285 . . . . 0.0 112.35 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -131.7 166.82 22.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.4 mttm . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 14.6 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.592 0.71 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 122.94 9.61 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -81.9 107.9 14.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.98 -138.73 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.74 -174.94 3.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.5 pt-20 -99.65 -20.9 16.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 70.7 m-80 -127.25 28.09 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 23.9 p -66.74 -21.95 66.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.67 HD23 ' SD ' ' A' ' 482' ' ' MET . 78.0 mt -121.94 17.3 10.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.67 146.61 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.52 2.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 80.6 mt -77.16 152.18 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.473 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 67.3 mt -118.26 139.99 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -125.62 148.33 49.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.694 HG22 HG23 ' A' ' 438' ' ' THR . 48.9 t -124.1 104.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 430' ' ' ILE . 75.3 mt -86.55 126.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -131.48 125.92 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.53 -149.88 20.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.03 146.41 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 472' ' ' GLU . 8.2 mt -117.14 166.85 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -90.85 -57.29 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 421' ' ' ILE . 26.5 m -48.69 -29.28 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 420' ' ' SER . 0.8 OUTLIER -163.72 173.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.113 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -104.94 -176.29 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.78 -38.79 87.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.25 -50.81 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -53.98 -58.57 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.88 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.109 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 437' ' ' VAL . 43.6 tttm -49.53 -50.09 43.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 47.4 t -56.0 -40.24 73.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.1 tp -65.07 -63.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 414' ' ' ILE . 64.6 mt -45.79 -40.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -77.75 -33.16 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -57.74 -20.81 37.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.454 ' HD2' ' HG ' ' A' ' 406' ' ' CYS . 81.5 m-85 -109.2 -4.76 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.12 -35.43 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -46.62 154.52 0.84 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -109.01 159.98 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 427' ' ' LYS . 79.8 t -131.71 118.02 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 413' ' ' VAL . 0.5 OUTLIER -138.73 139.06 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.67 3.75 72.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -115.3 131.62 56.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.77 120.38 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.9 m -128.75 -175.25 3.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.704 ' HG2' HD22 ' A' ' 465' ' ' LEU . 55.0 mtpt -71.76 -42.99 66.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.473 ' HG3' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -58.26 -25.56 61.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 24.3 m -51.46 138.26 22.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.14 -48.51 4.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 468' ' ' LYS . 87.1 m-85 -130.51 153.45 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 5.0 tp -120.15 104.34 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.0 105.24 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.451 ' O ' HD21 ' A' ' 418' ' ' LEU . 7.1 mtt -80.98 175.61 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -164.9 -109.24 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.5 mmt180 -125.78 165.6 18.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.6 t0 34.32 37.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 452' ' ' ARG . 20.0 m -77.59 136.17 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.16 124.09 9.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -56.99 -23.02 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.8 t -65.88 -15.17 62.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -82.83 -48.45 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.41 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 88.1 p -67.43 -25.49 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.48 -46.24 64.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.578 ' HE2' HD21 ' A' ' 465' ' ' LEU . 0.2 OUTLIER -78.03 -37.34 47.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.21 69.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.11 89.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -53.91 -46.35 71.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 443' ' ' LYS . 16.1 mt -76.16 -24.84 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.63 49.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 54.6 m -100.0 135.77 40.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.519 ' CB ' ' CD1' ' A' ' 447' ' ' TYR . 10.1 mmtp -72.56 117.67 14.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.71 128.66 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 42.6 pt -141.42 170.99 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.5 178.19 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.633 ' HB3' HD22 ' A' ' 418' ' ' LEU . 0.3 OUTLIER -45.75 -35.91 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.87 -37.65 73.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -64.35 -31.58 81.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.429 HD11 HG12 ' A' ' 430' ' ' ILE . 43.5 tp -67.06 -52.95 35.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.3 -51.98 66.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.98 -38.12 67.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.5 mt -60.55 -20.55 60.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.444 HG23 ' CE2' ' A' ' 433' ' ' TYR . 70.7 mt -84.84 -14.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -109.9 -7.83 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.4 p -107.75 -42.07 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.67 ' SD ' HD23 ' A' ' 407' ' ' LEU . 9.9 mtp -64.89 143.48 98.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.508 0.671 . . . . 0.0 110.874 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -165.75 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -139.74 164.19 26.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 33.5 mttm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.603 0.716 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 117.88 5.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.61 101.24 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.78 -156.56 10.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -73.73 -175.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.86 -28.09 12.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -122.65 28.98 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 14.7 p -69.05 -14.61 63.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 433' ' ' TYR . 65.6 mt -117.94 -2.58 11.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.96 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.7 20.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.585 HD11 ' CE ' ' A' ' 482' ' ' MET . 57.6 mt -86.67 134.56 33.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 412' ' ' PHE . 45.6 mt -99.56 155.68 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 56.0 m-85 -145.01 148.99 34.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.778 HG22 HG23 ' A' ' 438' ' ' THR . 51.6 t -128.97 104.91 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 28.1 mt -85.99 133.87 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.7 t -130.54 141.57 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -151.17 42.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.508 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 m -130.22 153.13 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 472' ' ' GLU . 16.9 mt -123.57 161.7 24.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.89 -61.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.1 p -48.45 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' HB3' ' A' ' 425' ' ' GLU . 0.9 OUTLIER -122.14 122.16 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.49 178.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.99 -40.19 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.08 -61.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.54 ' HB3' HG22 ' A' ' 421' ' ' ILE . 3.8 mm-40 -43.94 -47.99 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.82 92.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.466 ' HA ' HG21 ' A' ' 437' ' ' VAL . 52.0 tttt -55.09 -52.16 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -54.75 -39.7 68.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.85 -57.94 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 26.0 mt -49.08 -49.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.11 -34.86 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -58.73 -16.87 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.615 ' CE2' HD13 ' A' ' 479' ' ' ILE . 64.4 m-85 -113.11 11.38 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.26 -28.83 12.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -50.16 168.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -121.21 151.86 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' A' ' 427' ' ' LYS . 98.1 t -127.82 127.86 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.778 HG23 HG22 ' A' ' 413' ' ' VAL . 3.1 t -143.02 170.19 16.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.92 -26.81 8.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -93.1 137.73 32.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.75 109.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 m -121.06 179.08 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -54.66 -46.16 73.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -53.0 -26.93 16.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.435 HG22 HG21 ' A' ' 467' ' ' THR . 28.9 m -55.0 117.99 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -90.31 -39.72 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.547 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 92.1 m-85 -137.88 155.62 48.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 469' ' ' ILE . 3.1 tp -125.25 107.01 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.2 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 8.4 mmt -93.58 157.57 16.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -140.47 -117.24 1.38 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.2 ptp180 -123.15 170.64 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.865 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 2.2 t70 34.43 37.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 452' ' ' ARG . 29.0 m -95.54 150.85 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -74.92 161.06 53.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -85.24 -33.44 22.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -54.45 -46.59 73.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -46.71 -27.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.4 p -88.87 -47.07 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -42.42 -43.06 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -73.47 -39.5 64.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.16 -57.46 12.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 466' ' ' GLY . . . -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -42.91 -48.66 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.36 -16.75 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 463' ' ' ALA . . . 89.01 55.27 2.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 445' ' ' THR . 18.1 m -109.43 138.49 45.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.1 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.18 127.17 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 448' ' ' LEU . 79.0 mt -99.99 124.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.429 HD12 ' CA ' ' A' ' 475' ' ' LEU . 23.2 pt -130.62 177.78 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.05 -179.25 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.696 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.6 pm0 -52.11 -28.62 18.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.15 -45.24 15.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -63.99 -28.46 72.82 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.429 ' CA ' HD12 ' A' ' 470' ' ' ILE . 61.5 tp -67.87 -40.0 83.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.959 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.03 -30.15 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -70.68 -38.93 73.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 470' ' ' ILE . 14.4 mt -59.73 -17.34 34.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.615 HD13 ' CE2' ' A' ' 433' ' ' TYR . 87.5 mt -86.92 -24.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.76 -9.88 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.1 p -103.54 -41.66 5.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.585 ' CE ' HD11 ' A' ' 410' ' ' LEU . 13.0 mmm -67.12 139.88 95.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -165.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -125.63 170.39 17.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 mttp . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.563 0.697 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 117.38 5.05 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.227 . . . . 0.0 112.379 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -79.95 84.3 5.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -100.21 -138.18 10.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.88 -174.86 3.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.36 -21.08 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -126.77 33.3 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.0 p -76.54 -10.47 59.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 410' ' ' LEU . 79.0 mt -128.37 6.8 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.9 118.5 9.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.38 -30.69 9.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 407' ' ' LEU . 21.0 mt -79.95 140.16 36.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 444' ' ' LYS . 75.3 mt -106.28 142.97 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 61.2 m-85 -130.42 148.1 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 438' ' ' THR . 84.9 t -122.47 101.87 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 430' ' ' ILE . 61.7 mt -83.89 123.27 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.402 HG23 ' OG ' ' A' ' 454' ' ' SER . 8.4 t -122.74 144.21 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -153.15 45.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 11.5 m -130.94 160.83 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 7.5 mt -137.68 151.69 48.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -75.95 -62.66 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 8.9 m -40.39 -42.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 426' ' ' ALA . 4.7 pt -150.51 162.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 424' ' ' ASP . 14.8 mt-10 -102.67 155.53 18.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 422' ' ' GLU . 9.5 tpt85 -35.68 -32.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 422' ' ' GLU . 3.3 m-20 -73.8 -66.59 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -41.1 -65.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.09 -44.49 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.425 ' HG3' HG11 ' A' ' 437' ' ' VAL . 11.6 tttp -53.35 -52.88 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 t -51.13 -39.57 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -60.27 3.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 414' ' ' ILE . 37.4 mt -55.33 -43.71 72.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.81 -31.18 67.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -63.46 -31.03 72.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 479' ' ' ILE . 78.0 m-85 -96.28 4.84 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.23 -27.58 19.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -48.38 161.08 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -110.82 154.79 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.425 HG11 ' HG3' ' A' ' 427' ' ' LYS . 59.0 t -129.69 114.92 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 413' ' ' VAL . 13.8 t -130.72 170.27 14.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -112.38 51.76 0.68 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . 0.585 ' O ' HG21 ' A' ' 413' ' ' VAL . 7.6 t-20 -172.55 150.03 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 458' ' ' LYS . 57.8 t -102.6 109.24 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 444' ' ' LYS . 1.7 m -127.63 -176.13 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.835 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -61.14 -40.29 93.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.553 ' HG2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -64.41 -25.45 68.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.6 m -61.68 136.63 58.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.504 ' O ' HG23 ' A' ' 467' ' ' THR . 15.6 m120 -105.48 -49.48 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 478' ' ' LEU . 72.5 m-85 -129.62 154.96 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.631 HD23 HG12 ' A' ' 469' ' ' ILE . 11.3 tp -122.78 102.81 8.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.5 t -77.5 104.65 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.6 mtp -77.01 178.6 6.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 175.9 44.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 453' ' ' ASP . 1.0 OUTLIER -53.32 146.81 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 452' ' ' ARG . 1.6 t70 43.57 54.28 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 415' ' ' THR . 2.7 m -106.71 127.99 53.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -52.33 150.14 9.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.81 -39.76 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -44.31 -39.63 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' A' ' 441' ' ' VAL . 2.3 tppt? -50.7 -41.88 56.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.2 p -73.55 -29.13 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -54.91 -56.97 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -63.12 -47.51 82.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -42.97 -56.15 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.22 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.32 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.47 -30.91 68.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 101.92 42.57 2.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 446' ' ' ASN . 94.9 m -97.5 140.37 32.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -81.63 109.64 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.631 HG12 HD23 ' A' ' 448' ' ' LEU . 72.5 mt -82.97 129.69 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.131 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 475' ' ' LEU . 46.6 pt -140.33 173.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 472' ' ' GLU . 3.0 p30 -120.81 172.5 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.0 pm0 -35.15 -43.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 32.7 t0 -66.23 -52.79 44.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -50.8 -42.03 45.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.7 tp -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.8 -51.9 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.0 -36.52 65.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.636 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.4 mt -65.1 -25.77 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.2 mt -79.58 -27.27 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -91.31 -28.48 17.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -83.26 -47.89 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.415 ' CE ' HD11 ' A' ' 410' ' ' LEU . 15.4 mmm -57.77 141.86 79.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.73 169.67 22.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.8 mttp . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.1 mm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.623 0.725 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 116.42 4.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.39 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -75.94 83.13 2.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -96.92 -142.44 13.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.958 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.16 -174.96 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 5.1 pt-20 -103.22 -33.03 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.492 ' CB ' ' HG3' ' A' ' 485' ' ' LYS . 51.2 m-80 -122.47 26.28 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.958 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -63.03 -16.24 59.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.11 7.38 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.95 128.48 36.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.79 21.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.556 HD11 ' CE ' ' A' ' 482' ' ' MET . 7.5 mt -87.74 145.64 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 444' ' ' LYS . 68.4 mt -110.84 147.39 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -132.77 138.99 47.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 438' ' ' THR . 77.6 t -117.73 101.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 62.5 mt -81.06 119.63 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 415' ' ' THR . 9.1 t -121.36 116.02 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.48 -153.12 18.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.03 158.17 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 472' ' ' GLU . 0.9 OUTLIER -135.23 148.62 49.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.7 -58.12 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.5 m -44.71 -41.92 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 426' ' ' ALA . 3.0 pt -152.17 161.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.58 168.35 9.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -45.68 -35.56 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 427' ' ' LYS . 14.1 t70 -77.48 -63.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -38.76 -48.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -66.05 -37.67 86.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.612 ' HA ' HG21 ' A' ' 437' ' ' VAL . 50.7 tttt -58.88 -45.21 90.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -23.04 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 20.4 tp -81.47 -64.23 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 475' ' ' LEU . 27.6 mt -48.12 -36.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -76.68 -29.81 56.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.65 -14.55 61.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 479' ' ' ILE . 81.4 m-85 -114.01 6.91 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.19 -26.87 22.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.57 165.89 2.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -122.07 159.93 26.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 427' ' ' LYS . 94.5 t -133.62 117.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.552 HG23 HG22 ' A' ' 413' ' ' VAL . 13.3 t -132.24 164.41 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.93 49.3 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -169.59 134.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.887 0.375 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.483 HG23 ' HD2' ' A' ' 458' ' ' LYS . 81.2 t -79.9 121.01 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 29.8 t -127.69 179.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -71.39 -25.92 62.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.744 ' HB2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -79.59 -15.25 57.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -61.82 119.25 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.442 ' C ' HG23 ' A' ' 467' ' ' THR . 7.7 m-80 -93.83 -40.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 468' ' ' LYS . 80.6 m-85 -133.18 153.98 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 413' ' ' VAL . 11.6 tp -125.47 108.38 11.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.38 102.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.3 ptp -103.59 170.99 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 -103.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 453' ' ' ASP . 15.9 mmt180 -91.09 159.53 16.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.9 t70 34.4 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.3 t -82.78 105.64 13.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -56.01 173.76 1.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -113.22 -3.49 13.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.0 t -75.29 -32.62 61.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.483 ' HD2' HG23 ' A' ' 441' ' ' VAL . 31.2 mtmt -81.87 -57.89 3.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.0 p -46.0 -58.58 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -38.45 -43.73 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -69.07 -49.54 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.577 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -40.87 -58.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.44 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.29 -24.34 63.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.8 mt -98.76 17.79 18.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.77 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.472 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.577 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 60.6 m -103.48 126.49 50.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 447' ' ' TYR . 0.2 OUTLIER -72.39 111.44 7.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 16.8 mt -81.97 122.5 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 478' ' ' LEU . 28.0 pt -137.96 172.41 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.89 175.42 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 418' ' ' LEU . 16.4 pt-20 -38.62 -46.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -67.77 -49.56 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.91 -30.22 9.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 430' ' ' ILE . 50.9 tp -71.64 -62.22 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 29.9 mt -43.09 -41.93 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.23 -36.69 82.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 470' ' ' ILE . 11.0 mt -63.89 -23.07 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.508 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.4 mt -81.09 -15.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.129 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -105.36 -8.8 17.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 -38.79 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.5 mtp -62.93 142.26 97.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.1 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.94 155.23 17.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.527 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.492 ' HG3' ' CB ' ' A' ' 405' ' ' ASN . 4.5 ptpp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.1 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.594 0.711 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.589 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.6 Cg_endo -69.77 126.45 13.31 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 0.0 112.348 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -89.33 94.75 10.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.76 -135.73 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.28 -175.0 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -100.72 -19.56 15.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -128.24 30.82 5.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -71.69 -11.21 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.87 13.49 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.84 122.65 23.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.89 -35.24 5.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.8 157.78 29.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.769 0.319 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 412' ' ' PHE . 77.5 mt -115.1 154.17 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 38.6 m-85 -142.16 153.2 43.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.769 HG22 HG23 ' A' ' 438' ' ' THR . 98.5 t -133.06 102.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 426' ' ' ALA . 33.1 mt -83.68 122.74 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -125.74 132.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.16 -153.71 23.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.37 152.73 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.354 . . . . 0.0 111.139 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.2 mt -132.12 164.03 27.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -85.39 -66.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.5 p -41.92 -27.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 420' ' ' SER . 0.9 OUTLIER -161.88 165.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.91 164.45 13.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -39.29 -36.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 37.5 t0 -73.85 -66.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 424' ' ' ASP . 18.0 mm-40 -36.88 -53.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.584 ' HB3' HD13 ' A' ' 414' ' ' ILE . . . -56.53 -41.81 77.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 437' ' ' VAL . 38.3 tttt -58.4 -46.14 86.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -40.83 97.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.1 tp -63.47 -62.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 414' ' ' ILE . 54.8 mt -44.42 -43.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -75.35 -35.78 61.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -54.33 -21.83 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.33 -3.78 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 115.59 -40.3 2.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.22 162.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 427' ' ' LYS . 87.9 t -125.7 125.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.769 HG23 HG22 ' A' ' 413' ' ' VAL . 3.5 t -137.64 139.93 40.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -86.33 46.81 3.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -157.86 126.65 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 458' ' ' LYS . 48.3 t -80.6 100.83 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.179 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 51.9 m -121.29 164.73 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -50.94 -52.96 37.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -43.54 -32.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.9 m -48.94 130.69 18.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -99.15 -30.19 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 478' ' ' LEU . 65.9 m-85 -148.68 145.66 27.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.532 HD23 HG12 ' A' ' 469' ' ' ILE . 15.6 tp -115.81 98.88 6.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.21 106.05 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.5 139.03 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -122.24 -114.02 2.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -92.5 167.78 11.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 27.0 t70 38.02 45.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 70.4 m -101.55 173.26 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -99.18 147.48 18.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 457' ' ' SER . 49.0 tp60 -82.92 -47.41 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.893 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 456' ' ' GLN . 11.3 t -36.24 -46.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.496 ' HB3' HG21 ' A' ' 441' ' ' VAL . 24.0 mttm -55.37 -65.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.3 t -50.51 -44.78 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -46.81 -58.1 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -66.91 -43.39 83.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -45.38 -50.74 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.076 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.98 88.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.083 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.27 70.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 22.3 mt -93.76 22.97 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 51.61 52.65 32.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.525 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.5 m -109.68 126.27 53.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.136 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 106.42 4.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.532 HG12 HD23 ' A' ' 448' ' ' LEU . 62.6 mt -84.52 125.08 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 475' ' ' LEU . 14.7 pt -138.36 174.57 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -116.4 177.35 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.645 ' HB3' HD13 ' A' ' 418' ' ' LEU . 4.9 pt-20 -39.06 -46.28 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.91 -55.86 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.3 -38.27 19.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.539 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 470' ' ' ILE . 40.9 tp -58.56 -51.69 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.589 HD22 ' CD ' ' A' ' 400' ' ' PRO . 39.5 mt -57.04 -50.45 72.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.17 -33.55 65.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' ' 447' ' ' TYR . 12.5 mt -66.78 -15.92 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.06 -25.4 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -93.56 -28.16 16.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 27.2 p -84.09 -41.5 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 23.2 mmm -65.79 140.6 97.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.0 Cg_endo -69.83 -164.34 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.645 2.23 . . . . 0.0 112.315 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.58 174.2 20.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.4 mttm . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 17.0 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.614 0.721 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 122.96 9.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.709 2.272 . . . . 0.0 112.364 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -73.7 119.64 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -138.83 -156.72 7.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.29 -175.01 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.36 -20.54 15.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -126.91 29.52 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 32.0 p -68.98 -18.63 64.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.04 16.14 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -78.89 121.48 24.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.7 -24.51 21.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.478 HD11 ' CE ' ' A' ' 482' ' ' MET . 25.7 mt -89.85 150.09 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.5 144.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 57.0 m-85 -132.07 152.2 51.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.83 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 438' ' ' THR . 96.3 t -131.33 110.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.26 121.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 415' ' ' THR . 4.0 t -124.69 115.06 20.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.07 -153.8 16.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.428 ' CG2' ' HE ' ' A' ' 452' ' ' ARG . 2.4 m -131.31 150.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.64 145.14 51.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -72.44 -44.03 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 421' ' ' ILE . 11.0 m -55.04 -42.13 72.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.854 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.5 pt -156.33 161.01 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.91 169.76 10.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -52.12 -30.34 25.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.44 -55.95 4.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -47.37 -54.64 10.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.476 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . 0.43 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.8 tttm -53.46 -53.53 50.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -51.94 -40.58 61.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.7 tp -64.22 -53.61 46.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.503 HG12 HD11 ' A' ' 475' ' ' LEU . 59.3 mt -54.37 -38.98 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -77.86 -30.41 50.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -58.04 -24.28 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -110.34 4.79 21.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.83 -33.13 6.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.496 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -43.74 146.71 1.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -104.24 159.54 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 427' ' ' LYS . 91.8 t -133.26 116.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.61 ' O ' HG13 ' A' ' 413' ' ' VAL . 5.1 t -132.21 148.36 52.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.11 53.5 1.37 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 114.08 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.879 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.94 99.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.7 m -119.59 -175.16 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -63.34 -54.87 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -47.19 -28.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 49.4 m -58.37 126.0 25.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -95.53 -42.93 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 46.1 m-85 -132.12 149.48 52.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 469' ' ' ILE . 9.2 tp -120.05 106.95 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.14 102.76 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.636 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.1 mtt -82.79 161.92 21.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -154.61 -169.64 19.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.428 ' HE ' ' CG2' ' A' ' 417' ' ' VAL . 3.8 ttp180 -68.03 147.05 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.901 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.9 t70 43.24 52.18 5.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.6 p -81.86 176.38 9.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.77 141.44 15.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -74.78 -33.3 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 55.8 m -58.71 -41.64 86.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -55.06 -61.15 2.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 460' ' ' ASP . 28.6 p -51.83 -44.75 63.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 459' ' ' SER . 8.1 t70 -35.59 -67.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.462 ' HB3' HD12 ' A' ' 465' ' ' LEU . 7.2 mptt -57.87 -56.39 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -34.28 -48.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.99 84.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 461' ' ' LYS . . . -68.68 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 461' ' ' LYS . 28.2 mt -54.79 -32.07 59.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 86.97 62.98 1.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 6.7 m -107.06 139.24 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.167 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 19.5 mmtt -69.14 105.4 2.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.671 HG12 HD23 ' A' ' 448' ' ' LEU . 88.5 mt -85.62 131.11 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.54 177.38 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -126.05 177.34 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -38.87 -48.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -63.07 -49.52 74.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -56.67 -26.22 52.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 430' ' ' ILE . 64.0 tp -73.39 -48.08 36.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 479' ' ' ILE . 73.9 mt -62.58 -44.08 97.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 481' ' ' THR . 8.1 t-20 -61.63 -28.77 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.4 mt -70.67 -15.8 62.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 476' ' ' LEU . 31.0 mt -87.24 -17.31 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.75 -29.26 11.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 477' ' ' ASN . 58.3 p -83.31 -45.5 13.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.478 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.3 mmm -60.34 142.0 90.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.83 -166.69 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.316 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -133.89 165.01 24.38 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 35.8 mttm . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.596 0.712 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.14 5.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.353 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -71.97 102.62 2.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -125.78 -161.17 10.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.435 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.451 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -73.08 -175.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.731 0.301 . . . . 0.0 111.111 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -101.33 -20.84 15.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -126.04 36.73 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 29.1 p -78.67 -6.46 55.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 96.7 mt -132.96 5.55 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -69.35 116.76 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.31 -16.94 34.79 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.584 HD11 ' CE ' ' A' ' 482' ' ' MET . 48.8 mt -99.47 138.6 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 28.5 mt -101.96 151.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.429 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 43.4 m-85 -136.72 143.69 43.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 438' ' ' THR . 60.8 t -121.08 109.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.605 HG21 ' NE ' ' A' ' 423' ' ' ARG . 50.4 mt -90.5 120.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 415' ' ' THR . 6.5 t -118.74 113.03 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . 0.443 ' O ' ' NH1' ' A' ' 423' ' ' ARG . . . 99.21 175.17 31.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 417' ' ' VAL . 1.8 m -94.47 122.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.461 HD12 HH21 ' A' ' 423' ' ' ARG . 4.6 mt -90.26 100.45 13.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -40.88 -25.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 418' ' ' LEU . 4.3 p -71.97 -62.71 1.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 425' ' ' GLU . 0.4 OUTLIER -140.52 132.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -65.57 -175.55 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.605 ' NE ' HG21 ' A' ' 414' ' ' ILE . 8.2 mmp_? -58.71 -58.29 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -29.48 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 421' ' ' ILE . 9.3 mt-10 -71.04 -64.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -54.02 -62.51 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -41.85 -27.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.33 -51.45 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 475' ' ' LEU . 45.2 mt -61.03 -35.87 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.26 -29.66 38.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -60.56 -21.25 62.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -111.11 2.51 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.43 -27.52 15.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.436 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -48.63 157.15 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -114.57 157.56 22.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.5 t -131.73 123.45 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.851 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -134.59 155.72 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -101.29 37.03 3.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -160.16 125.14 3.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 458' ' ' LYS . 96.0 t -67.28 118.42 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 75.4 m -123.24 157.94 31.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.872 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -61.48 -14.34 28.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -86.59 -22.74 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 26.3 m -51.86 133.57 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.513 ' OD1' HD22 ' A' ' 410' ' ' LEU . 5.4 m-80 -97.22 -25.2 15.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 69.8 m-85 -157.57 131.11 7.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 469' ' ' ILE . 18.1 tp -98.13 116.23 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.35 94.52 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.506 ' CE ' HD21 ' A' ' 448' ' ' LEU . 6.4 mmt -86.39 166.47 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -159.59 -107.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -126.92 168.49 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.8 m-20 37.72 46.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.6 m -99.98 175.99 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.32 -177.51 40.27 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.435 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -115.18 -19.61 10.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.4 p -77.63 -19.16 55.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 441' ' ' VAL . 36.9 mmtm -72.49 -39.45 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 42.7 p -73.96 -52.18 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.38 -44.46 8.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -47.06 50.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -53.02 -53.65 47.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.079 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.0 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -54.84 -58.7 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.068 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 443' ' ' LYS . 12.3 mt -61.35 -23.7 65.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 93.64 53.81 1.76 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 3.5 m -107.98 134.59 50.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.14 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -74.91 116.67 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 448' ' ' LEU . 88.3 mt -87.3 123.55 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 475' ' ' LEU . 50.2 pt -140.1 168.98 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 471' ' ' ASP . 0.6 OUTLIER -115.26 173.92 6.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.4 pt-20 -34.12 -45.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -60.34 3.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.41 8.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 430' ' ' ILE . 23.2 tp -44.4 -45.64 9.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.73 -46.79 83.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.477 ' ND2' HG23 ' A' ' 481' ' ' THR . 8.1 t-20 -62.12 -31.29 71.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 478' ' ' LEU . 10.9 mt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 20.1 mt -82.96 -17.6 10.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.9 -16.91 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.842 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.477 HG23 ' ND2' ' A' ' 477' ' ' ASN . 61.1 p -97.04 -33.72 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.584 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.7 mmm -72.18 142.51 84.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.874 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -165.48 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.334 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -137.17 169.36 24.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 25.7 mttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.948 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 476' ' ' LEU . 12.7 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.665 0.745 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 128.75 16.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.738 2.292 . . . . 0.0 112.32 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 402' ' ' GLY . 0.0 OUTLIER -65.22 103.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLY . . . . . 0.494 ' N ' ' HE3' ' A' ' 401' ' ' LYS . . . -124.3 -161.48 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.486 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.3 -175.0 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.723 0.297 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.81 -23.79 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -125.08 30.84 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.8 p -69.49 -13.08 62.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.17 7.18 7.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -63.55 137.29 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 87.73 -29.91 5.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 76.7 mt -79.23 148.63 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 90.7 mt -119.91 145.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 67.1 m-85 -132.21 153.62 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.993 HG22 HG23 ' A' ' 438' ' ' THR . 99.5 t -128.56 103.2 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.521 HG22 ' NH1' ' A' ' 423' ' ' ARG . 21.6 mt -85.18 124.4 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -122.73 139.81 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 85.63 -157.04 30.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 417' ' ' VAL . 4.7 m -135.32 123.9 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.389 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.18 149.42 23.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -55.06 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.4 m -45.13 -53.83 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 426' ' ' ALA . 2.1 pt -142.15 128.44 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.98 165.04 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.521 ' NH1' HG22 ' A' ' 414' ' ' ILE . 0.1 OUTLIER -41.96 -43.62 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 425' ' ' GLU . 1.1 m-20 -64.25 -66.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 424' ' ' ASP . 37.9 mm-40 -36.75 -71.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.21 -56.03 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -39.84 -62.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -33.78 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 432' ' ' ARG . 15.5 tp -71.8 -66.23 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 414' ' ' ILE . 30.8 mt -45.81 -33.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.66 -25.06 26.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 429' ' ' LEU . 14.9 ttm180 -65.08 -16.9 63.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.92 6.9 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.87 -37.71 3.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.3 149.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -105.1 165.91 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.63 132.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' THR . . . . . 0.993 HG23 HG22 ' A' ' 413' ' ' VAL . 0.3 OUTLIER -143.18 129.95 20.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.52 76.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -104.77 139.69 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 413' ' ' VAL . 90.9 t -76.01 127.37 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 p -123.24 170.3 10.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.597 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -62.02 -32.93 73.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.922 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -70.5 -19.15 62.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.0 m -51.02 133.73 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 7.8 m120 -106.69 -22.81 12.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 58.2 m-85 -156.06 154.95 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 448' ' ' LEU . 1.8 tp -121.3 106.49 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.2 97.5 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.527 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.4 mtt -78.61 170.5 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -158.54 -107.51 0.24 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 ptp180 -131.11 172.75 11.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.2 m-20 34.53 38.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.6 t -83.08 -175.04 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -127.27 141.98 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -13.15 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.32 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 14.8 t -73.46 -44.63 57.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -55.71 -48.25 75.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.483 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 46.2 p -68.88 -33.76 74.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.52 -42.63 92.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LYS . . . . . 0.513 ' HE2' HD11 ' A' ' 465' ' ' LEU . 1.8 tmtp? -77.23 -34.07 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -63.37 -54.91 29.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.34 68.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.597 HD13 ' HA ' ' A' ' 443' ' ' LYS . 37.3 mt -71.44 -25.72 62.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 102.48 51.39 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 41.2 m -113.86 141.8 46.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.336 . . . . 0.0 111.159 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -85.56 139.95 31.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.527 HG23 ' HG3' ' A' ' 450' ' ' MET . 2.8 mp -102.22 122.01 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.8 179.49 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 474' ' ' GLY . 2.1 p-10 -124.79 166.76 15.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -38.96 -30.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.8 -42.96 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -59.65 -35.11 84.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 399' ' ' ILE . 0.5 OUTLIER -50.89 -49.26 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 481' ' ' THR . 50.0 t30 -57.58 -44.41 85.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.26 -17.72 3.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 97.5 mt -87.21 -28.23 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -98.32 -13.34 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 477' ' ' ASN . 43.3 p -97.11 -43.14 7.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.176 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.2 mmm -66.64 142.6 97.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.842 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.75 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.636 2.224 . . . . 0.0 112.386 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.07 157.75 20.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.5 mttt . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.916 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 31.6 t -166.74 110.63 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 1.7 t -98.77 168.75 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.893 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 76.57 167.66 26.32 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.477 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -76.27 129.65 36.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.837 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 36.8 t -62.17 -54.76 36.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -119.15 -134.13 4.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 393' ' ' ALA . 0.1 OUTLIER -92.09 -21.84 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 392' ' ' LYS . . . 36.87 47.0 0.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 395' ' ' GLY . 0.3 OUTLIER -53.25 134.13 39.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.612 ' N ' HD13 ' A' ' 394' ' ' LEU . . . 156.83 -24.01 0.48 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.446 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.5 t -87.88 28.45 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.403 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.677 ' HZ1' HD11 ' A' ' 476' ' ' LEU . 0.2 OUTLIER -167.06 175.63 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.905 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.24 121.85 23.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 11.3 mm -81.97 120.74 78.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 129.7 18.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -86.2 92.34 8.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -114.67 -139.68 7.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.64 -175.09 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.778 0.323 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.71 -20.4 13.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -127.09 32.83 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 28.1 p -75.55 -17.4 60.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 410' ' ' LEU . 59.5 mt -121.96 10.14 10.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -68.79 116.32 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.05 -21.55 24.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 24.2 mt -90.07 150.14 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.921 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.48 148.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.4 148.53 49.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.562 ' O ' HD12 ' A' ' 448' ' ' LEU . 99.5 t -127.05 108.09 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 25.8 mt -91.28 123.2 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 9.7 t -120.65 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 82.25 -153.86 32.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -127.13 154.55 37.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.091 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 8.1 mt -132.79 136.51 46.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -60.36 -63.62 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.808 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 419' ' ' GLU . 23.0 p -35.92 -56.65 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.5 OUTLIER -143.15 155.75 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -90.16 160.56 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -39.84 -37.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.58 -55.13 8.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.4 ' CD ' HG22 ' A' ' 421' ' ' ILE . 17.3 mt-10 -51.16 -65.29 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.39 -40.8 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 437' ' ' VAL . 36.2 tttm -58.3 -57.58 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.1 p -48.9 -30.52 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.51 -61.72 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 475' ' ' LEU . 33.7 mt -51.22 -34.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.5 -28.84 46.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -66.15 -14.95 62.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -110.5 -9.42 14.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 117.93 -24.84 8.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.9 157.56 21.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -106.63 156.29 18.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 427' ' ' LYS . 77.5 t -134.3 116.68 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 13.6 t -136.78 134.94 37.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.34 45.99 3.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -160.12 135.46 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.569 HG23 ' HD2' ' A' ' 458' ' ' LYS . 62.2 t -74.79 130.04 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.3 t -130.91 173.42 10.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -76.43 -19.58 57.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -88.98 -16.77 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.401 HG22 ' CG2' ' A' ' 467' ' ' THR . 96.7 m -48.05 127.58 12.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -94.99 -39.8 9.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE2' ' CB ' ' A' ' 468' ' ' LYS . 73.1 m-85 -144.64 150.77 37.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 413' ' ' VAL . 6.4 tp -117.98 107.89 14.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.61 106.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.112 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.6 mtt -92.11 165.99 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -152.26 -118.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 453' ' ' ASP . 11.4 ptm180 -119.49 173.22 7.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.8 t70 34.54 38.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 452' ' ' ARG . 61.5 m -99.82 151.9 20.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -77.08 163.24 52.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.526 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 2.3 pm0 -92.27 -12.31 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 1.8 t -69.48 -34.77 74.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 441' ' ' VAL . 3.9 tppt? -58.03 -43.79 86.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.435 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 86.1 p -66.36 -52.42 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -44.1 -64.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -54.21 -49.12 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -47.77 -58.33 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.25 -50.17 67.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -47.33 -55.83 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.2 mt -66.54 -26.11 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.55 53.05 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.401 ' CG2' HG22 ' A' ' 445' ' ' THR . 47.5 m -110.4 136.9 48.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 0.0 111.16 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.503 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -79.77 117.81 21.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 450' ' ' MET . 15.5 mt -89.7 130.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.2 pt -147.25 166.59 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 472' ' ' GLU . 0.4 OUTLIER -107.59 171.11 7.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 473' ' ' ASP . 2.6 pp20? -37.21 -43.03 0.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . 0.425 ' N ' ' CD ' ' A' ' 472' ' ' GLU . 16.2 t70 -60.8 -51.99 67.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -55.65 -35.21 61.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.429 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.504 HD11 HG12 ' A' ' 430' ' ' ILE . 57.1 tp -63.16 -47.32 83.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.949 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.677 HD11 ' HZ1' ' A' ' 397' ' ' LYS . 73.5 mt -57.27 -53.05 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -53.14 -39.85 63.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.28 -15.54 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 78.9 mt -90.18 -19.3 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.171 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.6 -20.97 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.5 p -91.86 -38.32 12.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.521 ' CE ' HD11 ' A' ' 410' ' ' LEU . 40.7 mmm -67.29 143.6 97.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.523 0.677 . . . . 0.0 110.908 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.81 -178.42 2.35 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -126.73 166.05 19.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.436 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -135.57 161.03 36.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 486' ' ' LYS . 0.1 OUTLIER -96.98 110.23 22.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 30.9 t -69.18 155.22 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -56.77 -38.74 72.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.14 135.56 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.16 148.65 22.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 57.9 mt -106.71 119.82 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 493' ' ' VAL . . . -61.51 -178.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.084 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 493' ' ' VAL . 14.7 p 34.17 39.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.55 65.87 4.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 13.0 t -147.08 161.65 40.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.0 m -150.55 164.44 35.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 55.6 m -59.08 -54.68 44.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.882 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.38 -53.69 3.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 1.1 t -57.93 119.49 6.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.864 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 2.1 m -86.08 42.93 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 145.19 141.36 3.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.452 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -45.1 -57.32 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.775 0.321 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -160.57 133.17 6.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.35 102.41 5.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -124.43 61.08 0.6 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.43 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.3 t -121.41 28.85 7.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.47 ' HD2' ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -120.47 168.0 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -125.18 113.73 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.474 HG23 ' HD2' ' A' ' 400' ' ' PRO . 27.5 mm -76.93 135.66 67.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.14 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 399' ' ' ILE . 54.1 Cg_endo -69.75 117.93 5.38 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.65 2.234 . . . . 0.0 112.373 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -70.28 108.79 4.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -129.96 -146.29 5.98 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.665 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.34 -175.24 4.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.079 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.65 -25.59 12.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -124.31 30.47 6.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -70.38 -16.31 62.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 61.0 mt -121.12 9.21 10.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -65.79 133.79 51.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 92.35 -33.52 4.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.54 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.06 139.94 38.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.878 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 412' ' ' PHE . 81.9 mt -105.07 156.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.154 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 91.5 m-85 -142.64 150.42 40.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 438' ' ' THR . 65.8 t -130.39 99.12 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 45.3 mt -81.81 130.99 34.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.153 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.446 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.6 t -128.88 145.98 51.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.35 42.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.89 152.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 111.107 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 451' ' ' GLY . 7.1 mt -122.92 173.85 7.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.73 -69.58 0.75 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 397' ' ' LYS . 60.8 p -40.58 -44.23 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 1.11 HD13 ' HB2' ' A' ' 426' ' ' ALA . 2.0 pp -142.08 176.98 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -122.88 164.33 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 15.1 tpt85 -42.49 -31.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.83 -68.61 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -44.67 -53.06 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 1.11 ' HB2' HD13 ' A' ' 421' ' ' ILE . . . -52.53 -42.52 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 437' ' ' VAL . 39.8 tttm -58.46 -50.35 74.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 21.1 p -54.59 -34.89 62.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.7 tp -67.55 -65.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 435' ' ' GLY . 55.2 mt -47.31 -40.02 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -76.08 -31.87 58.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.916 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.57 -16.08 62.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 479' ' ' ILE . 70.9 m-85 -113.34 3.96 16.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.89 -32.17 7.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.457 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -47.77 163.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.493 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -116.23 156.43 26.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 427' ' ' LYS . 84.9 t -130.7 128.01 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.836 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -141.26 149.86 41.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -89.72 9.17 78.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -127.91 137.24 52.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.921 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 462' ' ' ALA . 46.6 t -87.9 108.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.2 m -110.49 -178.62 3.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.928 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -77.59 -20.18 54.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -26.46 54.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 10.1 m -46.47 133.86 9.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 4.9 m-80 -102.47 -22.13 14.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 67.5 m-85 -156.01 155.11 32.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.889 HD23 HG12 ' A' ' 469' ' ' ILE . 17.2 tp -125.41 111.63 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 34.3 t -93.57 107.05 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.446 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 26.8 mtm -110.39 175.78 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 418' ' ' LEU . . . -158.55 -147.45 4.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.5 ptt180 -69.39 174.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.4 m-20 34.75 39.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.1 p -96.78 -177.6 3.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -143.83 174.55 24.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.503 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 1.2 pm0 -97.24 24.7 6.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.354 . . . . 0.0 110.948 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 15.1 t -86.08 -42.92 13.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -80.29 -39.62 28.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.0 p -71.46 -30.53 66.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -52.47 65.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.419 ' NZ ' HD11 ' A' ' 465' ' ' LEU . 0.9 OUTLIER -74.03 -28.39 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.444 ' HB2' HG11 ' A' ' 441' ' ' VAL . . . -69.67 -42.38 74.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.73 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -45.81 -41.06 10.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.928 HD13 ' HA ' ' A' ' 443' ' ' LYS . 11.6 mt -85.41 -24.03 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 103.5 51.05 1.0 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 59.1 m -100.56 138.9 37.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.817 0.341 . . . . 0.0 111.152 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 468' ' ' LYS . 0.3 OUTLIER -74.36 117.32 16.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.889 HG12 HD23 ' A' ' 448' ' ' LEU . 34.0 mt -94.96 131.36 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.119 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 475' ' ' LEU . 21.6 pt -142.84 174.23 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.62 178.97 4.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.438 ' OE1' HD22 ' A' ' 418' ' ' LEU . 5.7 pt-20 -41.06 -45.43 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.03 -55.08 24.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 470' ' ' ILE . . . -46.28 -30.29 4.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.0 tp -67.92 -59.87 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.53 -42.85 45.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.949 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -62.89 -36.99 85.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.1 mt -62.75 -22.9 66.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.408 HD13 ' CE2' ' A' ' 433' ' ' TYR . 58.6 mt -83.43 -28.3 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -88.86 -22.3 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.7 p -91.23 -47.87 7.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 11.9 mmm -59.61 139.39 89.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.504 0.669 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.74 -165.18 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.367 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.46 157.09 17.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -134.62 165.18 25.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -117.9 108.08 14.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.953 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 43.5 t -102.05 169.47 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -91.45 43.5 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -114.3 151.89 32.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -106.39 170.63 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 491' ' ' ILE . 5.0 mp -100.99 127.31 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.089 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -117.51 103.83 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.067 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.37 89.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -102.76 129.0 49.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 11.4 t -89.74 3.75 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.1 p -75.64 159.21 31.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.0 110.855 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 62.9 p -69.84 150.88 46.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -92.52 -103.99 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.4 t -62.73 109.97 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.871 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.3 m -137.33 127.71 26.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -81.95 113.74 3.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.511 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -86.1 -43.87 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 81.72 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 394' ' ' LEU . 2.3 tt -68.58 -8.37 41.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 140.75 -117.67 1.29 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.49 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.1 t -133.35 34.08 3.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -133.8 171.38 14.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.18 132.84 38.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.73 125.18 91.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 0.0 111.108 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 117.7 5.24 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -76.78 95.37 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -108.54 -152.37 15.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -70.9 -177.13 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 0.0 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 2.8 pt-20 -101.05 -29.15 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.489 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 67.7 m-20 -122.14 20.11 10.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.923 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.9 p -59.26 -25.64 64.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.466 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 68.0 mt -108.36 14.9 24.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.67 143.3 34.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 86.33 -16.6 43.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.59 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.5 mt -100.1 153.2 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.815 0.341 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 412' ' ' PHE . 95.4 mt -113.49 155.52 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 411' ' ' ILE . 91.1 m-85 -144.29 135.31 25.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 438' ' ' THR . 41.9 t -115.84 100.37 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 63.9 mt -81.88 121.38 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.59 130.8 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.15 -152.27 22.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.81 152.63 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -132.25 159.4 39.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.24 -65.19 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 421' ' ' ILE . 10.6 t -39.74 -31.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 420' ' ' SER . 1.3 pt -161.2 160.88 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.12 170.32 8.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -47.95 -20.19 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -92.56 -65.86 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -42.07 -37.94 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.66 -42.33 67.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 25.3 ttmt -58.76 -58.58 7.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 28.1 t -47.07 -36.76 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.0 tp -64.66 -64.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 475' ' ' LEU . 63.4 mt -49.89 -44.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -68.16 -32.65 73.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -66.06 -17.75 64.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.466 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 57.0 m-85 -108.21 1.57 22.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.02 -29.65 10.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.25 153.34 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 437' ' ' VAL . 9.3 tmtm? -105.78 146.92 29.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 99.5 t -122.45 121.34 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.626 ' O ' HG13 ' A' ' 413' ' ' VAL . 9.0 t -139.44 143.82 37.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -91.24 44.96 2.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.44 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -163.56 121.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.78 126.45 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.6 m -128.49 169.12 14.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -68.32 -21.65 64.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -85.44 -7.05 59.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 58.6 m -61.26 127.37 31.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -97.3 -29.12 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -151.83 150.96 30.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 469' ' ' ILE . 14.2 tp -119.76 108.85 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.43 105.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.502 ' HG3' HG23 ' A' ' 469' ' ' ILE . 4.2 mtt -80.27 168.98 18.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.23 -110.37 0.24 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 453' ' ' ASP . 14.7 mmt180 -125.66 172.39 9.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 452' ' ' ARG . 29.4 t0 34.56 39.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 96.6 p -83.64 165.88 18.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -113.31 130.29 9.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.535 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.49 -20.71 21.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 110.913 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 87.4 p -69.73 -30.24 67.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -63.11 -56.19 18.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.9 t -63.93 -45.96 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -40.3 -53.69 2.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -64.98 -35.57 81.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -61.66 -63.15 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.079 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.32 -41.39 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.54 69.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.5 -26.22 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 99.8 48.95 1.56 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 19.8 m -111.49 145.68 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -84.24 142.43 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 448' ' ' LEU . 25.9 mt -109.61 127.88 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.23 172.73 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 472' ' ' GLU . 51.0 m-20 -117.86 170.73 8.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.721 ' HB3' HD13 ' A' ' 418' ' ' LEU . 6.7 pt-20 -35.92 -41.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.71 -51.44 62.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.31 -27.64 32.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 430' ' ' ILE . 52.0 tp -69.76 -51.75 31.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.919 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 479' ' ' ILE . 90.3 mt -52.26 -48.73 65.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.08 -36.7 77.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.18 -17.25 57.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 476' ' ' LEU . 30.7 mt -88.56 -15.65 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -106.95 -15.29 14.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 20.9 p -97.82 -41.73 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.59 ' CE ' HD11 ' A' ' 410' ' ' LEU . 12.2 mmm -64.43 140.73 98.05 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.71 -173.26 0.68 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.698 2.265 . . . . 0.0 112.382 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -107.34 151.27 16.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 1.8 mptp? -127.98 154.79 45.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 485' ' ' LYS . 15.7 mtpt 33.15 47.59 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.832 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.6 p -86.71 104.36 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 488' ' ' LYS . 0.0 OUTLIER -52.93 -32.68 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -108.9 128.22 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.72 157.15 42.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 492' ' ' ALA . 49.6 mm -121.95 84.81 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.109 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 491' ' ' ILE . . . 34.43 48.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 88.5 t -85.7 108.12 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 50.01 42.21 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.1 m -56.62 131.62 49.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 1.5 t -154.39 150.47 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 38.6 m -107.7 104.64 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -167.32 -101.71 0.15 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.0 t -126.25 -49.73 1.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.874 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 39.0 t -71.48 108.79 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 87.62 79.73 1.25 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 392' ' ' LYS . 9.1 tmtt? -108.25 115.05 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -50.75 115.76 1.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.738 HD13 HG23 ' A' ' 421' ' ' ILE . 1.5 pp -98.51 -13.19 20.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 155.44 60.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 2.2 m 48.29 28.2 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.943 0.401 . . . . 0.0 110.862 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -108.34 176.98 4.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.61 116.3 14.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.1 mm -86.91 124.62 68.64 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 0.0 111.149 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 125.98 12.76 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.675 2.25 . . . . 0.0 112.303 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 92.52 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -107.02 -150.3 16.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -78.95 -175.03 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -100.19 -27.78 13.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -123.07 31.4 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.0 p -68.97 -19.33 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.8 -5.94 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -60.19 126.39 27.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.11 -23.71 32.64 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 15.0 mt -94.25 153.96 17.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 81.8 mt -116.46 143.51 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 88.3 m-85 -134.48 146.23 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 438' ' ' THR . 93.9 t -121.08 112.79 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 87.4 mt -95.56 121.48 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.154 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 15.4 t -122.95 147.36 46.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.32 -154.16 47.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.17 142.19 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.36 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.565 HD22 ' OE1' ' A' ' 472' ' ' GLU . 8.9 mt -113.96 140.24 48.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.89 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -47.63 74.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 78.6 p -50.86 -50.11 57.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.802 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.2 pt -151.48 168.47 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -97.81 162.06 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -38.9 -45.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -65.21 -62.43 1.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -46.37 -62.98 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -52.38 -53.51 44.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -44.04 -53.35 6.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.4 t -49.88 -31.22 11.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -66.07 -60.06 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 475' ' ' LEU . 72.6 mt -53.68 -40.03 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.08 -25.35 55.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -67.24 -20.01 65.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 403' ' ' ALA . 60.4 m-85 -111.92 7.96 20.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.47 -38.38 3.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.501 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.29 156.54 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -110.14 148.23 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.54 123.11 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.0 t -137.61 161.68 35.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -102.24 22.9 36.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -143.53 140.63 30.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 458' ' ' LYS . 21.1 t -93.58 110.87 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.8 p -115.95 -175.66 2.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -70.35 -22.43 62.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -80.44 -17.54 51.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 18.2 m -58.53 139.38 55.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.51 -31.21 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.555 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 76.1 m-85 -149.48 140.58 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.573 HD23 HG12 ' A' ' 469' ' ' ILE . 10.9 tp -110.72 106.43 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.0 t -77.46 102.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.403 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 3.2 mmt -75.93 166.71 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -156.54 -126.79 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.439 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 mmt-85 -110.64 175.11 5.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.7 t0 34.41 38.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 15.9 p -83.39 118.29 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.85 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 457' ' ' SER . . . -82.53 24.06 5.22 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 455' ' ' GLY . 13.5 pt20 36.16 30.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 455' ' ' GLY . 17.3 t -80.66 -29.46 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.45 ' HB3' HG23 ' A' ' 441' ' ' VAL . 23.2 mtmt -93.15 -22.68 18.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.403 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 93.0 p -69.51 -16.03 63.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -65.47 -62.76 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -62.7 -46.19 89.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -48.01 -56.12 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.18 66.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -77.96 -18.53 55.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.17 15.04 30.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.11 29.26 62.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.569 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 67.7 m -82.16 127.79 33.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 0.0 111.112 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -74.39 129.94 38.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.573 HG12 HD23 ' A' ' 448' ' ' LEU . 92.2 mt -102.79 121.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 29.7 pt -127.9 173.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.9 p30 -118.34 166.84 12.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.85 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.565 ' OE1' HD22 ' A' ' 418' ' ' LEU . 4.9 pm0 -35.31 -32.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 471' ' ' ASP . 12.4 t0 -71.93 -53.74 12.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -51.62 -36.55 40.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 430' ' ' ILE . 46.0 tp -61.59 -49.4 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.88 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 77.6 mt -52.84 -49.21 66.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -59.38 -41.59 89.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.6 mt -58.53 -16.68 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 479' ' ' ILE . 39.5 mt -89.24 -16.71 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -107.6 -13.66 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 6.4 p -100.48 -31.36 11.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 33.1 mmm -76.27 140.51 69.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.854 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -166.39 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.28 166.45 19.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -133.94 157.95 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.43 164.34 25.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 28.8 t -173.88 142.38 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -53.29 -35.72 60.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -66.15 144.97 56.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -148.43 176.34 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 36.0 mt -96.41 87.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -45.54 153.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.41 127.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.153 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.3 82.9 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 15.2 m -50.39 147.7 4.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 52.4 p -124.59 -46.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.878 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 5.3 t -62.68 -60.87 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.46 -115.66 4.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.471 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.9 m -130.42 -49.81 1.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.898 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 16.6 m -72.76 142.6 48.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.887 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -169.29 -101.23 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -169.93 133.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.05 150.76 22.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 394' ' ' LEU . 2.9 tt -59.35 -20.66 56.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 113.09 -84.47 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.459 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 10.6 p -73.25 1.76 8.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -175.01 167.97 3.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.05 119.7 30.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 42.8 mm -82.26 122.74 79.49 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.657 0.741 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 121.0 7.68 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.309 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -75.59 95.95 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -118.71 -133.46 4.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -100.05 -175.17 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 2.7 pt-20 -102.55 -23.7 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 73.5 m-80 -125.64 30.55 5.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 18.3 p -71.52 -19.26 62.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.55 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 84.4 mt -118.66 9.43 12.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.62 139.28 40.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.07 31.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.517 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.42 HD11 ' CE ' ' A' ' 482' ' ' MET . 12.3 mt -93.71 164.23 13.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.404 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 73.0 mt -123.33 145.05 30.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 12.4 m-85 -131.44 155.03 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.537 ' O ' HD12 ' A' ' 448' ' ' LEU . 95.5 t -133.6 105.14 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 430' ' ' ILE . 54.8 mt -85.93 133.1 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -134.4 130.52 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.177 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.05 -151.31 21.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.454 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.9 m -134.02 154.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 0.0 111.1 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.3 mt -134.86 147.83 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -70.89 -58.81 3.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 30.1 t -42.34 -44.81 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.43 158.95 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.116 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 424' ' ' ASP . 15.1 mt-10 -99.58 159.77 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -38.14 -31.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 422' ' ' GLU . 0.2 OUTLIER -76.55 -64.64 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -43.39 -60.91 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -46.63 -45.96 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.065 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 437' ' ' VAL . 28.7 tttt -54.67 -43.16 72.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -61.11 -38.36 86.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.4 -63.09 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 414' ' ' ILE . 62.9 mt -45.96 -37.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.167 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.35 -34.7 48.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -56.45 -16.24 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -115.3 -3.47 12.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.44 -45.48 1.28 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -41.18 141.2 1.13 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.5 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -102.37 160.44 14.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 427' ' ' LYS . 59.0 t -128.36 119.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.493 ' CG2' HG22 ' A' ' 413' ' ' VAL . 12.5 t -124.37 166.44 15.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.7 50.58 0.77 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.469 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -170.96 124.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.37 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.23 111.69 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.183 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . 0.412 ' HB3' ' CD ' ' A' ' 444' ' ' LYS . 12.9 t -126.67 -175.01 3.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -67.29 -53.52 29.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.412 ' CD ' ' HB3' ' A' ' 442' ' ' SER . 0.0 OUTLIER -50.76 -19.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 35.8 m -62.73 123.7 19.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.29 -53.32 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 468' ' ' LYS . 57.1 m-85 -126.51 160.21 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 413' ' ' VAL . 10.5 tp -129.94 104.76 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -77.75 105.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.0 mmt -87.9 171.42 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -169.24 -127.52 0.93 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.0 mmp_? -92.46 167.15 12.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.3 t70 34.08 36.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.847 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 452' ' ' ARG . 54.5 p -69.75 127.19 32.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.99 139.95 27.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.436 ' NE2' ' H ' ' A' ' 456' ' ' GLN . 1.6 pm0 -64.57 -11.7 37.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.937 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 96.3 p -78.91 -27.11 43.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -66.66 -42.91 85.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 460' ' ' ASP . 33.7 p -81.29 -60.94 2.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 459' ' ' SER . 0.3 OUTLIER -36.9 -57.41 0.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -60.33 -44.5 95.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -54.46 -64.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -37.99 -52.74 1.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.93 76.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 462' ' ' ALA . 11.3 mt -92.32 23.11 4.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 40.12 60.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.501 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.596 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.9 m -110.99 136.15 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 447' ' ' TYR . 21.2 mttp -76.11 141.76 41.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 13.9 mt -118.57 141.67 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.597 HD13 HD12 ' A' ' 478' ' ' LEU . 25.8 pt -152.08 171.09 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -115.83 177.99 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 473' ' ' ASP . 0.6 OUTLIER -45.75 -35.16 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . 0.456 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 21.3 t0 -71.46 -52.08 20.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -53.91 -45.43 70.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.522 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 470' ' ' ILE . 50.1 tp -50.55 -41.52 54.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.98 -51.35 62.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.7 -32.16 65.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 470' ' ' ILE . 14.5 mt -65.52 -17.04 64.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.65 -17.46 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -103.97 -28.72 11.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.1 p -85.84 -25.38 26.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.134 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.467 ' CG ' ' O ' ' A' ' 478' ' ' LEU . 63.7 mmm -82.02 140.68 46.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.553 0.692 . . . . 0.0 110.917 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.2 Cg_endo -69.76 -165.86 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.666 2.244 . . . . 0.0 112.397 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.88 19.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -134.82 152.17 51.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -92.78 89.71 6.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 1.8 m -103.53 -49.34 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt 65.87 42.63 3.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 490' ' ' GLU . 23.6 m-85 -112.84 159.9 18.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 489' ' ' TYR . 37.6 mt-10 -37.93 139.71 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.44 106.03 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -67.4 105.57 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.072 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 495' ' ' THR . 60.0 t -104.92 141.68 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.92 51.72 10.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 493' ' ' VAL . 82.2 p -116.12 94.71 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.14 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.418 ' CD ' ' C ' ' A' ' 496' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 1.6 t 67.23 42.88 2.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.845 0.355 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 39.0 m -99.13 -59.89 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -118.44 174.69 15.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.5 m -80.37 176.25 9.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 110.838 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 14.3 t -88.75 86.84 7.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 36.86 46.29 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.75 107.74 15.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -114.72 50.97 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.9 tt -83.89 112.25 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -151.03 36.03 0.9 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.454 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.4 t -103.48 19.04 20.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.893 0.378 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -104.53 150.96 24.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -113.38 116.32 29.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 45.6 mm -89.32 122.37 68.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.647 0.737 . . . . 0.0 111.12 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 118.49 5.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -65.33 104.25 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.94 -152.11 8.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -88.0 -174.97 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -100.53 -26.94 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.465 ' O ' ' CE ' ' A' ' 485' ' ' LYS . 50.7 m-80 -123.23 27.32 7.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 26.5 p -68.43 -10.12 53.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.01 8.97 5.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . 0.43 ' CD ' ' OD1' ' A' ' 405' ' ' ASN . 14.9 tt0 -68.22 124.24 22.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.33 -29.49 12.25 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.545 HD22 ' OD1' ' A' ' 446' ' ' ASN . 72.2 mt -81.06 143.3 32.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.808 0.337 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 444' ' ' LYS . 93.2 mt -109.15 144.53 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 38.5 m-85 -129.22 155.35 45.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 438' ' ' THR . 55.5 t -134.12 102.35 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 30.7 mt -84.27 126.63 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.6 t -132.31 118.43 19.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.47 -161.02 16.25 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.09 132.0 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.731 HD13 ' HB3' ' A' ' 472' ' ' GLU . 10.0 mt -101.26 179.88 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.57 -42.55 6.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 17.5 m -63.52 -55.22 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.41 130.5 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -68.03 156.23 37.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 423' ' ' ARG . 0.8 OUTLIER -40.24 -35.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -49.09 -47.67 44.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -59.1 -41.57 88.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -55.44 -57.6 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -46.94 -28.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.873 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.21 -53.13 7.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.99 -34.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.88 -29.42 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -61.64 -16.11 45.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.809 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -114.12 -1.78 13.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 110.74 -36.53 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.46 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -44.52 148.68 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.523 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -101.2 160.89 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 84.6 t -137.35 108.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 413' ' ' VAL . 8.9 t -128.73 150.08 50.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -95.14 50.89 1.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.71 147.42 25.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.0 110.898 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 54.7 t -99.18 101.75 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 85.0 p -123.19 175.25 6.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.42 ' HD2' HD22 ' A' ' 465' ' ' LEU . 1.9 mptm? -68.47 -16.4 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.552 ' HB3' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -80.57 -27.2 37.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.936 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.0 m -58.2 120.28 8.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.545 ' OD1' HD22 ' A' ' 410' ' ' LEU . 2.9 t-20 -91.83 -41.01 10.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.503 ' CE1' ' OD1' ' A' ' 446' ' ' ASN . 95.3 m-85 -130.12 156.11 45.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 469' ' ' ILE . 11.2 tp -131.21 105.68 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.14 104.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.651 ' HG2' HG23 ' A' ' 469' ' ' ILE . 3.4 mmt -82.7 163.6 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -163.42 -134.95 1.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 1.1 mmp_? -87.9 163.27 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 17.4 t70 34.42 36.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 452' ' ' ARG . 3.2 m -83.49 116.32 22.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -59.55 128.36 46.72 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.486 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -51.26 -35.88 39.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.815 0.34 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 90.3 p -46.17 -47.32 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -43.51 -52.99 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 1.2 t -68.65 -61.05 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 22.8 t70 -38.09 -62.1 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -58.83 -33.59 70.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.58 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -62.93 -50.07 72.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.65 -55.6 27.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -46.97 -50.65 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.42 HD22 ' HD2' ' A' ' 443' ' ' LYS . 13.0 mt -70.14 -28.76 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.882 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.77 48.71 1.9 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.521 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.58 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 29.1 m -104.33 150.09 24.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 111.102 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -90.54 133.04 35.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.651 HG23 ' HG2' ' A' ' 450' ' ' MET . 3.1 mp -104.76 120.16 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.131 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 21.9 pt -125.88 170.77 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 474' ' ' GLY . 0.9 OUTLIER -120.83 168.49 11.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.731 ' HB3' HD13 ' A' ' 418' ' ' LEU . 12.1 pt-20 -35.05 -44.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.44 -43.49 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -58.97 -29.78 65.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 25.4 tp -69.35 -49.34 56.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.1 mt -55.01 -46.75 75.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -57.72 -40.73 80.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -58.22 -17.68 20.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 74.5 mt -86.91 -18.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -102.92 -25.93 13.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.8 p -84.69 -46.84 11.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.511 ' CE ' HD11 ' A' ' 410' ' ' LEU . 10.7 mmm -59.85 141.06 89.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.528 0.68 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.5 Cg_endo -69.84 -170.31 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 403' ' ' ALA . . . -118.11 153.27 17.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.506 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 405' ' ' ASN . 6.0 mtmm -130.66 167.75 18.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -117.42 135.77 53.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 89.9 p -118.44 160.72 21.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -102.94 -40.51 6.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.71 136.91 51.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -113.99 145.54 41.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.04 98.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -117.72 105.58 12.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.089 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.0 p -42.74 139.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.33 167.88 17.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 75.0 p -48.37 158.52 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 96.6 p -159.35 127.87 5.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 110.881 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.8 t -168.7 165.01 12.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 177.22 68.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 27.8 m -65.0 135.78 56.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.858 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.3 m -78.58 -33.62 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -102.1 95.28 1.29 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.44 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -108.0 17.09 22.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.322 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.09 143.4 44.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 21.6 tp -83.57 -11.2 57.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 98.91 -21.08 47.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 2.1 m -131.16 27.96 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.838 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -147.53 160.93 42.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -134.36 139.33 45.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 33.8 mm -74.17 131.74 80.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.634 0.73 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.401 ' HD3' HD22 ' A' ' 476' ' ' LEU . 53.5 Cg_endo -69.81 120.31 7.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.631 2.221 . . . . 0.0 112.362 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -77.01 98.75 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -117.48 -152.25 9.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -84.6 -174.96 5.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -99.76 -21.42 15.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -126.74 31.55 5.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.858 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 22.6 p -72.68 -19.77 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 410' ' ' LEU . 55.5 mt -119.12 11.34 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -74.03 116.16 14.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 112.57 -28.15 9.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.545 HD11 ' CE ' ' A' ' 482' ' ' MET . 6.5 mt -87.76 149.45 24.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' A' ' 444' ' ' LYS . 87.7 mt -110.28 152.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 83.1 m-85 -139.39 140.24 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 441' ' ' VAL . 89.0 t -119.17 99.72 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.31 126.42 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.8 t -132.28 118.23 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 104.88 -170.19 17.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 417' ' ' VAL . 2.2 m -122.5 123.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 0.0 111.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' A' ' 472' ' ' GLU . 3.4 mt -97.52 -179.39 4.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -102.74 -67.07 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 26.2 t -39.97 -47.22 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 1.3 pt -150.57 122.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.149 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.93 174.5 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -49.25 -57.56 6.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -52.61 -42.76 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -65.02 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.27 -22.37 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.2 tttt -72.4 -51.22 21.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.5 m -58.15 -36.18 72.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.8 tp -62.39 -63.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 33.2 mt -48.9 -38.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -75.47 -29.0 59.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -65.75 -14.76 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -113.84 -0.44 14.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.0 -25.16 19.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.05 150.28 14.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -101.56 146.66 27.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 427' ' ' LYS . 54.9 t -125.35 118.76 53.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 413' ' ' VAL . 11.5 t -134.85 154.68 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.09 -35.35 27.5 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -96.28 142.14 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.667 ' HA ' HG21 ' A' ' 413' ' ' VAL . 33.7 t -81.79 137.65 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 59.3 m -123.04 -175.74 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.793 ' HA ' HD13 ' A' ' 465' ' ' LEU . 43.4 tttm -82.05 -16.54 49.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.954 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 411' ' ' ILE . 27.9 mmmt -89.43 -10.2 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 413' ' ' VAL . 1.9 m -52.48 121.14 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -88.69 -34.12 17.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.53 ' HB2' ' CE2' ' A' ' 412' ' ' PHE . 71.4 m-85 -150.5 131.24 14.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 450' ' ' MET . 12.0 tp -97.62 110.51 23.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.0 t -84.17 102.16 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.442 ' CE ' ' HB2' ' A' ' 459' ' ' SER . 2.8 mmt -80.85 166.21 21.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -166.42 -148.82 5.71 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.3 ttt180 -68.08 151.55 46.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.807 0.336 . . . . 0.0 110.883 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 452' ' ' ARG . 23.8 t70 36.39 44.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 12.1 t -78.24 103.0 7.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -48.24 136.86 15.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.482 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -56.93 -45.89 82.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.3 t -37.98 -43.84 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -49.07 -56.61 8.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.442 ' HB2' ' CE ' ' A' ' 450' ' ' MET . 8.4 t -68.16 -34.04 75.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.74 -65.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.403 ' HE3' HD11 ' A' ' 465' ' ' LEU . 36.2 tttt -62.19 -37.29 84.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -54.22 -54.78 35.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.85 -34.06 69.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.15 -56.23 18.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.793 HD13 ' HA ' ' A' ' 443' ' ' LYS . 46.2 mt -71.28 -0.18 9.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 68.47 53.18 22.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 29.5 m -105.96 129.84 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.153 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -67.07 132.71 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.62 129.07 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 25.4 pt -137.28 178.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.89 171.94 9.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.72 ' HB3' HD13 ' A' ' 418' ' ' LEU . 5.9 pt-20 -39.29 -40.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.83 -46.49 65.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.13 -33.21 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 29.6 tp -66.9 -58.39 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 479' ' ' ILE . 10.2 mt -45.31 -52.06 10.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.896 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 481' ' ' THR . 4.1 m120 -53.99 -48.16 70.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 478' ' ' LEU . 9.0 mt -51.32 -25.1 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 476' ' ' LEU . 62.3 mt -77.37 -27.01 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.175 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -96.5 -11.35 25.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 477' ' ' ASN . 31.0 p -101.62 -36.03 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.545 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.7 mtp -73.77 140.16 77.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.722 . . . . 0.0 110.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 54.3 Cg_endo -69.74 -163.82 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.394 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -134.57 175.36 20.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.439 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.73 136.23 35.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -56.16 160.26 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 29.5 t -163.9 124.99 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -55.37 -42.84 74.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -94.01 157.91 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -151.34 151.46 31.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 16.7 mm -122.46 106.28 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -61.58 154.99 23.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 494' ' ' GLU . 10.5 p -78.02 153.9 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 493' ' ' VAL . 6.5 mm-40 -79.49 106.25 11.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 31.5 p -98.9 110.77 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.909 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.5 m -123.09 123.86 41.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.832 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 29.7 m -72.59 164.37 26.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.875 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -74.86 -95.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.476 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 23.3 t -48.44 144.74 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 56.0 p -89.89 151.32 21.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 59.85 113.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -103.11 124.14 47.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -147.59 164.97 31.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 394' ' ' LEU . 1.9 pt? -127.16 24.25 6.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 88.35 -135.57 13.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.1 m -101.01 37.57 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 110.857 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -128.33 151.06 49.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 399' ' ' ILE . 5.4 tp10 -123.98 144.86 49.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.415 ' N ' ' HG3' ' A' ' 398' ' ' GLU . 40.7 mm -77.49 129.35 77.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.722 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.475 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.2 Cg_endo -69.79 126.23 13.04 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.684 2.256 . . . . 0.0 112.35 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -82.02 99.65 9.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -119.71 -150.02 8.54 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.413 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -82.73 -175.01 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.414 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.3 pt-20 -99.15 -24.0 15.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.414 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 72.3 m-80 -123.49 35.5 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.95 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 20.2 p -75.37 -9.0 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.579 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 88.8 mt -131.79 5.68 4.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -66.96 120.62 13.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.54 -27.3 17.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.45 HD11 ' CE ' ' A' ' 482' ' ' MET . 20.8 mt -88.98 142.28 27.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.799 0.333 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 444' ' ' LYS . 74.9 mt -101.29 151.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.161 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 91.8 m-85 -139.51 146.19 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.795 HG22 HG23 ' A' ' 438' ' ' THR . 85.7 t -124.99 102.76 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.781 HD11 HD12 ' A' ' 430' ' ' ILE . 14.5 mt -90.01 121.52 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.39 137.44 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 78.96 -165.64 51.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.0 m -105.74 159.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.155 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.582 HD22 ' HB3' ' A' ' 472' ' ' GLU . 5.1 mt -140.97 142.29 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.5 -39.28 94.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.509 ' CB ' HD13 ' A' ' 421' ' ' ILE . 5.7 t -60.78 -65.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -146.78 141.78 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -67.27 173.56 3.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -45.04 67.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.45 -42.33 68.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -61.38 -66.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -47.25 -37.18 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 437' ' ' VAL . 42.2 tttm -54.87 -56.77 15.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.0 m -47.06 -37.25 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.42 -64.75 0.79 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.781 HD12 HD11 ' A' ' 414' ' ' ILE . 46.2 mt -46.46 -36.17 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.86 -34.45 57.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -61.08 -18.46 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -108.42 -2.11 19.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 109.25 -36.61 4.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -46.98 148.77 2.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -101.02 154.37 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 427' ' ' LYS . 89.8 t -127.13 119.21 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.795 HG23 HG22 ' A' ' 413' ' ' VAL . 10.0 t -135.02 142.92 46.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . 0.524 ' C ' ' ND2' ' A' ' 440' ' ' ASN . . . -88.07 42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . 0.524 ' ND2' ' C ' ' A' ' 439' ' ' GLY . 1.5 m-80 -162.86 128.85 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.91 0.386 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.678 ' CG2' HD13 ' A' ' 448' ' ' LEU . 39.5 t -81.36 105.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 m -111.51 -174.48 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -71.82 -25.08 61.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.52 ' O ' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -81.83 -17.52 47.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.0 m -60.37 128.11 35.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -94.43 -38.2 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -141.11 153.29 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.678 HD13 ' CG2' ' A' ' 441' ' ' VAL . 52.2 tp -119.07 102.81 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.25 107.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.9 ptp -122.28 169.38 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.74 -104.46 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.3 OUTLIER -82.59 148.15 28.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 4.1 m-20 35.68 53.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 99.2 p -94.17 125.36 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -67.5 146.02 46.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -94.01 -30.67 14.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 0.0 110.891 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.2 t -55.27 -19.31 8.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.588 ' HD3' HG23 ' A' ' 441' ' ' VAL . 6.0 ttmt -94.53 -44.72 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.928 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 84.8 p -59.62 -30.55 68.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.53 -54.55 45.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -54.78 -23.98 20.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -74.36 -60.56 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.16 13.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -68.95 -64.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 18.3 mt -54.66 -29.66 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.51 43.36 1.59 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.437 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.628 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 27.6 m -103.14 135.54 44.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.112 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -74.97 138.05 42.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.451 HG12 HD23 ' A' ' 448' ' ' LEU . 66.7 mt -109.5 130.57 62.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 35.8 pt -142.7 172.21 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 473' ' ' ASP . 1.3 p-10 -115.4 169.0 9.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.582 ' HB3' HD22 ' A' ' 418' ' ' LEU . 1.7 pm0 -39.8 -25.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 471' ' ' ASP . 25.8 t70 -74.97 -49.49 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -61.51 -31.01 76.08 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 430' ' ' ILE . 24.3 tp -64.02 -49.3 72.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 110.895 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.475 HD22 ' CD ' ' A' ' 400' ' ' PRO . 26.1 mt -59.72 -51.94 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -57.49 -34.65 69.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.4 -15.06 32.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 55.5 mt -89.22 -24.85 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.17 -29.01 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.1 p -82.69 -38.56 23.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 410' ' ' LEU . 18.4 mmm -69.57 142.06 91.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 0.0 110.895 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.323 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -135.07 169.16 23.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -133.42 155.42 49.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -98.01 85.3 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 57.4 p -72.78 149.58 43.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.84 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -45.16 -51.89 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -87.4 127.24 35.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -99.24 167.48 10.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 21.5 mt -101.34 125.21 55.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -94.13 139.34 31.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.53 138.69 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -49.52 167.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 90.6 m -147.24 132.21 18.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 4.2 t -67.49 109.62 3.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 18.2 p -166.02 118.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 389' ' ' SER . . . -161.63 62.99 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 388' ' ' GLY . 1.9 t 35.41 43.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.895 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 41.0 m -115.98 117.84 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 392' ' ' LYS . . . 140.11 -179.62 18.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.45 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 391' ' ' GLY . 14.4 pttt 34.62 44.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -126.74 144.05 51.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.3 tt -73.25 117.74 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -125.67 65.04 0.56 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.541 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.7 t -134.29 22.35 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 0.0 110.851 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -153.62 177.35 11.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -123.16 124.66 43.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 15.0 mm -86.12 120.1 72.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.635 0.731 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 120.29 7.11 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.72 2.28 . . . . 0.0 112.401 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 108.46 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -130.56 -141.12 4.83 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -95.0 -176.15 3.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.28 -24.73 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 485' ' ' LYS . 36.1 m-20 -124.58 29.55 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -68.54 -23.57 64.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.2 mt -114.74 2.66 14.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -66.57 145.22 55.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 85.94 -26.37 6.11 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.84 159.45 16.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 412' ' ' PHE . 96.7 mt -122.11 155.12 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 55.4 m-85 -142.55 145.72 33.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 438' ' ' THR . 38.3 t -122.99 100.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.432 HD11 HD12 ' A' ' 430' ' ' ILE . 49.3 mt -81.4 122.12 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.461 ' CG2' ' HG2' ' A' ' 450' ' ' MET . 2.7 t -126.6 115.13 19.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 106.95 -153.92 16.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.66 158.03 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 111.156 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.8 mt -135.84 159.51 41.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 420' ' ' SER . 4.0 tp10 -77.21 -69.44 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 419' ' ' GLU . 20.1 m -35.22 -61.82 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 426' ' ' ALA . 0.4 OUTLIER -131.32 161.68 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 422' ' ' GLU . 6.9 mp0 -102.76 164.12 11.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 16.4 tpt85 -42.48 -30.87 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -65.76 0.95 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.93 -55.2 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.469 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -49.35 -53.22 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.5 ' HA ' HG21 ' A' ' 437' ' ' VAL . 30.7 tttm -44.91 -51.19 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 32.5 t -52.62 -34.06 49.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.47 -67.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.465 HG22 ' C ' ' A' ' 435' ' ' GLY . 65.4 mt -46.25 -35.79 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.56 -28.88 37.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -63.59 -19.78 65.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 403' ' ' ALA . 66.7 m-85 -112.47 2.29 16.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 435' ' ' GLY . . . 112.21 -45.87 1.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.525 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -37.97 148.36 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.504 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -102.06 161.42 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 427' ' ' LYS . 55.7 t -133.61 125.01 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.506 ' O ' HG13 ' A' ' 413' ' ' VAL . 12.8 t -144.16 170.49 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -118.65 50.86 0.78 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -156.35 135.19 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 107.31 15.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -129.23 -175.12 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.857 ' HD3' HD22 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -73.39 -48.42 34.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -50.65 -28.71 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.45 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 89.2 m -55.36 124.27 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.073 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -95.66 -44.74 7.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 61.4 m-85 -128.7 159.39 35.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.537 HD23 HG12 ' A' ' 469' ' ' ILE . 35.1 tp -130.09 102.88 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.03 107.96 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.118 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.461 ' HG2' ' CG2' ' A' ' 415' ' ' THR . 24.0 mtm -112.65 179.85 3.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.34 -102.21 0.16 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 453' ' ' ASP . 8.6 mmm-85 -92.41 161.24 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.2 t70 34.37 48.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 47.9 p -87.62 168.42 13.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -117.8 143.36 17.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 -28.84 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.966 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 89.7 p -59.54 -21.55 60.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.829 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 459' ' ' SER . 34.3 mttm -86.5 -67.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 458' ' ' LYS . 13.5 p -36.57 -64.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 461' ' ' LYS . 0.2 OUTLIER -42.09 -51.73 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.497 ' N ' ' CG ' ' A' ' 460' ' ' ASP . 0.0 OUTLIER -63.11 -31.74 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 459' ' ' SER . . . -65.2 -48.17 74.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.34 83.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -63.92 -30.63 71.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.857 HD22 ' HD3' ' A' ' 443' ' ' LYS . 14.0 mt -87.96 -24.23 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 105.18 28.45 5.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.453 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 4.1 m -92.95 137.36 32.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.356 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 447' ' ' TYR . 0.0 OUTLIER -81.22 114.29 19.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 448' ' ' LEU . 81.9 mt -86.02 131.83 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.139 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 475' ' ' LEU . 7.5 pt -148.98 178.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -117.94 -179.28 3.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.701 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.5 pm0 -50.58 -29.95 12.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.08 -51.21 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.95 -30.94 54.95 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.505 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 470' ' ' ILE . 32.1 tp -64.44 -42.78 95.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 75.1 mt -62.31 -52.96 61.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -59.26 -30.24 68.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 478' ' ' LEU . 12.0 mt -67.07 -15.18 63.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 69.7 mt -88.68 -20.54 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -102.62 -24.55 13.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 36.7 p -87.66 -31.36 19.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 25.9 mmm -75.88 141.1 71.27 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.73 -164.89 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.357 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.51 20.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.434 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 405' ' ' ASN . 50.3 mttm -138.41 158.04 45.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -108.04 90.24 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.6 t -85.66 145.8 27.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -72.66 -35.13 67.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.976 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.83 174.43 5.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.06 144.04 29.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 62.2 mt -97.55 121.21 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -125.51 122.05 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.24 140.21 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -98.07 142.98 29.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 29.3 p -73.28 100.32 3.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.156 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.862 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.8 t -157.47 166.52 32.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 97.9 p -40.15 128.93 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 162.35 161.29 11.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.473 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 9.1 t -63.03 101.32 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 2.2 m -165.74 157.87 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -107.58 147.17 16.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -87.5 -55.41 3.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.42 164.91 3.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 394' ' ' LEU . 1.3 pt? -129.63 154.83 46.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -155.25 153.61 24.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.8 m 59.57 25.34 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 110.857 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -172.29 157.14 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -124.84 114.89 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.404 HD13 ' CD2' ' A' ' 476' ' ' LEU . 23.5 mm -90.34 119.7 69.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.623 0.725 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 132.82 24.25 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.712 2.275 . . . . 0.0 112.315 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -80.82 84.58 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -99.15 -157.58 29.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.509 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.0 -175.09 2.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 111.069 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -101.65 -21.29 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -127.2 29.92 5.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.8 p -69.5 -21.73 63.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.486 ' HA ' HD12 ' A' ' 410' ' ' LEU . 20.9 mt -111.77 -0.77 15.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.28 115.47 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.3 26.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.595 HD11 ' CE ' ' A' ' 482' ' ' MET . 19.8 mt -91.77 140.3 29.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 444' ' ' LYS . 80.6 mt -106.83 149.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 82.4 m-85 -135.61 157.57 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 23.1 t -132.07 106.98 12.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 423' ' ' ARG . 39.1 mt -88.16 126.35 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 2.7 t -132.64 116.08 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 105.05 -154.47 17.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.09 155.51 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 111.078 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.722 HD22 ' OE1' ' A' ' 472' ' ' GLU . 2.4 mt -138.07 152.89 49.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 420' ' ' SER . 0.0 OUTLIER -74.36 -63.26 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 421' ' ' ILE . 48.1 m -37.67 -39.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.2 pt -161.19 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 423' ' ' ARG . 56.4 mt-10 -94.75 162.16 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.923 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 414' ' ' ILE . 13.8 tpt180 -38.36 -35.23 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 427' ' ' LYS . 4.8 t70 -74.91 -66.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.872 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 421' ' ' ILE . 14.1 mt-10 -43.78 -42.44 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.696 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -70.61 -30.96 67.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 424' ' ' ASP . 21.2 ttmt -67.19 -51.18 56.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.8 m -55.87 -25.29 41.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.9 tp -71.59 -57.1 4.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.7 -45.71 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -72.44 -26.89 62.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -67.07 -14.68 63.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -115.02 8.64 15.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.27 -6.8 63.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -70.79 170.11 47.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -126.94 154.13 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 77.4 t -129.78 123.16 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.07 172.23 7.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.119 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.42 10.84 61.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.71 149.78 16.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 445' ' ' THR . 4.9 t -87.28 117.79 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.9 m -121.75 177.62 5.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 465' ' ' LEU . 27.3 ttmt -59.09 -15.21 12.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 411' ' ' ILE . 1.6 mppt? -90.15 -21.64 22.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.701 HG21 HG13 ' A' ' 441' ' ' VAL . 96.1 m -61.06 126.63 28.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -93.7 -38.58 11.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.787 ' CE2' HD11 ' A' ' 478' ' ' LEU . 60.0 m-85 -138.94 148.33 43.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 469' ' ' ILE . 9.0 tp -115.05 104.26 11.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.51 104.62 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.156 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 12.7 mtt -86.29 176.13 8.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -174.08 -123.76 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 453' ' ' ASP . 2.2 mmp_? -96.94 156.95 16.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 452' ' ' ARG . 3.6 t70 34.56 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 29.2 m -60.35 161.03 7.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -89.53 175.58 42.48 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -95.62 -47.12 6.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 110.922 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 94.2 p -57.16 -27.77 62.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -55.08 -58.28 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 462' ' ' ALA . 3.9 t -73.07 -54.74 7.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.794 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 459' ' ' SER . 17.9 t70 -37.6 -70.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' ALA . 13.7 mmtm -55.06 -34.92 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -58.38 -65.39 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -50.14 -21.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 461' ' ' LYS . . . -75.44 -65.31 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 443' ' ' LYS . 7.3 mt -67.18 -5.83 15.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 83.54 49.77 4.75 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.466 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.609 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 25.0 m -94.52 133.96 37.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.147 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -80.92 102.24 9.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.483 HG12 HD23 ' A' ' 448' ' ' LEU . 48.3 mt -73.91 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.118 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 478' ' ' LEU . 46.6 pt -147.81 165.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -114.24 179.31 3.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.722 ' OE1' HD22 ' A' ' 418' ' ' LEU . 0.4 OUTLIER -48.5 -25.41 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.93 -40.38 18.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -69.15 -34.65 76.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.459 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.419 ' CA ' HD12 ' A' ' 470' ' ' ILE . 59.3 tp -64.23 -41.19 97.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.404 ' CD2' HD13 ' A' ' 399' ' ' ILE . 78.5 mt -61.19 -40.8 95.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.9 -34.75 79.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.3 mt -64.49 -14.76 58.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.37 -17.57 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -103.54 -22.79 13.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 76.7 p -91.96 -31.78 15.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.18 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.595 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.7 mmm -74.05 140.48 77.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.597 0.713 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -163.99 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -129.55 171.67 20.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -139.46 142.44 37.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -84.99 102.93 13.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 12.2 t -118.31 165.83 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -70.54 -25.66 63.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -70.55 147.02 49.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -147.92 149.03 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 491' ' ' ILE . 4.6 mp -98.07 120.35 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -88.24 112.1 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.9 p -132.92 141.83 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -122.27 89.74 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 11.1 t -83.74 150.38 25.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 30.6 m -94.22 -47.92 6.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 13.8 t -161.28 153.38 19.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -59.33 145.74 44.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.5 p -86.86 114.76 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 0.0 110.823 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 99.7 p -99.71 177.05 5.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 101.51 -163.16 17.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.462 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -75.49 145.36 41.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -117.9 90.05 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.074 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.8 tp -106.5 146.03 31.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -148.66 59.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.8 m -122.71 23.8 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.856 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.431 ' HA ' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -118.7 149.99 40.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.927 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -102.13 126.11 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.456 HG23 ' HD2' ' A' ' 400' ' ' PRO . 30.4 mm -94.37 135.39 24.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 111.139 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 399' ' ' ILE . 53.3 Cg_endo -69.81 118.54 5.74 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.676 2.251 . . . . 0.0 112.309 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -60.1 107.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -131.61 -144.3 5.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.5 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -96.44 -175.66 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.59 -21.25 17.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -126.04 18.24 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 15.6 p -58.59 -12.29 3.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 433' ' ' TYR . 70.5 mt -127.46 5.28 6.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.24 148.81 49.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.88 -29.33 3.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.461 HD11 ' CE ' ' A' ' 482' ' ' MET . 16.4 mt -87.6 152.6 22.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.788 0.328 . . . . 0.0 110.899 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 412' ' ' PHE . 86.4 mt -114.68 154.32 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.436 ' N ' HG22 ' A' ' 411' ' ' ILE . 68.1 m-85 -139.01 152.48 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 438' ' ' THR . 95.3 t -132.29 101.9 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.176 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.1 mt -84.48 128.11 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 5.2 t -126.04 134.23 51.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.85 -159.45 41.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 452' ' ' ARG . 4.2 m -122.95 160.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.5 mt -137.62 158.25 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 420' ' ' SER . 24.4 tt0 -80.76 -66.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 419' ' ' GLU . 27.3 m -38.49 -41.74 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.77 170.5 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.126 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -111.78 166.43 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -44.13 -40.17 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 2.2 t0 -68.45 -63.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -48.18 -58.86 3.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.55 -35.17 53.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -69.7 -50.13 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.8 t -54.94 -32.78 61.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -63.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 475' ' ' LEU . 73.5 mt -46.99 -48.5 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.174 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.78 -38.58 91.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.93 -14.69 9.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.439 ' CB ' ' HB2' ' A' ' 407' ' ' LEU . 72.8 m-85 -113.77 5.05 16.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 103.61 -37.47 3.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 407' ' ' LEU . . . -46.42 152.91 1.08 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -102.8 154.5 19.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.98 124.72 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 413' ' ' VAL . 11.9 t -139.62 171.09 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.171 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.1 -33.43 6.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.532 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -94.18 139.12 31.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.482 HG23 ' HE3' ' A' ' 458' ' ' LYS . 40.2 t -90.09 127.88 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 18.0 m -122.14 -174.68 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.422 ' HA ' HD13 ' A' ' 465' ' ' LEU . 49.2 mtpt -76.66 -11.86 59.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -89.29 -20.29 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 56.3 m -52.85 131.64 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.65 -40.06 9.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -141.15 153.37 45.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 413' ' ' VAL . 7.4 tp -121.41 106.33 11.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.53 105.4 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.425 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.1 mtt -87.37 168.76 12.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -153.62 -111.98 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -128.28 173.15 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 8.7 t0 34.45 38.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 83.1 p -80.38 -178.17 6.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -112.09 -168.88 18.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.45 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -104.6 -41.39 5.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.918 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.8 m -51.72 -45.7 63.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.482 ' HE3' HG23 ' A' ' 441' ' ' VAL . 0.2 OUTLIER -45.31 -57.58 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 460' ' ' ASP . 54.8 p -66.35 -57.05 8.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 459' ' ' SER . 3.9 t70 -35.07 -61.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -59.07 -57.26 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -41.97 -58.7 1.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.65 78.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -51.27 -42.99 61.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 443' ' ' LYS . 17.3 mt -80.71 -24.58 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 94.3 56.84 1.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 88.9 m -112.36 136.43 51.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 24.6 mttm -70.78 135.82 48.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.425 HG23 ' HG3' ' A' ' 450' ' ' MET . 71.0 mt -107.84 123.52 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.08 165.49 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.151 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -110.14 175.2 5.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -38.72 -44.51 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.76 -49.59 57.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -54.63 -22.62 25.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.468 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.508 HD11 HG12 ' A' ' 430' ' ' ILE . 58.1 tp -74.79 -47.96 28.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.72 -44.7 90.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 481' ' ' THR . 39.9 t30 -58.5 -34.69 71.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 478' ' ' LEU . 11.1 mt -64.97 -15.06 61.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 479' ' ' ILE . 52.4 mt -90.15 -15.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -106.18 -31.05 8.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 477' ' ' ASN . 40.1 p -83.24 -27.83 29.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.172 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.461 ' CE ' HD11 ' A' ' 410' ' ' LEU . 32.0 mmm -77.49 142.65 67.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.621 0.724 . . . . 0.0 110.844 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -165.91 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.479 ' CA ' ' CB ' ' A' ' 403' ' ' ALA . . . -134.2 158.39 23.34 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.463 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -127.9 172.31 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.12 146.83 40.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 2.1 t -135.85 143.94 45.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -54.75 10.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -115.06 131.51 56.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -104.63 170.08 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.0 mt -104.76 118.47 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -107.66 65.93 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.089 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.74 128.94 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.95 91.41 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 10.0 t -160.79 127.67 4.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 78.3 p -81.17 -43.92 18.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 36.7 t -118.03 160.06 22.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.822 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -146.99 -61.95 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 92.8 p -68.03 113.68 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 58.2 p -109.29 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.839 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 69.02 167.26 4.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -135.98 155.38 50.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -104.08 108.47 19.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 394' ' ' LEU . 4.3 pp -79.17 -8.22 58.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 158.1 -133.2 3.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 4.0 m -104.06 36.82 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.382 . . . . 0.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -116.06 174.04 6.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.95 123.28 36.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.95 121.39 68.06 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 122.37 9.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -76.96 96.18 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -111.17 -141.53 8.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.462 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -87.43 -175.38 5.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.13 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -102.61 -22.39 13.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -126.14 31.19 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.6 p -70.6 -19.62 62.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 43.4 mt -117.44 7.16 12.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.38 133.73 51.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 89.38 -25.62 10.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.553 HD11 ' CE ' ' A' ' 482' ' ' MET . 84.9 mt -83.48 143.46 30.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 96.9 mt -108.97 149.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -139.65 148.6 42.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 438' ' ' THR . 88.9 t -125.61 101.63 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 430' ' ' ILE . 34.2 mt -83.12 128.72 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.436 HG21 ' SD ' ' A' ' 450' ' ' MET . 9.0 t -130.57 143.57 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.55 -144.96 34.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.14 152.46 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.9 mt -129.63 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -65.98 -61.03 2.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 31.8 m -38.23 -59.73 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 426' ' ' ALA . 1.4 pt -140.91 153.78 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.91 175.03 9.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -55.08 -46.89 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 424' ' ' ASP . 0.5 OUTLIER -63.27 -55.8 21.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -62.94 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 421' ' ' ILE . . . -47.3 -48.44 25.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.6 tttt -48.28 -55.21 11.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 4.0 m -50.87 -37.36 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.17 -65.44 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 414' ' ' ILE . 49.9 mt -46.69 -39.42 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -79.22 -27.52 42.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -64.93 -19.4 65.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.522 ' CE2' HD13 ' A' ' 479' ' ' ILE . 76.0 m-85 -110.86 4.56 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.27 -25.0 23.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 430' ' ' ILE . . . -52.71 170.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.468 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 154.47 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 427' ' ' LYS . 39.9 t -129.21 121.71 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.132 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.515 HG23 HG22 ' A' ' 413' ' ' VAL . 0.1 OUTLIER -132.26 158.1 42.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.176 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -100.13 50.36 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -164.46 144.26 7.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.57 104.18 15.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 22.2 m -128.16 174.51 9.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -53.61 -56.65 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -40.81 -30.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 29.3 m -57.7 130.64 47.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -99.08 -35.13 10.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 468' ' ' LYS . 67.3 m-85 -143.82 164.67 29.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.517 HD23 HG12 ' A' ' 469' ' ' ILE . 22.7 tp -131.01 110.6 11.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.91 104.84 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.151 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.443 ' CE ' ' HB3' ' A' ' 459' ' ' SER . 4.4 mmt -96.73 159.89 14.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -146.36 -140.21 3.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.527 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -93.54 164.78 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.5 t70 38.29 46.83 0.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 20.3 p -83.18 -177.91 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -109.65 -179.68 20.96 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -108.28 -12.49 15.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 37.5 m -74.46 -49.3 22.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -56.54 -53.16 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.443 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 53.2 p -61.06 -42.71 99.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -42.89 -67.13 0.3 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 462' ' ' ALA . 32.4 tptt -59.8 -54.46 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -36.26 -46.39 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.085 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -67.54 -51.57 49.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -50.86 -47.5 60.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 -26.89 63.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 87.91 50.49 3.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 40.0 m -98.8 148.23 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 13.2 mmmt -79.85 112.65 17.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.517 HG12 HD23 ' A' ' 448' ' ' LEU . 63.7 mt -90.73 124.85 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.19 165.6 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.29 176.55 5.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -28.61 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.08 -49.09 14.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.84 61.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.74 -36.73 70.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.74 -33.37 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -70.17 -29.49 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.65 -22.91 64.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.522 HD13 ' CE2' ' A' ' 433' ' ' TYR . 67.4 mt -83.3 -16.88 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -103.45 -10.81 18.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 50.9 p -106.16 -39.41 5.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.553 ' CE ' HD11 ' A' ' 410' ' ' LEU . 34.3 mmm -66.87 141.65 96.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.572 0.701 . . . . 0.0 110.879 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -164.17 0.12 Allowed 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.727 2.285 . . . . 0.0 112.35 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -131.7 166.82 22.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 486' ' ' LYS . 31.4 mttm -139.52 166.3 24.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 485' ' ' LYS . 12.9 mtmt 33.23 46.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 93.0 p -120.25 171.7 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 488' ' ' LYS . 0.0 OUTLIER -113.34 -32.42 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CD1' ' HD2' ' A' ' 488' ' ' LYS . 41.5 m-85 -59.08 161.05 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.7 170.07 9.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 66.4 mt -99.79 119.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -106.07 135.42 47.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 89.8 t -97.46 131.12 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.64 131.22 11.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 69.9 p -42.57 133.81 3.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.183 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 51.0 m -103.62 99.78 9.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.849 0.356 . . . . 0.0 110.854 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 62.3 m -56.79 127.99 34.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 148.52 -52.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 1.4 t -54.77 163.78 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.913 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 50.8 p -101.87 167.22 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . 0.475 ' CA ' ' HG3' ' A' ' 425' ' ' GLU . . . 65.58 115.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -111.59 39.45 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -76.42 147.39 38.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.1 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 394' ' ' LEU . 2.7 pt? -108.61 -10.22 15.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 118.81 0.64 15.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 33.0 m -116.44 16.93 15.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.379 . . . . 0.0 110.809 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -125.97 96.25 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.29 131.26 35.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 14.6 mm -90.04 125.47 60.39 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.592 0.71 . . . . 0.0 111.1 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 122.94 9.61 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.691 2.261 . . . . 0.0 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -81.9 107.9 14.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -124.98 -138.73 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.525 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.74 -174.94 3.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 111.114 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 405' ' ' ASN . 4.5 pt-20 -99.65 -20.9 16.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 404' ' ' GLU . 70.7 m-80 -127.25 28.09 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 23.9 p -66.74 -21.95 66.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.67 HD23 ' SD ' ' A' ' 482' ' ' MET . 78.0 mt -121.94 17.3 10.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.67 146.61 42.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.52 2.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.512 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.521 HD11 ' CE ' ' A' ' 482' ' ' MET . 80.6 mt -77.16 152.18 34.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.473 ' CD1' ' HG3' ' A' ' 444' ' ' LYS . 67.3 mt -118.26 139.99 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -125.62 148.33 49.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.694 HG22 HG23 ' A' ' 438' ' ' THR . 48.9 t -124.1 104.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 430' ' ' ILE . 75.3 mt -86.55 126.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -131.48 125.92 33.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.53 -149.88 20.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.03 146.41 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 472' ' ' GLU . 8.2 mt -117.14 166.85 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -90.85 -57.29 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 421' ' ' ILE . 26.5 m -48.69 -29.28 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 420' ' ' SER . 0.8 OUTLIER -163.72 173.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.113 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -104.94 -176.29 3.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.78 -38.79 87.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.25 -50.81 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.475 ' HG3' ' CA ' ' A' ' 391' ' ' GLY . 5.1 mp0 -53.98 -58.57 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.88 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.109 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 437' ' ' VAL . 43.6 tttm -49.53 -50.09 43.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 47.4 t -56.0 -40.24 73.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 13.1 tp -65.07 -63.7 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 414' ' ' ILE . 64.6 mt -45.79 -40.17 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -77.75 -33.16 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -57.74 -20.81 37.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.454 ' HD2' ' HG ' ' A' ' 406' ' ' CYS . 81.5 m-85 -109.2 -4.76 16.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 116.12 -35.43 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -46.62 154.52 0.84 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -109.01 159.98 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 427' ' ' LYS . 79.8 t -131.71 118.02 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.694 HG23 HG22 ' A' ' 413' ' ' VAL . 0.5 OUTLIER -138.73 139.06 38.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -80.67 3.75 72.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -115.3 131.62 56.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.77 120.38 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.094 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.9 m -128.75 -175.25 3.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.704 ' HG2' HD22 ' A' ' 465' ' ' LEU . 55.0 mtpt -71.76 -42.99 66.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.473 ' HG3' ' CD1' ' A' ' 411' ' ' ILE . 0.0 OUTLIER -58.26 -25.56 61.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 24.3 m -51.46 138.26 22.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.14 -48.51 4.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 468' ' ' LYS . 87.1 m-85 -130.51 153.45 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 5.0 tp -120.15 104.34 10.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.4 t -79.0 105.24 7.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.451 ' O ' HD21 ' A' ' 418' ' ' LEU . 7.1 mtt -80.98 175.61 10.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -164.9 -109.24 0.22 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 453' ' ' ASP . 5.5 mmt180 -125.78 165.6 18.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.6 t0 34.32 37.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 452' ' ' ARG . 20.0 m -77.59 136.17 38.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -72.16 124.09 9.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -56.99 -23.02 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.8 t -65.88 -15.17 62.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -82.83 -48.45 10.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.41 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 88.1 p -67.43 -25.49 65.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.48 -46.24 64.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.578 ' HE2' HD21 ' A' ' 465' ' ' LEU . 0.2 OUTLIER -78.03 -37.34 47.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.21 69.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.11 89.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.097 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -53.91 -46.35 71.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.125 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 443' ' ' LYS . 16.1 mt -76.16 -24.84 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 97.63 49.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 54.6 m -100.0 135.77 40.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.84 0.352 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.519 ' CB ' ' CD1' ' A' ' 447' ' ' TYR . 10.1 mmtp -72.56 117.67 14.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.71 128.66 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 42.6 pt -141.42 170.99 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -114.5 178.19 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.633 ' HB3' HD22 ' A' ' 418' ' ' LEU . 0.3 OUTLIER -45.75 -35.91 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.87 -37.65 73.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -64.35 -31.58 81.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.429 HD11 HG12 ' A' ' 430' ' ' ILE . 43.5 tp -67.06 -52.95 35.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.3 -51.98 66.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.98 -38.12 67.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.5 mt -60.55 -20.55 60.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.444 HG23 ' CE2' ' A' ' 433' ' ' TYR . 70.7 mt -84.84 -14.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -109.9 -7.83 14.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 19.4 p -107.75 -42.07 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.67 ' SD ' HD23 ' A' ' 407' ' ' LEU . 9.9 mtp -64.89 143.48 98.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.508 0.671 . . . . 0.0 110.874 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -165.75 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.681 2.254 . . . . 0.0 112.327 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -139.74 164.19 26.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.498 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -123.96 153.5 41.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -99.92 99.65 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.899 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 45.4 t -82.82 136.73 34.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.839 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -61.81 -29.32 70.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 490' ' ' GLU . 2.0 p90 -113.26 144.64 42.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.928 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . 0.566 ' O ' ' CD2' ' A' ' 489' ' ' TYR . 12.3 pt-20 -78.91 164.78 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.7 mm -99.73 111.09 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -128.1 114.96 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.33 137.6 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.152 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -88.15 111.98 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 t -120.74 158.15 28.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 94.4 p -123.14 169.66 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 28.4 p -110.6 -3.75 15.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 141.95 100.65 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 m -124.42 137.87 54.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 110.893 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 82.8 p -76.39 155.92 33.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -90.23 -157.27 33.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -107.91 129.17 55.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -151.4 127.8 10.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 397' ' ' LYS . 10.9 tp -165.38 154.36 12.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.92 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.434 ' N ' ' HG ' ' A' ' 394' ' ' LEU . . . -59.4 -120.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.458 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 50.1 m -116.88 38.04 3.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.554 ' HB2' HD21 ' A' ' 394' ' ' LEU . 12.6 mmtp -105.28 173.69 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -125.42 112.99 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.64 116.6 39.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.603 0.716 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 117.88 5.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 0.0 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -71.61 101.24 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.78 -156.56 10.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -73.73 -175.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -101.86 -28.09 12.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -122.65 28.98 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.748 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 14.7 p -69.05 -14.61 63.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 433' ' ' TYR . 65.6 mt -117.94 -2.58 11.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -58.96 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.64 -26.7 20.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.585 HD11 ' CE ' ' A' ' 482' ' ' MET . 57.6 mt -86.67 134.56 33.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 412' ' ' PHE . 45.6 mt -99.56 155.68 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 56.0 m-85 -145.01 148.99 34.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.778 HG22 HG23 ' A' ' 438' ' ' THR . 51.6 t -128.97 104.91 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 28.1 mt -85.99 133.87 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.7 t -130.54 141.57 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -151.17 42.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.508 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.7 m -130.22 153.13 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' A' ' 472' ' ' GLU . 16.9 mt -123.57 161.7 24.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.89 -61.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 3.1 p -48.45 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.54 HG22 ' HB3' ' A' ' 425' ' ' GLU . 0.9 OUTLIER -122.14 122.16 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.49 178.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -55.99 -40.19 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.08 -61.43 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.54 ' HB3' HG22 ' A' ' 421' ' ' ILE . 3.8 mm-40 -43.94 -47.99 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.82 92.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.466 ' HA ' HG21 ' A' ' 437' ' ' VAL . 52.0 tttt -55.09 -52.16 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -54.75 -39.7 68.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.85 -57.94 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . . . . . . . . . 26.0 mt -49.08 -49.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -66.11 -34.86 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -58.73 -16.87 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.615 ' CE2' HD13 ' A' ' 479' ' ' ILE . 64.4 m-85 -113.11 11.38 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 97.26 -28.83 12.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -50.16 168.05 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.486 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -121.21 151.86 39.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' A' ' 427' ' ' LYS . 98.1 t -127.82 127.86 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.778 HG23 HG22 ' A' ' 413' ' ' VAL . 3.1 t -143.02 170.19 16.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -99.92 -26.81 8.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -93.1 137.73 32.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 34.7 t -95.75 109.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.101 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 m -121.06 179.08 4.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -54.66 -46.16 73.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -53.0 -26.93 16.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.435 HG22 HG21 ' A' ' 467' ' ' THR . 28.9 m -55.0 117.99 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -90.31 -39.72 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.547 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 92.1 m-85 -137.88 155.62 48.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 469' ' ' ILE . 3.1 tp -125.25 107.01 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.2 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 8.4 mmt -93.58 157.57 16.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -140.47 -117.24 1.38 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 453' ' ' ASP . 7.2 ptp180 -123.15 170.64 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.865 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 452' ' ' ARG . 2.2 t70 34.43 37.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 452' ' ' ARG . 29.0 m -95.54 150.85 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -74.92 161.06 53.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -85.24 -33.44 22.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -54.45 -46.59 73.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -46.71 -27.88 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.4 p -88.87 -47.07 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -42.42 -43.06 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -73.47 -39.5 64.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -58.16 -57.46 12.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 466' ' ' GLY . . . -59.12 -49.07 79.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -42.91 -48.66 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.36 -16.75 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 463' ' ' ALA . . . 89.01 55.27 2.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 445' ' ' THR . 18.1 m -109.43 138.49 45.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.1 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.18 127.17 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 448' ' ' LEU . 79.0 mt -99.99 124.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.429 HD12 ' CA ' ' A' ' 475' ' ' LEU . 23.2 pt -130.62 177.78 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.05 -179.25 4.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.696 ' HB3' HD13 ' A' ' 418' ' ' LEU . 1.6 pm0 -52.11 -28.62 18.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -82.15 -45.24 15.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -63.99 -28.46 72.82 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.429 ' CA ' HD12 ' A' ' 470' ' ' ILE . 61.5 tp -67.87 -40.0 83.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.959 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.03 -30.15 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -70.68 -38.93 73.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 470' ' ' ILE . 14.4 mt -59.73 -17.34 34.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.615 HD13 ' CE2' ' A' ' 433' ' ' TYR . 87.5 mt -86.92 -24.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -98.76 -9.88 23.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 38.1 p -103.54 -41.66 5.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.585 ' CE ' HD11 ' A' ' 410' ' ' LEU . 13.0 mmm -67.12 139.88 95.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.869 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -165.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -125.63 170.39 17.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -138.02 160.27 39.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -99.45 118.62 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 32.1 t -121.12 172.07 8.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -42.47 42.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -69.56 148.09 49.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . 0.407 ' OE2' ' C ' ' A' ' 490' ' ' GLU . 0.0 OUTLIER -132.35 162.86 30.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.37 127.52 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -102.69 159.09 15.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.77 122.28 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -89.4 149.01 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 57.6 m -88.65 135.85 33.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 87.1 p -118.85 -44.25 2.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.0 110.899 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 16.9 t -54.55 128.7 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -116.4 141.44 16.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.526 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.7 t -41.14 100.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 30.5 m -135.14 127.01 29.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -118.83 71.58 0.31 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.532 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 110.28 9.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 394' ' ' LEU . . . -143.89 132.78 22.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 394' ' ' LEU . 9.8 tt -37.57 98.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . -114.92 -26.28 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.485 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 12.7 p -76.9 1.61 17.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.994 0.426 . . . . 0.0 110.898 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.507 ' HB2' HD21 ' A' ' 394' ' ' LEU . 27.9 mttm -139.22 -178.89 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.903 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -135.99 124.02 22.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.36 127.11 93.12 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.563 0.697 . . . . 0.0 111.099 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 117.38 5.05 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.227 . . . . 0.0 112.379 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -79.95 84.3 5.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -100.21 -138.18 10.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -91.88 -174.86 3.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -100.36 -21.08 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -126.77 33.3 4.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 13.0 p -76.54 -10.47 59.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 410' ' ' LEU . 79.0 mt -128.37 6.8 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.9 118.5 9.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.38 -30.69 9.18 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 407' ' ' LEU . 21.0 mt -79.95 140.16 36.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 444' ' ' LYS . 75.3 mt -106.28 142.97 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 61.2 m-85 -130.42 148.1 52.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 438' ' ' THR . 84.9 t -122.47 101.87 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.143 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 430' ' ' ILE . 61.7 mt -83.89 123.27 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.402 HG23 ' OG ' ' A' ' 454' ' ' SER . 8.4 t -122.74 144.21 49.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.79 -153.15 45.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 11.5 m -130.94 160.83 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 7.5 mt -137.68 151.69 48.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -75.95 -62.66 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.49 ' HB3' HD12 ' A' ' 394' ' ' LEU . 8.9 m -40.39 -42.8 1.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 426' ' ' ALA . 4.7 pt -150.51 162.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 424' ' ' ASP . 14.8 mt-10 -102.67 155.53 18.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 422' ' ' GLU . 9.5 tpt85 -35.68 -32.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 422' ' ' GLU . 3.3 m-20 -73.8 -66.59 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -41.1 -65.19 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.565 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.09 -44.49 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.425 ' HG3' HG11 ' A' ' 437' ' ' VAL . 11.6 tttp -53.35 -52.88 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 t -51.13 -39.57 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -60.27 3.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 414' ' ' ILE . 37.4 mt -55.33 -43.71 72.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.16 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -70.81 -31.18 67.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -63.46 -31.03 72.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 479' ' ' ILE . 78.0 m-85 -96.28 4.84 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.23 -27.58 19.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -48.38 161.08 0.54 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -110.82 154.79 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.425 HG11 ' HG3' ' A' ' 427' ' ' LYS . 59.0 t -129.69 114.92 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 413' ' ' VAL . 13.8 t -130.72 170.27 14.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -112.38 51.76 0.68 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . 0.585 ' O ' HG21 ' A' ' 413' ' ' VAL . 7.6 t-20 -172.55 150.03 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 458' ' ' LYS . 57.8 t -102.6 109.24 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.164 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 444' ' ' LYS . 1.7 m -127.63 -176.13 3.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.835 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -61.14 -40.29 93.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.553 ' HG2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -64.41 -25.45 68.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 30.6 m -61.68 136.63 58.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.504 ' O ' HG23 ' A' ' 467' ' ' THR . 15.6 m120 -105.48 -49.48 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 478' ' ' LEU . 72.5 m-85 -129.62 154.96 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.631 HD23 HG12 ' A' ' 469' ' ' ILE . 11.3 tp -122.78 102.81 8.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.5 t -77.5 104.65 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.6 mtp -77.01 178.6 6.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 175.9 44.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 453' ' ' ASP . 1.0 OUTLIER -53.32 146.81 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 452' ' ' ARG . 1.6 t70 43.57 54.28 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 415' ' ' THR . 2.7 m -106.71 127.99 53.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -52.33 150.14 9.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.81 -39.76 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -44.31 -39.63 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' A' ' 441' ' ' VAL . 2.3 tppt? -50.7 -41.88 56.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 19.2 p -73.55 -29.13 62.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -54.91 -56.97 13.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -63.12 -47.51 82.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -42.97 -56.15 3.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.22 80.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.32 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 13.2 mt -69.47 -30.91 68.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 101.92 42.57 2.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.511 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 446' ' ' ASN . 94.9 m -97.5 140.37 32.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -81.63 109.64 16.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.631 HG12 HD23 ' A' ' 448' ' ' LEU . 72.5 mt -82.97 129.69 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.131 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 475' ' ' LEU . 46.6 pt -140.33 173.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 472' ' ' GLU . 3.0 p30 -120.81 172.5 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.0 pm0 -35.15 -43.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 472' ' ' GLU . 32.7 t0 -66.23 -52.79 44.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -50.8 -42.03 45.16 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 470' ' ' ILE . 53.7 tp -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.8 -51.9 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.0 -36.52 65.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.636 HD11 ' CE2' ' A' ' 447' ' ' TYR . 12.4 mt -65.1 -25.77 67.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.2 mt -79.58 -27.27 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -91.31 -28.48 17.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -83.26 -47.89 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.415 ' CE ' HD11 ' A' ' 410' ' ' LEU . 15.4 mmm -57.77 141.86 79.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.892 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -168.87 0.29 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -132.73 169.67 22.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -134.61 113.15 11.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -57.33 127.56 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 50.9 p -129.32 145.52 51.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -67.87 -44.31 77.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -101.95 -176.29 3.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -115.24 178.12 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.58 115.38 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.65 13.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 13.8 p -46.61 136.57 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -133.38 126.91 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 26.7 m -89.91 111.67 22.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.148 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 57.9 m -91.67 165.81 13.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.367 . . . . 0.0 110.868 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 63.5 p -154.27 141.97 19.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -128.76 -136.74 4.21 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 93.2 p -134.88 125.14 26.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.847 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 15.5 t -76.75 132.41 39.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 137.54 106.12 0.75 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -91.16 -55.12 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.8 132.38 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 395' ' ' GLY . 7.2 tt -58.23 113.39 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . 37.17 -135.6 0.77 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.4 t -96.71 34.04 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.877 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -120.15 -179.75 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -127.9 119.58 25.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 5.1 mm -81.32 121.24 80.02 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.623 0.725 . . . . 0.0 111.15 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 116.42 4.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 0.0 112.39 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -75.94 83.13 2.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -96.92 -142.44 13.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.958 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.16 -174.96 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 405' ' ' ASN . 5.1 pt-20 -103.22 -33.03 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.492 ' CB ' ' HG3' ' A' ' 485' ' ' LYS . 51.2 m-80 -122.47 26.28 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.958 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 17.2 p -63.03 -16.24 59.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 33.5 mt -116.11 7.38 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -70.95 128.48 36.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.79 21.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.556 HD11 ' CE ' ' A' ' 482' ' ' MET . 7.5 mt -87.74 145.64 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.744 HD12 ' HB2' ' A' ' 444' ' ' LYS . 68.4 mt -110.84 147.39 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -132.77 138.99 47.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 438' ' ' THR . 77.6 t -117.73 101.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 62.5 mt -81.06 119.63 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 415' ' ' THR . 9.1 t -121.36 116.02 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 102.48 -153.12 18.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.456 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.03 158.17 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 472' ' ' GLU . 0.9 OUTLIER -135.23 148.62 49.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.7 -58.12 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 70.5 m -44.71 -41.92 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 426' ' ' ALA . 3.0 pt -152.17 161.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -101.58 168.35 9.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -45.68 -35.56 4.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 427' ' ' LYS . 14.1 t70 -77.48 -63.88 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -38.76 -48.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -66.05 -37.67 86.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.612 ' HA ' HG21 ' A' ' 437' ' ' VAL . 50.7 tttt -58.88 -45.21 90.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -23.04 64.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 20.4 tp -81.47 -64.23 1.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.405 HG13 HD21 ' A' ' 475' ' ' LEU . 27.6 mt -48.12 -36.53 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -76.68 -29.81 56.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.65 -14.55 61.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . 0.508 ' CE2' HD13 ' A' ' 479' ' ' ILE . 81.4 m-85 -114.01 6.91 16.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 102.19 -26.87 22.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -54.57 165.89 2.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -122.07 159.93 26.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.612 HG21 ' HA ' ' A' ' 427' ' ' LYS . 94.5 t -133.62 117.87 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.552 HG23 HG22 ' A' ' 413' ' ' VAL . 13.3 t -132.24 164.41 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -108.93 49.3 0.86 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -169.59 134.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.887 0.375 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.483 HG23 ' HD2' ' A' ' 458' ' ' LYS . 81.2 t -79.9 121.01 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 29.8 t -127.69 179.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -71.39 -25.92 62.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.744 ' HB2' HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -79.59 -15.25 57.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 41.0 m -61.82 119.25 8.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.442 ' C ' HG23 ' A' ' 467' ' ' THR . 7.7 m-80 -93.83 -40.91 9.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 468' ' ' LYS . 80.6 m-85 -133.18 153.98 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 413' ' ' VAL . 11.6 tp -125.47 108.38 11.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.38 102.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.3 ptp -103.59 170.99 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -171.54 -103.43 0.17 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 453' ' ' ASP . 15.9 mmt180 -91.09 159.53 16.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.9 t70 34.4 38.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.3 t -82.78 105.64 13.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -56.01 173.76 1.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -113.22 -3.49 13.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.0 t -75.29 -32.62 61.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.483 ' HD2' HG23 ' A' ' 441' ' ' VAL . 31.2 mtmt -81.87 -57.89 3.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.0 p -46.0 -58.58 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -38.45 -43.73 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -69.07 -49.54 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.577 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -40.87 -58.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.44 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -59.29 -24.34 63.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 17.8 mt -98.76 17.79 18.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 58.77 41.95 96.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.472 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.577 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 60.6 m -103.48 126.49 50.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 447' ' ' TYR . 0.2 OUTLIER -72.39 111.44 7.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 16.8 mt -81.97 122.5 36.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 478' ' ' LEU . 28.0 pt -137.96 172.41 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -119.89 175.42 5.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 418' ' ' LEU . 16.4 pt-20 -38.62 -46.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -67.77 -49.56 61.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.91 -30.22 9.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 430' ' ' ILE . 50.9 tp -71.64 -62.22 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 29.9 mt -43.09 -41.93 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -67.23 -36.69 82.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 470' ' ' ILE . 11.0 mt -63.89 -23.07 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.508 HD13 ' CE2' ' A' ' 433' ' ' TYR . 60.4 mt -81.09 -15.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.129 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -105.36 -8.8 17.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 -38.79 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.556 ' CE ' HD11 ' A' ' 410' ' ' LEU . 2.5 mtp -62.93 142.26 97.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.547 0.689 . . . . 0.0 110.853 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.1 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -123.94 155.23 17.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.527 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.492 ' HG3' ' CB ' ' A' ' 405' ' ' ASN . 4.5 ptpp? -140.46 146.77 38.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -70.01 139.01 52.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 1.9 t -66.77 158.94 29.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -76.09 -37.12 58.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.91 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -81.23 162.51 23.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.15 166.83 16.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 5.0 mp -93.59 127.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -92.41 135.43 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.084 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.1 140.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 117.8 4.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 65.5 p -109.93 102.69 11.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.3 m -39.87 148.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.361 . . . . 0.0 110.903 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 24.1 p -76.35 156.26 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 151.72 -120.19 1.06 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.519 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.2 m -119.36 159.77 23.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 60.4 m -60.21 -45.22 93.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -140.5 176.43 21.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 393' ' ' ALA . 11.1 ptpt -122.92 112.47 17.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 392' ' ' LYS . . . 67.28 54.13 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.094 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 395' ' ' GLY . 0.1 OUTLIER -85.46 -15.4 43.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . 33.96 43.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 3.5 p -122.11 2.57 9.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.837 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -158.38 146.28 18.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -122.65 123.54 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.82 121.49 84.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.594 0.711 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.589 ' CD ' HD22 ' A' ' 476' ' ' LEU . 53.6 Cg_endo -69.77 126.45 13.31 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 0.0 112.348 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -89.33 94.75 10.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -116.76 -135.73 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -93.28 -175.0 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -100.72 -19.56 15.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -128.24 30.82 5.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 27.5 p -71.69 -11.21 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 88.4 mt -130.87 13.49 5.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -74.84 122.65 23.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.89 -35.24 5.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.478 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.8 157.78 29.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.769 0.319 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 412' ' ' PHE . 77.5 mt -115.1 154.17 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 447' ' ' TYR . 38.6 m-85 -142.16 153.2 43.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.769 HG22 HG23 ' A' ' 438' ' ' THR . 98.5 t -133.06 102.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 426' ' ' ALA . 33.1 mt -83.68 122.74 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 1.8 t -125.74 132.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.16 -153.71 23.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.37 152.73 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.354 . . . . 0.0 111.139 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 472' ' ' GLU . 1.2 mt -132.12 164.03 27.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -85.39 -66.81 0.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.5 p -41.92 -27.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 420' ' ' SER . 0.9 OUTLIER -161.88 165.36 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.91 164.45 13.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -39.29 -36.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 424' ' ' ASP . 37.5 t0 -73.85 -66.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 424' ' ' ASP . 18.0 mm-40 -36.88 -53.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.584 ' HB3' HD13 ' A' ' 414' ' ' ILE . . . -56.53 -41.81 77.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 437' ' ' VAL . 38.3 tttt -58.4 -46.14 86.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -40.83 97.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 17.1 tp -63.47 -62.27 1.79 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 414' ' ' ILE . 54.8 mt -44.42 -43.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -75.35 -35.78 61.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -54.33 -21.83 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -108.33 -3.78 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 115.59 -40.3 2.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.22 162.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.52 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -117.09 157.82 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 427' ' ' LYS . 87.9 t -125.7 125.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.157 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.769 HG23 HG22 ' A' ' 413' ' ' VAL . 3.5 t -137.64 139.93 40.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -86.33 46.81 3.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -157.86 126.65 5.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 458' ' ' LYS . 48.3 t -80.6 100.83 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.179 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 51.9 m -121.29 164.73 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -50.94 -52.96 37.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 444' ' ' LYS . 0.0 OUTLIER -43.54 -32.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.9 m -48.94 130.69 18.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -99.15 -30.19 12.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.61 ' CD2' HD11 ' A' ' 478' ' ' LEU . 65.9 m-85 -148.68 145.66 27.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.532 HD23 HG12 ' A' ' 469' ' ' ILE . 15.6 tp -115.81 98.88 6.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.21 106.05 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.5 139.03 45.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 418' ' ' LEU . . . -122.24 -114.02 2.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -92.5 167.78 11.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.905 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 27.0 t70 38.02 45.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 70.4 m -101.55 173.26 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.808 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -99.18 147.48 18.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 457' ' ' SER . 49.0 tp60 -82.92 -47.41 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.893 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 456' ' ' GLN . 11.3 t -36.24 -46.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.496 ' HB3' HG21 ' A' ' 441' ' ' VAL . 24.0 mttm -55.37 -65.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.3 t -50.51 -44.78 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -46.81 -58.1 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -66.91 -43.39 83.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -45.38 -50.74 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.076 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.98 88.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.083 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.27 70.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 22.3 mt -93.76 22.97 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 51.61 52.65 32.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.525 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 20.5 m -109.68 126.27 53.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.136 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 106.42 4.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.532 HG12 HD23 ' A' ' 448' ' ' LEU . 62.6 mt -84.52 125.08 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 475' ' ' LEU . 14.7 pt -138.36 174.57 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -116.4 177.35 4.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.645 ' HB3' HD13 ' A' ' 418' ' ' LEU . 4.9 pt-20 -39.06 -46.28 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -61.91 -55.86 25.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -48.3 -38.27 19.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.539 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 470' ' ' ILE . 40.9 tp -58.56 -51.69 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.87 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.589 HD22 ' CD ' ' A' ' 400' ' ' PRO . 39.5 mt -57.04 -50.45 72.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.923 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.17 -33.55 65.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' ' 447' ' ' TYR . 12.5 mt -66.78 -15.92 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.06 -25.4 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -93.56 -28.16 16.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 27.2 p -84.09 -41.5 17.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . . . . . . . . . 23.2 mmm -65.79 140.6 97.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.0 Cg_endo -69.83 -164.34 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.645 2.23 . . . . 0.0 112.315 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -133.58 174.2 20.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -139.5 129.5 25.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -74.95 117.25 16.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . 0.627 ' CB ' HD11 ' A' ' 491' ' ' ILE . 8.6 t -43.17 134.76 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -47.55 35.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -101.75 155.75 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -59.49 142.35 52.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.627 HD11 ' CB ' ' A' ' 487' ' ' SER . 20.4 mm -98.53 142.17 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -100.86 97.37 7.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 491' ' ' ILE . 57.8 t -137.78 129.32 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 40.66 45.12 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 25.9 p -102.12 131.83 48.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 25.2 t -108.43 111.93 24.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.841 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 19.0 m -103.08 84.4 2.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -168.64 -167.07 28.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.2 p -135.64 141.04 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 3.6 m -81.48 88.79 6.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . -158.08 63.96 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -144.11 139.54 28.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -118.68 158.09 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 1.1 pp -129.03 8.74 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 154.98 33.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.9 m 57.65 38.11 27.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.81 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -103.88 174.66 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.57 102.6 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 17.0 mm -79.17 120.21 79.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.614 0.721 . . . . 0.0 111.121 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 122.96 9.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.709 2.272 . . . . 0.0 112.364 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -73.7 119.64 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -138.83 -156.72 7.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.45 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -79.29 -175.01 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.763 0.316 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -101.36 -20.54 15.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -126.91 29.52 5.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 32.0 p -68.98 -18.63 64.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.04 16.14 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -78.89 121.48 24.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.7 -24.51 21.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.478 HD11 ' CE ' ' A' ' 482' ' ' MET . 25.7 mt -89.85 150.09 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 110.963 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 68.5 mt -112.5 144.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 57.0 m-85 -132.07 152.2 51.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.83 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 438' ' ' THR . 96.3 t -131.33 110.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.26 121.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 415' ' ' THR . 4.0 t -124.69 115.06 20.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 108.07 -153.8 16.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.428 ' CG2' ' HE ' ' A' ' 452' ' ' ARG . 2.4 m -131.31 150.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.64 145.14 51.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -72.44 -44.03 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 421' ' ' ILE . 11.0 m -55.04 -42.13 72.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.854 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 426' ' ' ALA . 1.5 pt -156.33 161.01 2.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.91 169.76 10.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -52.12 -30.34 25.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.44 -55.95 4.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -47.37 -54.64 10.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.476 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . 0.43 ' HA ' HG21 ' A' ' 437' ' ' VAL . 33.8 tttm -53.46 -53.53 50.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 2.2 m -51.94 -40.58 61.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 16.7 tp -64.22 -53.61 46.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.503 HG12 HD11 ' A' ' 475' ' ' LEU . 59.3 mt -54.37 -38.98 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.13 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -77.86 -30.41 50.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -58.04 -24.28 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -110.34 4.79 21.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 106.83 -33.13 6.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.496 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -43.74 146.71 1.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.481 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -104.24 159.54 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 427' ' ' LYS . 91.8 t -133.26 116.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.61 ' O ' HG13 ' A' ' 413' ' ' VAL . 5.1 t -132.21 148.36 52.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.11 53.5 1.37 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 114.08 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.879 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.94 99.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 2.7 m -119.59 -175.16 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -63.34 -54.87 30.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' A' ' 445' ' ' THR . 0.0 OUTLIER -47.19 -28.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 444' ' ' LYS . 49.4 m -58.37 126.0 25.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -95.53 -42.93 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 46.1 m-85 -132.12 149.48 52.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 469' ' ' ILE . 9.2 tp -120.05 106.95 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.14 102.76 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.636 ' HG3' HG23 ' A' ' 469' ' ' ILE . 6.1 mtt -82.79 161.92 21.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -154.61 -169.64 19.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.428 ' HE ' ' CG2' ' A' ' 417' ' ' VAL . 3.8 ttp180 -68.03 147.05 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.901 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.9 t70 43.24 52.18 5.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.6 p -81.86 176.38 9.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.77 141.44 15.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -74.78 -33.3 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 55.8 m -58.71 -41.64 86.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -55.06 -61.15 2.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 460' ' ' ASP . 28.6 p -51.83 -44.75 63.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 459' ' ' SER . 8.1 t70 -35.59 -67.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.462 ' HB3' HD12 ' A' ' 465' ' ' LEU . 7.2 mptt -57.87 -56.39 22.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 461' ' ' LYS . . . -34.28 -48.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.99 84.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.081 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 461' ' ' LYS . . . -68.68 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.079 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 461' ' ' LYS . 28.2 mt -54.79 -32.07 59.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 86.97 62.98 1.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 6.7 m -107.06 139.24 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.167 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 447' ' ' TYR . 19.5 mmtt -69.14 105.4 2.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.671 HG12 HD23 ' A' ' 448' ' ' LEU . 88.5 mt -85.62 131.11 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.54 177.38 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -126.05 177.34 6.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -38.87 -48.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -63.07 -49.52 74.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -56.67 -26.22 52.79 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 430' ' ' ILE . 64.0 tp -73.39 -48.08 36.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 479' ' ' ILE . 73.9 mt -62.58 -44.08 97.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 481' ' ' THR . 8.1 t-20 -61.63 -28.77 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 478' ' ' LEU . 11.4 mt -70.67 -15.8 62.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.963 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 476' ' ' LEU . 31.0 mt -87.24 -17.31 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -102.75 -29.26 11.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.835 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 477' ' ' ASN . 58.3 p -83.31 -45.5 13.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.115 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.478 ' CE ' HD11 ' A' ' 410' ' ' LEU . 19.3 mmm -60.34 142.0 90.74 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.1 Cg_endo -69.83 -166.69 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.316 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -133.89 165.01 24.38 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -135.44 120.49 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -73.04 86.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 16.5 m -104.6 136.16 44.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -75.55 -42.72 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -60.61 108.63 0.86 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.11 168.82 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 18.2 mm -112.84 70.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . 49.45 50.06 18.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 493' ' ' VAL . 7.6 p -46.25 122.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . 0.451 ' O ' ' CD ' ' A' ' 494' ' ' GLU . 2.5 pp20? -103.66 135.48 45.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 21.6 p -119.84 98.22 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.895 -179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 53.5 p -72.13 142.72 49.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 94.6 p -129.99 104.75 7.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 175.66 -162.67 32.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 87.5 p -62.25 140.78 58.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.824 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 1.1 t -109.79 120.68 43.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 97.99 161.59 30.79 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.469 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -81.82 113.01 19.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.306 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -84.91 169.49 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.967 HD23 ' O ' ' A' ' 394' ' ' LEU . 7.5 tt -79.86 -12.59 59.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 103.7 -65.97 0.34 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.8 p -85.47 2.14 45.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.404 ' HB2' ' NZ ' ' A' ' 397' ' ' LYS . 0.0 OUTLIER -164.12 179.13 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -136.53 141.88 43.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 34.4 mm -86.96 122.3 71.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.14 5.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.353 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -71.97 102.62 2.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . -125.78 -161.17 10.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.435 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.451 ' CB ' ' HA3' ' A' ' 484' ' ' GLY . . . -73.08 -175.06 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.731 0.301 . . . . 0.0 111.111 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -101.33 -20.84 15.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -126.04 36.73 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . . . . . . . . . 29.1 p -78.67 -6.46 55.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 412' ' ' PHE . 96.7 mt -132.96 5.55 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -69.35 116.76 10.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 108.31 -16.94 34.79 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.584 HD11 ' CE ' ' A' ' 482' ' ' MET . 48.8 mt -99.47 138.6 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 28.5 mt -101.96 151.22 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.429 ' CZ ' HD22 ' A' ' 407' ' ' LEU . 43.4 m-85 -136.72 143.69 43.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 438' ' ' THR . 60.8 t -121.08 109.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.123 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.605 HG21 ' NE ' ' A' ' 423' ' ' ARG . 50.4 mt -90.5 120.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 415' ' ' THR . 6.5 t -118.74 113.03 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.443 ' O ' ' NH1' ' A' ' 423' ' ' ARG . . . 99.21 175.17 31.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 417' ' ' VAL . 1.8 m -94.47 122.37 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.461 HD12 HH21 ' A' ' 423' ' ' ARG . 4.6 mt -90.26 100.45 13.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -40.88 -25.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 418' ' ' LEU . 4.3 p -71.97 -62.71 1.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 425' ' ' GLU . 0.4 OUTLIER -140.52 132.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -65.57 -175.55 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.605 ' NE ' HG21 ' A' ' 414' ' ' ILE . 8.2 mmp_? -58.71 -58.29 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -29.48 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 421' ' ' ILE . 9.3 mt-10 -71.04 -64.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.91 96.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -54.02 -62.51 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.8 m -41.85 -27.35 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 19.2 tp -80.33 -51.45 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 475' ' ' LEU . 45.2 mt -61.03 -35.87 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.12 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.26 -29.66 38.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -60.56 -21.25 62.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.837 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -111.11 2.51 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 107.43 -27.52 15.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.476 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.436 ' C ' HG22 ' A' ' 430' ' ' ILE . . . -48.63 157.15 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.466 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -114.57 157.56 22.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.5 t -131.73 123.45 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.851 HG23 HG22 ' A' ' 413' ' ' VAL . 0.0 OUTLIER -134.59 155.72 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -101.29 37.03 3.8 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -160.16 125.14 3.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.43 HG23 ' HD2' ' A' ' 458' ' ' LYS . 96.0 t -67.28 118.42 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 75.4 m -123.24 157.94 31.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.872 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -61.48 -14.34 28.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -86.59 -22.74 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 26.3 m -51.86 133.57 31.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.133 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.513 ' OD1' HD22 ' A' ' 410' ' ' LEU . 5.4 m-80 -97.22 -25.2 15.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 446' ' ' ASN . 69.8 m-85 -157.57 131.11 7.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.934 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.708 HD23 HG12 ' A' ' 469' ' ' ILE . 18.1 tp -98.13 116.23 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -86.35 94.52 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.506 ' CE ' HD21 ' A' ' 448' ' ' LEU . 6.4 mmt -86.39 166.47 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -159.59 -107.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 453' ' ' ASP . 0.0 OUTLIER -126.92 168.49 14.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 452' ' ' ARG . 1.8 m-20 37.72 46.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.6 m -99.98 175.99 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -93.32 -177.51 40.27 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.435 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -115.18 -19.61 10.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.4 p -77.63 -19.16 55.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 441' ' ' VAL . 36.9 mmtm -72.49 -39.45 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 42.7 p -73.96 -52.18 13.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.883 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -44.38 -44.46 8.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -47.06 50.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 467' ' ' THR . . . -53.02 -53.65 47.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.079 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.0 72.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -54.84 -58.7 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.068 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.872 HD13 ' HA ' ' A' ' 443' ' ' LYS . 12.3 mt -61.35 -23.7 65.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 93.64 53.81 1.76 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' A' ' 462' ' ' ALA . 3.5 m -107.98 134.59 50.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 111.14 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -74.91 116.67 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.708 HG12 HD23 ' A' ' 448' ' ' LEU . 88.3 mt -87.3 123.55 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 475' ' ' LEU . 50.2 pt -140.1 168.98 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 471' ' ' ASP . 0.6 OUTLIER -115.26 173.92 6.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 471' ' ' ASP . 3.4 pt-20 -34.12 -45.13 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -60.34 3.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.41 8.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 430' ' ' ILE . 23.2 tp -44.4 -45.64 9.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 74.9 mt -63.73 -46.79 83.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.477 ' ND2' HG23 ' A' ' 481' ' ' THR . 8.1 t-20 -62.12 -31.29 71.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 478' ' ' LEU . 10.9 mt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 20.1 mt -82.96 -17.6 10.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -105.9 -16.91 14.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.842 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.477 HG23 ' ND2' ' A' ' 477' ' ' ASN . 61.1 p -97.04 -33.72 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.584 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.7 mmm -72.18 142.51 84.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.874 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -165.48 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.334 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 403' ' ' ALA . . . -137.17 169.36 24.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -136.52 129.24 30.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.2 106.58 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 75.0 p -68.12 145.27 54.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -14.3 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -119.51 147.06 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -99.38 153.04 19.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 71.3 mt -102.86 132.83 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.171 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . -78.4 118.58 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 p -52.7 131.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -157.31 138.35 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 19.2 p -71.02 159.92 33.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.6 m -124.82 121.77 35.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.795 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 53.0 m -98.42 130.47 45.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . -118.09 83.85 0.36 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 16.8 t -79.14 115.44 18.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 68.1 m -115.06 116.86 29.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' GLY . . . . . . . . . . . . . . . 173.03 -45.92 0.16 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm 44.64 47.19 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -151.39 140.91 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 397' ' ' LYS . 1.1 pt? -125.09 -172.51 2.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 394' ' ' LEU . . . -25.62 -90.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -120.48 33.08 5.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' LYS . . . . . 0.618 ' HB2' HD11 ' A' ' 394' ' ' LEU . 2.1 mmmm -137.04 152.54 50.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -119.22 119.11 33.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.458 HD13 HD11 ' A' ' 476' ' ' LEU . 12.7 mm -87.36 121.86 71.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.665 0.745 . . . . 0.0 111.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 128.75 16.51 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.738 2.292 . . . . 0.0 112.32 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 402' ' ' GLY . 0.0 OUTLIER -65.22 103.54 0.79 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . 0.494 ' N ' ' HE3' ' A' ' 401' ' ' LYS . . . -124.3 -161.48 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.486 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 406' ' ' CYS . . . -74.3 -175.0 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.723 0.297 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -101.81 -23.79 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -125.08 30.84 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 403' ' ' ALA . 19.8 p -69.49 -13.08 62.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.17 7.18 7.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -63.55 137.29 58.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 87.73 -29.91 5.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' A' ' 482' ' ' MET . 76.7 mt -79.23 148.63 32.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 90.7 mt -119.91 145.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 447' ' ' TYR . 67.1 m-85 -132.21 153.62 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.993 HG22 HG23 ' A' ' 438' ' ' THR . 99.5 t -128.56 103.2 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.521 HG22 ' NH1' ' A' ' 423' ' ' ARG . 21.6 mt -85.18 124.4 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -122.73 139.81 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 85.63 -157.04 30.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 417' ' ' VAL . 4.7 m -135.32 123.9 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.916 0.389 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.18 149.42 23.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -55.06 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 66.4 m -45.13 -53.83 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 426' ' ' ALA . 2.1 pt -142.15 128.44 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.98 165.04 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.521 ' NH1' HG22 ' A' ' 414' ' ' ILE . 0.1 OUTLIER -41.96 -43.62 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 425' ' ' GLU . 1.1 m-20 -64.25 -66.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 424' ' ' ASP . 37.9 mm-40 -36.75 -71.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 421' ' ' ILE . . . -41.21 -56.03 2.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' LYS . . . . . . . . . . . . . 62.6 tttt -39.84 -62.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -33.78 1.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 432' ' ' ARG . 15.5 tp -71.8 -66.23 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 414' ' ' ILE . 30.8 mt -45.81 -33.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -85.66 -25.06 26.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 429' ' ' LEU . 14.9 ttm180 -65.08 -16.9 63.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.92 6.9 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . 105.87 -37.71 3.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.505 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -42.3 149.01 0.44 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -105.1 165.91 10.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.63 132.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.993 HG23 HG22 ' A' ' 413' ' ' VAL . 0.3 OUTLIER -143.18 129.95 20.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.52 76.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -104.77 139.69 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.514 ' HA ' HG21 ' A' ' 413' ' ' VAL . 90.9 t -76.01 127.37 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.9 p -123.24 170.3 10.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.597 ' HA ' HD13 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -62.02 -32.93 73.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.922 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -70.5 -19.15 62.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 53.0 m -51.02 133.73 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 447' ' ' TYR . 7.8 m120 -106.69 -22.81 12.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 412' ' ' PHE . 58.2 m-85 -156.06 154.95 31.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 448' ' ' LEU . 1.8 tp -121.3 106.49 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.2 97.5 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.527 ' HG3' HG23 ' A' ' 469' ' ' ILE . 9.4 mtt -78.61 170.5 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -158.54 -107.51 0.24 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 453' ' ' ASP . 9.9 ptp180 -131.11 172.75 11.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 452' ' ' ARG . 5.2 m-20 34.53 38.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 13.6 t -83.08 -175.04 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . -127.27 141.98 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -13.15 62.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.32 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 14.8 t -73.46 -44.63 57.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -55.71 -48.25 75.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.483 ' HB3' ' CE ' ' A' ' 450' ' ' MET . 46.2 p -68.88 -33.76 74.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.52 -42.63 92.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LYS . . . . . 0.513 ' HE2' HD11 ' A' ' 465' ' ' LEU . 1.8 tmtp? -77.23 -34.07 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ALA . . . . . . . . . . . . . . . -63.37 -54.91 29.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . . . . . . . . . . . -56.1 -36.34 68.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ALA . . . . . . . . . . . . . . . -58.37 -49.55 76.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.597 HD13 ' HA ' ' A' ' 443' ' ' LYS . 37.3 mt -71.44 -25.72 62.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . 102.48 51.39 1.05 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.484 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' THR . . . . . . . . . . . . . 41.2 m -113.86 141.8 46.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.336 . . . . 0.0 111.159 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -85.56 139.95 31.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.527 HG23 ' HG3' ' A' ' 450' ' ' MET . 2.8 mp -102.22 122.01 53.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ILE . . . . . . . . . . . . . 41.7 pt -125.8 179.49 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 474' ' ' GLY . 2.1 p-10 -124.79 166.76 15.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -38.96 -30.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.8 -42.96 48.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 471' ' ' ASP . . . -59.65 -35.11 84.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.494 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.22 -51.91 67.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 399' ' ' ILE . 0.5 OUTLIER -50.89 -49.26 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 481' ' ' THR . 50.0 t30 -57.58 -44.41 85.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 13.0 mt -54.26 -17.72 3.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 97.5 mt -87.21 -28.23 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -98.32 -13.34 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 477' ' ' ASN . 43.3 p -97.11 -43.14 7.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.176 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' MET . . . . . 0.618 ' CE ' HD11 ' A' ' 410' ' ' LEU . 30.2 mmm -66.64 142.6 97.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.721 . . . . 0.0 110.842 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 406' ' ' CYS . 53.9 Cg_endo -69.75 -164.49 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.636 2.224 . . . . 0.0 112.386 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -126.07 157.75 20.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -135.45 115.38 13.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 486' ' ' LYS . 0.1 OUTLIER -72.4 136.58 46.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 42.2 t -134.6 153.7 51.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -121.34 -28.39 4.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -78.68 10.61 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.79 140.3 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.507 ' O ' HG22 ' A' ' 491' ' ' ILE . 61.0 mt -116.48 74.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ALA . . . . . . . . . . . . . . . 38.71 52.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 493' ' ' VAL . 7.9 p -58.02 112.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.72 154.27 38.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 76.9 p -143.01 130.63 21.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.977 . . . . . . . . 0 0 . 1 stop_ save_